Professional Documents
Culture Documents
102 2
BUREAU OF HEALTH PROMOTION
DEPARTMENT OF HEALTH
THE EXECUTIVE YUAN
TAIWAN
FEBRUARY 2013
.......................................................................................... x
99 ........................................................................ xii
................................................................................................................. xiii
.....................................................................................xv
.................................................................................... xvi
........................................................................................ xxi
99 ......................................................................... 1
................................................................................................................... 2
10 ............................................................... 3
( ICD-O-3 C00 - C14 C07 - C08 C11 ) ....... 6
( ICD-O-3 C00 - C06 ) .............................................................................. 8
( ICD-O-3 C00 C44.0 ) ................................................ 10
( ICD-O-3 C01 - C02 ) ......................................................................... 11
( ICD-O-3 C03 ) ............................................................................. 12
( ICD-O-3 C04 ) ............................................................................. 13
( ICD-O-3 C05 - C06 ) .............................. 14
( ICD-O-3 C09 - C10 ) ............................................................................ 15
( ICD-O-3 C12 - C13 ) ............................................................................ 16
( ICD-O-3 C14 ) ...................................... 17
Head and Neck Surgery and Oncology, 3rd ............................... 18
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 19
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 20
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 21
( ICD-O-3 C07 - C08 ) ............................................................................ 22
( ICD-O-3 C11 ) ........................................................................................... 24
( ICD-O-3 C15 - C26C48 )
( ICD-O-3 C15 ) .................................................................................... 26
( ICD-O-3 C16 ) ........................................................................................ 28
( ICD-O-3 C17 ) .................................................................................... 30
-i-
- ii -
- iii -
99 ........................................................... 139
...................... 140
10 ....................................................... 164
...................... 184
......................... 248
.................. 256
......................... 260
.................. 268
10 ....................... 272
...................... 276
......................... 398
.................. 406
......................... 410
72 99 .............................................................................. 478
() ................................. 494
99 ....................................................... 495
- iv -
99 15 ........................................... 499
................................................................................................................ 501
....................................................................................... 506
99 ...................................... 513
..................................................... 517
................................. 517
..................................................... 517
...................................... 518
1
0~39 ....................... 518
................................. 521
..................................................... 521
...................................... 522
0~39 1 ....................... 522
40~59 ....................... 523
1
60 ................... 523
..................................................... 525
................................. 525
..................................................... 525
...................................... 526
0~39 1 ....................... 526
40~59 ....................... 527
60 1 ................... 527
.............................................. 529
.......................... 529
.............................................. 529
................................................................................................ 530
0~49 .................. 531
-v-
................................. 533
...................................... 534
0~49 ......................... 534
50~69 ....................... 535
70 ...................... 535
..................................................... 537
................................. 537
..................................................... 537
................. 538
0~49 ......................... 539
50~69 1 ..................... 539
70 ...................... 540
........................................................ 541
..................................... 541
........................................................ 541
..................... 542
0~49 ............................. 543
50~69 1 ........................ 543
70 ......................... 544
..................................................... 545
................................. 545
..................................................... 545
...................................... 546
0~49 1 ....................... 546
50~69 ....................... 547
70 1 ................... 547
MAC .......................................... 548
..................................................... 549
- vi -
................................. 549
..................................................... 549
...................................... 550
1
0~49 ....................... 550
........................................................ 553
..................................... 553
........................................................ 553
(C220)
................................................................................................... 554
(C220)0~49 .................. 556
(C220)50~64 1 2 ............ 556
(C220)65 ........ 558
(C221) 2
................................................................................................... 558
(C221)0~49 .................. 560
(C221)50~64 ................ 561
(C221)65 1 2
................................................................................................ 561
BCLC(C220) ................. 562
..................................................... 565
................................. 565
..................................................... 565
() .................. 566
() 0~49 1 .. 566
() 50~69 ... 567
() 70
................................................................................................ 567
()
- vii -
................................................................................................ 568
..................................................... 569
................................. 569
..................................................... 569
...................................... 570
0~34 1 ....................... 570
35~49 ....................... 572
50~69 1 ..................... 572
70 ...................... 574
.............................................. 577
FIGO ............................................ 577
............ 578
.............................................. 578
FIGO ............................ 579
0~29 FIGO ............................. 580
30~49 FIGO ............ 581
50~69 FIGO ............ 582
70 FIGO ........... 583
............................... 584
0~29 1 .......................... 584
30~49 ............ 585
50~69 1 .......... 585
70 ........... 586
.............................................. 587
.......................... 587
.............................................. 587
............................... 588
0~39 1 ............... 588
40~59 ................ 589
60 1 ............ 589
FIGO ............................ 590
- viii -
................................................. 591
............................. 591
................................................. 591
................................... 592
0~39 1 ................... 592
40~59 ................... 593
60 1 ................ 593
FIGO ............................... 594
.............................................. 595
.......................... 595
.............................................. 595
.......... 596
0~59 .................. 598
60~74 1 ............. 598
................................................. 603
............................. 603
................................................. 603
............. 604
0~49 ..................... 606
50~69 1 ................. 606
70 .................. 608
.......................................... 611
Ann Arbor ................................... 611
Ann Arbor ................. 612
0~39 Ann Arbor
............................................................................................... 613
40~59 Ann Arbor
................................................................................................ 614
60 Ann Arbor
................................................................................................ 615
- ix -
-x-
- xi -
99
- xii -
71 10 3
92 5
68 50
2
1
101 5 206 50 99
68 1 1
International Classification of Diseases for Oncology
ICD-O 5 2 3
68 90
ICD-O, Field Trial EditionICD-O-FT 91 1 1
ICD-O, Third EditionICD-O-3
- xiii -
()
99
100
()
99 8
36912
12
95
96 1 1
95 33 50
93
97 98
()
- xiv -
()
1.
2.
- xv -
1.
2.
a.
b.
c.
d.
3.
4.
1.
2.
- xvi -
()
15
101 5 99
120,389 8,628
90,649
50,892 39,757
ICD-O-3 99
29,740
99
129,017
120,389
16,568
112,449
16,131
104,258
787
111,662
787
103,471
12,825
98,837
11,855
91,616
689
98,148
658
90.958
312
97,836
309
90,649
LymphomaLeukemia
Kaposi Sarcoma
99
%
97,836
90,649
31,181
29,740
24.17%
24.70%
99
10 391.37
437.40 344.91
- xvii -
1.
2.
3.
4.
5.
98
99
12,663
9,041
4,083
1,515
2,064
14,040
9,655
4,392
1,737
2,238
1,377
614
309
222
174
*
10.87%
6.79%
7.57%
14.65%
8.43%
*= - 100%
88
91
93
94
IARC
Percentage of Death Certificate Only Cases,
DCO%Percentage of
Morphologically Verified Cases, MV%
IARC DCO% MV%
()
- xviii -
90
91.28% 99 97.00%
93
23 17
() DCO%
DCO% 87 8.78% 99
0.85% 97-99 DCO%
97-99
97 *
98 *
DCO
**
99
DCO
DCO
**
**
9,341
22
0.23%
10,356
23
0.22%
11,295
21
0.19%
11,812
94
0.79%
13,377
89
0.66%
15,012
60
0.40%
11,077
267
2.35%
11,456
266
2.27%
11,043
184
1.64%
9,868
216
2.14%
10,943
198
1.78%
10,676
179
1.65%
3,690
23
0.62%
4,088
41
0.99%
4,398
39
0.88%
6,112
17
0.28%
6,741
16
0.24%
6,739
18
0.27%
3,890
43
1.09%
4,145
43
1.03%
4,092
29
0.70%
5,159
16
0.31%
5,369
14
0.26%
5,018
10
0.20%
2,896
0.21%
3,310
0.15%
3,346
0.27%
1,436
0.07%
1,518
0.07%
1,743
0.06%
87,604
1,040
1.17%
97,338
1,077
1.09%
97,836
839
0.86%
* 97 98 101 6
** DCO%=DCO DCO 100%
() MV%
MV%MV%
- xix -
MV%
99 MV% 91.11% 89.09%
93.42%
91
92
96
97
Head and Neck Surgery and Oncology, 3rd
WHO 2008
97
97
92 93
92 SARS
http://tcr.cph.ntu.edu.tw/main.php?Page=A5B3
- xx -
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76. ()
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
- xxi -
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
- xxii -
201.
202.
203.
204.
205.
206.
- xxiii -
99
-1-
71 10 99 41,046
28.36% 10 177.21
10 3 129.62
90,649 10 391.37 10 3
296.67 10
()
50,892
39,757
64
60
437.40
344.91
( 10 )
2
( 10 )
3
( 10 )
()
303.57
231.31
340.66
256.23
1.33
()
26,022
15,024
69
70
223.65
130.34
146.88
79.97
169.28
92.27
1.83
( 10 )
2
( 10 )
3
( 10 )
()
1. 96
2. 3.2 1976 3 2000
-2-
10
2b
10 10 99
ICD-O-3
1
2
3
4
5
6
7
8
9
10
C50
C18-C21
C22
C33-C34
C61
C00-C143
6a
2a
2b
58.63
40.34
32.41
29.10
24.17
20.07
63.16
45.32
36.07
33.61
28.77
21.68
9,655
14,040
11,023
10,615
4,392
6,560
83.76
60.62
47.59
45.83
37.75
28.32
4,392
18.96
13.48
14.59
1,169
5.05
3.58
3.85
999
4.31
3.01
3.25
C16
C54
C53
C444
3,854
1,737
1,680
2,978
16.64
15.07
14.57
12.86
10.30
10.47
9.74
7.85
12.03
11.25
10.81
9.29
C00-C80
90,649
391.37
265.83
296.67
2a
2b
6b
6a
6a
10 10 99
ICD-O-3
1
2
3
4
5
6
7
8
9
10
C50
6a
11,234
97.46
68.32
73.45
C50
1,579
13.70
6a
9.69
10.29
C50
9,655
83.76
6a
58.63
63.16
14,975
11,029
5,017
64.65
47.62
43.52
43.24
32.43
30.84
48.44
36.08
34.15
C53
3,337
28.95
6a
21.10
23.34
C53
1,680
14.57
6a
9.74
10.81
10,626
4,396
6,607
45.88
37.78
28.53
29.13
24.19
20.22
33.64
28.79
21.84
4,422
19.09
13.57
14.69
1,178
5.09
3.61
3.88
1,007
4.35
3.04
3.28
C16
C54
C444
3,888
1,741
3,271
16.79
15.10
14.12
10.40
10.49
8.62
12.14
11.27
10.21
C00-C80
97,836
422.40
288.07
321.09
2a
2b
C18-C21
C22
C53
C33-C34
C61
C00-C143
6a
6b
6a
10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10
C33-C34
C22
C18-C21
C50
C00-C143
C16
C61
C15
C25
C53
C00-C97
8,194
7,744
4,676
1,706
2,370
2,261
1,021
1,563
1,470
704
35.38
33.43
20.19
14.80
10.23
9.76
8.78
6.75
6.35
6.11
41,046
177.21
6a
6b
6a
21.43
21.82
12.18
9.98
7.12
5.76
4.67
4.56
3.97
3.79
25.38
24.84
14.41
10.86
7.74
6.87
6.04
5.02
4.62
4.34
112.37
129.62
-3-
10
2b
10 10 99
ICD-O-3
2a
2b
C18-C21
8,143
69.99
48.58
54.39
C22
7,751
66.62
47.52
52.34
C33-C34
6,697
57.56
37.49
43.68
C00-C143
6,028
51.81
37.62
40.56
3,967
34.09
24.82
26.80
1,086
9.33
6.78
7.27
975
8.38
6.01
6.48
C61
4,392
37.75
24.17
28.77
C16
2,415
20.76
13.14
15.43
C15
2,091
17.97
12.77
13.81
C444
1,575
13.54
8.62
10.20
C67
1,427
12.26
7.88
9.24
10
C11
1,194
10.26
7.54
8.22
C00-C80
50,892
437.40
303.57
340.66
2a
2b
8,736
7,752
6,705
6,069
75.08
66.63
57.63
52.16
52.42
47.52
37.52
37.87
58.50
52.35
43.73
40.84
3,991
34.30
24.97
26.97
1,095
9.41
6.84
7.34
983
8.45
6.07
6.54
10 10 99
ICD-O-3
1
2
3
4
5
6
7
8
9
10
C18-C21
C22
C33-C34
C00-C143
C61
C16
C15
C67
C444
C11
4,396
2,436
2,113
1,868
1,733
1,194
37.78
20.94
18.16
16.05
14.89
10.26
24.19
13.26
12.90
10.42
9.50
7.54
28.79
15.57
13.96
12.16
11.24
8.22
C00-C80
52,308
449.57
312.14
350.21
2a
2b
5,454
5,412
2,719
2,198
1,457
1,446
1,021
855
628
582
46.87
46.51
23.37
18.89
12.52
12.43
8.78
7.35
5.40
5.00
32.36
29.07
14.67
13.58
8.80
7.56
4.67
4.81
3.51
3.59
36.34
34.63
17.35
14.71
9.62
9.04
6.04
5.57
4.07
4.02
26,022
223.65
146.88
169.28
10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10
C22
C33-C34
C18-C21
C00-C143
C15
C16
C61
C25
C82-C85
C91-C95
C00-C97
-4-
10
2b
10 10 99
ICD-O-3
1
2
3
4
5
6
7
8
9
10
C50
C18-C21
C33-C34
C22
C73
C54
C53
C16
C56, C57.0-C57.4
C443
C00-C80
2a
2b
9,655
5,897
3,918
3,272
1,838
1,737
1,680
1,439
1,245
1,403
83.76
51.16
33.99
28.39
15.95
15.07
14.57
12.48
10.80
12.17
58.63
32.65
21.38
18.00
11.96
10.47
9.74
7.66
7.83
7.13
63.16
36.84
24.27
20.54
12.91
11.25
10.81
8.85
8.46
8.44
39,757
344.91
231.31
256.23
10 10 99
ICD-O-3
1
2
3
C50
2a
2b
11,234
97.46
68.32
73.45
C50
1,579
13.70
9.69
10.29
C50
9,655
83.76
58.63
63.16
C18-C21
6,239
54.13
34.69
39.04
C53
5,017
43.52
30.84
34.15
C53
3,337
28.95
21.10
23.34
C53
1,680
14.57
9.74
10.81
C33-C34
3,921
34.02
21.40
24.29
C22
3,277
28.43
18.03
20.57
C73
1,838
15.95
11.96
12.91
C54
1,741
15.10
10.49
11.27
C443
1,538
13.34
7.79
9.24
C16
1,452
12.60
7.73
8.93
10
C56, C57.0-C57.4
1,248
10.83
7.85
8.48
C00-C80
45,528
394.97
266.99
295.29
2a
2b
2,782
2,290
1,957
1,706
815
704
615
434
386
363
24.13
19.87
16.98
14.80
7.07
6.11
5.34
3.77
3.35
3.15
14.35
11.85
9.87
9.98
4.09
3.79
3.17
2.53
2.38
1.82
16.76
13.95
11.68
10.86
4.84
4.34
3.72
2.79
2.62
2.19
15,024
130.34
79.97
92.27
10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10
C33-C34
C22
C18-C21
C50
C16
C53
C25
C56, C57.0-C57.4
C91-C95
C82-C85
C00-C97
3.
4. 5 2
-5-
()
ICD-O-FT
ICD-O-3
ICD-9
ICD-10
99
7.24% 5.77%
4 15 4
16 99
6,560 2,370
()
6,028
532
53
60
51.81
4.62
(10)
2
(10)
3
37.62
3.09
(10)
40.56
3.41
()
11.89
()
2,198
172
56
69
18.89
1.49
13.58
0.92
(10)
14.71
1.05
()
14.01
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
-6-
6,560
6,48898.90%98.89%99.06%
93.45%84.77%
5,633
93.45
5,626
99.88
451
84.77
451
100.00
204
3.38
204
100.00
11
2.07
11
100.00
10
0.17
10
100.00
0.56
100.00
37
0.61
37
100.00
43
8.08
43
100.00
32
0.53
32
100.00
0.56
100.00
40
0.66
27
67.50
1.32
85.71
0.08
100.00
1.50
100.00
11
0.18
11
100.00
0.19
100.00
0.07
100.00
52
0.86
9.62
0.94
20.00
74
73
98.65
58
58
100.00
5,961
98.89
532
527
99.06
6,028
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
6,560
66.43%
3,981
66.04
377
70.86
4,358
66.43
3,156
52.36
198
37.22
3,354
51.13
2,997
49.72
179
33.65
3,176
48.41
0.19
0.19
537
8.91
38
7.14
575
8.77
331
5.49
36
6.77
367
5.59
-7-
()
ICD-O-FT
ICD-O-3
ICD-9
C00 - C06
140-145 (142)
ICD-10
C00 - C06
99 5.42 %
4.02% 99
4,911
1,650
()
4,453
458
53
60
38.27
3.97
(10)
2
(10)
3
27.86
2.68
(10)
30.07
2.95
()
10.19
()
1,499
151
56
69
12.88
1.31
9.32
0.81
(10)
10.07
0.92
()
10.95
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
-8-
4,9114,875
99.27%99.26%99.34%
92.77%83.62%
4,131
92.77
4,130
99.98
383
83.62
383
100.00
203
4.56
203
100.00
11
2.40
11
100.00
0.04
100.00
0.44
100.00
32
0.72
32
100.00
43
9.39
43
100.00
18
0.40
18
100.00
0.44
100.00
22
0.49
14
63.64
1.09
80.00
0.11
100.00
1.75
100.00
0.20
100.00
0.22
100.00
0.07
100.00
28
0.63
14.29
0.66
33.33
24
24
100.00
17
17
100.00
4,420
99.26
458
455
99.34
4,453
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
4,911
78.40%
*
3,496
78.51
354
77.29
3,850
78.40
1,944
43.66
145
31.66
2,089
42.54
1,806
40.56
129
28.17
1,935
39.40
0.22
0.22
316
7.10
27
5.90
343
6.98
243
5.46
28
6.11
271
5.52
-9-
( C44.0 )
ICD-O-FT
ICD-O-3
T-140
C00
99 228
3.48%
()
210
18
57
71
1.80
0.16
1.36
0.10
(10)
1.45
0.11
()
13.18
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 10 -
ICD-O-FT
ICD-O-3
T-141
C01 - C02
99 1,805
27.52%
()
1,583
222
52
56
13.61
1.93
9.90
1.34
(10)
10.72
1.46
()
7.34
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 11 -
ICD-O-FT
ICD-O-3
T-143
C03
99 445
6.78%
()
384
61
55
66
3.30
0.53
2.35
0.34
(10)
2.56
0.38
()
6.74
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 12 -
ICD-O-FT
ICD-O-3
T-144
C04
99 164
2.50%
()
151
13
53
55
1.30
0.11
0.92
0.07
(10)
0.99
0.08
()
12.38
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 13 -
ICD-O-FT
ICD-O-3
T-145
C05 - C06
99
2,269 34.59%
()
2,125
144
53
64
18.26
1.25
13.33
0.83
(10)
14.34
0.92
()
15.59
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 14 -
ICD-O-FT
ICD-O-3
T-146
C09 - C10
99 635
9.68%
()
586
49
53
55
5.04
0.43
3.66
0.28
(10)
3.92
0.31
()
12.65
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 15 -
ICD-O-FT
ICD-O-3
T-148
C12 - C13
99 942
14.36%
()
921
21
56
58
7.92
0.18
5.68
0.12
(10)
6.12
0.13
()
47.08
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 16 -
ICD-O-FT
ICD-O-3
T-149
C14
99
72 1.10%
()
68
55
67
0.58
0.03
0.42
0.02
(10)
0.45
0.02
()
22.50
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 17 -
Oral cavity
C00
Lip
C02
C03
C04
Floor of mouth
ICD-O-3
(p.6-p.17)
Oral cavity
C09
Tonsil
C10
Oropharynx
Hypopharynx
C12
Pyriform sinus
C13
Hypopharynx
- 18 -
Oropharynx
Pharynx and
ill-defined sites in
lip, oral cavity and
pharynx
Hypopharynx
Pharynx and
ill-defined sites in
lip, oral cavity and
pharynx
rd
ICD-O-FT
ICD-O-3
99
4.85%994,392
()
3,967
425
53
61
34.09
3.69
24.82
2.47
(10)
26.80
2.73
()
9.82
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 19 -
rd
T-1410T-1416T-1453T-1454T-146T1491T-1498
C01C024C051C052C09C10C142
ICD-O-3
C148
99
1.29%991,169
()
1,086
83
54
54
9.33
0.72
6.78
0.49
(10)
7.27
0.53
()
13.72
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 20 -
rd
ICD-O-FT T-148T-1490
ICD-O-3
C12C13C140
99
1.10%99999
()
975
24
56
58
8.38
0.21
6.01
0.13
(10)
6.48
0.15
()
43.20
( 10 )
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 21 -
ICD-O-FT
T-142
ICD-O-3
ICD-9
ICD-10
C07 - C08
142
C07 - C08
99
0.26%0.15%
252728
3399236
62
()
131
105
54
50
1.13
0.91
(10)
2
(10)
3
0.80
0.66
(10)
0.89
0.73
()
1.22
()
40
22
63
62
0.34
0.19
0.25
0.11
(10)
0.27
0.13
()
2.08
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 22 -
236232
98.31%98.47%98.10%
17.56%30.48%
21
16.03
21
100.00
19
18.10
19
100.00
12
9.16
12
100.00
0.95
100.00
21
16.03
21
100.00
3.81
100.00
23
17.56
23
100.00
32
30.48
32
100.00
11
8.40
11
100.00
21
20.00
21
100.00
6.11
100.00
7.62
100.00
12
9.16
12
100.00
3.81
100.00
1.53
100.00
17
12.98
17
100.00
13
12.38
13
100.00
1.53
100.00
0.95
100.00
1.53
1.90
11
100.00
12
12
100.00
129
98.47
105
103
98.10
11
131
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
236
81.36%
105
80.15
87
82.86
192
81.36
77
58.78
54
51.43
131
55.51
44
33.59
19
18.10
63
26.69
5.34
2.86
10
4.24
5.34
10
9.52
17
7.20
- 23 -
ICD-O-FT
T-147
ICD-O-3
ICD-9
ICD-10
C11
147
C11
99
1.73%1.60%
101811
17991,571
658
()
1,194
377
51
50
10.26
3.27
(10)
2
(10)
3
7.54
2.30
(10)
8.22
2.52
()
3.26
()
505
153
58
58
4.34
1.33
3.17
0.89
(10)
3.43
0.99
()
3.46
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 24 -
1,5711,555
98.98%98.83%99.47%
66.00%59.15%
19
1.59
19
100.00
11
2.92
11
100.00
34
2.85
34
100.00
2.12
100.00
788
66.00
788
100.00
223
59.15
223
100.00
289
24.20
289
100.00
117
31.03
117
100.00
0.34
100.00
0.27
100.00
17
1.42
17
100.00
0.53
100.00
30
2.51
27
90.00
12
3.18
11
91.67
0.08
100.00
12
1.01
8.33
0.80
66.67
17
17
100.00
23
22
95.65
1,180
98.83
377
375
99.47
1,194
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,571
89.56%
0.34
1.33
0.57
1,059
88.69
348
92.31
1,407
89.56
983
82.33
315
83.55
1,298
82.62
95
7.96
26
6.90
121
7.70
73
6.11
11
2.92
84
5.35
- 25 -
ICD-O-FT
T-150
ICD-O-3
ICD-9
ICD-10
C15
150
C15
992.47%
3.81%
724520
992,238(ICD-O-3 C15 C26C48)6.53%1,563
()
2,091
147
56
69
17.97
1.28
(10)
2
(10)
3
12.77
13.81
0.90
()
15.34
()
1,457
106
58
75
12.52
0.92
8.80
0.51
(10)
9.62
0.61
()
15.77
(10)
2
(10)
0.77
(10)
1. 96
2. 3.2 1976 3 2000
- 26 -
2,2382,202
98.39%98.42%97.96%
91.49%80.95%
1,913
91.49
1,911
99.90
119
80.95
119
100.00
76
3.63
75
98.68
16
10.88
16
100.00
0.24
100.00
31
1.48
31
100.00
3.40
100.00
26
1.24
26
100.00
2.04
66.67
0.19
100.00
0.10
100.00
0.05
100.00
0.68
100.00
33
1.58
9.09
2.04
33.33
2,091
100.00
2,058
98.42
147
100.00
144
97.96
1. 96ICD-O-3 M-CODEp.497
2,238
68.81%
*
657
31.42
36
24.49
693
30.97
1,458
69.73
82
55.78
1,540
68.81
1,421
67.96
76
51.70
1,497
66.89
0.05
0.05
627
29.99
41
27.89
668
29.85
185
8.85
23
15.65
208
9.29
- 27 -
ICD-O-FT
T-151
ICD-O-3
ICD-9
ICD-10
C16
151
C16
994.25%
5.51%
6865
993,854(ICD-O-3
C15 - C26C48)11.25%2,261
()
2,415
1,439
71
69
20.76
12.48
(10)
2
(10)
3
13.14
7.66
(10)
15.43
8.85
()
1.74
()
1,446
815
75
73
12.43
7.07
7.56
4.09
(10)
9.04
4.84
()
1.87
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 28 -
3,8543,784
98.18%98.14%98.26%
88.61%85.20%
2,140
88.61
2,132
99.63
1,226
85.20
1,224
99.84
0.21
100.00
0.14
100.00
32
1.33
32
100.00
0.21
100.00
47
1.95
47
100.00
16
1.11
16
100.00
31
1.28
24
77.42
17
1.18
17
100.00
0.08
50.00
0.14
100.00
127
5.26
124
97.64
151
10.49
146
96.69
0.08
100.00
0.07
100.00
29
1.20
10.34
21
1.46
14.29
92
92
100.00
112
112
100.00
27
27
100.00
41
41
100.00
2,370
98.14
1,439
1,414
98.26
2,415
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
3,85461.00%
1,449
60.00
902
62.68
2,351
61.00
265
10.97
94
6.53
359
9.31
1,031
42.69
589
40.93
1,620
42.03
0.04
0.04
506
20.95
278
19.32
784
20.34
351
14.53
191
13.27
542
14.06
- 29 -
ICD-O-FT
T-152
ICD-O-3
ICD-9
ICD-10
C17
152
C17
99
0.36%0.33%
232522
2999325
(ICD-O-3 C15 - C26C48)0.95%
135
()
(10)
2
(10)
3
(10)
()
190
135
64
67
1.63
1.17
1.14
1.27
1.48
0.78
0.86
1
()
91
44
71
75
0.78
0.38
0.52
0.22
(10)
0.60
0.26
()
2.31
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 30 -
325318
97.85%97.37%98.52%
43.68%52.59%
77
40.53
76
98.70
44
32.59
44
100.00
2.63
100.00
4.44
100.00
3.68
100.00
4.44
100.00
4.21
100.00
0.74
100.00
0.74
100.00
83
43.68
82
98.80
71
52.59
71
100.00
1.58
100.00
1.48
100.00
0.53
100.00
0.74
100.00
3.16
50.00
2.22
33.33
43
100.00
21
21
100.00
185
97.37
135
133
98.52
43
190
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
325
68.31%
*
119
62.63
103
76.30
222
68.31
13
6.84
2.22
16
4.92
64
33.68
42
31.11
106
32.62
43
22.63
16
11.85
59
18.15
28
14.74
14
10.37
42
12.92
- 31 -
ICD-O-FT
ICD-O-3
ICD-9
ICD-10
T-153T-154
C18 - C21
153154
C18 - C21
99
15.49%
11.39%12
3399
14,040(ICD-O-3 C15 C26C48)40.99%
4,676
()
8,143
5,897
66
67
69.99
51.16
(10)
2
(10)
3
48.58
32.65
(10)
54.39
36.84
()
1.48
()
2,719
1,957
73
73
23.37
16.98
14.67
9.87
(10)
17.35
11.68
()
1.49
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 32 -
14,040
13,69097.51%97.59%
97.39%
94.95%94.47%
99
593342130131
7,732
94.95
7,718
99.82
5,571
94.47
5,559
99.78
78
0.96
76
97.44
59
1.00
58
98.31
56
0.69
56
100.00
64
1.09
63
98.44
73
0.90
49
67.12
42
0.71
24
57.14
20
0.25
19
95.00
17
0.29
16
94.12
0.02
100.00
0.01
100.00
0.10
100.00
181
2.22
26
14.36
138
2.34
17
12.32
27
100.00
10
10
100.00
7,947
97.59
5,897
5,743
97.39
27
8,143
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
14,040
78.94%
*
6,413
78.75
4,670
79.19
11,083
78.94
1,122
13.78
651
11.04
1,773
12.63
4,295
52.74
3,073
52.11
7,368
52.48
825
10.13
654
11.09
1,479
10.53
760
9.33
538
9.12
1,298
9.25
- 33 -
ICD-O-FT
T-153
ICD-O-3
ICD-9
ICD-10
C18
153
C18
99
9.53%8.05%99
8,635(ICD-O-3 C15 C26C48)25.21%3,306
()
4,871
3,764
67
67
41.86
32.65
(10)
2
(10)
3
28.75
20.75
(10)
32.36
23.48
()
1.38
()
1,880
1,426
74
74
16.16
12.37
10.06
7.15
(10)
11.96
8.48
()
1.41
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 34 -
8,6358,353
96.73%96.90%96.52%
95.13%
95.19%
4,634
95.13
4,624
99.78
3,583
95.19
3,574
99.75
12
0.25
11
91.67
12
0.32
12
100.00
21
0.43
21
100.00
14
0.37
14
100.00
51
1.05
34
66.67
31
0.82
17
54.84
0.16
100.00
0.08
100.00
0.02
100.00
144
2.96
21
14.58
121
3.21
13
10.74
24
100.00
100.00
4,720
96.90
3,764
3,633
96.52
24
4,871
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
8,635
78.38%
3,800
78.01
2,968
78.85
6,768
78.38
140
2.87
87
2.31
227
2.63
2,398
49.23
1,897
50.40
4,295
49.74
507
10.41
428
11.37
935
10.83
515
10.57
374
9.94
889
10.30
- 35 -
ICD-O-FT
T-154
ICD-O-3
ICD-9
ICD-10
C19 - C21
154
C19 - C21
99
5.96%
3.34%99
5,405(ICD-O-3 C15 - C26C48)15.78%
1,370
()
3,272
2,133
65
66
28.12
18.50
(10)
2
(10)
3
19.83
11.90
(10)
22.04
13.35
()
1.65
()
839
531
72
73
7.21
4.61
4.60
2.71
(10)
5.38
3.20
()
1.68
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 36 -
5,405
5,33798.74%98.62%98.92%
94.68%
93.20%
3,098
94.68
3,094
99.87
1,988
93.20
1,985
99.85
66
2.02
65
98.48
47
2.20
46
97.87
35
1.07
35
100.00
50
2.34
49
98.00
12
0.37
12
100.00
38
1.78
37
97.37
22
0.67
15
68.18
11
0.52
63.64
12
0.37
11
91.67
14
0.66
13
92.86
0.03
100.00
0.03
100.00
0.28
100.00
37
1.13
13.51
17
0.80
23.53
100.00
100.00
3,227
98.62
2,133
2,110
98.92
3
3,272
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
5,405
79.83%
2,613
79.86
1,702
79.79
4,315
79.83
982
30.01
564
26.44
1,546
28.60
1,897
57.98
1,176
55.13
3,073
56.85
318
9.72
226
10.60
544
10.06
245
7.49
164
7.69
409
7.57
- 37 -
ICD-O-FT
T-155
ICD-O-3
ICD-9
ICD-10
C22
155
C22
99
12.16%18.87%
241
29911,023
(ICD-O-3 C15 - C26C48)32.18%
7,744
()
(10)
2
(10)
3
(10)
()
7,751
3,272
62
70
66.62
28.39
47.52
52.34
2.55
18.00
20.54
1
()
5,454
2,290
65
73
46.87
19.87
32.36
11.85
(10)
36.34
13.95
()
2.61
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 38 -
11,023
5,26747.78%48.73%45.54%
91.87%86.22%
7,121
91.87
3,307
46.44
2,821
86.22
1,163
41.23
471
6.08
336
71.34
381
11.64
271
71.13
53
0.68
52
98.11
14
0.43
14
100.00
24
0.31
24
100.00
19
0.58
19
100.00
12
0.15
12
100.00
0.15
80.00
16
0.21
16
100.00
0.21
100.00
13
0.17
12
92.31
0.03
100.00
13
0.17
11
84.62
0.18
100.00
0.06
100.00
0.09
100.00
0.01
100.00
0.06
100.00
22
0.28
4.55
13
0.40
100.00
100.00
3,777
48.73
3,272
1,490
45.54
9
7,751
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
11,023
23.64%
*
( PEIT/PAIT, RFA )
20.75
13.72
2,606
1,182
23.64
10.72
1,927
733
24.86
9.46
PEIT/PAIT
165
2.13
89
2.72
254
2.30
RFA
567
7.32
359
10.97
926
8.40
TAE/TACE
TAE
TACE
( TAE,
PEIT/PAIT, RFA )
679
449
0.01
0.03
0.02
2,191
28.27
874
26.71
3,065
27.81
501
6.46
183
5.59
684
6.21
1,765
22.77
716
21.88
2,481
22.51
210
2.71
96
2.93
306
2.78
676
908
138
1,576
1,282
8.72
11.71
1.78
20.33
16.54
202
243
27
616
623
6.17
7.43
0.83
18.83
19.04
878
1,151
165
2,192
1,905
7.97
10.44
1.50
19.89
17.28
- 39 -
ICD-O-FT
T-156
ICD-O-3
ICD-9
ICD-10
C23 - C24
156
C23 - C24
99
1.02%1.29%
191714
1299924
(ICD-O-3 C15 - C26C48)2.70%
529
()
486
438
71
72
4.18
3.80
(10)
2
(10)
3
2.70
2.28
(10)
3.14
2.67
()
1.18
()
283
246
73
73
2.43
2.13
1.56
1.27
(10)
1.83
1.49
()
1.23
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 40 -
924750
81.17%80.04%82.42%
81.69%84.93%
397
81.69
343
86.40
372
84.93
329
88.44
11
2.26
11
100.00
1.37
100.00
25
5.14
25
100.00
18
4.11
18
100.00
16
3.29
50.00
13
2.97
46.15
0.23
100.00
37
7.61
5.41
28
6.39
3.57
100.00
389
80.04
438
361
82.42
4
486
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
924
51.41%
241
49.59
234
53.42
475
51.41
64
13.17
55
12.56
119
12.88
128
26.34
98
22.37
226
24.46
150
30.86
135
30.82
285
30.84
89
18.31
79
18.04
168
18.18
- 41 -
ICD-O-FT
T-157
ICD-O-3
ICD-9
ICD-10
C25
157
C25
991.81%
3.58%
131487
991,643(ICDO-3 C15 - C26C48)4.80%1,470
()
(10)
2
(10)
3
(10)
()
937
706
68
71
8.05
6.12
5.39
6.13
1.42
3.73
4.33
1
()
855
615
70
73
7.35
5.34
4.81
3.17
(10)
5.57
3.72
()
1.50
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 42 -
1,6431,119
68.11%69.58%66.15%
60.41%59.21%
566
60.41
539
95.23
418
59.21
392
93.78
0.32
100.00
0.57
100.00
0.11
100.00
0.71
100.00
47
5.02
47
100.00
36
5.10
34
94.44
90
9.61
53
58.89
53
7.51
22
41.51
0.21
100.00
0.28
100.00
0.21
100.00
0.14
100.00
226
24.12
2.21
187
26.49
3.74
100.00
652
69.58
706
467
66.15
6
937
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,643
43.34%
185
19.74
143
20.25
328
19.96
141
15.05
110
15.58
251
15.28
413
44.08
299
42.35
712
43.34
403
43.01
327
46.32
730
44.43
197
21.02
125
17.71
322
19.60
- 43 -
ICD-O-FT
T-158
ICD-O-3
ICD-9
ICD-10
C48
158
C48
99
0.17%0.22%
303029
2699157
(ICD-O-3 C15 - C26C48)0.46%
91
()
80
77
57
58
0.69
0.67
(10)
2
(10)
3
0.58
0.51
(10)
0.60
0.54
()
1.11
()
35
56
66
67
0.30
0.49
0.22
0.32
(10)
0.24
0.36
()
0.67
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 44 -
157141
89.81%86.25%93.51%
36.25%25.97%
29
36.25
29
100.00
20
25.97
20
100.00
5.00
100.00
15
19.48
15
100.00
6.25
100.00
2.60
100.00
2.50
100.00
5.19
100.00
18
22.50
12
66.67
3.90
100.00
8.75
100.00
12
15.58
12
100.00
6.25
100.00
10
12.99
10
100.00
2.50
100.00
7.79
83.33
10.00
37.50
6.49
20.00
100.00
100.00
69
86.25
77
72
93.51
80
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
157
70.06%
52
65.00
58
75.32
110
70.06
27
33.75
12
15.58
39
24.84
22
27.50
24
31.17
46
29.30
1.30
1.30
10.00
10.39
16
10.19
- 45 -
ICD-O-FT
ICD-O-3
ICD-9
ICD-10
T-159
C26
159
C26
99
0.06%
0.52%3636
192399
51(ICD-O-3 C15 - C26C48)0.15%
212
()
(10)
2
(10)
3
(10)
()
19
32
60
60
0.16
0.28
0.11
0.12
0.57
0.19
0.21
1
()
139
73
72
74
1.19
0.63
0.78
0.37
(10)
0.90
0.44
()
2.05
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 46 -
5148
94.12%89.47%96.88%
63.16%
53.13%
5.26
100.00
17
53.13
17
100.00
5.26
100.00
3.13
100.00
15.79
100.00
6.25
100.00
12
63.16
11
91.67
12
37.50
11
91.67
10.53
50.00
100.00
17
89.47
32
31
96.88
19
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
51
52.94%
10
52.63
14
43.75
24
47.06
9.38
9.38
42.11
19
59.38
27
52.94
26.32
18.75
11
21.57
21.05
6.25
11.76
- 47 -
ICD-O-FT T-160
ICD-O-3
ICD-9
ICD-10
C30 - C31
160
C30 - C31
99
0.19%
0.09%2731
313499
172(ICD-O-3 C30 - C39)
1.46%36
()
119
53
59
56
1.02
0.46
(10)
2
(10)
3
0.73
0.34
(10)
0.80
0.36
()
2.22
()
22
14
65
59
0.19
0.12
0.14
0.08
(10)
0.15
0.09
()
1.67
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 48 -
172
16897.67%97.48%98.11%
57.98%37.74%
69
57.98
67
97.10
20
37.74
20
100.00
6.72
100.00
13.21
100.00
2.52
100.00
1.89
100.00
2.52
100.00
5.66
100.00
11
9.24
11
100.00
15.09
100.00
13
10.92
13
100.00
11.32
100.00
2.52
100.00
5.66
100.00
5.88
100.00
7.55
75.00
1.68
50.00
1.89
100.00
31
100.00
21
20
95.24
116
97.48
53
52
98.11
31
119
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
172
63.37%
75
63.03
34
64.15
109
63.37
72
60.50
23
43.40
95
55.23
55
46.22
14
26.42
69
40.12
0.84
1.89
1.16
10
8.40
7.55
14
8.14
11
9.24
16.98
20
11.63
- 49 -
ICD-O-FT
T-161
ICD-O-3
ICD-9
ICD-10
C32
161
C32
990.70%
0.45%
17361738
99635
(ICD-O-3 C30 - C39)5.40%186
()
602
33
62
65
(10)
2
(10)
3
5.17
3.62
0.29
0.18
(10)
4.00
0.21
()
19.05
()
178
70
60
1.53
0.07
0.96
0.05
(10)
1.13
0.05
()
22.60
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 50 -
635 625
98.43%98.50%96.97%
96.35%84.85%
580
96.35
580
100.00
28
84.85
28
100.00
0.50
100.00
0.83
100.00
6.06
100.00
1.00
66.67
3.03
100.00
3.03
100.00
1.33
12.50
3.03
100.00
100.00
593
98.50
33
32
96.97
602
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
63559.37%
290
48.17
18
54.55
308
48.50
357
59.30
20
60.61
377
59.37
206
34.22
21.21
213
33.54
31
5.15
3.03
32
5.04
63
10.47
6.06
65
10.24
- 51 -
ICD-O-FT
T-162
ICD-O-3
ICD-9
ICD-10
C33 - C34
162
C33 - C34
99
11.71%
19.96%33
2199
10,615(ICD-O-3 C30 - C39)90.26%
8,194
()
(10)
2
(10)
3
(10)
()
6,697
3,918
71
67
57.56
33.99
37.49
43.68
1.80
21.38
24.27
1
()
5,412
2,782
74
72
46.51
24.13
29.07
14.35
(10)
34.63
16.76
()
2.07
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 52 -
10,615
9,88493.11%92.68%93.85%
44.11%74.86%
1,660
24.79
1,649
99.34
234
5.97
232
99.15
2,954
44.11
2,936
99.39
2,933
74.86
2,919
99.52
49
0.73
47
95.92
41
1.05
41
100.00
43
0.64
43
100.00
21
0.54
21
100.00
784
11.71
777
99.11
91
2.32
90
98.90
64
0.96
64
100.00
20
0.51
20
100.00
45
0.67
45
100.00
46
1.17
46
100.00
15
0.22
15
100.00
26
0.66
26
100.00
472
7.05
458
97.03
211
5.39
201
95.26
421
6.29
407
96.67
197
5.03
187
94.92
182
2.72
138
75.82
81
2.07
58
71.60
0.09
83.33
0.05
100.00
0.12
100.00
0.08
100.00
415
6.20
22
5.30
209
5.33
18
8.61
29
100.00
21
21
100.00
6,207
92.68
3,918
3,677
93.85
29
6,697
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
10,615
61.13%
*
1,073
16.02
981
25.04
2,054
19.35
2,005
29.94
882
22.51
2,887
27.20
4,075
60.85
2,414
61.61
6,489
61.13
11
0.16
0.10
15
0.14
2,327
34.75
1,251
31.93
3,578
33.71
1,059
15.81
475
12.12
1,534
14.45
- 53 -
ICD-O-FT
T-163
ICD-O-3
ICD-9
ICD-10
C38.4
163
C38.4
99
0.07%0.05%
323735
369962
(ICD-O-3 C30 - C39)0.53%
22
()
(10)
2
(10)
3
(10)
()
43
19
64
66
0.37
0.16
0.26
0.29
2.42
0.11
0.12
1
()
10
12
72
75
0.09
0.10
0.06
0.05
0.07
0.07
(10)
2
(10)
3
(10)
()
1. 96
2. 3.2 1976 3 2000
- 54 -
6259
95.16%97.67%89.47%
88.37%84.21%
38
88.37
38
100.00
16
84.21
15
93.75
11.63
80.00
15.79
66.67
100.00
42
97.67
19
17
89.47
43
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
6259.68%
20.93
31.58
15
24.19
9.30
10.53
9.68
31
72.09
31.58
37
59.68
12
27.91
31.58
18
29.03
18.60
31.58
14
22.58
- 55 -
ICD-O-FT T-164
ICD-O-3
C37 - C38(C38.4)
ICD-9
ICD-10
164
C37 - C38(C38.4)
99
0.30%
0.33%2427
222799
276(ICD-O-3 C30 - C39)2.35%
134
()
168
108
56
56
1.44
0.94
(10)
2
(10)
3
1.09
0.68
(10)
1.20
0.73
()
1.64
()
87
47
61
61
0.75
0.41
0.55
0.28
(10)
0.60
0.31
()
1.94
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 56 -
276
25893.48%92.86%94.44%
56.55%77.78%
95
56.55
91
95.79
84
77.78
83
98.81
21
12.50
21
100.00
0.93
100.00
22
13.10
21
95.45
8.33
100.00
4.17
100.00
2.78
100.00
2.38
100.00
3.70
100.00
5.36
100.00
0.93
100.00
1.19
100.00
0.93
100.00
4.76
12.50
4.63
31
100.00
22
22
100.00
156
92.86
108
102
94.44
31
168
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
276
52.17%
84
50.00
60
55.56
144
52.17
67
39.88
54
50.00
121
43.84
80
47.62
40
37.04
120
43.48
25
14.88
18
16.67
43
15.58
19
11.31
16
14.81
35
12.68
- 57 -
ICD-O-FT p.497
ICD-O-3
p.497
ICD-9
204-208
ICD-10
C91 - C95
992.01%
2.36%
1212109
991,823968
()
1,087
736
61
59
9.34
6.39
(10)
2
(10)
3
7.30
5.29
(10)
7.91
5.48
()
1.44
()
582
386
68
66
5.00
3.35
3.59
2.38
(10)
4.02
2.62
()
1.53
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 58 -
1,8231,802
98.85%99.08%98.51%
39.10%41.98%
425
39.10
425
100.00
309
41.98
308
99.68
131
12.05
131
100.00
104
14.13
104
100.00
148
13.62
148
100.00
77
10.46
75
97.40
89
8.19
89
100.00
46
6.25
45
97.83
19
1.75
19
100.00
16
2.17
15
93.75
135
12.42
133
98.52
95
12.91
92
96.84
124
11.41
118
95.16
76
10.33
74
97.37
0.18
100.00
0.27
100.00
0.46
100.00
1.09
87.50
0.83
77.78
0.41
100.00
1,087
100.00
1,077
99.08
736
100.00
725
98.51
96ICD-O-3 M-CODEp.497
1,82370.98%
0.09
0.09
30
2.76
20
2.72
50
2.74
767
70.56
527
71.60
1,294
70.98
139
12.79
109
14.81
248
13.60
0.18
0.82
0.44
59
5.43
38
5.16
97
5.32
154
14.17
113
15.35
267
14.65
30
2.76
16
2.17
46
2.52
- 59 -
ICD-O-FT
p.497
ICD-O-3
p.497
99 223
12.89%
()
131
104
24
25
1.13
0.90
1.45
1.45
(10)
1.33
1.23
()
1.08
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 60 -
210
93.19%
12
9.16
14
13.46
26
11.06
122
93.13
97
93.27
219
93.19
84
64.12
72
69.23
156
66.38
18
13.74
11
10.58
29
12.34
5.34
11
10.58
18
7.66
0.76
0.96
0.85
- 61 -
ICD-O-FT
p.497
ICD-O-3
p.497
99 135
7.41%
()
89
46
69
65
0.76
0.40
0.53
0.27
(10)
0.60
0.29
()
2.07
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 62 -
135
58.52%
54
60.67
25
54.35
79
58.52
22
24.72
10
21.74
32
23.70
4.49
2.17
3.70
3.37
6.52
4.44
- 63 -
ICD-O-FT
p.497
ICD-O-3
p.497
99 734
40.26%
()
425
309
62
58
3.65
2.68
2.70
1.94
(10)
2.99
2.13
()
1.40
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 64 -
734
78.75%
0.24
0.24
11
2.59
1.29
15
2.04
328
77.18
250
80.91
578
78.75
23
5.41
23
7.44
46
6.27
0.47
0.97
0.68
32
7.53
27
8.74
59
8.04
95
22.35
56
18.12
151
20.57
1.65
1.29
11
1.50
- 65 -
ICD-O-FT
p.497
ICD-O-3
p.497
99 225
12.34%
()
148
77
51
51
1.27
0.67
0.95
0.49
(10)
1.05
0.54
()
1.94
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 66 -
225
91.56%
3.38
3.38
135
91.22
71
92.21
206
91.56
1.30
1.30
2.70
2.70
6.08
7.79
15
6.67
1.35
1.30
1.33
- 67 -
ICD-O-FT
T-170
ICD-O-3
ICD-9
ICD-10
C40 - C41
170
C40 - C41
99
0.18%
0.26%2828
242599
163108
()
89
74
32
35
0.76
0.64
(10)
2
(10)
3
0.77
0.63
(10)
0.77
0.65
()
1.18
()
58
50
61
54
0.50
0.43
0.40
0.38
(10)
0.43
0.39
()
1.10
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 68 -
163
15595.09%94.38%95.95%
41.57%51.35%
37
41.57
37
100.00
38
51.35
38
100.00
19
21.35
18
94.74
12
16.22
12
100.00
1.12
2.70
100.00
12
13.48
12
100.00
9.46
100.00
5.62
100.00
1.35
100.00
1.35
100.00
8.99
100.00
8.11
100.00
3.37
100.00
5.41
100.00
4.49
25.00
4.05
10
100.00
100.00
84
94.38
74
71
95.95
Ewing
10
89
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
163
71.17%
62
69.66
54
72.97
116
71.17
19
21.35
13
17.57
32
19.63
51
57.30
45
60.81
96
58.90
10
11.24
8.11
16
9.82
12
13.48
10.81
20
12.27
- 69 -
ICD-O-FT
ICD-O-3
T-171
C47C49
ICD-9
ICD-10
171
C47C49
99
0.56%
0.40%2021
202499
508
166
()
276
232
56
55
2.37
2.01
(10)
2
(10)
3
1.75
1.51
(10)
1.93
1.63
()
1.18
()
107
59
57
64
0.92
0.51
0.68
0.36
(10)
0.76
0.41
()
1.85
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 70 -
508
49797.83%97.83%
97.84%
30.43%21.12%
50
18.12
50
100.00
38
16.38
38
100.00
84
30.43
82
97.62
46
19.83
45
97.83
17
6.16
17
100.00
18
7.76
18
100.00
3.26
100.00
12
5.17
12
100.00
20
7.25
20
100.00
19
8.19
19
100.00
11
3.99
11
100.00
15
6.47
15
100.00
( Schwann ) 12
4.35
12
100.00
3.45
100.00
3.26
100.00
1.72
100.00
37
13.41
37
100.00
49
21.12
49
100.00
22
7.97
21
95.45
18
7.76
16
88.89
0.36
100.00
1.45
25.00
2.16
60.00
21
100.00
16
16
100.00
270
97.83
232
227
97.84
21
276
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
508
75.98%
*
211
76.45
175
75.43
386
75.98
110
39.86
80
34.48
190
37.40
42
15.22
49
21.12
91
17.91
0.43
0.43
19
6.88
15
6.47
34
6.69
26
9.42
27
11.64
53
10.43
- 71 -
ICD-O-FT
T-173
ICD-O-3
ICD-9
C44
172173
ICD-10
C43 - C44
99
3.29%0.50%
81021
21992,978
206
()
1,575
1,403
73
74
13.54
12.17
(10)
2
(10)
3
8.62
7.13
(10)
10.20
8.44
()
1.21
()
113
93
67
75
0.97
0.81
0.65
0.46
(10)
0.74
0.54
()
1.37
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 72 -
2,9782,958
99.33%99.43%99.22%
42.79%52.74%
99293128-129
674
42.79
672
99.70
740
52.74
738
99.73
504
32.00
502
99.60
391
27.87
388
99.23
77
4.89
77
100.00
51
3.64
51
100.00
125
7.94
124
99.20
87
6.20
84
96.55
23
1.46
23
100.00
25
1.78
25
100.00
10
0.63
90.00
0.21
100.00
154
9.78
154
100.00
104
7.41
102
98.08
0.06
100.00
0.44
57.14
0.14
50.00
45
100.00
30
30
100.00
1,566
99.43
1,403
1,392
99.22
45
1,575
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
2,978
89.46%
*
1,403
89.08
1,261
89.88
2,664
89.46
120
7.62
82
5.84
202
6.78
53
3.37
22
1.57
75
2.52
10
0.63
0.43
16
0.54
32
2.03
23
1.64
55
1.85
110
6.98
99
7.06
209
7.02
- 73 -
ICD-O-FT
T-173
( M-87203 - M-87903 )
ICD-O-3
ICD-9
ICD-10
C44
172
C43
( M-87203 - M-87903 )
99
0.23%0.28%
99212
116
()
125
87
66
67
1.07
0.75
(10)
2
(10)
3
0.74
0.47
(10)
0.85
0.54
()
1.57
()
65
51
67
68
0.56
0.44
0.38
0.27
(10)
0.43
0.31
()
1.39
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 74 -
212
81.13%
102
81.60
70
80.46
172
81.13
22
17.60
10.34
31
14.62
18
14.40
8.05
25
11.79
6.40
4.60
12
5.66
10
8.00
2.30
12
5.66
12
9.60
11
12.64
23
10.85
- 75 -
ICD-O-FT
ICD-O-3
C44
ICD-9
ICD-10
173
C44
( M-87203 - M-87903 )
99
3.05%
0.22%992,766
90
()
1,450
1,316
73
74
12.46
11.42
(10)
2
(10)
3
7.88
6.66
(10)
9.35
7.90
()
1.18
()
48
42
68
84
0.41
0.36
0.27
0.19
(10)
0.31
0.23
()
1.35
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 76 -
2,7662,750
99.42%99.38%99.47%
46.48%56.23%
674
46.48
672
99.70
740
56.23
738
99.73
504
34.76
502
99.60
391
29.71
388
99.23
77
5.31
77
100.00
51
3.88
51
100.00
23
1.59
23
100.00
25
1.90
25
100.00
10
0.69
90.00
0.23
100.00
154
10.62
154
100.00
104
7.90
102
98.08
0.07
100.00
0.48
57.14
0.15
50.00
45
100.00
30
30
100.00
1,442
99.45
1,316
1,308
99.39
45
1,450
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
2,766
90.09%
1,301
89.72
1,191
90.50
2,492
90.09
98
6.76
73
5.55
171
6.18
35
2.41
15
1.14
50
1.81
0.14
0.15
0.14
22
1.52
21
1.60
43
1.55
98
6.76
88
6.69
186
6.72
- 77 -
ICD-O-FT
T-174T-175
ICD-O-3
ICD-9
C50
174175
ICD-10
C50
99
10.65%0.04%
4.16%0.03%134
43599
9,65539
1,70612
()
39
9,655
66
52
(10)
2
(10)
3
(10)
()
0.34
0.21
83.76
58.63
()
12
1,706
77
57
0.10
14.80
0.06
9.98
0.07
10.86
155.14
(10)
2
(10)
3
0.24
63.16
(10)
263.17
()
1. 96
2. 3.2 1976 3 2000
- 78 -
9,6559,608
99.51%39
39100%
89.33%82.05%
9931,579
132133
32
82.05
32
100.00
8,625
89.33
8,622
99.97
242
2.51
242
100.00
47
0.49
47
100.00
364
3.77
364
100.00
54
0.56
54
100.00
Paget
16
0.17
16
100.00
12.82
100.00
179
1.85
178
99.44
2.56
100.00
64
0.66
56
87.50
2.56
100.00
18
0.19
18
100.00
46
0.48
11
23.91
19
19
100.00
39
100.00
9,655
9,608
99.51
39
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
9,694
91.20%
*
84.62
23.08
46.15
71.79
5.13
7.69
8,808
4,344
6,521
6,068
298
255
91.23
44.99
67.54
62.85
3.09
2.64
8,841
4,353
6,539
6,096
300
258
91.20
44.90
67.45
62.88
3.09
2.66
33
9
18
28
2
3
- 79 -
ICD-O-FT
T-180
ICD-O-3
ICD-9
ICD-10
C53
179180
C53C55
99
1.85%1.72%
7699
1,680(ICD-O-3 C51 - C58)
34.84%704
()
1,680
()
704
56
65
(10)
2
(10)
3
(10)
(10)
14.57
(10)
9.74
(10)
10.81
6.11
3.79
4.34
1. 96
2. 3.2 1976 3 2000
- 80 -
1,6801,670
99.40%
1,68074.97%
993,337134135
1,254
74.64
1,252
99.84
50
2.98
50
100.00
275
16.37
275
100.00
0.48
100.00
41
2.44
41
100.00
40
2.38
39
97.50
12
0.71
41.67
100.00
1,670
99.40
1,680
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,680
55.95%
878
52.26
940
55.95
720
42.86
0.18
0.18
108
6.43
120
7.14
- 81 -
ICD-O-FT
T-182
ICD-O-3
ICD-9
ICD-10
C54
182
C54
99
1.92%0.46%
61499
1,737(ICD-O-3 C51 C58)36.02%189
()
1,737
()
189
54
58
(10)
2
(10)
3
(10)
(10)
15.07
(10)
10.47
(10)
11.25
1.64
1.11
1.21
1. 96
2. 3.2 1976 3 2000
- 82 -
1,7371,731
99.65%
1,73775.79%
1,313
75.59
1,312
99.92
34
1.96
34
100.00
0.17
100.00
163
9.38
163
100.00
0.52
88.89
58
3.34
58
100.00
47
2.71
47
100.00
Muller
95
5.47
95
100.00
0.12
100.00
0.40
100.00
0.35
33.33
100.00
1,731
99.65
1,737
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,737
90.96%
1,580
90.96
500
28.79
395
22.74
160
9.21
12
0.69
39
2.25
68
3.91
- 83 -
ICD-O-FT
T-183
ICD-O-3
C56C57.0 -
C57.4
ICD-9
ICD-10
183
C56C57.0 -
C57.4
99
1.37%
1.06%98
991,245
(ICD-O-3 C51 - C58)25.82%
434
()
1,245
()
434
52
59
(10)
2
(10)
3
(10)
(10)
10.80
(10)
7.83
(10)
8.46
3.77
2.53
2.79
1. 96
2. 3.2 1976 3 2000
- 84 -
1,245
1,17994.70%
1,24530.28%
159
12.77
145
91.19
377
30.28
375
99.47
159
12.77
159
100.00
169
13.57
169
100.00
51
4.10
51
100.00
37
2.97
32
86.49
0.16
100.00
209
16.79
205
98.09
27
2.17
21
77.78
15
1.20
14
93.33
0.16
100.00
38
3.05
10.53
100.00
1,179
94.70
1,245
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,245
88.59%
1,103
88.59
24
1.93
925
74.30
17
1.37
0.40
64
5.14
52
4.18
- 85 -
ICD-O-FT
ICD-O-3
T-184
C51 - C52C57.7 - C57.9
ICD-9
ICD-10
184
C51 - C52C57.7 - C57.9
99
0.17%
0.09%23
3199
152(ICD-O-3 C51 - C58)
3.15%
37
()
152
()
37
63
70
(10)
2
(10)
3
(10)
(10)
1.32
(10)
0.88
(10)
0.98
0.32
0.19
0.23
1. 96
2. 3.2 1976 3 2000
- 86 -
152
14998.03%
15257.72%
86
56.58
86
100.00
5.92
100.00
5.26
100.00
14
9.21
14
100.00
5.92
100.00
1.32
100.00
12
7.89
12
100.00
3.95
100.00
0.66
100.00
3.29
40.00
152
100.00
149
98.03
Paget
1. 96ICD-O-3 M-CODEp.497
152
54.61%
83
54.61
51
33.55
39
25.66
13
8.55
30
19.74
- 87 -
()
ICD-O-FT
ICD-O-3
ICD-9
ICD-10
T-185
C61
185
C61
99()
4.85%2.49%
5799
()4,392(ICD-O-3 C60
C63)94.23%()1,021
()
4,392
()
1,021
74
80
(10)
(10)
37.75
(10)
(10)
24.17
(10)
8.78
4.67
(10)
28.77
6.04
1. 96
2. 3.2 1976 3 2000
- 88 -
4,392()
4,30498.00%
4,39297.18%
4,268
97.18
4,262
99.86
27
0.61
27
100.00
19
0.43
12
63.16
0.05
100.00
76
1.73
1.32
100.00
4,304
98.00
4,392
100.00
1. 96ICD-O-3 M-CODEp.497
2.
4,392()
61.43%
*
**
1,873
42.65
1,272
28.96
46
1.05
2,698
61.43
***
269
6.12
374
8.52
339
7.72
*
**prostatectomy, cryoprostatectomy, hyperthermia, TURP
***
- 89 -
ICD-O-FT
T-186
ICD-O-3
ICD-9
ICD-10
C62
186
C62
99
0.20%0.04%
223299
178(ICD-O-3 C60
C63)3.82%17
()
178
()
17
28
30
(10)
2
(10)
3
(10)
1.53
1.49
1.54
(10)
2
(10)
3
(10)
0.15
0.12
0.13
1. 96
2. 3.2 1976 3 2000
- 90 -
178177
99.44%
17851.12%
91
51.12
91
100.00
2.25
100.00
3.37
100.00
54
30.34
54
100.00
14
7.87
14
100.00
0.56
100.00
2.25
100.00
1.69
100.00
0.56
12
100.00
177
99.44
12
178
100.00
1. 96ICD-O-3 M-CODEp.497
2.
178
89.89%
160
89.89
43
24.16
61
34.27
1.12
1.69
1.69
2.25
- 91 -
ICD-O-FT
T-187
ICD-O-3
C60C63
ICD-9
ICD-10
187
C60C63
99
0.10%
0.04%30
339991
(ICD-O-3 C60 C63)1.95%
17
()
91
()
17
66
56
(10)
2
(10)
3
(10)
(10)
0.78
(10)
0.53
(10)
0.60
0.15
0.10
0.11
1. 96
2. 3.2 1976 3 2000
- 92 -
91
8997.80%
9152.75%
48
52.75
48
100.00
6.59
100.00
Paget
22
24.18
22
100.00
2.20
100.00
1.10
100.00
9.89
100.00
3.30
33.33
100.00
89
97.80
91
100.00
1. 96ICD-O-3 M-CODEp.497
2.
91
87.91%
80
87.91
9.89
12
13.19
1.10
3.30
5.49
- 93 -
ICD-O-FT
T-188
ICD-O-3
ICD-9
ICD-10
C67
188
C67
99
2.17%1.79%
91612
13991,964
(ICD-O-3 C64 C68)44.22%735
()
1,427
537
72
72
12.26
4.66
(10)
2
(10)
3
7.88
2.80
(10)
9.24
3.28
()
2.82
()
504
231
78
77
4.33
2.00
2.47
1.08
(10)
3.08
1.34
()
2.30
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 94 -
1,964
1,93098.27%98.25%98.32%
93.06%92.18%
99441168
136137
1,328
93.06
1,316
99.10
495
92.18
491
99.19
36
2.52
36
100.00
14
2.61
14
100.00
0.63
100.00
10
1.86
10
100.00
20
1.40
20
100.00
10
1.86
10
100.00
11
0.77
11
100.00
0.28
100.00
0.19
100.00
19
1.33
31.58
1.30
28.57
100.00
1,402
98.25
537
528
98.32
3
1,427
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,964
88.49%
1,253
87.81
485
90.32
1,738
88.49
136
9.53
52
9.68
188
9.57
695
48.70
260
48.42
955
48.63
0.07
0.07
300
21.02
94
17.50
394
20.06
76
5.33
44
8.19
120
6.11
86
6.03
23
4.28
109
5.55
- 95 -
ICD-O-FT
T-189.0
ICD-O-3
ICD-9
ICD-10
C64
189.0
C64
991.13%
1.19%
14201415
991,028(ICD-O-3 C64 - C68)
23.15%490
()
678
350
61
63
5.83
3.04
(10)
2
(10)
3
4.20
2.05
(10)
4.60
2.27
()
2.03
()
289
201
74
77
2.48
1.74
1.54
1.00
(10)
1.83
1.20
()
1.53
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 96 -
1,028916
89.11%89.97%87.43%
92.04%89.71%
624
92.04
574
91.99
314
89.71
282
89.81
1.03
100.00
0.86
100.00
10
1.47
90.00
10
2.86
10
100.00
13
1.92
10
76.92
10
2.86
80.00
0.88
100.00
0.29
100.00
0.15
100.00
17
2.51
17.65
12
3.43
16.67
100.00
100.00
610
89.97
350
306
87.43
2
678
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,028
71.89%
490
72.27
249
71.14
739
71.89
35
5.16
11
3.14
46
4.47
99
14.60
37
10.57
136
13.23
0.29
0.29
12
1.77
1.14
16
1.56
59
8.70
33
9.43
92
8.95
102
15.04
48
13.71
150
14.59
- 97 -
ICD-O-FT
ICD-O-3
ICD-9
ICD-10
T-189.1 - T-189.9
C65 - C66C68
189.1-189.9
C65 - C66C68
99
1.60%
0.76%1513
181899
1,449(ICD-O-3 C64 - C68)32.63%
313
()
675
774
68
71
5.80
6.71
(10)
2
(10)
3
4.03
4.17
(10)
4.56
4.79
()
0.95
()
149
164
76
76
1.28
1.42
0.80
0.79
0.96
0.96
(10)
2
(10)
3
(10)
()
1. 96
2. 3.2 1976 3 2000
- 98 -
1,449
1,40496.89%96.89%96.90%
85.19%91.47%
575
85.19
560
97.39
708
91.47
692
97.74
15
2.22
15
100.00
1.16
100.00
60
8.89
60
100.00
35
4.52
35
100.00
1.04
100.00
10
1.48
10
100.00
1.16
88.89
0.39
100.00
0.15
100.00
0.13
100.00
1.04
14.29
1.16
22.22
100.00
100.00
654
96.89
774
750
96.90
675
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
1,449
76.60%
516
76.44
594
76.74
1,110
76.60
70
10.37
66
8.53
136
9.39
216
32.00
194
25.06
410
28.30
10
1.48
14
1.81
24
1.66
66
9.78
71
9.17
137
9.45
78
11.56
101
13.05
179
12.35
- 99 -
ICD-O-FT
T-190
ICD-O-3
ICD-9
ICD-10
C69
190
C69
99
0.07%0.02%
313438
399961
8
()
39
22
40
44
0.34
0.19
(10)
2
(10)
3
0.49
0.27
(10)
0.42
0.23
()
1.83
()
83
72
0.03
0.04
0.01
0.05
(10)
0.02
0.04
()
0.50
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 100 -
6147
77.05%84.62%63.64%
33.33%
40.91%
13
33.33
61.54
31.82
14.29
10
25.64
10
100.00
40.91
77.78
12.82
100.00
9.09
100.00
12.82
100.00
9.09
100.00
2.56
100.00
5.13
100.00
2.56
100.00
9.09
100.00
2.56
100.00
2.56
17
100.00
29
29
100.00
33
84.62
22
14
63.64
17
39
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
61
72.13%
31
79.49
13
59.09
44
72.13
15.38
27.27
12
19.67
23.08
36.36
17
27.87
5.13
4.55
4.92
- 101 -
ICD-O-FT
T-191
ICD-O-3
ICD-9
ICD-10
C71
191
C71
99
0.81%1.22%
181913
1199734
(ICD-O-3 C71 C72)93.03%501
()
420
314
51
52
(10)
2
(10)
3
3.61
3.29
2.72
2.41
(10)
3.35
2.47
()
1.36
()
286
215
55
58
2.46
1.87
1.89
1.53
(10)
2.06
1.59
()
1.30
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 102 -
734632
86.10%87.14%84.71%
41.43%39.81%
74
17.62
71
95.95
54
17.20
53
98.15
174
41.43
165
94.83
125
39.81
111
88.80
12
2.86
10
83.33
2.55
87.50
23
5.48
23
100.00
24
7.64
23
95.83
42
10.00
29
69.05
33
10.51
25
75.76
15
3.57
15
100.00
2.23
100.00
10
2.38
10
100.00
2.87
77.78
11
2.62
11
100.00
2.55
100.00
23
5.48
19
82.61
2.87
77.78
1.90
87.50
11
3.50
81.82
0.32
100.00
0.48
50.00
1.27
100.00
26
6.19
19.23
21
6.69
19.05
27
27
100.00
30
30
100.00
366
87.14
314
266
84.71
420
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
734
72.89%
*
309
267
214
1
28
38
73.57
63.57
50.95
0.24
6.67
9.05
226
194
145
1
27
31
71.97
61.78
46.18
0.32
8.60
9.87
- 103 -
535
461
359
1
1
55
69
72.89
62.81
48.91
0.24
0.32
7.49
9.40
ICD-O-FT T-192
ICD-O-3
C70C72
ICD-9
ICD-10
192
C70C72
99
0.06%
0.06%3534
343499
55(ICD-O-3 C71 C72)
6.97%24
()
(10)
2
(10)
3
(10)
()
25
30
49
52
0.21
0.26
0.18
0.19
0.83
0.22
0.23
1
()
11
13
36
59
0.09
0.11
0.09
0.08
(10)
0.10
0.09
()
1.11
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 104 -
55
4480.00%72.00%86.67%
40.00%36.67%
6.67
100.00
12.00
100.00
10.00
100.00
16.00
100.00
23.33
100.00
10
40.00
70.00
11
36.67
81.82
3.33
100.00
4.00
100.00
20.00
40.00
16.67
80.00
4.00
100.00
4.00
3.33
100.00
66.67
18
72.00
30
26
86.67
25
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
55
72.73%
17
68.00
23
76.67
40
72.73
10
40.00
11
36.67
21
38.18
12.00
6.67
9.09
4.00
6.67
5.45
16.00
16.67
16.36
- 105 -
ICD-O-FT
T-193
ICD-O-3
ICD-9
ICD-10
C73
193
C73
99
2.66%0.33%
16526
22992,409
135
()
571
1,838
49
47
4.91
15.95
(10)
2
(10)
3
3.66
11.96
(10)
4.02
12.91
()
0.31
()
56
79
70
73
0.48
0.69
0.31
0.40
(10)
0.36
0.48
()
0.75
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 106 -
2,4092,390
99.21%99.30%99.18%
83.89%89.99%
479
83.89
476
99.37
1,654
89.99
1,653
99.94
47
8.23
47
100.00
107
5.82
105
98.13
11
1.93
11
100.00
22
1.20
22
100.00
0.70
100.00
0.16
100.00
0.11
100.00
10
1.75
10
100.00
16
0.87
15
93.75
0.88
100.00
0.27
100.00
10
1.75
10
100.00
14
0.76
13
92.86
0.18
100.00
0.70
75.00
15
0.82
33.33
100.00
15
15
100.00
567
99.30
1,838
1,823
99.18
571
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
2,409
93.03%
513
89.84
1,728
94.02
2,241
93.03
322
56.39
1,043
56.75
1,365
56.66
14
2.45
12
0.65
26
1.08
376
65.85
1,312
71.38
1,688
70.07
19
3.33
27
1.47
46
1.91
32
5.60
57
3.10
89
3.69
- 107 -
ICD-O-FT
T-194
ICD-O-3
ICD-9
ICD-10
C74 - C75
194
C74 - C75
99
0.06%0.10%
343230
309951
43
()
25
26
49
45
0.21
0.23
(10)
2
(10)
3
0.27
0.31
(10)
0.24
0.27
()
0.89
()
19
24
52
43
0.16
0.21
0.20
0.25
(10)
0.18
0.24
()
0.75
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 108 -
5143
84.31%88.00%80.77%
24.00%
34.62%
24.00
100.00
34.62
100.00
16.00
100.00
30.77
87.50
16.00
75.00
7.69
100.00
4.00
100.00
3.85
100.00
8.00
50.00
24.00
100.00
3.85
100.00
8.00
50.00
19.23
20.00
100.00
100.00
22
88.00
26
21
80.77
25
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
51
64.71%
19
76.00
14
53.85
33
64.71
20.00
11.54
15.69
28.00
10
38.46
17
33.33
4.00
3.85
3.92
8.00
7.69
7.84
12.00
26.92
10
19.61
- 109 -
ICD-O-FT
T-196
M-CODEp.497
ICD-O-3
C77
M-CODEp.497
991,312
()
779
533
61
61
6.70
4.62
4.92
3.25
(10)
5.45
3.59
()
1.52
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 110 -
1,312
1,29999.01%99.10%98.87%
151
151100.00%1,029
1,08099.91%
99.84%100.00%
1,312
81.64%83.30%
92
11.81
92
100.00
59
11.07
59
100.00
636
81.64
635
99.84
444
83.30
444
100.00
51
6.55
45
88.24
30
5.63
24
80.00
779
100.00
772
99.10
533
100.00
527
98.87
96ICD-O-3 M-CODEp.497
- 111 -
ICD-O-FT T-140 - T-199 (T-196) M-CODEp.497
ICD-O-3
991,603
()
880
723
66
63
7.56
6.27
5.56
4.32
(10)
6.13
4.78
()
1.28
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 112 -
1,603
1,573 98.13% 97.84%
98.48%21
21100.00%1,002
99999.70%
99.82%99.56%502
47895.22%93.99%
96.80%
1,603
61.70%63.49%
11
1.25
11
100.00
10
1.38
10
100.00
543
61.70
542
99.82
459
63.49
457
99.56
283
32.16
266
93.99
219
30.29
212
96.80
18
2.05
18
100.00
1.11
100.00
25
2.84
24
96.00
27
3.73
25
92.59
880
54.90
861
97.84
723
45.10
712
98.48
96ICD-O-3 M-CODEp.497
- 113 -
( ICD-O-3 M-CODEp.497 )
C00
C77
ICD-O-3
151
1,080
81
1,312
C44.0
C01-C02
21
22
C03
C05-C06
11
11
C09-C10
82
87
C12-C13
C14
C07-C08
22
23
C11
37
40
C16
193
204
C17
61
64
C18
30
31
C19-C21
C22
12
14
C23-C24
C25
C48
C26
C30-C31
47
52
C32
C33-C34
39
50
C38.4
- 114 -
( ICD-O-3 M-CODEp.497)
53
86
490
582
C40-C41
13
14
C47, C49
28
37
C44
74
75
C50
18
19
C53
C54
C55
C56
C61
C62
12
12
C63
C67
C64-C66, C68
C69
46
46
C71
52
57
C70, C72
10
C73
18
19
C74-C75
C76
C80
13
20
172
2,082
502
159
2,915
C37-C38.3, C38.8
C42
C00-C80
- 115 -
39
10
ICD-O-3
ICD-O-FT
p.497
ICD-O-3
p.497
ICD-9
ICD-10
201
C81
99
0.19%0.04%
262935
3799172
(ICD-O-3 M-CODEp.497)5.90%
18
()
103
69
36
29
0.89
0.60
(10)
2
(10)
3
0.84
0.54
(10)
0.85
0.57
()
1.49
()
10
56
44
0.09
0.07
0.06
0.06
(10)
0.07
0.06
()
1.17
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 116 -
172172
100.00%
51.46%57.97%
10
9.71
10
100.00
5.80
100.00
2.91
100.00
100.00
14
13.59
14
100.00
11
15.94
11
100.00
53
51.46
53
100.00
40
57.97
40
100.00
23
22.33
23
100.00
14
20.29
14
100.00
103
100.00
103
100.00
69
100.00
69
100.00
96ICD-O-3 M-CODEp.501
172
87.79%
17
16.50
13.04
26
15.12
36
34.95
29
42.03
65
37.79
87
84.47
64
92.75
151
87.79
18
17.48
12
17.39
30
17.44
2.91
2.91
6.80
4.35
10
5.81
5.83
4.35
5.23
- 117 -
p.497
p.497
ICD-O-FT
ICD-O-3
ICD-9
200202-203
ICD-10
C82 - C85
99
2.30%
2.41%1111
910992,082
(ICD-O-3 M-CODEp.497)71.42%
991
()
1,179
903
63
62
10.13
7.83
(10)
2
(10)
3
7.30
5.39
(10)
8.13
5.97
()
1.36
()
628
363
71
74
5.40
3.15
3.51
1.82
(10)
4.07
2.19
()
1.86
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 118 -
2,0822,078
99.81%99.83%99.78%
B
81.68%87.15%
963
81.68
961
99.79
787
87.15
786
99.87
T/NK
216
18.32
216
100.00
116
12.85
115
100.00
1,179
100.00
1,177
99.83
903
100.00
901
99.78
96ICD-O-3 M-CODEp.497
2,082
75.41%
208
17.64
176
19.49
384
18.44
164
13.91
137
15.17
301
14.46
906
76.84
664
73.53
1,570
75.41
732
62.09
555
61.46
1,287
61.82
0.68
0.22
10
0.48
19
1.61
14
1.55
33
1.59
117
9.92
75
8.31
192
9.22
125
10.60
100
11.07
225
10.81
- 119 -
ICD-O-FT
ICD-O-3
ICD-10
M-973
M-97313 M-97343
C90
990.55%
0.73%
21221619
99502(ICD-O3 M-CODEp.497)17.22%
300
()
283
219
69
69
2.43
1.90
(10)
2
(10)
3
1.66
1.21
(10)
1.88
1.36
()
1.38
()
192
108
73
72
1.65
0.94
1.03
0.57
(10)
1.24
0.66
()
1.88
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 120 -
502478
95.22%26693.99%212
96.80%
50269.92%
2.83
12
5.48
20
3.98
62
21.91
43
19.63
105
20.92
196
69.26
155
70.78
351
69.92
177
62.54
120
54.79
297
59.16
117
41.34
89
40.64
206
41.04
25
8.83
19
8.68
44
8.76
73
25.80
65
29.68
138
27.49
1.77
3.20
12
2.39
- 121 -
ICD-O-FT
T-199
ICD-O-3
ICD-9
ICD-10
C80
199
C80
99
1.02%1.04%
99929
428
()
538
391
69
73
4.62
3.39
(10)
2
(10)
3
3.06
2.00
(10)
3.52
2.36
()
1.49
()
271
157
69
74
2.33
1.36
1.53
0.78
(10)
1.75
0.94
()
1.86
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
- 122 -
929721
77.61%78.81%75.96%
27.88%38.87%
150
27.88
148
98.67
152
38.87
149
98.03
93
17.29
93
100.00
14
3.58
14
100.00
0.93
100.00
0.26
100.00
1.49
100.00
1.28
100.00
0.37
100.00
0.51
100.00
34
6.32
34
100.00
53
13.55
51
96.23
118
21.93
106
89.83
56
14.32
53
94.64
0.26
100.00
10
1.86
10
100.00
1.79
100.00
0.56
100.00
0.26
100.00
0.19
100.00
0.77
66.67
114
21.19
14
12.28
96
24.55
11
11.46
13
100.00
85.71
424
78.81
391
297
75.96
13
538
100.00
100.00
1. 96ICD-O-3 M-CODEp.497
2.
929
30.03%
39
7.25
65
16.62
104
11.19
127
23.61
28
7.16
155
16.68
164
30.48
115
29.41
279
30.03
0.19
0.51
0.32
0.26
0.26
181
33.64
135
34.53
316
34.02
206
38.29
139
35.55
345
37.14
- 123 -
- 124 -
99
- 125 -
99
ICD-O-3
1
C00-C14
C15
C16
C17
C18-C21
C22
C23-C24
C25
C48
C30
C32
C33-C34
1
|
4
5
|
9
10
|
14
15
|
19
41
GENDER
TOTAL
Male
Female
Total
47
Male
22
Female
Total
22
Male
21
Female
13
Total
34
Male
Female
Total
Male
593
Female
342
Total
935
Male
Female
Total
Male
Female
Total
11
Male
Female
Total
Male
Female
Total
Male
Female
Total
Male
21
Female
Total
23
Male
Female
Total
11
1. C00-C14 C00-C06C09-C10C12-C14
- 126 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
10
- C00-C142
-
10
- C15
-
4 C16
-
- C17
-
11
31
79
93
110
112
61
41
26
20
61
57
51
57
24
33
13
15 C18-C21
10
18
51
140
150
161
169
85
74
39
25
- C22
-
- C23-C24
-
- C25
-
- C48
-
- C30
-
- C32
-
2 C33-C34
-
- 127 -
80
| 85+
84
ICD-O-3
99
ICD-O-3
C44
GENDER
TOTAL
1
|
4
5
|
9
10
|
14
15
|
19
Male
158
Female
135
Total
293
1,579
C50
Female
C50
Male
C53
Female
3,337
C54
Female
C56
Female
C51-C52,
Female
77
Male
C57.7-C57.9
C61
C60,C63
Male
14
C67
Male
441
Female
168
Total
609
Male
Female
Total
Male
67
Female
84
Total
151
Male
10
Female
Total
14
Male
1,416
Female
5,771
Total
7,187
C64
C65-C66,
C68
C69
2. C67
- 128 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
| 85+
84
14
12
23
22
30
23
14
20
21
23
23
13 C44
21
34
ICD-O-3
13
28
17
43
43
53
46
13
28
72
166
399
304
226
157
93
62
35
16
2 C50
1 C50
53
177
470
444
461
430
341
280
207
178
134
94
42
24 C53
- C54
- C56
10
10
13
14
1 C51-C52,
C57.7-C57.9
- C60,C63
16
18
26
48
49
60
50
83
49
24
22
27
36
22
11
35 C67
6
19
27
32
72
71
87
86
105
60
41
- C64
-
12
12
12
10
12
23
14
3 C65-C66,
5 C68
20
16
24
31
26
10
2 C69
-
16
19
42
73
135
186
186
217
161
183
117
75
62
195
503
523
645
869
733
624
466
407
319
231
122
69
64
198
519
542
687
942
868
810
652
624
480
414
239
144
- 129 -
C61
ICD-O-FT
T-153T-154
ICD-O-3
C18 - C21
99
935104.0410 3
3.12593105.1010
3 4.1034210
2.971032.20
()
593
342
62
61
5.10
2.97
3.84
2.04
(10)
4.10
2.20
()
1.86
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
4. 52
- 130 -
935
935100.00%
96.63%96.49%
573
96.63
573
100.00
330
96.49
330
100.00
1.01
100.00
1.17
100.00
14
2.36
14
100.00
2.34
100.00
593
100.00
593
100.00
342
100.00
342
100.00
935
90.16%
531
89.54
312
91.23
843
90.16
0.34
0.88
0.53
0.67
1.75
10
1.07
0.17
0.17
44
7.42
22
6.43
66
7.06
- 131 -
ICD-O-FT
T-174T-175
ICD-O-3
C50
991,5793
10 13.70 10 3
10.29100.03103
0.02
()
1,579
77
51
0.03
13.70
0.01
9.69
0.02
10.29
514.50
(10)
2
(10)
3
(10)
()
1. 96
2. 3.2 1976 3 2000
4. 52
- 132 -
1,5791,579
100.00%3
3100.00%
66.67%
87.78%
33.33
100.00
1,386
87.78
1,386
100.00
0.06
100.00
37
2.34
37
100.00
10
0.63
10
100.00
66.67
100.00
134
8.49
134
100.00
11
0.70
11
100.00
100.00
100.00
1,579
100.00
1,579
100.00
1,579
95.07%
100.00
1,501
95.06
1,504
95.07
510
32.30
510
32.30
14
0.89
14
0.89
33.33
913
57.82
914
57.77
0.06
0.06
42
2.66
42
2.66
- 133 -
ICD-O-FT
T-180
ICD-O-3
C53
993,33710
28.9510323.34
()
3,337
45
(10)
28.95
(10)
2
(10)
21.10
23.34
1. 96
2. 3.2 1976 3 2000
4. 52
- 134 -
3,3373,338
100.00%
90.74%
3,029
90.77
3,029
100.00
0.15
100.00
89
2.67
89
100.00
214
6.41
213
99.53
3,337
100.00
3,337
100.00
3,337
88.97%
2,969
88.97
0.27
0.09
0.09
297
8.90
- 135 -
ICD-O-FT
T-188
ICD-O-3
C67
9960910
2.6310 3 1.97441
103.791032.92
168101.46103
1.07
()
441
168
69
68
3.79
1.46
2.54
0.97
(10)
2.92
1.07
()
2.73
(10)
2
(10)
3
1. 96
2. 3.2 1976 3 2000
4. 52
- 136 -
609607
99.67%
99.32%98.81%
438
99.32
438
100.00
166
98.81
164
98.80
0.60
100.00
0.45
100.00
0.23
100.00
0.60
100.00
441
100.00
441
100.00
168
100.00
166
98.81
60993.92%
420
95.24
152
90.48
572
93.92
0.91
1.19
0.99
**
265
60.09
98
58.33
363
59.61
94
21.32
36
21.43
130
21.35
0.91
0.60
0.82
12
2.72
12
7.14
24
3.94
*
**
- 137 -
- 138 -
99
- 139 -
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
ICD-O-3
C00-C80
C00-C14
C00-C14
15
|
19
30
68
63
91
156
Female
39,757
24
59
42
85
99
Total
90,649
54
127
105
176
255
Male
7,353
14
Female
1,014
Total
8,367
20
Male
6,028
Female
532
Total
6,560
Male
3,967
Female
425
Total
4,392
Male
1,086
Female
83
Total
1,169
Male
975
Female
24
Total
999
C44.0
Male
210
Female
18
Total
228
Male
1,583
TONGUE
Female
222
Total
1,805
Male
384
GUM
Female
61
Total
445
Male
151
FLOOR OF MOUTH
Female
13
Total
164
Male
2,125
Female
144
Total
2,269
Male
586
OROPHARYNX
Female
49
Total
635
HYPOPRAYNX
MOUTH
C09-C10
10
|
14
50,892
OROPHARYNX
C05-C06
5
|
9
Male
C04
TOTAL
1
|
4
ORAL CAVITY
C03
GENDER
ALL SITES
C01-C02
HYPOPHARYNX
C00
1. 96 ICD-O-3 M-CODE
p.497
2. ICD-O-3
C00-C06C09-C10C12-C14
- 140 -
20
|
24
25
|
29
30
|
34
191
342
206
487
397
829 1,658 2,744 4,906 7,732 9,692 11,031 9,223 9,476 9,727 9,484 7,766 5,267
212
35
|
39
462
40
|
44
11
48
12
21
43
62
23
69
255
524
20
121
354
707
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
125
101
67
89
65
51
32
1,288
824
591
431
310
193
101
977
619
451
291
196
124
60
ICD-O-3
69 C00-C14
135
24
142
85+
245
80
|
84
723
126
342
75
|
79
1,163
77
524
70
|
74
2
58 C00-C14
10
18
70
66
59
48
58
43
36
26
27
131
372
1,043
678
499
349
239
160
84
20
110
269
502
639
736
618
383
286
182
109
75
34
16
19
40
50
50
50
39
52
34
31
23
27
118
285
521
679
786
668
433
325
234
143
106
57
60
117
190
207
185
125
83
47
36
24
17
17
10
62
122
207
224
195
132
90
51
44
27
25
88
150
184
174
111
82
62
51
25
18
25
88
153
187
180
113
84
64
52
27
20
19
21
36
38
27
30
20
- C00
19
22
36
39
30
33
23
57
124
215
252
287
251
144
97
73
43
21
9 C01-C02
14
13
30
36
27
27
23
13
12
10
14
60
138
228
282
323
278
171
120
86
55
31
16
15
41
43
79
65
38
35
19
19
14
11
16
44
47
83
73
46
39
30
25
20
13
10
14
29
32
33
17
- C04
11
14
31
35
35
17
10
45
141
264
370
392
318
218
160
83
56
46
11
14
16
14
12
24
13
13
10
50
143
269
381
406
334
232
172
107
69
59
29
33
65
111
112
96
63
43
26
20
11
10
33
68
120
122
102
68
46
28
26
14
- 141 -
8 C03
20 C05-C06
3 C09-C10
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C12-C13
C14
GENDER
Male
HYPOPHARYNX
Female
C11
1
|
4
5
|
9
10
|
14
15
|
19
921
21
TOTAL
Total
942
Male
68
Female
Total
72
Male
131
Female
105
Total
236
Male
1,194
10
NASOPHARYNX
Female
377
Total
1,571
12
C07-C08
C15-C26,
Male
22,112
C48
Female
12,143
11
Total
34,255
18
Male
2,091
ESOPHAGUS
Female
147
C15
C16
C17
C18-C21
Total
2,238
Male
2,415
STOMACH
Female
1,439
Total
3,854
Male
190
SMALL INTESTINE
Female
135
Total
325
Male
8,143
Female
5,897
Total
14,040
Male
4,871
COLON
Female
3,764
Total
8,635
Male
3,272
Female
2,133
Total
5,405
AND ANUS
C18
C19-C21
ANUS
1. 96 ICD-O-3 M-CODE
p.497
- 142 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
24
87
144
168
165
104
76
60
45
25
24
87
146
171
170
106
78
62
46
27
19
21
11
- C14
10
21
12
11
14
14
20
19
10
11
1 C07-C08
15
12
10
11
10
10
26
26
24
27
27
19
14
14
16
14
24
87
97
161
171
205
167
96
63
47
38
10
12
27
29
41
56
58
51
31
15
21
17
12
36
114
126
202
227
263
218
127
78
68
55
19
13
25
77
197
435
889 1,614 2,347 3,046 2,671 2,651 2,504 2,396 1,998 1,237 C15-C26,
46
120
192
310
34
123
317
627 1,199 2,192 3,313 4,359 3,973 4,227 4,230 4,070 3,275 2,268
54
192
316
385
361
239
165
126
98
86
58 C15
13
14
13
22
11
21
22
17
55
199
321
398
375
252
187
137
119
108
75
11
36
60
104
202
246
219
227
283
372
391
258 C16
21
33
54
95
112
137
130
139
176
188
184
160
12
32
69
114
199
314
383
349
366
459
560
575
418
17
21
19
23
21
24
20
19
10
11
15
24
21
10
11
14
11
24
31
30
38
45
45
30
30
23
10
32
82
135
221
414
969
933
818
514 C18-C21
24
72
109
169
341
579
717
699
554
503
13
56
154
244
390
21
52
74
129
218
443
624
625
662
569
561
546
341 C18
16
53
70
108
203
351
439
409
483
461
464
357
346
37
105
144
237
421
903
687
11
30
61
92
196
310
448
429
472
400
372
272
173 C19-C21
19
39
61
138
228
278
248
266
256
235
197
157
19
49
100
153
334
538
726
677
738
656
607
469
330
578
85+
ICD-O-3
18 C12-C13
10 C11
717
- 143 -
657
749
9 C17
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C22
C23-C24
GENDER
C48
C26
C33-C34
C38.4
15
|
19
TOTAL
Male
7,751
Female
3,272
Total
11,023
Male
486
Female
438
Total
924
Male
937
PANCREAS
Female
706
Total
1,643
Male
80
Female
77
Total
157
Male
19
Female
32
Total
51
Male
7,630
Female
4,131
Total
11,761
Male
119
Female
53
Total
172
Male
602
LARYNX
Female
33
Total
635
Male
6,697
Female
3,918
Total
10,615
Male
43
PLEURA
Female
19
Total
62
C32
10
|
14
ORGANS
C30-C31
5
|
9
C30-C39
1
|
4
DUCTS
C25
C37-C38.3,
Male
168
C38.8
Female
108
Total
276
1. 96 ICD-O-3 M-CODE
p.497
- 144 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
32
83
185
376
668
865 1,172
970
936
914
769
500
259 C22
16
33
43
79
172
370
500
605
541
361
218
12
40
99
218
419
861
477
32
23
60
47
51
65
75
70
47 C23-C24
10
27
40
38
51
81
87
48
43
10
16
42
50
100
85
102
146
162
118
90
11
26
54
87
104
108
108
118
118
111
87 C25
10
18
27
46
58
70
74
106
121
88
76
21
44
81
133
162
178
182
224
239
199
163
2 C48
11
12
12
19
14
20
13
19
12
15
3 C26
12
10
13
53
71
175
337
540
774
777
610 C30-C39
11
32
51
158
255
367
506
453
479
416
347
12
24
85
122
333
592
957
11
16
17
12
12
16
3 C30-C31
12
18
22
23
15
19
20
10
20
50
79
100
77
72
59
61
38
22
52
83
104
80
76
64
62
42
37
31
55
130
262
421
635
669
811
954 1,156
995
567 C33-C34
25
44
140
234
344
477
433
455
516
405
338
11
56
99
270
496
905
- C38.4
12
14
17
20
15
16
12
14
13
11
11
12
12
17
10
11
18
28
21
32
32
26
21
25
18
15
316
- 145 -
539
509
499
85+
ICD-O-3
34 C32
6 C37-C38.3,
1 C38.8
7
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C42
C40-C41
C47, C49
GENDER
C44
C44
5
|
9
10
|
14
15
|
19
1,087
21
14
24
29
736
36
15
TOTAL
Male
LEUKEMIA
Female
Total
1,823
10
57
22
39
36
Male
89
12
13
Female
74
11
Total
163
23
22
Male
276
12
Female
232
Total
508
21
Male
1,575
SKIN
Female
1,403
Total
2,978
Male
125
Female
87
Total
212
Male
1,450
Female
1,316
Total
2,766
Female
9,655
Male
39
Female
4,822
13
11
Female
C50
1
|
4
SOFT TISSUES
C44
FEMALE BREAST
C50
MALE BREAST
C51-C58
C55
UTERUS, NOS
1. 96 ICD-O-3 M-CODE
p.497
4. ICD-O-3 M-CODE p.497
5. ICD-O-3 C44 M-87203 - M-87903
- 146 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
22
34
49
41
41
70
91
79
72
83
118
110
113
12
27
36
40
30
50
49
73
56
56
68
70
54
45
34
61
85
81
71
120
140
152
128
139
186
180
167
115
- C40-C41
11
10
12
10
10
10
10
11
10
15
35
25
34
21
12
22
26
20
12 C47, C49
14
11
19
21
21
21
18
13
28
16
10
10
13
14
25
21
34
56
46
55
39
25
50
42
30
22
10
16
29
34
51
55
81
102
122
153
196
261
262
197 C44
21
16
21
38
57
77
103
95
107
197
212
211
237
14
37
45
55
89
112
158
205
217
260
393
473
473
434
11
14
15
10
21
11
13
14
11
10
18
24
16
22
24
32
19
18
14
27
28
46
51
72
91
108
138
186
240
251
185 C44
18
14
19
33
52
68
90
93
100
183
201
203
231
13
32
41
47
79
103
140
181
201
238
369
441
454
416
14
91
281
890
701
479
282
159
116 C50
5 C50
39
71
169
254
411
686
815
766
453
360
269
217
177
- 147 -
85+
ICD-O-3
4
70 C42
5
12 C44
107 C51-C58
1 C55
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C53
GENDER
1
|
4
5
|
9
10
|
14
15
|
19
TOTAL
Female
1,680
Female
1,737
Female
1,245
11
11
C57.7-C57.9
Female
152
CERVIX UTERI
C54
CORPUS UTERI
C56,
C51-C52,
C60-C63
Male
4,661
17
Male
4,392
Male
178
17
Male
91
Male
2,780
URINARY TRACT
Female
1,661
Total
4,441
Male
1,427
BLADDER
Female
537
C61
PROSTATE GLAND
C62
TESTIS
C60,C63
C64-C68
C67
C64
Total
1,964
Male
678
KIDNEY
Female
350
Total
1,028
1. 96 ICD-O-3 M-CODE
p.497
- 148 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
13
61
92
149
211
236
228
148
144
116
103
110
66
C53
23
55
65
140
269
381
338
180
127
73
50
21
12
C54
31
34
50
95
116
190
183
182
106
78
68
44
30
14
C56,
ICD-O-3
C57.0-C57.4
14
13
18
19
10
11
20
15
14
C51-C52,
C57.7-C57.9
37
41
30
22
17
33
95
236
405
657
888
917
825
435
C60-C63
19
79
222
396
647
874
911
813
427
C61
37
40
29
20
C62
10
10
10
14
12
C60,C63
23
48
76
154
216
307
276
325
364
423
318
228
C64-C68
11
22
34
55
98
160
192
213
258
253
205
147
11
34
70
110
209
314
467
468
538
622
676
523
375
14
32
64
87
138
118
156
200
247
207
150
18
41
50
49
66
85
89
76
49
10
20
38
82
128
188
167
222
285
336
283
199
13
27
24
60
78
102
79
61
71
57
52
39
11
26
21
30
40
42
36
38
36
33
21
20
38
50
81
108
142
121
97
109
93
85
60
- 149 -
C67
C64
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C70, C72
C74-C75
1
|
4
5
|
9
10
|
14
15
|
19
TOTAL
Male
348
RENAL PELVIS
Female
396
Total
744
Male
200
URETER
Female
251
Total
451
Male
16
Female
Total
24
Male
Female
Total
11
Male
107
Female
112
Total
219
Male
39
Female
22
Total
61
13
Male
445
12
18
18
15
Female
344
12
13
Total
789
11
18
30
31
24
Male
420
12
17
18
12
BRAIN
Female
314
11
12
Total
734
10
18
28
30
21
Male
25
Female
30
Total
55
Male
571
THYROID GLAND
Female
1,838
12
14
NERVOUS SYSTEM
C73
GENDER
NERVOUS SYSTEM
C71
Total
2,409
12
19
Male
25
Female
26
Total
51
1. 96 ICD-O-3 M-CODE
p.497
- 150 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
12
15
27
41
39
53
43
62
30
17
10
16
36
55
58
60
64
49
39
14
25
43
77
94
111
103
126
79
56
17
17
24
36
25
34
16
16
20
33
35
53
42
29
30
13
20
37
57
71
78
76
45
46
12
17
20
21
13
13
12
17
21
20
15
10
19
24
34
41
41
28
10
11
18
20
20
32
39
38
38
34
43
32
20
20
13
10
17
26
26
23
26
38
26
26
27
26
10
21
26
37
46
58
62
64
76
60
69
59
46
30
21
11
16
19
18
30
37
36
37
32
41
31
20
18
11
10
15
24
23
22
21
37
22
24
25
25
21
23
34
42
53
59
57
74
54
65
56
45
27
17
11
28
59
64
59
66
77
71
43
27
26
14
14
72
119
129
186
240
277
268
202
109
89
57
35
17
12
83
147
188
250
299
343
345
273
152
116
83
49
31
18
- 151 -
ICD-O-3
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
ICD-O-3
C76
C80
GENDER
1
|
4
5
|
9
10
|
14
15
|
19
TOTAL
Male
Female
Total
15
Male
538
Female
391
Total
929
Male
1,659
15
23
31
Female
1,256
13
Total
2,915
12
24
27
44
MALIGNANT LYMPHOMA
1. 96 ICD-O-3 M-CODE
p.497
- 152 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
- C76
19
31
46
57
41
56
59
71
64
64 C80
13
19
25
25
35
34
52
50
74
51
11
13
32
50
71
82
76
90
111
121
138
115
25
45
44
53
50
105
127
169
154
178
169
180
171
110
21
48
41
39
58
80
107
131
136
121
145
151
90
59
46
93
85
92
108
185
234
300
290
299
314
331
261
169
- 153 -
85+
ICD-O-3
99
WHO 2008 1
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
1
|
4
5
|
9
10
|
14
15
|
19
1,087
21
14
24
29
736
36
15
GENDER
TOTAL
Male
Female
Total
1,823
10
57
22
39
36
Male
425
Female
309
Total
734
13
Male
60
Female
41
Total
101
Male
38
Female
21
Total
59
Male
Female
Total
Male
132
Female
93
Total
225
Male
183
Female
145
Total
328
Male
Myeloid sarcoma
Female
Total
Male
Female
Total
Male
131
17
10
14
14
Female
104
30
Total
235
47
17
19
16
B /
Male
116
16
12
13
Female
101
30
Total
217
46
15
17
15
- 154 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
22
34
49
41
41
70
91
79
72
83
118
110
113
70
12
27
36
40
30
50
49
73
56
56
68
70
54
45
34
61
85
81
71
120
140
152
128
139
186
180
167
115
18
17
18
17
27
36
36
33
30
50
46
41
28
13
14
25
13
26
18
34
22
14
36
28
24
22
12
31
31
43
30
53
54
70
55
44
86
74
65
50
10
11
10
11
10
13
12
20
22
18
12
10
16
12
10
16
10
17
18
30
38
30
21
15
11
25
18
11
20
17
13
11
14
14
10
15
10
19
10
10
10
13
13
21
14
29
21
40
28
16
39
27
23
21
10
10
12
14
18
13
15
12
10
11
17
13
15
11
- 155 -
99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
1
|
4
5
|
9
10
|
14
15
|
19
15
GENDER
T /
Male
Female
TOTAL
Total
18
Male
148
Female
77
Total
225
Male
89
Female
46
Total
135
Male
19
Female
16
Total
35
Male
135
MYELOPROLIFERATIVE NEOPLASMS
Female
95
Total
230
Male
124
MYELODYSPLASTIC SYNDROMES
Female
76
Total
200
Male
Female
Total
Male
OTHER LEUKEMIA
Female
Total
13
Male
LEUKEMIA, NOS
Female
Total
12
- 156 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
16
13
13
17
14
10
10
26
17
16
19
25
18
13
12
18
11
15
10
11
14
15
10
13
13
12
19
21
22
14
17
11
17
11
16
20
16
10
12
11
16
14
12
17
22
20
15
27
20
34
21
16
13
14
15
16
28
13
13
15
11
14
17
22
28
31
39
19
- 157 -
99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
GENDER
1
|
4
5
|
9
10
|
14
15
|
19
TOTAL
Male
1,659
15
23
31
MALIGNANT LYMPHOMA
Female
1,256
13
Total
2,915
12
24
27
44
Male
103
13
HODGKIN LYMPHOMA
Female
69
Total
172
19
Male
1,179
11
18
NON-HODGKIN LYMPHOMA
Female
903
Total
2,082
17
12
24
Male
963
10
Female
787
Total
1,750
11
14
Male
116
Female
126
Total
242
Male
27
Female
41
Total
68
Male
26
Lymphoplasmacytic lymphoma
Female
Total
31
Male
104
Follicular lymphoma
Female
122
Total
226
Male
41
Female
14
Total
55
Burkitt
Male
35
Burkitt lymphoma
Female
14
Total
49
B ()
Male
597
Female
480
Total
1,077
- 158 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
25
45
44
53
50
105
127
169
154
178
169
180
171
110
21
48
41
39
58
80
107
131
136
121
145
151
90
59
46
93
85
92
108
185
234
300
290
299
314
331
261
169
11
12
12
10
20
10
21
32
13
12
10
11
13
13
31
37
40
41
78
92
123
109
116
123
131
122
80
11
28
31
33
50
64
83
94
99
93
94
102
61
45
24
59
68
73
91
142
175
217
208
209
217
233
183
125
19
27
34
31
57
78
108
87
100
101
106
107
75
10
25
24
24
42
52
76
81
88
83
84
94
53
44
17
44
51
58
73
109
154
189
175
183
185
200
160
119
14
15
13
15
15
13
16
14
13
12
13
12
10
12
17
30
21
28
25
28
27
20
11
11
19
13
13
10
10
25
18
18
16
10
13
21
36
37
31
29
14
11
10
12
14
10
14
22
20
35
42
70
51
60
61
62
76
59
17
16
13
20
31
32
42
48
54
58
68
37
35
27
30
35
40
66
74
112
99
114
119
130
113
94
- 159 -
99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
1
|
4
5
|
9
10
|
14
15
|
19
GENDER
TOTAL
Male
Female
Total
12
Male
37
Female
21
Total
58
T/NK
Male
216
Female
116
Total
332
10
NK/T
Male
31
Female
18
Total
49
T / Sezary
Male
23
Female
17
Total
40
Male
Female
Total
Male
Female
Total
Male
Female
Total
Male
83
Female
32
Total
115
Male
26
Female
18
Total
44
Male
21
Female
10
Total
31
- 160 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
12
10
10
21
14
15
22
16
22
25
15
12
13
11
10
10
15
17
15
18
33
21
28
33
26
32
33
23
11
11
13
10
12
13
11
15
16
14
- 161 -
99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED
1
|
4
5
|
9
10
|
14
15
|
19
GENDER
TOTAL
T /
Male
Female
Total
Male
23
Female
10
Total
33
Male
283
Female
219
Total
502
Male
18
Other LPD
Female
Total
26
Male
18
Female
Total
26
Male
76
Female
57
Total
133
- 162 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
16
21
26
32
47
36
36
40
20
13
15
28
27
25
42
35
19
10
29
36
54
59
72
78
71
59
30
11
12
10
12
15
18
12
13
24
16
12
- 163 -
10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010
ICD-O-3
C00-C80
ALL SITES
C00-C14
C00-C14
ORAL CAVITY
OROPHARYNX
HYPOPRAYNX
C44.0
C00
C01-C02
TONGUE
C03
GUM
C04
FLOOR OF MOUTH
C05-C06
C09-C10
OROPHARYNX
C12-C13
HYPOPHARYNX
C14
C07-C08
C11
NASOPHARYNX
C15-C26, C48
2. 2 1976
3. 3 2000
4. ICD-O-3
C00-C06C09-C10C12-C14
- 164 -
TOTAL
MALE
CRUDE
RATE
2
ASR2
3
ASR3
CASE
NUMBER
90,649
391.37
265.83
296.67
8,367
36.12
25.69
6,560
28.32
4,392
FEMALE
CRUDE
RATE
2
ASR2
3
ASR3
CASE
NUMBER
CRUDE
RATE
2
ASR2
3
ASR3
50,892
437.40
303.57
340.66
39,757
344.91
231.31
256.23
C00-C80
27.82
7,353
63.20
45.96
49.67
1,014
8.80
6.05
6.66
C00-C14
20.07
21.68
6,028
51.81
37.62
40.56
532
4.62
3.09
3.41
C00-C144
18.96
13.48
14.59
3,967
34.09
24.82
26.80
425
3.69
2.47
2.73
1,169
5.05
3.58
3.85
1,086
9.33
6.78
7.27
83
0.72
0.49
0.53
999
4.31
3.01
3.25
975
8.38
6.01
6.48
24
0.21
0.13
0.15
228
0.98
0.72
0.77
210
1.80
1.36
1.45
18
0.16
0.10
0.11
C00
1,805
7.79
5.56
6.02
1,583
13.61
9.90
10.72
222
1.93
1.34
1.46
C01-C02
445
1.92
1.33
1.45
384
3.30
2.35
2.56
61
0.53
0.34
0.38
C03
164
0.71
0.49
0.53
151
1.30
0.92
0.99
13
0.11
0.07
0.08
C04
2,269
9.80
6.98
7.53
2,125
18.26
13.33
14.34
144
1.25
0.83
0.92
C05-C06
635
2.74
1.94
2.09
586
5.04
3.66
3.92
49
0.43
0.28
0.31
C09-C10
942
4.07
2.84
3.07
921
7.92
5.68
6.12
21
0.18
0.12
0.13
C12-C13
72
0.31
0.21
0.23
68
0.58
0.42
0.45
0.03
0.02
0.02
C14
236
1.02
0.73
0.81
131
1.13
0.80
0.89
105
0.91
0.66
0.73
C07-C08
1,571
6.78
4.89
5.33
1,194
10.26
7.54
8.22
377
3.27
2.30
2.52
C11
34,255
147.89
98.39
110.57
22,112
190.04
131.93
147.25
12,143
105.34
66.58
75.74
CASE
NUMBER
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 165 -
ICD-O-3
C15-C26, C48
10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED
ICD-O-3
C15
ESOPHAGUS
C16
STOMACH
C17
SMALL INTESTINE
C18-C21
C18
COLON
C19-C21
C22
C23-C24
C25
PANCREAS
C48
C26
C30-C39
C30-C31
C32
LARYNX
C33-C34
C38.4
PLEURA
C37-C38.3, C38.8
2. 2 1976
3. 3 2000
- 166 -
TOTAL
CASE
NUMBER
MALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
FEMALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
CRUDE
RATE
2
2
ASR
3
3
ASR
ICD-O-3
2,238
9.66
6.66
7.23
2,091
17.97
12.77
13.81
147
1.28
0.77
0.90
C15
3,854
16.64
10.30
12.03
2,415
20.76
13.14
15.43
1,439
12.48
7.66
8.85
C16
325
1.40
0.96
1.06
190
1.63
1.14
1.27
135
1.17
0.78
0.86
C17
14,040
60.62
40.34
45.32
8,143
69.99
48.58
54.39
5,897
51.16
32.65
36.84
C18-C21
8,635
37.28
24.62
27.78
4,871
41.86
28.75
32.36
3,764
32.65
20.75
23.48
C18
5,405
23.34
15.72
17.54
3,272
28.12
19.83
22.04
2,133
18.50
11.90
13.35
C19-C21
11,023
47.59
32.41
36.07
7,751
66.62
47.52
52.34
3,272
28.39
18.00
20.54
C22
924
3.99
2.49
2.91
486
4.18
2.70
3.14
438
3.80
2.28
2.67
C23-C24
1,643
7.09
4.54
5.21
937
8.05
5.39
6.13
706
6.12
3.73
4.33
C25
157
0.68
0.54
0.57
80
0.69
0.58
0.60
77
0.67
0.51
0.54
C48
51
0.22
0.15
0.17
19
0.16
0.11
0.12
32
0.28
0.19
0.21
C26
11,761
50.78
32.56
37.40
7,630
65.58
43.20
49.98
4,131
35.84
22.71
25.69
C30-C39
172
0.74
0.53
0.58
119
1.02
0.73
0.80
53
0.46
0.34
0.36
C30-C31
635
2.74
1.85
2.05
602
5.17
3.62
4.00
33
0.29
0.18
0.21
C32
10,615
45.83
29.10
33.61
6,697
57.56
37.49
43.68
3,918
33.99
21.38
24.27
62
0.27
0.19
0.21
43
0.37
0.26
0.29
19
0.16
0.11
0.12
C38.4
276
1.19
0.89
0.96
168
1.44
1.09
1.20
108
0.94
0.68
0.73
C37-C38.3, C38.8
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 167 -
C33-C34
10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED
ICD-O-3
C42
LEUKEMIA
C40-C41
C47, C49
C44
SKIN
7
C44
C44
C50
FEMALE BREAST
C50
MALE BREAST
C51-C58
C55
UTERUS, NOS
C53
CERVIX UTERI
C54
CORPUS UTERI
C56, C57.0-C57.4
C51-C52, C57.7-C57.9
C60-C63
2. 2 1976
3. 3 2000
6. ICD-O-3
M-CODE p.497
7. ICD-O-3
C44M-87203 - M-87903
- 168 -
TOTAL
CASE
NUMBER
MALE
2
2
ASR
CASE
NUMBER
CRUDE
RATE
3
3
ASR
FEMALE
CRUDE
RATE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
ICD-O-3
1,823
7.87
6.27
6.66
1,087
9.34
7.30
7.91
736
6.39
5.29
5.48
C426
163
0.70
0.70
0.71
89
0.76
0.77
0.77
74
0.64
0.63
0.65
C40-C41
508
2.19
1.63
1.78
276
2.37
1.75
1.93
232
2.01
1.51
1.63
C47, C49
2,978
12.86
7.85
9.29
1,575
13.54
8.62
10.20
1,403
12.17
7.13
8.44
C44
212
0.92
0.60
0.69
125
1.07
0.74
0.85
87
0.75
0.47
0.54
C447
2,766
11.94
7.24
8.60
1,450
12.46
7.88
9.35
1,316
11.42
6.66
7.90
C44
9,655
83.76
58.63
63.16
9,655
83.76
58.63
63.16
C50
39
0.34
0.21
0.24
39
0.34
0.21
0.24
C50
4,822
41.83
28.96
31.54
4,822
41.83
28.96
31.54
0.07
0.04
0.05
0.07
0.04
0.05
C55
1,680
14.57
9.74
10.81
1,680
14.57
9.74
10.81
C53
1,737
15.07
10.47
11.25
1,737
15.07
10.47
11.25
C54
1,245
10.80
7.83
8.46
1,245
10.80
7.83
8.46
C56, C57.0-C57.4
152
1.32
0.88
0.98
152
1.32
0.88
0.98
C51-C52, C57.7-C57.9
4,661
40.06
26.19
30.90
4,661
40.06
26.19
30.90
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 169 -
C51-C58
C60-C63
10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED
ICD-O-3
C61
PROSTATE GLAND
C62
TESTIS
C60,C63
C64-C68
URINARY TRACT
C67
BLADDER
C64
KIDNEY
C65
RENAL PELVIS
C66
URETER
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
BRAIN
C70, C72
C73
THYROID GLAND
C74-C75
2. 2 1976
3. 3 2000
- 170 -
TOTAL
CASE
NUMBER
MALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
FEMALE
CRUDE
RATE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
ICD-O-3
4,392
37.75
24.17
28.77
4,392
37.75
24.17
28.77
C61
178
1.53
1.49
1.54
178
1.53
1.49
1.54
C62
91
0.78
0.53
0.60
91
0.78
0.53
0.60
C60,C63
4,441
19.17
12.46
14.24
2,780
23.89
16.11
18.40
1,661
14.41
9.02
10.33
C64-C68
1,964
8.48
5.26
6.16
1,427
12.26
7.88
9.24
537
4.66
2.80
3.28
C67
1,028
4.44
3.10
3.41
678
5.83
4.20
4.60
350
3.04
2.05
2.27
C64
744
3.21
2.11
2.41
348
2.99
2.07
2.35
396
3.44
2.15
2.46
C65
451
1.95
1.28
1.45
200
1.72
1.20
1.35
251
2.18
1.34
1.54
C66
24
0.10
0.07
0.08
16
0.14
0.10
0.11
0.07
0.04
0.05
C68.0-C68.1
11
0.05
0.03
0.03
0.03
0.03
0.03
0.06
0.03
0.04
C68.8
219
0.95
0.62
0.71
107
0.92
0.63
0.72
112
0.97
0.60
0.70
C68.9
61
0.26
0.38
0.33
39
0.34
0.49
0.42
22
0.19
0.27
0.23
C69
789
3.41
3.05
3.11
445
3.82
3.47
3.54
344
2.98
2.63
2.70
C70-C72
734
3.17
2.85
2.91
420
3.61
3.29
3.35
314
2.72
2.41
2.47
C71
55
0.24
0.20
0.21
25
0.21
0.18
0.19
30
0.26
0.22
0.23
C70, C72
2,409
10.40
7.83
8.49
571
4.91
3.66
4.02
1,838
15.95
11.96
12.91
51
0.22
0.28
0.25
25
0.21
0.27
0.24
26
0.23
0.31
0.27
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 171 -
C73
C74-C75
10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED
ICD-O-3
C76
C80
MALIGNANT LYMPHOMA
2. 2 1976
3. 3 2000
- 172 -
TOTAL
CASE
NUMBER
MALE
2
2
ASR
CASE
NUMBER
CRUDE
RATE
3
3
ASR
FEMALE
CRUDE
RATE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
ICD-O-3
15
0.06
0.05
0.05
0.08
0.07
0.07
0.05
0.04
0.04
C76
929
4.01
2.51
2.92
538
4.62
3.06
3.52
391
3.39
2.00
2.36
C80
2,915
12.59
9.00
9.95
1,659
14.26
10.48
11.58
1,256
10.90
7.57
8.37
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 173 -
10 99 WHO 2008 1
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010
Myeloid sarcoma
B /
B lymphoblastic leukemia / lymphoma
T /
T lymphoblastic leukemia / lymphoma
- 174 -
TOTAL
MALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
9.34
7.30
7.91
736
6.39
5.29
5.48
425
3.65
2.70
2.99
309
2.68
1.94
2.13
0.39
60
0.52
0.46
0.48
41
0.36
0.28
0.30
0.16
0.19
38
0.33
0.20
0.24
21
0.18
0.11
0.13
0.04
0.03
0.03
0.03
0.02
0.02
0.05
0.03
0.04
225
0.97
0.65
0.75
132
1.13
0.78
0.90
93
0.81
0.53
0.61
328
1.42
1.05
1.14
183
1.57
1.17
1.28
145
1.26
0.95
1.02
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.04
0.03
0.02
0.02
0.02
0.04
0.03
0.04
235
1.01
1.45
1.28
131
1.13
1.45
1.33
104
0.90
1.45
1.23
217
0.94
1.35
1.19
116
1.00
1.28
1.17
101
0.88
1.43
1.21
18
0.08
0.09
0.09
15
0.13
0.16
0.16
0.03
0.02
0.02
2
2
ASR
CASE
NUMBER
FEMALE
3
3
ASR
CASE
NUMBER
CRUDE
RATE
1,823
7.87
6.27
6.66
1,087
734
3.17
2.31
2.54
101
0.44
0.37
59
0.25
CRUDE
RATE
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 175 -
MYELOPROLIFERATIVE NEOPLASMS
MYELODYSPLASTIC SYNDROMES
OTHER LEUKEMIA
LEUKEMIA, NOS
- 176 -
TOTAL
MALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
1.27
0.95
1.05
77
0.67
0.49
0.54
89
0.76
0.53
0.60
46
0.40
0.27
0.29
0.12
19
0.16
0.11
0.13
16
0.14
0.09
0.11
0.67
0.76
135
1.16
0.77
0.90
95
0.82
0.58
0.63
0.86
0.53
0.63
124
1.07
0.68
0.80
76
0.66
0.40
0.47
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
13
0.06
0.04
0.04
0.04
0.03
0.03
0.07
0.05
0.05
12
0.05
0.04
0.04
0.08
0.07
0.07
0.03
0.01
0.02
2
2
ASR
CASE
NUMBER
FEMALE
3
3
ASR
CASE
NUMBER
CRUDE
RATE
225
0.97
0.72
0.79
148
135
0.58
0.39
0.44
35
0.15
0.10
230
0.99
200
CRUDE
RATE
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 177 -
MALIGNANT LYMPHOMA
HODGKIN LYMPHOMA
NON-HODGKIN LYMPHOMA
B
B-cell lymphoid neoplasms
Lymphoplasmacytic lymphoma
Follicular lymphoma
Burkitt
Burkitt lymphoma
B ()
Diffuse large B-cell lymphoma (any subtype)
B
Primary mediastinal (thymic) large B-cell lymphoma
- 178 -
TOTAL
MALE
2
ASR2
CASE
NUMBER
9.95
0.69
8.99
1,750
FEMALE
CRUDE
RATE
2
ASR2
3
ASR3
CASE
NUMBER
1,659
14.26
10.48
11.58
1,256
0.71
103
0.89
0.84
0.85
6.32
7.03
1,179
10.13
7.30
7.56
5.22
5.83
963
8.28
242
1.04
0.73
0.81
116
68
0.29
0.19
0.22
31
0.13
0.09
226
0.98
55
3
ASR3
10.90
7.57
8.37
69
0.60
0.54
0.57
8.13
903
7.83
5.39
5.97
5.84
6.55
787
6.83
4.63
5.14
1.00
0.70
0.78
126
1.09
0.76
0.84
27
0.23
0.15
0.18
41
0.36
0.23
0.26
0.10
26
0.22
0.16
0.18
0.04
0.02
0.03
0.69
0.75
104
0.89
0.65
0.71
122
1.06
0.74
0.79
0.24
0.14
0.17
41
0.35
0.21
0.26
14
0.12
0.08
0.09
49
0.21
0.22
0.21
35
0.30
0.35
0.33
14
0.12
0.08
0.09
1,077
4.65
3.13
3.54
597
5.13
3.50
3.98
480
4.16
2.77
3.11
12
0.05
0.05
0.05
0.06
0.05
0.06
0.04
0.04
0.05
CRUDE
RATE
2,915
12.59
9.00
172
0.74
2,082
3
ASR3
2
ASR2
CASE
NUMBER
CRUDE
RATE
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 179 -
B
Other B-cell lymphomas
T/NK
T/NK-cell lymphoid neoplasms
NK/T
Extranodal NK/T cell lymphoma, nasal or other type
T / Sezary
Cutaneous T cell lymphoma (Including Mycosis fungoides / Szary syndrome)
T
Enteropathy-type T-cell lymphoma
T
Hepatosplenic T-cell lymphoma
T
Subcutaneous panniculitis-like T-cell Lymphoma
T
Peripheral T-cell lymphoma, NOS
T
Angioimmunoblastic T-cell lymphoma
T /
Adult T-cell lymphoma / leukemia
T
Other T-cell lymphoma / leukemia
- 180 -
TOTAL
MALE
2
2
ASR
3
3
ASR
CASE
NUMBER
CRUDE
RATE
2
2
ASR
3
3
ASR
0.32
0.23
0.25
21
0.18
0.13
0.14
216
1.86
1.46
1.58
116
1.01
0.76
0.82
0.16
31
0.27
0.20
0.21
18
0.16
0.11
0.12
0.13
0.14
23
0.20
0.15
0.17
17
0.15
0.11
0.12
0.03
0.02
0.02
0.03
0.02
0.02
0.02
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.03
0.03
0.03
0.03
0.02
0.02
0.03
0.04
0.04
115
0.50
0.36
0.40
83
0.71
0.53
0.59
32
0.28
0.19
0.21
44
0.19
0.13
0.15
26
0.22
0.16
0.18
18
0.16
0.10
0.12
31
0.13
0.12
0.13
21
0.18
0.16
0.17
10
0.09
0.09
0.09
0.03
0.02
0.02
0.02
0.01
0.01
0.03
0.03
0.03
33
0.14
0.15
0.15
23
0.20
0.21
0.21
10
0.09
0.08
0.09
2
2
ASR
CASE
NUMBER
FEMALE
3
3
ASR
CASE
NUMBER
CRUDE
RATE
58
0.25
0.18
0.20
37
332
1.43
1.10
1.19
49
0.21
0.15
40
0.17
CRUDE
RATE
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 181 -
Other LPD
- 182 -
TOTAL
MALE
2
ASR2
CASE
NUMBER
FEMALE
2
ASR2
3
ASR3
CASE
NUMBER
CRUDE
RATE
2
ASR2
3
ASR3
2.43
1.66
1.88
219
1.90
1.21
1.36
18
0.15
0.23
0.20
0.07
0.13
0.11
0.16
18
0.15
0.23
0.20
0.07
0.13
0.11
0.43
76
0.65
0.45
0.51
57
0.49
0.31
0.36
3
ASR3
CASE
NUMBER
CRUDE
RATE
502
2.17
1.43
1.62
283
26
0.11
0.19
0.16
26
0.11
0.19
133
0.57
0.38
CRUDE
RATE
NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.
- 183 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010
C00 - C80
10 10
10
2 3
10 10
10
2 3
5,765
1,262,554
456.61
269.07
303.85
5,351
1,356,218
394.55
236.56
262.64
3,322
754,586
440.24
309.20
345.45
2,778
775,361
358.28
240.68
267.50
811
193,573
418.96
282.12
314.91
642
190,561
336.90
218.50
242.34
776
206,243
376.26
294.31
328.59
705
209,101
337.16
249.15
275.79
2,028
525,788
385.71
305.24
346.54
1,878
556,511
337.46
255.89
283.51
1,646
381,903
431.00
315.82
354.00
1,460
390,370
374.00
259.02
287.00
673
134,036
502.10
353.96
396.62
565
138,354
408.37
274.30
303.33
8,062
1,935,668
416.50
323.71
364.52
6,762
1,961,699
344.70
247.83
276.82
3,818
1,009,274
378.29
299.75
337.76
2,883
992,786
290.39
226.30
252.46
896
264,014
339.38
242.88
272.41
722
249,001
289.96
208.92
230.33
1,194
234,682
508.77
318.61
361.27
832
225,804
368.46
233.32
256.95
1,244
291,177
427.23
268.54
303.41
912
269,791
338.04
212.63
234.93
3,122
793,368
393.51
307.15
345.00
2,393
772,752
309.67
232.15
257.20
3,029
670,812
451.54
312.15
349.63
2,020
636,474
317.37
207.96
229.96
1,202
271,053
443.46
277.75
310.61
830
255,438
324.93
206.50
225.86
1,948
374,746
519.82
322.29
359.18
1,162
342,907
338.87
200.24
219.16
1,573
283,284
555.27
327.36
366.00
1,005
259,964
386.59
218.21
240.55
2,838
562,141
504.86
319.60
357.99
2,110
539,380
391.19
239.94
265.26
2,990
636,341
469.87
327.25
364.44
2,171
607,195
357.55
239.60
265.88
2,105
449,267
468.54
300.67
336.25
1,469
424,242
346.26
218.60
241.22
238
49,769
478.21
287.11
320.00
145
47,149
307.54
183.94
203.02
881
174,584
504.63
318.27
357.66
528
164,221
321.52
201.08
224.29
586
120,747
485.31
317.65
351.06
358
109,926
325.67
195.43
217.91
123
49,871
246.64
153.05
174.00
64
47,493
134.76
85.96
95.63
16
5,744
278.55
208.04
218.86
4,200
190.48
110.32
124.02
22,566
5,397,185
418.11
294.89
332.00
18,809
5,454,961
344.81
235.18
261.39
11,329
2,635,767
429.82
306.44
343.77
8,283
2,564,082
323.04
221.89
244.53
15,385
3,251,327
473.19
316.76
354.08
11,703
3,182,015
367.79
237.49
262.76
1,467
295,331
496.73
317.69
354.63
886
274,147
323.18
198.87
221.79
139
55,615
249.93
158.58
178.80
72
51,693
139.28
88.02
98.00
9,087
2,017,140
450.49
283.48
318.83
8,129
2,131,579
381.36
237.59
263.84
5,934
1,441,543
411.64
308.14
346.38
5,250
1,484,897
353.56
252.18
279.39
13,855
3,364,779
411.77
318.11
358.12
11,399
3,404,840
334.79
243.71
272.46
7,672
1,724,239
444.95
300.03
336.34
5,520
1,655,235
333.49
218.06
240.81
13,826
2,980,563
463.87
302.66
338.51
9,135
2,756,345
331.42
212.32
233.69
368
106,961
344.05
270.88
302.44
239
94,002
254.25
185.94
205.83
50,892 11,635,225
437.40
303.57
340.66
39,757
11,526,898
344.91
231.31
256.23
2. * 5 4
- 184 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
10 10
10
2 3
10 10
10
2 3
361
1,262,554
28.59
18.64
20.26
54
1,356,218
3.98
2.34
2.58
397
754,586
52.61
36.92
39.95
25
775,361
3.22
2.14
2.42
76
193,573
39.26
27.18
29.01
190,561
2.62
1.38
1.70
66
206,243
32.00
25.66
27.94
11
209,101
5.26
3.96
4.34
233
525,788
44.31
34.46
37.29
23
556,511
4.13
3.01
3.42
164
381,903
42.94
31.33
33.52
16
390,370
4.10
2.85
3.24
97
134,036
72.37
56.19
59.58
138,354
5.78
4.24
4.47
933
1,935,668
48.20
36.15
38.82
94
1,961,699
4.79
3.52
3.87
427
1,009,274
42.31
33.53
36.46
45
992,786
4.53
3.55
3.96
109
264,014
41.29
31.70
34.33
13
249,001
5.22
3.69
4.10
89
234,682
37.92
27.79
29.75
225,804
1.77
0.68
0.96
115
291,177
39.49
28.23
31.03
10
269,791
3.71
2.40
2.67
408
793,368
51.43
40.15
43.42
31
772,752
4.01
3.01
3.32
487
670,812
72.60
53.32
57.43
34
636,474
5.34
3.36
3.73
181
271,053
66.78
45.92
49.72
255,438
3.52
2.36
2.61
322
374,746
85.92
58.04
62.45
15
342,907
4.37
2.90
3.21
249
283,284
87.90
59.26
63.40
11
259,964
4.23
2.23
2.59
300
562,141
53.37
36.11
39.27
27
539,380
5.01
3.28
3.55
441
636,341
69.30
49.65
53.30
18
607,195
2.96
1.96
2.12
305
449,267
67.89
47.08
50.76
46
424,242
10.84
6.64
7.30
15
49,769
30.14
21.83
22.70
47,149
139
174,584
79.62
56.01
60.82
12
164,221
7.31
4.85
5.01
105
120,747
86.96
63.30
66.38
20
109,926
18.19
11.82
12.46
49,871
10.03
6.95
7.36
47,493
2.11
1.96
1.81
5,744
69.64
54.48
58.50
4,200
2,176
5,397,185
40.32
29.55
31.93
236
5,454,961
4.33
2.95
3.27
1,631
2,635,767
61.88
46.00
49.64
112
2,564,082
4.37
2.96
3.28
1,968
3,251,327
60.53
42.60
45.85
151
3,182,015
4.75
3.07
3.40
244
295,331
82.62
59.04
63.14
32
274,147
11.67
7.67
8.04
55,615
16.18
11.02
11.77
51,693
1.93
1.78
1.64
758
2,017,140
37.58
25.32
27.46
79
2,131,579
3.71
2.28
2.54
636
1,441,543
44.12
33.46
35.96
63
1,484,897
4.24
2.99
3.36
1,679
3,364,779
49.90
38.43
41.43
151
3,404,840
4.43
3.19
3.59
922
1,724,239
53.47
38.73
41.82
84
1,655,235
5.07
3.33
3.64
1,951
2,980,563
65.46
45.98
49.51
136
2,756,345
4.93
3.36
3.60
52
106,961
48.62
37.27
40.00
16
94,002
17.02
11.25
13.05
6,028 11,635,225
51.81
37.62
40.56
532
11,526,898
4.62
3.09
3.41
- 185 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C44.0 C00
10 10
10
2 3
10 10
10
2 3
1,262,554
0.32
0.23
0.24
1,356,218
0.07
0.02
0.04
16
754,586
2.12
1.46
1.59
775,361
193,573
1.55
1.23
1.27
190,561
206,243
209,101
525,788
1.71
1.30
1.42
556,511
381,903
0.79
0.48
0.54
390,370
134,036
4.48
4.01
3.85
138,354
31
1,935,668
1.60
1.29
1.34
1,961,699
0.10
0.07
0.09
1,009,274
0.59
0.38
0.45
992,786
264,014
1.14
1.00
1.05
249,001
0.40
0.38
0.38
234,682
1.28
0.85
0.89
225,804
291,177
1.03
0.91
0.89
269,791
793,368
1.01
0.79
0.90
772,752
0.13
0.10
0.11
15
670,812
2.24
1.65
1.76
636,474
0.31
0.11
0.16
271,053
2.58
1.72
1.81
255,438
0.39
0.30
0.30
16
374,746
4.27
2.68
2.96
342,907
0.29
0.20
0.20
15
283,284
5.30
3.69
3.90
259,964
18
562,141
3.20
2.30
2.38
539,380
0.19
0.16
0.15
17
636,341
2.67
1.78
2.00
607,195
0.16
0.12
0.12
10
449,267
2.23
1.72
1.76
424,242
1.41
0.81
0.89
49,769
47,149
10
174,584
5.73
4.33
4.53
164,221
120,747
5.80
4.23
4.45
109,926
0.91
0.48
0.53
49,871
47,493
5,744
4,200
53
5,397,185
0.98
0.77
0.81
5,454,961
0.07
0.04
0.05
55
2,635,767
2.09
1.55
1.69
2,564,082
0.20
0.13
0.14
85
3,251,327
2.61
1.89
2.00
3,182,015
0.25
0.16
0.17
17
295,331
5.76
4.29
4.50
274,147
0.36
0.20
0.22
55,615
51,693
20
2,017,140
0.99
0.68
0.73
2,131,579
0.05
0.01
0.03
21
1,441,543
1.46
1.16
1.21
1,484,897
45
3,364,779
1.34
1.11
1.15
3,404,840
0.09
0.06
0.08
39
1,724,239
2.26
1.64
1.76
1,655,235
0.30
0.25
0.24
81
2,980,563
2.72
1.94
2.08
2,756,345
0.18
0.10
0.11
106,961
0.93
0.63
0.63
94,002
4.26
2.63
3.10
210 11,635,225
1.80
1.36
1.45
18
11,526,898
0.16
0.10
0.11
- 186 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C01 - C02
10 10
10
2 3
10 10
10
2 3
102
1,262,554
8.08
5.37
5.87
24
1,356,218
1.77
1.10
1.19
116
754,586
15.37
10.73
11.75
12
775,361
1.55
1.03
1.15
21
193,573
10.85
8.32
8.57
190,561
2.10
1.16
1.36
15
206,243
7.27
5.81
6.43
209,101
2.87
2.29
2.43
62
525,788
11.79
9.12
9.77
10
556,511
1.80
1.16
1.42
54
381,903
14.14
10.11
11.04
390,370
1.79
1.37
1.50
24
134,036
17.91
13.05
14.49
138,354
2.17
1.79
1.79
247
1,935,668
12.76
9.44
10.21
37
1,961,699
1.89
1.38
1.46
125
1,009,274
12.39
9.77
10.69
16
992,786
1.61
1.39
1.45
28
264,014
10.61
8.02
8.69
249,001
3.21
2.22
2.53
19
234,682
8.10
5.82
6.52
225,804
0.44
0.12
0.21
34
291,177
11.68
8.12
8.99
269,791
1.11
0.58
0.68
116
793,368
14.62
11.25
12.19
18
772,752
2.33
1.84
1.94
116
670,812
17.29
12.87
13.86
12
636,474
1.89
1.18
1.29
47
271,053
17.34
12.23
12.89
255,438
1.17
0.96
1.03
74
374,746
19.75
14.10
14.93
342,907
2.62
1.79
1.97
50
283,284
17.65
12.35
13.44
259,964
1.92
1.02
1.12
80
562,141
14.23
10.01
10.85
12
539,380
2.22
1.32
1.50
122
636,341
19.17
13.76
14.88
607,195
1.48
0.99
1.05
85
449,267
18.92
13.06
14.16
13
424,242
3.06
2.21
2.38
49,769
6.03
4.04
4.57
47,149
27
174,584
15.47
10.86
12.01
164,221
3.04
2.22
2.22
15
120,747
12.42
9.21
9.49
109,926
4.55
3.50
3.50
49,871
2.01
1.13
1.22
47,493
5,744
4,200
591
5,397,185
10.95
8.03
8.74
99
5,454,961
1.81
1.29
1.40
415
2,635,767
15.74
11.91
12.77
52
2,564,082
2.03
1.41
1.54
534
3,251,327
16.42
11.52
12.53
61
3,182,015
1.92
1.30
1.43
42
295,331
14.22
10.19
10.99
10
274,147
3.65
2.72
2.72
55,615
1.80
1.00
1.08
51,693
218
2,017,140
10.81
7.34
8.02
36
2,131,579
1.69
1.08
1.18
176
1,441,543
12.21
9.21
9.96
30
1,484,897
2.02
1.43
1.60
433
3,364,779
12.87
9.79
10.64
63
3,404,840
1.85
1.34
1.47
252
1,724,239
14.62
10.81
11.70
34
1,655,235
2.05
1.45
1.56
491
2,980,563
16.47
11.65
12.57
56
2,756,345
2.03
1.45
1.53
106,961
7.48
6.12
6.63
94,002
2.13
1.35
1.46
1,583 11,635,225
13.61
9.90
10.72
222
11,526,898
1.93
1.34
1.46
- 187 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C03
10 10
10
2 3
10 10
10
2 3
30
1,262,554
2.38
1.53
1.67
1,356,218
0.37
0.24
0.24
26
754,586
3.45
2.51
2.68
775,361
0.52
0.39
0.42
193,573
2.07
1.28
1.37
190,561
206,243
3.88
3.72
3.83
209,101
0.96
0.54
0.72
16
525,788
3.04
2.11
2.40
556,511
0.36
0.27
0.30
381,903
2.36
1.89
1.94
390,370
0.26
0.10
0.18
10
134,036
7.46
5.73
5.97
138,354
0.72
0.45
0.49
72
1,935,668
3.72
2.82
3.04
17
1,961,699
0.87
0.63
0.70
21
1,009,274
2.08
1.67
1.85
992,786
0.50
0.37
0.43
264,014
3.41
2.42
2.69
249,001
234,682
1.70
1.20
1.28
225,804
0.44
0.15
0.22
291,177
2.40
1.67
1.88
269,791
14
793,368
1.76
1.29
1.44
772,752
0.39
0.26
0.33
39
670,812
5.81
4.28
4.56
636,474
0.31
0.22
0.25
11
271,053
4.06
2.56
2.91
255,438
1.57
0.84
1.00
14
374,746
3.74
2.26
2.56
342,907
17
283,284
6.00
3.77
4.08
259,964
16
562,141
2.85
1.57
1.84
539,380
0.37
0.31
0.31
26
636,341
4.09
3.05
3.19
607,195
0.49
0.29
0.37
20
449,267
4.45
2.86
3.11
424,242
1.41
0.75
0.86
49,769
47,149
174,584
4.01
2.40
2.90
164,221
1.22
0.72
0.77
120,747
3.31
2.30
2.57
109,926
0.91
0.72
0.67
49,871
47,493
5,744
4,200
155
5,397,185
2.87
2.11
2.29
30
5,454,961
0.55
0.36
0.40
94
2,635,767
3.57
2.54
2.81
11
2,564,082
0.43
0.26
0.31
124
3,251,327
3.81
2.64
2.84
17
3,182,015
0.53
0.33
0.38
11
295,331
3.72
2.39
2.79
274,147
1.09
0.71
0.72
55,615
51,693
56
2,017,140
2.78
1.89
2.05
2,131,579
0.42
0.29
0.30
47
1,441,543
3.26
2.52
2.68
1,484,897
0.40
0.24
0.31
110
3,364,779
3.27
2.49
2.71
23
3,404,840
0.68
0.48
0.55
52
1,724,239
3.02
2.00
2.24
14
1,655,235
0.85
0.42
0.52
112
2,980,563
3.76
2.57
2.79
2,756,345
0.25
0.20
0.19
106,961
4.67
3.20
3.55
94,002
1.06
0.89
0.97
384 11,635,225
3.30
2.35
2.56
61
11,526,898
0.53
0.34
0.38
- 188 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C04
10 10
10
2 3
10 10
10
2 3
1,262,554
0.63
0.37
0.40
1,356,218
0.07
0.04
0.05
754,586
1.06
0.72
0.79
775,361
193,573
2.07
1.28
1.41
190,561
206,243
0.97
0.70
0.78
209,101
525,788
0.38
0.33
0.33
556,511
0.36
0.32
0.34
381,903
0.79
0.59
0.62
390,370
134,036
2.24
1.88
1.93
138,354
28
1,935,668
1.45
1.03
1.13
1,961,699
0.15
0.09
0.10
1,009,274
0.89
0.65
0.71
992,786
0.10
0.07
0.08
264,014
0.76
0.72
0.71
249,001
0.40
0.26
0.28
234,682
1.70
1.20
1.36
225,804
291,177
0.69
0.48
0.56
269,791
14
793,368
1.76
1.46
1.47
772,752
13
670,812
1.94
1.36
1.50
636,474
0.16
0.05
0.08
271,053
1.48
0.97
1.07
255,438
374,746
2.13
1.28
1.43
342,907
283,284
2.47
1.80
1.79
259,964
562,141
1.25
0.81
0.89
539,380
0.37
0.24
0.26
12
636,341
1.89
1.33
1.40
607,195
0.16
0.10
0.11
449,267
1.78
1.25
1.34
424,242
49,769
2.01
1.82
1.69
47,149
174,584
0.57
0.37
0.40
164,221
120,747
0.83
0.57
0.57
109,926
0.91
0.48
0.53
49,871
47,493
5,744
4,200
59
5,397,185
1.09
0.76
0.83
5,454,961
0.11
0.07
0.08
41
2,635,767
1.56
1.15
1.22
2,564,082
0.12
0.08
0.10
49
3,251,327
1.51
1.07
1.13
3,182,015
0.09
0.06
0.07
295,331
0.68
0.46
0.48
274,147
0.36
0.20
0.22
55,615
51,693
16
2,017,140
0.79
0.50
0.55
2,131,579
0.05
0.03
0.03
14
1,441,543
0.97
0.74
0.78
1,484,897
0.13
0.11
0.12
48
3,364,779
1.43
1.09
1.17
3,404,840
0.15
0.10
0.11
23
1,724,239
1.33
0.89
0.98
1,655,235
0.18
0.11
0.12
50
2,980,563
1.68
1.18
1.26
2,756,345
0.07
0.05
0.05
106,961
94,002
151 11,635,225
1.30
0.92
0.99
13
11,526,898
0.11
0.07
0.08
- 189 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C05 - C06
10 10
10
2 3
10 10
10
2 3
115
1,262,554
9.11
6.13
6.66
11
1,356,218
0.81
0.46
0.52
152
754,586
20.14
14.31
15.41
775,361
0.64
0.36
0.47
25
193,573
12.92
8.48
9.32
190,561
0.52
0.22
0.34
16
206,243
7.76
6.16
6.67
209,101
1.43
1.13
1.20
83
525,788
15.79
12.16
13.19
556,511
0.72
0.65
0.66
59
381,903
15.45
11.15
11.92
390,370
1.54
1.05
1.19
38
134,036
28.35
22.51
23.85
138,354
2.17
1.51
1.64
314
1,935,668
16.22
12.34
13.14
25
1,961,699
1.27
1.03
1.13
160
1,009,274
15.85
12.68
13.69
16
992,786
1.61
1.22
1.43
41
264,014
15.53
11.73
12.86
249,001
1.20
0.83
0.91
24
234,682
10.23
7.31
7.80
225,804
0.44
0.30
0.32
39
291,177
13.39
9.84
10.83
269,791
2.22
1.52
1.69
154
793,368
19.41
15.13
16.30
772,752
0.65
0.45
0.53
177
670,812
26.39
19.33
20.80
13
636,474
2.04
1.27
1.44
66
271,053
24.35
17.23
18.66
255,438
0.39
0.26
0.28
115
374,746
30.69
21.09
22.58
342,907
1.46
0.91
1.04
95
283,284
33.54
22.62
24.12
259,964
1.15
0.69
0.82
99
562,141
17.61
11.89
12.98
539,380
0.74
0.50
0.54
154
636,341
24.20
17.30
18.54
607,195
0.33
0.24
0.24
104
449,267
23.15
16.12
17.60
16
424,242
3.77
2.12
2.37
49,769
12.06
8.71
8.95
47,149
48
174,584
27.49
19.43
21.12
164,221
1.22
0.83
0.83
38
120,747
31.47
23.18
24.28
109,926
8.19
4.94
5.38
49,871
2.01
1.44
1.59
47,493
5,744
34.82
34.63
36.23
4,200
734
5,397,185
13.60
10.05
10.82
66
5,454,961
1.21
0.84
0.94
595
2,635,767
22.57
16.83
18.11
28
2,564,082
1.09
0.73
0.82
707
3,251,327
21.74
15.36
16.53
39
3,182,015
1.23
0.75
0.85
86
295,331
29.12
20.92
22.36
11
274,147
4.01
2.50
2.68
55,615
5.39
3.88
4.11
51,693
267
2,017,140
13.24
9.09
9.82
16
2,131,579
0.75
0.42
0.49
221
1,441,543
15.33
11.54
12.43
17
1,484,897
1.14
0.85
0.93
623
3,364,779
18.52
14.35
15.41
40
3,404,840
1.17
0.89
1.02
312
1,724,239
18.09
13.27
14.29
19
1,655,235
1.15
0.74
0.82
666
2,980,563
22.34
15.71
16.90
44
2,756,345
1.60
1.04
1.14
28
106,961
26.18
19.53
21.24
94,002
7.45
4.82
5.74
2,125 11,635,225
18.26
13.33
14.34
144
11,526,898
1.25
0.83
0.92
- 190 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C09 - C10
10 10
10
2 3
10 10
10
2 3
42
1,262,554
3.33
2.19
2.34
1,356,218
0.66
0.35
0.42
31
754,586
4.11
2.82
3.05
775,361
0.39
0.29
0.31
193,573
4.13
2.97
3.05
190,561
206,243
2.91
2.33
2.44
209,101
22
525,788
4.18
3.32
3.56
556,511
0.18
0.11
0.12
18
381,903
4.71
3.55
3.71
390,370
0.51
0.33
0.37
10
134,036
7.46
5.74
5.89
138,354
0.72
0.50
0.54
95
1,935,668
4.91
3.69
3.97
1,961,699
0.31
0.20
0.23
48
1,009,274
4.76
3.75
4.07
992,786
0.50
0.37
0.42
13
264,014
4.92
4.08
4.28
249,001
15
234,682
6.39
4.68
5.01
225,804
0.44
0.12
0.21
291,177
2.75
1.91
2.10
269,791
40
793,368
5.04
4.10
4.43
772,752
0.13
0.10
0.10
40
670,812
5.96
4.33
4.71
636,474
0.63
0.53
0.52
16
271,053
5.90
4.10
4.41
255,438
38
374,746
10.14
6.78
7.21
342,907
17
283,284
6.00
3.81
4.19
259,964
0.77
0.43
0.51
28
562,141
4.98
3.36
3.64
539,380
0.74
0.47
0.52
41
636,341
6.44
4.62
4.96
607,195
0.33
0.21
0.22
25
449,267
5.56
3.86
4.06
424,242
0.71
0.48
0.51
49,769
2.01
1.31
1.42
47,149
12
174,584
6.87
4.76
5.23
164,221
0.61
0.39
0.42
12
120,747
9.94
7.40
7.53
109,926
2.73
1.70
1.85
49,871
47,493
2.11
1.96
1.81
5,744
4,200
235
5,397,185
4.35
3.22
3.45
21
5,454,961
0.38
0.23
0.27
156
2,635,767
5.92
4.40
4.74
2,564,082
0.23
0.19
0.19
171
3,251,327
5.26
3.68
3.94
17
3,182,015
0.53
0.35
0.38
24
295,331
8.13
5.87
6.20
274,147
1.46
0.93
1.01
55,615
51,693
1.93
1.78
1.64
73
2,017,140
3.62
2.42
2.61
12
2,131,579
0.56
0.34
0.39
64
1,441,543
4.44
3.42
3.59
1,484,897
0.27
0.18
0.20
160
3,364,779
4.76
3.67
3.98
10
3,404,840
0.29
0.19
0.21
92
1,724,239
5.34
3.98
4.19
1,655,235
0.36
0.25
0.26
191
2,980,563
6.41
4.45
4.81
16
2,756,345
0.58
0.39
0.42
106,961
3.74
3.42
3.39
94,002
1.06
1.12
1.12
586 11,635,225
5.04
3.66
3.92
49
11,526,898
0.43
0.28
0.31
- 191 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C12 - C13
10 10
10
2 3
10 10
10
2 3
59
1,262,554
4.67
2.78
3.03
1,356,218
0.15
0.09
0.09
46
754,586
6.10
4.19
4.48
775,361
0.13
0.07
0.08
10
193,573
5.17
3.29
3.69
190,561
17
206,243
8.24
6.22
7.01
209,101
37
525,788
7.04
5.75
6.24
556,511
0.54
0.39
0.43
17
381,903
4.45
3.40
3.56
390,370
134,036
4.48
3.28
3.60
138,354
137
1,935,668
7.08
5.21
5.65
1,961,699
0.15
0.09
0.12
54
1,009,274
5.35
4.23
4.59
992,786
0.20
0.13
0.15
12
264,014
4.55
3.47
3.74
249,001
19
234,682
8.10
6.42
6.58
225,804
19
291,177
6.53
4.62
5.05
269,791
0.37
0.30
0.30
54
793,368
6.81
5.39
5.81
772,752
0.39
0.26
0.31
81
670,812
12.07
8.89
9.56
636,474
27
271,053
9.96
6.38
7.20
255,438
56
374,746
14.94
9.67
10.57
342,907
48
283,284
16.94
11.24
11.87
259,964
0.38
0.09
0.14
49
562,141
8.72
5.90
6.37
539,380
0.37
0.27
0.28
58
636,341
9.11
6.58
7.02
607,195
49
449,267
10.91
7.53
8.05
424,242
0.24
0.18
0.18
49,769
8.04
5.95
6.08
47,149
30
174,584
17.18
12.28
12.98
164,221
1.22
0.69
0.78
27
120,747
22.36
15.78
16.71
109,926
49,871
6.02
4.38
4.55
47,493
5,744
34.82
19.84
22.27
4,200
327
5,397,185
6.06
4.31
4.67
5,454,961
0.15
0.10
0.11
255
2,635,767
9.67
7.10
7.71
2,564,082
0.23
0.14
0.16
277
3,251,327
8.52
6.00
6.41
3,182,015
0.16
0.10
0.11
57
295,331
19.30
13.71
14.51
274,147
0.73
0.41
0.46
55,615
8.99
6.15
6.58
51,693
105
2,017,140
5.21
3.31
3.58
2,131,579
0.14
0.08
0.09
87
1,441,543
6.04
4.57
4.99
1,484,897
0.20
0.13
0.15
241
3,364,779
7.16
5.52
5.94
3,404,840
0.18
0.10
0.13
137
1,724,239
7.95
5.57
6.02
1,655,235
0.18
0.12
0.13
336
2,980,563
11.27
7.90
8.49
2,756,345
0.22
0.14
0.15
106,961
5.61
4.37
4.57
94,002
921 11,635,225
7.92
5.68
6.12
21
11,526,898
0.18
0.12
0.13
- 192 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C14
10 10
10
2 3
10 10
10
2 3
1,262,554
0.08
0.05
0.05
1,356,218
0.07
0.04
0.04
754,586
0.27
0.19
0.19
775,361
193,573
0.52
0.31
0.34
190,561
206,243
0.97
0.72
0.78
209,101
525,788
0.38
0.37
0.38
556,511
0.18
0.12
0.14
381,903
0.26
0.17
0.18
390,370
134,036
138,354
1,935,668
0.46
0.33
0.34
1,961,699
0.05
0.03
0.03
1,009,274
0.40
0.40
0.39
992,786
264,014
0.38
0.28
0.30
249,001
234,682
0.43
0.31
0.31
225,804
291,177
1.03
0.67
0.74
269,791
793,368
1.01
0.75
0.88
772,752
670,812
0.89
0.60
0.67
636,474
271,053
1.11
0.72
0.77
255,438
374,746
0.27
0.18
0.19
342,907
283,284
259,964
562,141
0.53
0.28
0.33
539,380
11
636,341
1.73
1.22
1.31
607,195
449,267
0.89
0.68
0.68
424,242
0.24
0.08
0.12
49,769
47,149
174,584
2.29
1.58
1.65
164,221
120,747
0.83
0.64
0.77
109,926
49,871
47,493
5,744
4,200
22
5,397,185
0.41
0.30
0.32
5,454,961
0.04
0.02
0.02
20
2,635,767
0.76
0.53
0.60
2,564,082
0.04
0.02
0.02
21
3,251,327
0.65
0.45
0.47
3,182,015
0.03
0.01
0.02
295,331
1.69
1.22
1.31
274,147
55,615
51,693
2,017,140
0.15
0.10
0.10
2,131,579
0.05
0.02
0.03
1,441,543
0.42
0.31
0.33
1,484,897
0.07
0.04
0.04
19
3,364,779
0.56
0.40
0.44
3,404,840
0.03
0.02
0.02
15
1,724,239
0.87
0.57
0.64
1,655,235
24
2,980,563
0.81
0.58
0.61
2,756,345
106,961
94,002
1.06
0.44
0.67
68 11,635,225
0.58
0.42
0.45
11,526,898
0.03
0.02
0.02
- 193 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C07 - C08
10 10
10
2 3
10 10
10
2 3
12
1,262,554
0.95
0.80
0.85
14
1,356,218
1.03
0.65
0.72
754,586
0.80
0.58
0.67
775,361
0.39
0.38
0.38
193,573
1.03
0.78
0.89
190,561
1.05
0.50
0.66
206,243
0.97
0.72
0.78
209,101
525,788
0.76
0.58
0.63
556,511
0.72
0.57
0.61
381,903
1.05
0.70
0.74
390,370
1.02
0.74
0.85
134,036
0.75
0.57
0.57
138,354
0.72
0.91
0.93
28
1,935,668
1.45
1.15
1.29
15
1,961,699
0.76
0.54
0.60
13
1,009,274
1.29
0.97
1.12
992,786
0.91
0.65
0.77
264,014
2.27
1.81
1.99
249,001
1.61
1.29
1.37
234,682
0.85
0.43
0.52
225,804
0.89
0.39
0.44
291,177
2.06
1.55
1.63
269,791
0.37
0.30
0.30
793,368
0.50
0.40
0.41
772,752
0.91
0.72
0.82
670,812
1.34
0.95
1.08
636,474
1.26
0.94
1.05
271,053
0.74
0.20
0.37
255,438
0.78
0.44
0.54
374,746
342,907
0.29
0.26
0.31
283,284
1.06
0.55
0.64
259,964
0.77
0.64
0.60
562,141
1.25
0.67
0.80
539,380
1.48
1.03
1.16
636,341
1.41
1.05
1.11
607,195
0.99
0.66
0.76
449,267
1.11
0.81
0.89
424,242
1.65
1.19
1.33
49,769
47,149
174,584
1.72
1.12
1.24
164,221
1.83
1.44
1.51
120,747
2.48
1.39
1.73
109,926
0.91
0.35
0.42
49,871
47,493
2.11
1.68
1.85
5,744
4,200
71
5,397,185
1.32
0.98
1.09
47
5,454,961
0.86
0.60
0.67
19
2,635,767
0.72
0.50
0.56
22
2,564,082
0.86
0.64
0.72
35
3,251,327
1.08
0.73
0.81
31
3,182,015
0.97
0.72
0.79
295,331
2.03
1.22
1.42
274,147
1.46
1.02
1.09
55,615
51,693
1.93
1.56
1.72
18
2,017,140
0.89
0.72
0.78
17
2,131,579
0.80
0.56
0.60
13
1,441,543
0.90
0.65
0.70
11
1,484,897
0.74
0.56
0.63
45
3,364,779
1.34
1.00
1.17
30
3,404,840
0.88
0.66
0.74
25
1,724,239
1.45
1.06
1.15
13
1,655,235
0.79
0.61
0.66
26
2,980,563
0.87
0.58
0.65
31
2,756,345
1.12
0.75
0.85
106,961
3.74
2.77
3.18
94,002
1.06
0.89
0.97
131 11,635,225
1.13
0.80
0.89
105
11,526,898
0.91
0.66
0.73
- 194 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C11
10 10
10
2 3
10 10
10
2 3
124
1,262,554
9.82
6.93
7.59
41
1,356,218
3.02
1.95
2.13
94
754,586
12.46
8.97
9.81
24
775,361
3.10
2.10
2.35
16
193,573
8.27
5.64
6.19
190,561
2.62
1.45
1.71
19
206,243
9.21
8.03
8.62
209,101
2.87
2.08
2.28
46
525,788
8.75
6.89
7.57
20
556,511
3.59
2.41
2.81
34
381,903
8.90
6.52
6.94
14
390,370
3.59
2.58
2.87
134,036
5.22
3.81
3.98
138,354
5.78
4.18
4.32
201
1,935,668
10.38
7.61
8.28
69
1,961,699
3.52
2.41
2.73
108
1,009,274
10.70
8.50
9.16
21
992,786
2.12
1.70
1.84
26
264,014
9.85
7.13
8.10
10
249,001
4.02
3.16
3.44
35
234,682
14.91
10.99
11.86
225,804
3.10
2.04
2.37
36
291,177
12.36
9.13
9.99
269,791
2.59
2.18
2.25
64
793,368
8.07
6.17
6.75
22
772,752
2.85
2.18
2.35
69
670,812
10.29
7.97
8.66
16
636,474
2.51
1.72
1.87
25
271,053
9.22
6.14
7.08
10
255,438
3.91
3.12
3.22
35
374,746
9.34
6.53
7.19
342,907
2.04
1.19
1.33
24
283,284
8.47
5.73
6.20
16
259,964
6.15
4.01
4.36
53
562,141
9.43
6.61
6.91
16
539,380
2.97
2.18
2.34
74
636,341
11.63
8.18
8.97
19
607,195
3.13
2.26
2.41
52
449,267
11.57
8.10
8.82
22
424,242
5.19
3.72
4.05
49,769
18.08
13.00
13.65
47,149
4.24
3.56
3.66
18
174,584
10.31
7.30
7.90
164,221
4.26
2.65
3.03
21
120,747
17.39
12.63
13.94
109,926
7.28
5.47
5.51
49,871
6.02
4.13
4.76
47,493
5,744
17.41
11.13
11.13
4,200
565
5,397,185
10.47
7.77
8.47
166
5,454,961
3.04
2.10
2.32
239
2,635,767
9.07
6.79
7.47
75
2,564,082
2.93
2.12
2.32
347
3,251,327
10.67
7.61
8.22
121
3,182,015
3.80
2.69
2.92
39
295,331
13.21
9.43
10.32
15
274,147
5.47
3.75
3.99
55,615
7.19
4.87
5.42
51,693
218
2,017,140
10.81
7.65
8.37
65
2,131,579
3.05
2.00
2.21
122
1,441,543
8.46
6.43
6.96
53
1,484,897
3.57
2.46
2.76
352
3,364,779
10.46
8.01
8.72
110
3,404,840
3.23
2.29
2.54
176
1,724,239
10.21
7.63
8.27
60
1,655,235
3.62
2.73
2.93
302
2,980,563
10.13
7.11
7.77
82
2,756,345
2.97
2.13
2.30
24
106,961
22.44
18.41
19.38
94,002
7.45
5.80
6.32
1,194 11,635,225
10.26
7.54
8.22
377
11,526,898
3.27
2.30
2.52
- 195 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C15
10 10
10
2 3
10 10
10
2 3
159
1,262,554
12.59
7.60
8.33
19
1,356,218
1.40
0.73
0.86
125
754,586
16.57
11.21
12.25
10
775,361
1.29
0.90
0.93
42
193,573
21.70
14.80
16.01
190,561
2.10
1.39
1.51
36
206,243
17.46
13.16
14.52
209,101
0.96
0.67
0.77
83
525,788
15.79
12.77
13.79
556,511
1.26
0.97
1.10
50
381,903
13.09
9.57
10.45
390,370
26
134,036
19.40
14.39
15.21
138,354
1.45
0.53
0.86
342
1,935,668
17.67
13.25
14.51
32
1,961,699
1.63
1.11
1.37
143
1,009,274
14.17
11.59
12.51
15
992,786
1.51
1.09
1.37
27
264,014
10.23
7.66
8.18
249,001
1.20
0.84
0.92
53
234,682
22.58
15.67
16.81
225,804
56
291,177
19.23
13.52
14.57
269,791
1.85
0.70
0.93
148
793,368
18.65
14.33
15.81
10
772,752
1.29
0.93
1.08
138
670,812
20.57
15.07
16.16
636,474
1.41
0.99
1.06
71
271,053
26.19
17.93
19.19
255,438
1.96
1.45
1.48
75
374,746
20.01
13.47
14.45
342,907
0.29
0.26
0.29
72
283,284
25.42
16.58
17.87
259,964
0.77
0.33
0.42
105
562,141
18.68
12.19
13.31
539,380
1.11
0.46
0.58
130
636,341
20.43
14.65
15.55
607,195
0.33
0.20
0.25
96
449,267
21.37
14.75
15.62
424,242
0.94
0.53
0.60
12
49,769
24.11
15.49
16.81
47,149
55
174,584
31.50
21.49
23.32
164,221
2.44
1.80
1.82
39
120,747
32.30
23.36
24.29
109,926
3.64
1.63
2.05
49,871
16.04
9.70
11.32
47,493
2.11
0.57
1.02
5,744
4,200
858
5,397,185
15.90
11.37
12.36
80
5,454,961
1.47
0.89
1.07
515
2,635,767
19.54
14.37
15.54
32
2,564,082
1.25
0.86
0.94
616
3,251,327
18.95
13.04
14.04
26
3,182,015
0.82
0.47
0.54
94
295,331
31.83
22.21
23.67
274,147
2.92
1.76
1.96
55,615
14.38
8.80
10.30
51,693
1.93
0.52
0.94
284
2,017,140
14.08
8.91
9.75
29
2,131,579
1.36
0.80
0.90
237
1,441,543
16.44
12.39
13.44
15
1,484,897
1.01
0.68
0.80
554
3,364,779
16.46
12.58
13.60
44
3,404,840
1.29
0.89
1.05
347
1,724,239
20.12
14.12
15.40
26
1,655,235
1.57
0.89
1.06
647
2,980,563
21.71
15.03
16.12
27
2,756,345
0.98
0.49
0.57
14
106,961
13.09
9.01
9.84
94,002
5.32
3.96
4.40
2,091 11,635,225
17.97
12.77
13.81
147
11,526,898
1.28
0.77
0.90
- 196 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C16
10 10
10
2 3
10 10
10
2 3
336
1,262,554
26.61
12.94
15.61
183
1,356,218
13.49
7.04
8.15
117
754,586
15.51
9.78
11.64
81
775,361
10.45
6.94
7.76
50
193,573
25.83
16.41
18.53
31
190,561
16.27
9.88
11.17
41
206,243
19.88
13.56
16.38
27
209,101
12.91
8.70
10.39
111
525,788
21.11
16.47
18.98
61
556,511
10.96
8.28
9.30
66
381,903
17.28
11.32
13.79
50
390,370
12.81
8.18
9.56
28
134,036
20.89
13.26
15.75
19
138,354
13.73
8.89
9.90
421
1,935,668
21.75
16.26
18.98
236
1,961,699
12.03
8.66
10.07
208
1,009,274
20.61
15.25
17.66
118
992,786
11.89
9.00
10.44
46
264,014
17.42
10.87
12.89
33
249,001
13.25
9.08
10.27
87
234,682
37.07
20.74
24.55
35
225,804
15.50
7.69
9.36
59
291,177
20.26
12.63
14.28
31
269,791
11.49
6.47
7.15
157
793,368
19.79
14.69
17.35
79
772,752
10.22
7.35
8.49
112
670,812
16.70
10.65
12.36
87
636,474
13.67
7.58
8.82
48
271,053
17.71
9.75
11.52
23
255,438
9.00
6.01
6.55
72
374,746
19.21
11.20
12.73
41
342,907
11.96
5.93
6.51
42
283,284
14.83
7.68
9.07
34
259,964
13.08
5.67
6.62
106
562,141
18.86
11.03
12.69
81
539,380
15.02
7.49
8.86
117
636,341
18.39
11.49
13.57
74
607,195
12.19
7.86
8.87
82
449,267
18.25
10.81
12.47
52
424,242
12.26
6.48
7.63
10
49,769
20.09
9.65
11.90
10
47,149
21.21
10.95
12.55
66
174,584
37.80
20.17
24.06
31
164,221
18.88
8.72
11.29
22
120,747
18.22
9.43
11.27
17
109,926
15.46
6.50
8.41
11
49,871
22.06
12.94
14.57
47,493
10.53
5.35
6.66
5,744
4,200
1,248
5,397,185
23.12
14.83
17.43
694
5,454,961
12.72
8.11
9.39
500
2,635,767
18.97
12.70
14.77
291
2,564,082
11.35
7.21
8.17
568
3,251,327
17.47
10.55
12.43
401
3,182,015
12.60
7.37
8.49
88
295,331
29.80
15.75
18.81
48
274,147
17.51
7.79
10.10
11
55,615
19.78
11.66
13.15
51,693
9.67
4.93
6.15
453
2,017,140
22.46
11.92
14.35
264
2,131,579
12.39
7.04
8.06
296
1,441,543
20.53
14.22
16.68
188
1,484,897
12.66
8.65
9.90
661
3,364,779
19.64
14.23
16.77
411
3,404,840
12.07
8.66
10.13
364
1,724,239
21.11
13.11
15.28
216
1,655,235
13.05
7.81
8.81
601
2,980,563
20.16
12.13
14.06
340
2,756,345
12.34
6.60
7.73
31
106,961
28.98
22.91
26.10
16
94,002
17.02
11.33
13.45
2,415 11,635,225
20.76
13.14
15.43
1,439
11,526,898
12.48
7.66
8.85
- 197 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C17
10 10
10
2 3
10 10
10
2 3
15
1,262,554
1.19
0.66
0.75
14
1,356,218
1.03
0.56
0.65
13
754,586
1.72
1.10
1.32
11
775,361
1.42
0.88
1.05
193,573
2.58
1.98
2.03
190,561
1.57
0.92
1.02
206,243
0.48
0.48
0.52
209,101
0.96
0.85
0.84
12
525,788
2.28
1.78
2.04
556,511
0.54
0.53
0.54
13
381,903
3.40
2.32
2.69
390,370
0.77
0.63
0.63
134,036
1.49
0.83
1.08
138,354
0.72
0.63
0.63
23
1,935,668
1.19
0.98
1.06
18
1,961,699
0.92
0.72
0.81
1,009,274
0.69
0.79
0.82
992,786
0.91
0.75
0.82
264,014
1.52
0.93
1.14
249,001
1.61
1.12
1.24
234,682
1.70
1.19
1.27
225,804
1.33
0.78
0.89
291,177
1.03
0.59
0.68
269,791
0.37
0.08
0.15
18
793,368
2.27
1.74
1.96
13
772,752
1.68
1.25
1.44
10
670,812
1.49
1.07
1.16
636,474
1.10
0.81
0.85
271,053
1.11
0.66
0.74
255,438
1.57
1.06
1.05
374,746
2.40
1.58
1.73
342,907
0.58
0.49
0.48
283,284
3.18
2.05
2.31
259,964
1.54
0.87
0.95
11
562,141
1.96
1.13
1.30
11
539,380
2.04
1.27
1.37
10
636,341
1.57
0.98
1.12
13
607,195
2.14
1.39
1.58
449,267
1.56
1.01
1.11
424,242
0.47
0.31
0.32
49,769
47,149
174,584
3.44
2.47
2.74
164,221
1.83
1.29
1.32
120,747
4.14
2.82
2.96
109,926
3.64
1.97
2.26
49,871
47,493
5,744
4,200
62
5,397,185
1.15
0.87
0.94
54
5,454,961
0.99
0.67
0.76
52
2,635,767
1.97
1.41
1.57
29
2,564,082
1.13
0.82
0.87
65
3,251,327
2.00
1.26
1.45
45
3,182,015
1.41
0.88
0.98
11
295,331
3.72
2.60
2.82
274,147
2.55
1.56
1.70
55,615
51,693
28
2,017,140
1.39
0.82
0.95
25
2,131,579
1.17
0.64
0.74
33
1,441,543
2.29
1.69
1.91
12
1,484,897
0.81
0.66
0.67
52
3,364,779
1.55
1.26
1.38
40
3,404,840
1.17
0.92
1.02
15
1,724,239
0.87
0.63
0.67
12
1,655,235
0.72
0.51
0.53
59
2,980,563
1.98
1.29
1.45
45
2,756,345
1.63
0.98
1.09
106,961
94,002
1.06
0.73
0.78
190 11,635,225
1.63
1.14
1.27
135
11,526,898
1.17
0.78
0.86
- 198 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C18 - C21
10 10
10
2 3
10 10
10
2 3
1,016
1,262,554
80.47
47.53
53.22
759
1,356,218
55.96
31.13
35.31
579
754,586
76.73
54.04
60.04
451
775,361
58.17
38.22
43.26
118
193,573
60.96
41.69
46.27
99
190,561
51.95
31.78
35.56
144
206,243
69.82
54.53
60.92
101
209,101
48.30
35.88
39.89
367
525,788
69.80
56.66
63.93
285
556,511
51.21
38.47
43.83
289
381,903
75.67
55.64
62.36
216
390,370
55.33
37.43
41.83
111
134,036
82.81
57.05
64.58
67
138,354
48.43
30.62
34.50
1,291
1,935,668
66.70
52.45
58.44
963
1,961,699
49.09
35.37
40.36
628
1,009,274
62.22
49.98
56.18
428
992,786
43.11
33.55
38.26
150
264,014
56.82
39.12
44.69
98
249,001
39.36
27.18
30.41
167
234,682
71.16
44.90
50.55
123
225,804
54.47
31.87
35.69
210
291,177
72.12
44.96
50.61
139
269,791
51.52
29.15
33.07
485
793,368
61.13
48.05
53.91
372
772,752
48.14
35.20
39.77
481
670,812
71.70
49.01
54.95
314
636,474
49.33
30.45
34.01
173
271,053
63.83
39.97
44.22
146
255,438
57.16
33.17
36.46
279
374,746
74.45
44.62
49.89
172
342,907
50.16
24.73
28.08
216
283,284
76.25
42.51
48.48
141
259,964
54.24
27.35
30.67
400
562,141
71.16
44.59
50.18
334
539,380
61.92
34.30
38.96
477
636,341
74.96
52.17
58.29
345
607,195
56.82
35.46
40.68
322
449,267
71.67
45.06
50.74
199
424,242
46.91
28.23
31.38
30
49,769
60.28
37.36
40.66
23
47,149
48.78
28.76
31.91
120
174,584
68.73
42.83
47.85
74
164,221
45.06
27.73
30.69
74
120,747
61.29
35.85
41.63
38
109,926
34.57
20.08
22.08
14
49,871
28.07
17.85
19.69
47,493
18.95
12.99
13.81
5,744
4,200
23.81
5.88
7.06
3,724
5,397,185
69.00
48.94
54.74
2,710
5,454,961
49.68
32.69
37.05
1,785
2,635,767
67.72
48.27
54.09
1,289
2,564,082
50.27
32.42
36.38
2,424
3,251,327
74.55
49.51
55.46
1,776
3,182,015
55.81
33.96
38.30
194
295,331
65.69
39.88
45.20
112
274,147
40.85
24.69
27.25
14
55,615
25.17
16.12
17.78
10
51,693
19.34
12.37
13.23
1,595
2,017,140
79.07
49.70
55.47
1,210
2,131,579
56.77
33.61
38.06
1,029
1,441,543
71.38
53.80
60.39
768
1,484,897
51.72
36.06
40.56
2,239
3,364,779
66.54
52.31
58.40
1,634
3,404,840
47.99
34.73
39.76
1,185
1,724,239
68.73
46.11
51.57
879
1,655,235
53.10
32.89
36.68
2,038
2,980,563
68.38
43.54
49.13
1,370
2,756,345
49.70
29.08
32.66
41
106,961
38.33
32.03
34.72
25
94,002
26.60
19.45
21.75
8,143 11,635,225
69.99
48.58
54.39
5,897
11,526,898
51.16
32.65
36.84
2. * 2
- 199 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C18
10 10
10
2 3
10 10
10
2 3
635
1,262,554
50.29
29.08
32.75
521
1,356,218
38.42
21.19
24.12
360
754,586
47.71
32.94
37.01
282
775,361
36.37
23.81
27.01
79
193,573
40.81
28.00
31.41
67
190,561
35.16
21.23
23.81
99
206,243
48.00
37.18
41.80
76
209,101
36.35
26.72
29.93
209
525,788
39.75
31.59
36.03
182
556,511
32.70
24.33
27.90
169
381,903
44.25
32.20
36.37
140
390,370
35.86
24.10
27.17
62
134,036
46.26
31.97
36.11
51
138,354
36.86
23.19
25.95
779
1,935,668
40.24
31.61
35.32
590
1,961,699
30.08
21.80
24.96
412
1,009,274
40.82
32.36
36.46
295
992,786
29.71
23.32
26.40
94
264,014
35.60
24.15
27.67
71
249,001
28.51
19.58
21.93
101
234,682
43.04
27.15
30.69
81
225,804
35.87
20.21
22.87
113
291,177
38.81
23.96
27.06
80
269,791
29.65
17.46
19.60
274
793,368
34.54
26.87
30.25
223
772,752
28.86
21.26
24.01
297
670,812
44.27
30.62
34.07
210
636,474
32.99
20.53
22.93
95
271,053
35.05
21.70
24.17
98
255,438
38.37
21.29
23.77
157
374,746
41.90
24.88
27.93
88
342,907
25.66
12.22
14.24
113
283,284
39.89
21.21
24.76
83
259,964
31.93
14.75
16.85
211
562,141
37.54
23.50
26.53
198
539,380
36.71
19.98
22.90
266
636,341
41.80
28.75
32.37
215
607,195
35.41
21.93
25.21
209
449,267
46.52
28.62
32.64
124
424,242
29.23
18.03
19.73
19
49,769
38.18
23.08
25.26
14
47,149
29.69
18.15
19.83
73
174,584
41.81
25.37
28.71
50
164,221
30.45
17.95
20.15
34
120,747
28.16
16.33
19.01
19
109,926
17.28
9.65
10.88
49,871
18.05
11.19
12.60
47,493
10.53
7.30
7.89
5,744
4,200
23.81
5.88
7.06
2,312
5,397,185
42.84
30.09
33.80
1,781
5,454,961
32.65
21.52
24.42
1,032
2,635,767
39.15
27.77
31.17
801
2,564,082
31.24
19.92
22.51
1,409
3,251,327
43.34
28.34
32.03
1,107
3,182,015
34.79
21.05
23.79
107
295,331
36.23
21.59
24.66
69
274,147
25.17
14.58
16.36
55,615
16.18
10.15
11.43
51,693
11.61
7.16
7.80
995
2,017,140
49.33
30.33
34.12
803
2,131,579
37.67
22.20
25.22
618
1,441,543
42.87
31.99
36.18
516
1,484,897
34.75
24.01
27.14
1,368
3,364,779
40.66
31.74
35.61
1,030
3,404,840
30.25
21.97
25.22
703
1,724,239
40.77
27.18
30.43
560
1,655,235
33.83
20.83
23.30
1,157
2,980,563
38.82
24.48
27.76
833
2,756,345
30.22
17.57
19.79
18
106,961
16.83
14.21
15.44
15
94,002
15.96
11.36
12.69
4,871 11,635,225
41.86
28.75
32.36
3,764
11,526,898
32.65
20.75
23.48
2. * 2
- 200 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C19 - C21
10 10
10
2 3
10 10
10
2 3
381
1,262,554
30.18
18.45
20.47
238
1,356,218
17.55
9.94
11.19
219
754,586
29.02
21.11
23.03
169
775,361
21.80
14.40
16.25
39
193,573
20.15
13.68
14.86
32
190,561
16.79
10.55
11.75
45
206,243
21.82
17.35
19.11
25
209,101
11.96
9.16
9.96
158
525,788
30.05
25.08
27.90
103
556,511
18.51
14.14
15.93
120
381,903
31.42
23.44
25.99
76
390,370
19.47
13.33
14.66
49
134,036
36.56
25.07
28.47
16
138,354
11.56
7.44
8.55
512
1,935,668
26.45
20.83
23.12
373
1,961,699
19.01
13.58
15.40
216
1,009,274
21.40
17.61
19.72
133
992,786
13.40
10.23
11.86
56
264,014
21.21
14.97
17.02
27
249,001
10.84
7.60
8.49
66
234,682
28.12
17.75
19.85
42
225,804
18.60
11.66
12.82
97
291,177
33.31
21.00
23.54
59
269,791
21.87
11.69
13.47
211
793,368
26.60
21.19
23.65
149
772,752
19.28
13.94
15.76
184
670,812
27.43
18.38
20.88
104
636,474
16.34
9.92
11.08
78
271,053
28.78
18.27
20.05
48
255,438
18.79
11.88
12.68
122
374,746
32.56
19.74
21.96
84
342,907
24.50
12.51
13.83
103
283,284
36.36
21.30
23.72
58
259,964
22.31
12.61
13.82
189
562,141
33.62
21.09
23.65
136
539,380
25.21
14.32
16.07
211
636,341
33.16
23.42
25.92
130
607,195
21.41
13.53
15.47
113
449,267
25.15
16.44
18.10
75
424,242
17.68
10.20
11.65
11
49,769
22.10
14.28
15.40
47,149
19.09
10.60
12.08
47
174,584
26.92
17.46
19.14
24
164,221
14.61
9.77
10.54
40
120,747
33.13
19.53
22.62
19
109,926
17.28
10.43
11.20
49,871
10.03
6.66
7.09
47,493
8.42
5.69
5.92
5,744
4,200
1,412
5,397,185
26.16
18.85
20.94
929
5,454,961
17.03
11.17
12.63
753
2,635,767
28.57
20.50
22.92
488
2,564,082
19.03
12.49
13.87
1,015
3,251,327
31.22
21.17
23.43
669
3,182,015
21.02
12.91
14.51
87
295,331
29.46
18.29
20.54
43
274,147
15.69
10.11
10.88
55,615
8.99
5.96
6.35
51,693
7.74
5.21
5.43
600
2,017,140
29.75
19.37
21.35
407
2,131,579
19.09
11.41
12.84
411
1,441,543
28.51
21.81
24.21
252
1,484,897
16.97
12.05
13.41
871
3,364,779
25.89
20.58
22.79
604
3,404,840
17.74
12.76
14.54
482
1,724,239
27.95
18.94
21.14
319
1,655,235
19.27
12.06
13.38
881
2,980,563
29.56
19.06
21.38
537
2,756,345
19.48
11.50
12.87
23
106,961
21.50
17.81
19.29
10
94,002
10.64
8.09
9.06
3,272 11,635,225
28.12
19.83
22.04
2,133
11,526,898
18.50
11.90
13.35
- 201 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C22
10 10
10
2 3
10 10
10
2 3
687
1,262,554
54.41
33.79
37.43
297
1,356,218
21.90
12.10
14.11
552
754,586
73.15
52.94
57.72
250
775,361
32.24
21.18
24.17
126
193,573
65.09
44.19
48.65
62
190,561
32.54
21.22
23.35
117
206,243
56.73
47.57
51.86
72
209,101
34.43
25.89
28.92
317
525,788
60.29
48.86
54.67
125
556,511
22.46
17.01
19.67
293
381,903
76.72
56.12
62.31
135
390,370
34.58
23.63
26.87
128
134,036
95.50
66.73
75.55
79
138,354
57.10
34.92
39.77
1,084
1,935,668
56.00
43.83
48.29
410
1,961,699
20.90
15.66
18.10
475
1,009,274
47.06
38.31
42.60
190
992,786
19.14
15.25
17.81
123
264,014
46.59
34.83
38.20
58
249,001
23.29
16.10
17.75
153
234,682
65.19
43.25
47.45
62
225,804
27.46
15.50
17.41
221
291,177
75.90
47.70
53.67
90
269,791
33.36
17.93
20.59
459
793,368
57.85
46.20
50.55
214
772,752
27.69
20.77
23.54
472
670,812
70.36
49.86
54.91
176
636,474
27.65
16.47
18.45
161
271,053
59.40
37.78
41.89
84
255,438
32.88
18.25
20.19
422
374,746
112.61
72.57
78.90
158
342,907
46.08
21.71
24.80
281
283,284
99.19
59.86
65.90
144
259,964
55.39
26.98
30.46
535
562,141
95.17
61.67
67.72
215
539,380
39.86
22.26
25.11
551
636,341
86.59
60.67
66.84
226
607,195
37.22
23.46
26.90
311
449,267
69.22
45.85
49.97
124
424,242
29.23
16.91
18.93
64
49,769
128.59
82.32
89.86
22
47,149
46.66
23.90
26.52
104
174,584
59.57
40.24
44.09
39
164,221
23.75
13.51
15.24
86
120,747
71.22
46.59
51.65
36
109,926
32.75
15.68
18.81
23
49,871
46.12
29.04
32.13
47,493
6.32
3.88
4.13
5,744
104.46
71.83
75.36
4,200
2,986
5,397,185
55.33
40.24
44.46
1,241
5,454,961
22.75
15.21
17.49
1,831
2,635,767
69.47
50.95
56.01
757
2,564,082
29.52
18.64
21.11
2,715
3,251,327
83.50
56.95
62.64
1,195
3,182,015
37.55
22.48
25.51
190
295,331
64.33
42.86
47.21
75
274,147
27.36
14.45
16.77
29
55,615
52.14
33.52
36.73
51,693
5.80
3.63
3.87
1,239
2,017,140
61.42
40.67
44.71
547
2,131,579
25.66
15.14
17.45
981
1,441,543
68.05
51.70
57.48
473
1,484,897
31.85
22.53
25.56
1,904
3,364,779
56.59
44.45
48.89
764
3,404,840
22.44
16.87
19.43
1,213
1,724,239
70.35
48.65
53.59
522
1,655,235
31.54
18.57
21.09
2,331
2,980,563
78.21
52.38
57.63
933
2,756,345
33.85
19.20
21.71
56
106,961
52.36
40.69
44.79
23
94,002
24.47
15.30
17.92
7,751 11,635,225
66.62
47.52
52.34
3,272
11,526,898
28.39
18.00
20.54
2. * 1
- 202 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C23 - C24
10 10
10
2 3
10 10
10
2 3
60
1,262,554
4.75
2.76
3.15
57
1,356,218
4.20
2.15
2.58
32
754,586
4.24
2.69
3.18
28
775,361
3.61
2.27
2.68
10
193,573
5.17
3.71
4.14
10
190,561
5.25
3.18
3.60
206,243
3.88
2.84
3.18
209,101
3.35
2.51
2.69
14
525,788
2.66
1.86
2.19
19
556,511
3.41
2.53
2.99
19
381,903
4.98
3.23
3.91
16
390,370
4.10
2.68
3.18
134,036
2.24
1.70
1.81
138,354
4.34
2.40
2.97
76
1,935,668
3.93
2.91
3.33
62
1,961,699
3.16
2.42
2.76
41
1,009,274
4.06
2.62
3.19
24
992,786
2.42
1.86
2.24
11
264,014
4.17
3.09
3.44
249,001
2.41
1.73
1.84
20
234,682
8.52
4.73
5.57
16
225,804
7.09
3.90
4.55
291,177
3.09
1.88
2.14
12
269,791
4.45
1.79
2.28
27
793,368
3.40
2.58
2.91
23
772,752
2.98
2.06
2.40
28
670,812
4.17
2.63
3.08
29
636,474
4.56
2.27
2.74
11
271,053
4.06
2.02
2.59
12
255,438
4.70
2.27
2.70
14
374,746
3.74
2.28
2.54
18
342,907
5.25
2.67
2.94
14
283,284
4.94
2.51
3.01
12
259,964
4.62
2.22
2.55
26
562,141
4.63
2.57
3.06
32
539,380
5.93
3.15
3.63
21
636,341
3.30
2.21
2.58
22
607,195
3.62
2.34
2.66
22
449,267
4.90
3.11
3.53
16
424,242
3.77
1.77
2.19
49,769
6.03
2.08
2.89
47,149
4.24
0.97
1.58
10
174,584
5.73
3.19
3.87
164,221
2.44
1.33
1.55
120,747
4.14
2.40
2.56
109,926
4.55
2.14
2.46
49,871
2.01
1.08
1.29
47,493
5,744
4,200
235
5,397,185
4.35
2.93
3.37
194
5,454,961
3.56
2.29
2.68
94
2,635,767
3.57
2.36
2.74
101
2,564,082
3.94
2.31
2.70
140
3,251,327
4.31
2.63
3.10
134
3,182,015
4.21
2.36
2.78
15
295,331
5.08
2.87
3.33
274,147
3.28
1.67
1.94
55,615
1.80
0.96
1.15
51,693
92
2,017,140
4.56
2.73
3.14
85
2,131,579
3.99
2.17
2.59
54
1,441,543
3.75
2.64
3.06
58
1,484,897
3.91
2.64
3.08
144
3,364,779
4.28
3.08
3.60
106
3,404,840
3.11
2.28
2.69
77
1,724,239
4.47
2.80
3.24
59
1,655,235
3.56
1.91
2.25
115
2,980,563
3.86
2.33
2.71
127
2,756,345
4.61
2.54
2.91
106,961
1.87
0.74
1.34
94,002
2.13
1.17
1.50
486 11,635,225
4.18
2.70
3.14
438
11,526,898
3.80
2.28
2.67
2. * 1
- 203 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C25
10 10
10
2 3
10 10
10
2 3
124
1,262,554
9.82
5.62
6.30
98
1,356,218
7.23
3.79
4.39
61
754,586
8.08
5.49
6.34
49
775,361
6.32
3.86
4.73
18
193,573
9.30
6.33
6.90
12
190,561
6.30
3.35
4.20
16
206,243
7.76
5.92
6.59
12
209,101
5.74
3.42
4.22
32
525,788
6.09
4.65
5.41
35
556,511
6.29
5.04
5.61
31
381,903
8.12
6.23
6.87
24
390,370
6.15
4.77
5.12
14
134,036
10.44
7.41
8.15
10
138,354
7.23
4.41
5.06
162
1,935,668
8.37
6.09
7.09
109
1,961,699
5.56
3.95
4.70
67
1,009,274
6.64
5.31
5.95
45
992,786
4.53
3.72
4.20
11
264,014
4.17
2.20
2.88
14
249,001
5.62
2.96
3.86
24
234,682
10.23
5.97
6.98
13
225,804
5.76
2.25
2.98
30
291,177
10.30
7.21
7.68
23
269,791
8.53
3.52
4.41
57
793,368
7.18
5.76
6.33
40
772,752
5.18
3.53
4.26
40
670,812
5.96
3.88
4.47
33
636,474
5.18
3.10
3.47
31
271,053
11.44
6.68
7.62
15
255,438
5.87
3.20
3.87
32
374,746
8.54
5.05
5.72
19
342,907
5.54
2.96
3.26
17
283,284
6.00
3.31
3.76
18
259,964
6.92
3.43
3.84
57
562,141
10.14
5.89
6.86
32
539,380
5.93
3.09
3.55
35
636,341
5.50
3.76
4.33
58
607,195
9.55
5.80
6.85
45
449,267
10.02
6.02
6.92
25
424,242
5.89
3.19
3.75
49,769
8.04
4.66
5.11
47,149
2.12
1.79
1.79
19
174,584
10.88
6.35
7.45
164,221
5.48
3.22
3.63
120,747
5.80
4.04
4.28
12
109,926
10.92
6.95
7.23
49,871
4.01
3.23
3.23
47,493
5,744
17.41
8.75
10.07
4,200
452
5,397,185
8.37
5.69
6.45
326
5,454,961
5.98
3.72
4.41
192
2,635,767
7.28
5.07
5.74
142
2,564,082
5.54
3.45
3.94
264
3,251,327
8.12
5.19
5.94
217
3,182,015
6.82
3.96
4.58
26
295,331
8.80
5.39
6.14
21
274,147
7.66
4.72
5.08
55,615
5.39
3.97
4.12
51,693
185
2,017,140
9.17
5.55
6.28
147
2,131,579
6.90
3.81
4.49
111
1,441,543
7.70
5.77
6.46
93
1,484,897
6.26
4.45
5.04
273
3,364,779
8.11
6.14
7.02
180
3,404,840
5.29
3.73
4.49
124
1,724,239
7.19
4.71
5.32
100
1,655,235
6.04
3.44
3.98
236
2,980,563
7.92
4.85
5.57
183
2,756,345
6.64
3.62
4.14
106,961
3.74
3.32
3.21
94,002
2.13
1.87
1.95
937 11,635,225
8.05
5.39
6.13
706
11,526,898
6.12
3.73
4.33
- 204 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C48
10 10
10
2 3
10 10
10
2 3
11
1,262,554
0.87
0.84
0.84
1,356,218
0.59
0.41
0.44
754,586
0.66
0.61
0.60
775,361
0.64
0.45
0.51
193,573
1.03
0.57
0.73
190,561
1.57
1.10
1.23
206,243
0.48
0.59
0.60
209,101
525,788
0.57
0.46
0.52
556,511
0.90
0.77
0.82
381,903
390,370
0.77
0.59
0.59
134,036
138,354
0.72
0.44
0.50
14
1,935,668
0.72
0.66
0.68
1,961,699
0.36
0.25
0.27
10
1,009,274
0.99
0.80
0.86
992,786
0.71
0.60
0.68
264,014
1.14
1.34
1.26
249,001
1.61
1.20
1.32
234,682
2.13
1.11
1.34
225,804
291,177
1.03
0.91
0.98
269,791
1.11
0.68
0.75
793,368
0.63
0.63
0.64
772,752
0.65
0.82
0.78
670,812
0.45
0.39
0.42
636,474
0.47
0.35
0.37
271,053
0.37
0.32
0.30
255,438
0.78
0.50
0.52
374,746
0.53
0.28
0.34
342,907
0.87
0.50
0.58
283,284
259,964
1.54
1.29
1.31
562,141
0.53
0.39
0.44
539,380
0.74
0.70
0.70
636,341
0.79
0.86
0.82
607,195
0.49
0.30
0.34
449,267
0.45
0.30
0.31
424,242
1.18
0.73
0.80
49,769
47,149
174,584
164,221
0.61
0.49
0.54
120,747
0.83
0.52
0.60
109,926
0.91
0.51
0.59
49,871
2.01
0.79
1.19
47,493
5,744
4,200
49
5,397,185
0.91
0.77
0.81
32
5,454,961
0.59
0.42
0.46
14
2,635,767
0.53
0.44
0.47
18
2,564,082
0.70
0.60
0.61
15
3,251,327
0.46
0.42
0.42
25
3,182,015
0.79
0.58
0.62
295,331
0.34
0.20
0.23
274,147
0.73
0.50
0.56
55,615
1.80
0.74
1.11
51,693
16
2,017,140
0.79
0.76
0.75
13
2,131,579
0.61
0.42
0.47
1,441,543
0.42
0.32
0.37
12
1,484,897
0.81
0.64
0.69
27
3,364,779
0.80
0.75
0.77
22
3,404,840
0.65
0.54
0.58
12
1,724,239
0.70
0.46
0.53
10
1,655,235
0.60
0.36
0.41
18
2,980,563
0.60
0.46
0.49
18
2,756,345
0.65
0.54
0.55
106,961
0.93
0.58
0.62
94,002
2.13
1.69
1.78
80 11,635,225
0.69
0.58
0.60
77
11,526,898
0.67
0.51
0.54
- 205 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C26
10 10
10
2 3
10 10
10
2 3
1,262,554
0.08
0.04
0.05
1,356,218
0.44
0.27
0.28
754,586
0.13
0.04
0.08
775,361
0.39
0.26
0.30
193,573
190,561
206,243
0.48
0.34
0.39
209,101
0.48
0.34
0.38
525,788
556,511
0.18
0.08
0.15
381,903
390,370
134,036
138,354
1,935,668
0.05
0.06
0.06
1,961,699
0.31
0.25
0.26
1,009,274
0.10
0.07
0.08
992,786
0.10
0.07
0.08
264,014
249,001
234,682
0.43
0.32
0.41
225,804
0.44
0.12
0.21
291,177
269,791
793,368
0.50
0.38
0.44
772,752
0.26
0.18
0.19
670,812
0.15
0.10
0.12
636,474
0.47
0.42
0.43
271,053
0.37
0.31
0.31
255,438
0.39
0.24
0.27
374,746
342,907
283,284
0.71
0.44
0.47
259,964
562,141
539,380
0.37
0.26
0.28
636,341
0.16
0.09
0.11
607,195
0.49
0.39
0.39
449,267
0.67
0.43
0.47
424,242
0.24
0.19
0.18
49,769
47,149
174,584
0.57
0.42
0.53
164,221
0.61
0.34
0.39
120,747
109,926
49,871
47,493
5,744
4,200
5,397,185
0.09
0.07
0.07
15
5,454,961
0.27
0.19
0.21
2,635,767
0.23
0.16
0.18
2,564,082
0.27
0.19
0.21
3,251,327
0.22
0.13
0.15
3,182,015
0.28
0.21
0.22
295,331
0.34
0.25
0.32
274,147
0.36
0.21
0.24
55,615
51,693
2,017,140
0.10
0.04
0.05
2,131,579
0.42
0.27
0.29
1,441,543
0.07
0.04
0.05
1,484,897
0.13
0.07
0.10
3,364,779
0.09
0.07
0.08
3,404,840
0.18
0.11
0.13
1,724,239
0.06
0.04
0.04
1,655,235
0.18
0.13
0.13
12
2,980,563
0.40
0.26
0.29
11
2,756,345
0.40
0.30
0.31
106,961
94,002
1.06
0.75
0.82
19 11,635,225
0.16
0.11
0.12
32
11,526,898
0.28
0.19
0.21
- 206 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C30 - C31
10 10
10
2 3
10 10
10
2 3
1,262,554
0.63
0.38
0.46
1,356,218
0.66
0.44
0.47
11
754,586
1.46
1.07
1.14
775,361
0.26
0.16
0.18
193,573
190,561
0.52
0.22
0.34
206,243
1.45
1.33
1.35
209,101
0.48
0.49
0.46
525,788
0.57
0.53
0.52
556,511
0.90
0.61
0.71
381,903
1.05
0.83
0.82
390,370
0.51
0.32
0.35
134,036
2.24
1.80
1.78
138,354
1.45
1.31
1.30
28
1,935,668
1.45
1.14
1.30
1,961,699
0.46
0.33
0.40
11
1,009,274
1.09
0.85
1.01
992,786
0.60
0.50
0.53
264,014
1.89
1.75
1.76
249,001
0.80
0.70
0.72
234,682
1.28
0.73
0.84
225,804
1.33
0.80
0.86
291,177
0.69
0.50
0.54
269,791
793,368
1.01
0.77
0.86
772,752
0.26
0.45
0.36
670,812
0.60
0.34
0.41
636,474
271,053
0.74
0.46
0.50
255,438
0.39
0.32
0.35
374,746
0.80
0.50
0.51
342,907
0.87
0.58
0.59
283,284
0.71
0.41
0.47
259,964
562,141
0.71
0.48
0.52
539,380
0.19
0.10
0.11
636,341
0.79
0.56
0.60
607,195
0.33
0.25
0.25
449,267
1.11
0.82
0.83
424,242
0.47
0.28
0.31
49,769
47,149
174,584
1.15
0.47
0.63
164,221
120,747
0.83
0.52
0.60
109,926
49,871
4.01
2.78
3.41
47,493
5,744
4,200
60
5,397,185
1.11
0.80
0.91
31
5,454,961
0.57
0.40
0.44
20
2,635,767
0.76
0.55
0.61
11
2,564,082
0.43
0.40
0.40
34
3,251,327
1.05
0.76
0.79
11
3,182,015
0.35
0.24
0.25
295,331
1.02
0.49
0.61
274,147
55,615
3.60
2.48
3.05
51,693
19
2,017,140
0.94
0.62
0.70
11
2,131,579
0.52
0.33
0.36
13
1,441,543
0.90
0.76
0.75
11
1,484,897
0.74
0.53
0.59
34
3,364,779
1.01
0.71
0.85
11
3,404,840
0.32
0.23
0.25
17
1,724,239
0.99
0.73
0.78
1,655,235
0.36
0.24
0.27
36
2,980,563
1.21
0.85
0.92
13
2,756,345
0.47
0.41
0.40
106,961
94,002
119 11,635,225
1.02
0.73
0.80
53
11,526,898
0.46
0.34
0.36
- 207 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C32
10 10
10
2 3
10 10
10
2 3
70
1,262,554
5.54
3.02
3.49
1,356,218
0.52
0.29
0.32
39
754,586
5.17
3.55
3.92
775,361
0.39
0.30
0.29
13
193,573
6.72
4.65
5.03
190,561
0.52
0.31
0.34
12
206,243
5.82
4.87
5.23
209,101
13
525,788
2.47
1.68
2.14
556,511
0.36
0.20
0.27
11
381,903
2.88
2.26
2.38
390,370
134,036
5.22
3.58
3.92
138,354
1.45
1.00
1.08
89
1,935,668
4.60
3.40
3.75
1,961,699
0.15
0.10
0.12
51
1,009,274
5.05
4.12
4.60
992,786
0.20
0.16
0.17
264,014
2.65
1.72
2.00
249,001
12
234,682
5.11
3.52
3.79
225,804
291,177
2.75
1.91
2.05
269,791
1.11
0.58
0.67
43
793,368
5.42
4.63
4.95
772,752
0.39
0.32
0.36
37
670,812
5.52
4.21
4.43
636,474
0.31
0.19
0.21
17
271,053
6.27
4.00
4.38
255,438
0.39
0.24
0.27
15
374,746
4.00
2.71
2.93
342,907
17
283,284
6.00
3.02
3.55
259,964
26
562,141
4.63
3.15
3.43
539,380
0.19
0.06
0.09
42
636,341
6.60
4.48
4.97
607,195
0.33
0.22
0.24
40
449,267
8.90
5.91
6.49
424,242
0.24
0.10
0.12
49,769
10.05
6.17
6.70
47,149
10
174,584
5.73
4.03
4.37
164,221
16
120,747
13.25
9.34
9.92
109,926
49,871
4.01
2.25
2.50
47,493
5,744
4,200
262
5,397,185
4.85
3.38
3.77
16
5,454,961
0.29
0.19
0.22
125
2,635,767
4.74
3.56
3.86
2,564,082
0.31
0.20
0.23
187
3,251,327
5.75
3.84
4.24
3,182,015
0.28
0.18
0.19
26
295,331
8.80
6.15
6.59
274,147
55,615
3.60
1.99
2.22
51,693
109
2,017,140
5.40
3.22
3.66
10
2,131,579
0.47
0.29
0.31
56
1,441,543
3.88
2.87
3.20
1,484,897
0.34
0.21
0.24
170
3,364,779
5.05
4.04
4.38
3,404,840
0.26
0.20
0.23
87
1,724,239
5.05
3.55
3.88
1,655,235
0.24
0.16
0.17
169
2,980,563
5.67
3.78
4.15
2,756,345
0.18
0.10
0.12
106,961
8.41
6.73
7.84
94,002
602 11,635,225
5.17
3.62
4.00
33
11,526,898
0.29
0.18
0.21
- 208 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C33 - C34
10 10
10
2 3
10 10
10
2 3
771
1,262,554
61.07
33.68
38.75
584
1,356,218
43.06
23.38
26.78
392
754,586
51.95
34.59
40.17
280
775,361
36.11
23.42
26.58
119
193,573
61.48
39.70
46.04
64
190,561
33.59
19.57
22.62
94
206,243
45.58
34.16
39.75
65
209,101
31.09
22.10
24.90
231
525,788
43.93
32.80
39.19
168
556,511
30.19
22.47
25.59
221
381,903
57.87
41.67
47.85
129
390,370
33.05
22.21
24.93
71
134,036
52.97
36.49
41.65
52
138,354
37.58
22.52
26.17
1,104
1,935,668
57.03
43.29
50.93
617
1,961,699
31.45
22.60
26.12
530
1,009,274
52.51
38.75
45.67
242
992,786
24.38
18.60
21.49
134
264,014
50.75
33.93
39.32
76
249,001
30.52
18.03
21.27
231
234,682
98.43
55.89
66.13
109
225,804
48.27
27.71
30.80
156
291,177
53.58
29.83
35.38
98
269,791
36.32
21.00
23.40
400
793,368
50.42
37.06
43.78
213
772,752
27.56
20.04
22.84
420
670,812
62.61
39.33
46.38
239
636,474
37.55
22.79
25.72
153
271,053
56.45
31.58
36.93
69
255,438
27.01
16.31
17.75
250
374,746
66.71
36.64
42.90
125
342,907
36.45
18.90
21.01
241
283,284
85.07
46.10
52.59
116
259,964
44.62
22.10
24.53
374
562,141
66.53
39.84
45.60
227
539,380
42.09
24.33
26.85
331
636,341
52.02
34.88
39.93
197
607,195
32.44
20.69
23.39
236
449,267
52.53
30.63
35.96
120
424,242
28.29
15.57
17.86
31
49,769
62.29
33.09
38.42
20
47,149
42.42
22.86
25.26
100
174,584
57.28
33.71
38.94
48
164,221
29.23
15.97
18.84
81
120,747
67.08
39.53
45.72
49
109,926
44.58
24.61
27.56
24
49,871
48.12
30.25
34.46
47,493
18.95
12.06
13.17
5,744
34.82
24.93
28.31
4,200
47.62
20.32
27.65
3,139
5,397,185
58.16
38.67
45.20
1,855
5,454,961
34.01
21.95
25.14
1,454
2,635,767
55.16
36.29
42.78
814
2,564,082
31.75
20.47
23.06
1,897
3,251,327
58.35
36.92
42.52
1,141
3,182,015
35.86
21.62
24.33
181
295,331
61.29
36.01
41.62
97
274,147
35.38
19.53
22.45
26
55,615
46.75
29.61
33.78
11
51,693
21.28
12.78
14.38
1,163
2,017,140
57.66
33.96
39.19
864
2,131,579
40.53
23.38
26.71
736
1,441,543
51.06
36.80
42.88
478
1,484,897
32.19
21.94
24.97
1,858
3,364,779
55.22
40.62
47.89
1,010
3,404,840
29.66
21.39
24.57
1,050
1,724,239
60.90
37.79
44.05
579
1,655,235
34.98
21.33
23.89
1,829
2,980,563
61.36
36.97
42.89
951
2,756,345
34.50
19.83
22.35
45
106,961
42.07
32.27
37.73
27
94,002
28.72
20.16
22.43
6,697 11,635,225
57.56
37.49
43.68
3,918
11,526,898
33.99
21.38
24.27
- 209 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C38.4
10 10
10
2 3
10 10
10
2 3
1,262,554
0.24
0.15
0.16
1,356,218
0.29
0.21
0.22
754,586
0.93
0.72
0.79
775,361
193,573
190,561
206,243
209,101
0.48
0.49
0.46
525,788
0.19
0.13
0.14
556,511
381,903
390,370
134,036
1.49
0.81
1.00
138,354
1,935,668
0.21
0.17
0.17
1,961,699
0.10
0.09
0.08
1,009,274
0.50
0.46
0.49
992,786
0.10
0.09
0.10
264,014
0.76
0.53
0.61
249,001
234,682
0.85
0.50
0.55
225,804
291,177
269,791
0.37
0.34
0.31
793,368
0.25
0.16
0.21
772,752
0.26
0.14
0.20
670,812
0.60
0.31
0.41
636,474
0.16
0.09
0.10
271,053
255,438
374,746
342,907
0.29
0.08
0.10
283,284
0.35
0.12
0.17
259,964
0.38
0.28
0.30
562,141
0.53
0.38
0.39
539,380
0.19
0.04
0.08
636,341
0.31
0.24
0.24
607,195
0.16
0.08
0.11
449,267
0.22
0.13
0.15
424,242
0.47
0.31
0.32
49,769
2.01
0.64
0.96
47,149
174,584
1.15
0.93
0.97
164,221
120,747
0.83
0.57
0.57
109,926
49,871
47,493
5,744
4,200
16
5,397,185
0.30
0.24
0.25
5,454,961
0.16
0.14
0.14
2,635,767
0.27
0.15
0.19
2,564,082
0.16
0.08
0.10
17
3,251,327
0.52
0.35
0.39
3,182,015
0.16
0.09
0.10
295,331
1.02
0.78
0.81
274,147
55,615
51,693
10
2,017,140
0.50
0.35
0.38
2,131,579
0.19
0.14
0.14
1,441,543
0.21
0.12
0.14
1,484,897
0.07
0.06
0.06
11
3,364,779
0.33
0.29
0.31
3,404,840
0.18
0.14
0.15
1,724,239
0.46
0.29
0.34
1,655,235
0.12
0.03
0.06
2,980,563
0.30
0.19
0.21
2,756,345
0.18
0.11
0.12
106,961
1.87
1.25
1.34
94,002
43 11,635,225
0.37
0.26
0.29
19
11,526,898
0.16
0.11
0.12
2. * 1
- 210 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C37 - C38.3C38.8
10 10
10
2 3
10 10
10
2 3
15
1,262,554
1.19
0.96
0.98
1,356,218
0.66
0.46
0.49
12
754,586
1.59
0.99
1.20
11
775,361
1.42
0.98
1.06
193,573
0.52
0.29
0.33
190,561
0.52
0.28
0.32
206,243
1.94
1.41
1.53
209,101
0.96
0.75
0.75
525,788
1.71
1.26
1.45
556,511
0.72
1.00
0.86
381,903
1.05
1.01
1.00
10
390,370
2.56
1.99
2.12
134,036
2.24
1.57
1.85
138,354
0.72
0.45
0.49
26
1,935,668
1.34
1.12
1.22
18
1,961,699
0.92
0.63
0.68
16
1,009,274
1.59
1.17
1.34
992,786
0.50
0.37
0.44
264,014
1.14
0.83
0.93
249,001
0.80
0.55
0.67
234,682
1.70
1.10
1.24
225,804
0.44
0.30
0.32
291,177
1.03
0.87
0.85
269,791
1.11
0.86
0.96
793,368
1.13
0.97
1.04
772,752
0.65
0.51
0.54
670,812
1.04
0.81
0.88
636,474
0.31
0.24
0.26
271,053
1.84
1.78
1.80
255,438
1.17
0.83
0.82
374,746
1.33
1.09
1.13
342,907
0.29
0.25
0.25
283,284
2.12
1.20
1.37
259,964
2.31
1.46
1.57
562,141
1.60
0.95
1.14
11
539,380
2.04
1.39
1.48
13
636,341
2.04
1.35
1.55
607,195
0.82
0.54
0.60
449,267
0.89
1.16
1.01
424,242
1.41
0.82
0.96
49,769
2.01
1.82
1.69
47,149
174,584
3.44
2.28
2.49
164,221
120,747
0.83
0.58
0.63
109,926
1.82
1.03
1.18
49,871
4.01
2.15
3.04
47,493
5,744
4,200
72
5,397,185
1.33
1.05
1.14
41
5,454,961
0.75
0.52
0.57
35
2,635,767
1.33
1.07
1.15
15
2,564,082
0.59
0.54
0.52
52
3,251,327
1.60
1.12
1.24
50
3,182,015
1.57
1.08
1.18
295,331
2.37
1.59
1.73
274,147
0.73
0.41
0.47
55,615
3.60
1.98
2.78
51,693
27
2,017,140
1.34
0.96
1.04
20
2,131,579
0.94
0.64
0.69
21
1,441,543
1.46
1.12
1.24
18
1,484,897
1.21
1.08
1.07
47
3,364,779
1.40
1.18
1.27
27
3,404,840
0.79
0.57
0.62
35
1,724,239
2.03
1.43
1.61
14
1,655,235
0.85
0.65
0.69
35
2,980,563
1.17
0.83
0.91
28
2,756,345
1.02
0.63
0.71
106,961
2.80
2.88
2.87
94,002
168 11,635,225
1.44
1.09
1.20
108
11,526,898
0.94
0.68
0.73
- 211 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
162
1,262,554
12.83
8.59
9.34
84
1,356,218
6.19
4.36
4.66
66
754,586
8.75
7.19
7.63
30
775,361
3.87
3.10
3.28
17
193,573
8.78
8.05
8.24
16
190,561
8.40
6.78
6.95
17
206,243
8.24
6.15
6.65
12
209,101
5.74
4.64
5.13
43
525,788
8.18
7.40
7.94
45
556,511
8.09
8.32
8.23
25
381,903
6.55
4.84
5.46
23
390,370
5.89
5.84
5.82
14
134,036
10.44
6.16
7.46
10
138,354
7.23
4.99
5.46
164
1,935,668
8.47
7.26
7.83
128
1,961,699
6.52
6.04
6.16
96
1,009,274
9.51
8.42
9.04
80
992,786
8.06
7.05
7.53
25
264,014
9.47
7.39
8.04
18
249,001
7.23
5.83
6.10
41
234,682
17.47
12.09
13.53
22
225,804
9.74
9.67
9.37
16
291,177
5.49
3.92
4.29
269,791
3.34
2.83
2.81
72
793,368
9.08
7.63
8.37
47
772,752
6.08
5.17
5.55
44
670,812
6.56
5.32
5.62
35
636,474
5.50
3.50
3.99
26
271,053
9.59
7.31
7.70
16
255,438
6.26
3.71
4.15
27
374,746
7.20
4.71
5.25
17
342,907
4.96
2.63
2.92
32
283,284
11.30
6.63
7.67
19
259,964
7.31
5.75
5.83
71
562,141
12.63
10.36
10.70
36
539,380
6.67
5.58
5.51
52
636,341
8.17
6.94
7.30
40
607,195
6.59
6.30
6.22
46
449,267
10.24
7.61
8.43
30
424,242
7.07
6.52
6.34
49,769
2.01
1.20
1.32
47,149
2.12
1.80
1.80
23
174,584
13.17
8.79
9.90
10
164,221
6.09
4.87
5.04
120,747
5.80
3.81
4.39
109,926
4.55
2.46
3.01
49,871
47,493
6.32
4.50
4.79
5,744
4,200
538
5,397,185
9.97
7.83
8.49
369
5,454,961
6.76
5.68
5.92
212
2,635,767
8.04
6.49
6.98
160
2,564,082
6.24
4.87
5.17
307
3,251,327
9.44
7.30
7.87
189
3,182,015
5.94
5.19
5.21
30
295,331
10.16
6.76
7.66
15
274,147
5.47
3.88
4.20
55,615
51,693
5.80
4.17
4.44
228
2,017,140
11.30
8.11
8.77
114
2,131,579
5.35
3.91
4.17
116
1,441,543
8.05
6.50
7.06
106
1,484,897
7.14
6.54
6.67
297
3,364,779
8.83
7.34
8.07
229
3,404,840
6.73
5.79
6.18
148
1,724,239
8.58
6.82
7.29
101
1,655,235
6.10
4.61
4.87
293
2,980,563
9.83
7.54
8.09
181
2,756,345
6.57
5.82
5.79
106,961
2.80
2.87
2.76
94,002
4.26
2.67
3.25
1,087 11,635,225
9.34
7.30
7.91
736
11,526,898
6.39
5.29
5.48
- 212 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
66
1,262,554
5.23
3.28
3.62
40
1,356,218
2.95
1.83
2.08
21
754,586
2.78
1.91
2.17
11
775,361
1.42
0.86
1.09
193,573
2.58
2.45
2.46
190,561
2.10
1.22
1.43
206,243
1.94
1.33
1.60
209,101
1.43
1.24
1.40
17
525,788
3.23
2.55
2.91
24
556,511
4.31
4.33
4.32
381,903
1.83
1.46
1.58
390,370
2.05
1.70
1.76
134,036
2.24
1.39
1.70
138,354
2.17
1.75
1.78
61
1,935,668
3.15
2.68
2.87
48
1,961,699
2.45
2.09
2.20
34
1,009,274
3.37
2.92
3.13
28
992,786
2.82
2.01
2.39
10
264,014
3.79
2.79
3.14
11
249,001
4.42
2.93
3.29
17
234,682
7.24
5.23
5.75
225,804
2.66
1.90
2.02
291,177
3.09
2.10
2.33
269,791
1.48
0.84
0.95
28
793,368
3.53
2.80
3.20
23
772,752
2.98
2.19
2.52
19
670,812
2.83
1.80
2.14
13
636,474
2.04
1.16
1.38
12
271,053
4.43
3.75
3.69
10
255,438
3.91
2.28
2.56
13
374,746
3.47
2.29
2.52
342,907
2.33
1.30
1.46
15
283,284
5.30
3.30
3.83
259,964
1.92
0.91
1.13
25
562,141
4.45
3.13
3.39
18
539,380
3.34
3.07
2.90
23
636,341
3.61
2.84
3.07
17
607,195
2.80
2.06
2.26
22
449,267
4.90
2.89
3.53
13
424,242
3.06
2.34
2.51
49,769
2.01
1.20
1.32
47,149
2.12
1.80
1.80
174,584
4.58
3.66
3.87
164,221
3.65
2.11
2.42
120,747
4.14
2.43
2.88
109,926
3.64
2.23
2.59
49,871
47,493
2.11
1.44
1.59
5,744
4,200
206
5,397,185
3.82
2.91
3.17
144
5,454,961
2.64
1.91
2.12
89
2,635,767
3.38
2.51
2.81
78
2,564,082
3.04
2.23
2.42
117
3,251,327
3.60
2.49
2.81
76
3,182,015
2.39
1.80
1.91
13
295,331
4.40
3.17
3.48
10
274,147
3.65
2.14
2.47
55,615
51,693
1.93
1.34
1.48
87
2,017,140
4.31
2.82
3.14
51
2,131,579
2.39
1.47
1.71
36
1,441,543
2.50
1.94
2.17
42
1,484,897
2.83
2.54
2.60
116
3,364,779
3.45
2.79
3.07
88
3,404,840
2.58
1.94
2.19
65
1,724,239
3.77
2.96
3.17
41
1,655,235
2.48
1.65
1.84
118
2,980,563
3.96
2.76
3.09
84
2,756,345
3.05
2.23
2.36
106,961
0.93
0.62
0.71
94,002
2.13
1.87
1.95
425 11,635,225
3.65
2.70
2.99
309
11,526,898
2.68
1.94
2.13
- 213 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
16
1,262,554
1.27
1.50
1.39
1,356,218
0.59
1.05
0.87
754,586
0.93
1.66
1.38
775,361
0.39
0.81
0.65
193,573
1.03
1.83
1.65
190,561
3.15
3.67
3.33
206,243
0.48
0.62
0.58
209,101
0.48
0.28
0.36
525,788
0.76
1.43
1.14
556,511
0.72
1.43
1.17
381,903
0.26
0.17
0.18
390,370
0.51
1.36
1.07
134,036
0.75
0.56
0.62
138,354
0.72
0.54
0.54
23
1,935,668
1.19
1.38
1.31
21
1,961,699
1.07
1.72
1.47
16
1,009,274
1.59
2.04
1.89
11
992,786
1.11
1.53
1.33
264,014
1.14
1.02
1.04
249,001
1.61
2.05
1.84
234,682
0.43
0.47
0.48
225,804
2.21
4.81
3.82
291,177
1.03
1.04
1.03
269,791
0.37
1.06
0.78
14
793,368
1.76
1.94
1.86
772,752
1.04
1.28
1.14
670,812
1.04
1.58
1.35
636,474
0.63
0.69
0.67
271,053
0.74
0.74
0.79
255,438
0.39
0.38
0.38
374,746
0.80
0.64
0.70
342,907
0.29
0.13
0.14
283,284
1.06
1.10
1.07
259,964
1.15
2.10
1.77
10
562,141
1.78
3.04
2.66
539,380
0.56
1.09
0.94
636,341
1.10
1.94
1.67
10
607,195
1.65
2.97
2.46
449,267
1.11
1.62
1.44
424,242
0.71
2.44
1.79
49,769
47,149
174,584
1.15
0.71
0.93
164,221
1.22
2.06
1.85
120,747
109,926
0.91
0.23
0.42
49,871
47,493
2.11
1.61
1.61
5,744
4,200
65
5,397,185
1.20
1.44
1.35
57
5,454,961
1.04
1.62
1.38
30
2,635,767
1.14
1.45
1.32
18
2,564,082
0.70
0.91
0.81
34
3,251,327
1.05
1.63
1.43
25
3,182,015
0.79
1.63
1.32
295,331
0.68
0.42
0.54
274,147
1.09
1.33
1.29
55,615
51,693
1.93
1.48
1.48
23
2,017,140
1.14
1.55
1.39
11
2,131,579
0.52
0.97
0.80
1,441,543
0.62
0.92
0.80
14
1,484,897
0.94
1.39
1.21
41
3,364,779
1.22
1.45
1.37
32
3,404,840
0.94
1.43
1.23
18
1,724,239
1.04
1.23
1.18
15
1,655,235
0.91
1.27
1.11
40
2,980,563
1.34
1.86
1.67
31
2,756,345
1.12
2.01
1.66
106,961
94,002
1.06
0.35
0.63
131 11,635,225
1.13
1.45
1.33
104
11,526,898
0.90
1.45
1.23
- 214 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
26
1,262,554
2.06
1.46
1.62
1,356,218
0.37
0.22
0.23
14
754,586
1.86
1.36
1.56
775,361
0.90
0.59
0.62
193,573
0.52
0.35
0.35
190,561
1.57
1.09
1.14
206,243
0.48
0.21
0.25
209,101
0.48
0.48
0.48
525,788
1.33
1.14
1.28
556,511
0.72
0.78
0.79
381,903
1.57
1.13
1.23
390,370
1.02
0.73
0.87
134,036
2.98
1.76
2.08
138,354
1.45
1.18
1.24
25
1,935,668
1.29
1.02
1.11
19
1,961,699
0.97
0.69
0.78
1,009,274
0.89
0.68
0.74
992,786
0.71
0.63
0.67
264,014
0.76
0.37
0.50
249,001
234,682
2.13
2.41
2.28
225,804
1.33
1.12
1.26
291,177
0.34
0.23
0.25
269,791
793,368
0.50
0.35
0.42
772,752
0.13
0.10
0.12
670,812
1.04
0.81
0.89
636,474
0.47
0.33
0.40
271,053
1.48
1.05
1.23
255,438
0.39
0.09
0.16
374,746
1.07
0.73
0.76
342,907
0.87
0.28
0.35
283,284
1.41
0.70
0.81
259,964
1.15
0.79
0.90
562,141
1.42
0.94
1.04
539,380
0.56
0.20
0.28
636,341
1.10
0.85
0.92
607,195
0.66
0.41
0.49
449,267
1.78
1.52
1.64
424,242
0.94
0.67
0.69
49,769
47,149
174,584
0.57
0.13
0.24
164,221
120,747
109,926
49,871
47,493
5,744
4,200
70
5,397,185
1.30
1.00
1.08
38
5,454,961
0.70
0.53
0.58
26
2,635,767
0.99
0.74
0.83
12
2,564,082
0.47
0.34
0.39
51
3,251,327
1.57
1.13
1.26
27
3,182,015
0.85
0.56
0.63
295,331
0.34
0.08
0.14
274,147
55,615
51,693
40
2,017,140
1.98
1.42
1.60
12
2,131,579
0.56
0.35
0.37
19
1,441,543
1.32
0.94
1.06
14
1,484,897
0.94
0.81
0.86
36
3,364,779
1.07
0.81
0.90
24
3,404,840
0.70
0.54
0.60
22
1,724,239
1.28
0.99
1.08
10
1,655,235
0.60
0.43
0.49
29
2,980,563
0.97
0.70
0.77
17
2,756,345
0.62
0.39
0.47
106,961
1.87
2.25
2.05
94,002
148 11,635,225
1.27
0.95
1.05
77
11,526,898
0.67
0.49
0.54
- 215 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
19
1,262,554
1.50
0.84
0.95
1,356,218
0.66
0.37
0.42
754,586
0.93
0.66
0.70
775,361
0.39
0.29
0.30
193,573
1.55
1.27
1.35
190,561
1.05
0.33
0.59
206,243
0.97
0.90
0.89
209,101
525,788
0.19
0.14
0.14
556,511
0.72
0.57
0.60
381,903
0.26
0.23
0.25
390,370
0.26
0.16
0.17
134,036
0.75
0.47
0.54
138,354
14
1,935,668
0.72
0.57
0.69
1,961,699
0.36
0.28
0.31
1,009,274
0.40
0.34
0.40
992,786
0.50
0.46
0.47
264,014
1.14
0.82
0.96
249,001
234,682
0.43
0.29
0.31
225,804
291,177
0.34
0.29
0.29
269,791
0.37
0.12
0.18
793,368
0.50
0.35
0.41
772,752
0.39
0.24
0.29
670,812
0.30
0.20
0.22
636,474
0.31
0.19
0.22
271,053
1.48
0.85
0.99
255,438
0.39
0.30
0.30
374,746
342,907
0.29
0.24
0.22
283,284
0.71
0.20
0.33
259,964
562,141
1.25
0.97
1.01
539,380
0.56
0.44
0.43
636,341
0.94
0.48
0.62
607,195
0.66
0.42
0.46
449,267
0.45
0.32
0.34
424,242
49,769
47,149
174,584
2.86
2.35
2.42
164,221
120,747
109,926
49,871
47,493
5,744
4,200
47
5,397,185
0.87
0.61
0.70
24
5,454,961
0.44
0.29
0.33
11
2,635,767
0.42
0.28
0.32
11
2,564,082
0.43
0.31
0.33
26
3,251,327
0.80
0.53
0.59
11
3,182,015
0.35
0.24
0.24
295,331
1.69
1.37
1.42
274,147
55,615
51,693
26
2,017,140
1.29
0.77
0.86
12
2,131,579
0.56
0.34
0.37
1,441,543
0.55
0.46
0.48
1,484,897
0.47
0.29
0.35
23
3,364,779
0.68
0.54
0.62
11
3,404,840
0.32
0.27
0.29
12
1,724,239
0.70
0.40
0.48
1,655,235
0.24
0.14
0.16
20
2,980,563
0.67
0.45
0.50
12
2,756,345
0.44
0.30
0.31
106,961
94,002
89 11,635,225
0.76
0.53
0.60
46
11,526,898
0.40
0.27
0.29
- 216 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
16
1,262,554
1.27
0.76
0.88
14
1,356,218
1.03
0.61
0.70
754,586
0.53
0.39
0.43
775,361
0.39
0.27
0.31
193,573
1.55
1.20
1.28
190,561
0.52
0.47
0.47
206,243
1.94
1.23
1.45
209,101
0.48
0.49
0.46
525,788
1.71
1.37
1.53
556,511
0.54
0.45
0.49
381,903
0.52
0.60
0.58
390,370
0.51
0.98
0.81
134,036
2.98
1.74
2.09
138,354
1.45
0.53
0.86
24
1,935,668
1.24
0.92
1.08
17
1,961,699
0.87
0.66
0.72
18
1,009,274
1.78
1.36
1.58
19
992,786
1.91
1.48
1.67
264,014
0.76
0.66
0.68
249,001
0.80
0.55
0.63
234,682
2.13
1.30
1.55
225,804
1.77
0.88
1.10
291,177
0.69
0.26
0.39
269,791
1.11
0.82
0.90
14
793,368
1.76
1.37
1.55
772,752
0.91
0.84
0.89
670,812
0.45
0.26
0.32
636,474
0.47
0.28
0.32
271,053
0.74
0.45
0.49
255,438
374,746
0.80
0.39
0.55
342,907
283,284
2.12
1.14
1.31
259,964
2.31
1.61
1.60
562,141
0.89
0.50
0.60
539,380
0.37
0.31
0.31
636,341
0.47
0.27
0.33
607,195
0.33
0.16
0.22
449,267
0.89
0.48
0.58
424,242
0.94
0.48
0.58
49,769
47,149
174,584
0.57
0.13
0.24
164,221
120,747
0.83
0.64
0.77
109,926
49,871
47,493
5,744
4,200
74
5,397,185
1.37
0.93
1.09
61
5,454,961
1.12
0.76
0.86
31
2,635,767
1.18
0.81
0.93
13
2,564,082
0.51
0.39
0.42
28
3,251,327
0.86
0.55
0.64
21
3,182,015
0.66
0.50
0.52
295,331
0.68
0.35
0.47
274,147
55,615
51,693
20
2,017,140
0.99
0.63
0.72
17
2,131,579
0.80
0.49
0.56
22
1,441,543
1.53
1.14
1.27
1,484,897
0.61
0.59
0.59
44
3,364,779
1.31
0.94
1.13
40
3,404,840
1.17
0.89
0.99
10
1,724,239
0.58
0.41
0.46
12
1,655,235
0.72
0.48
0.53
39
2,980,563
1.31
0.79
0.93
16
2,756,345
0.58
0.41
0.44
106,961
94,002
1.06
0.44
0.67
135 11,635,225
1.16
0.77
0.90
95
11,526,898
0.82
0.58
0.63
- 217 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
15
1,262,554
1.19
0.58
0.70
1,356,218
0.37
0.15
0.22
754,586
1.06
0.72
0.86
775,361
0.13
0.08
0.09
193,573
1.03
0.55
0.72
190,561
206,243
1.45
0.62
0.74
209,101
2.39
1.66
1.96
525,788
0.95
0.77
0.94
556,511
0.54
0.39
0.44
381,903
1.83
1.09
1.44
390,370
1.28
0.73
0.91
134,036
0.75
0.24
0.43
138,354
1.45
0.99
1.03
13
1,935,668
0.67
0.51
0.59
12
1,961,699
0.61
0.43
0.52
11
1,009,274
1.09
0.77
0.93
992,786
0.91
0.88
0.93
264,014
1.52
1.36
1.35
249,001
12
234,682
5.11
2.39
3.16
225,804
1.77
0.96
1.16
291,177
269,791
793,368
0.88
0.68
0.79
772,752
0.65
0.52
0.59
670,812
0.45
0.34
0.35
636,474
0.47
0.20
0.27
271,053
0.37
0.32
0.30
255,438
1.17
0.65
0.75
374,746
0.80
0.46
0.53
342,907
0.87
0.26
0.35
283,284
0.35
0.09
0.16
259,964
0.38
0.28
0.30
14
562,141
2.49
1.51
1.69
539,380
0.93
0.37
0.49
636,341
0.79
0.48
0.58
607,195
0.49
0.27
0.34
449,267
0.67
0.41
0.50
424,242
0.94
0.46
0.54
49,769
47,149
174,584
2.86
1.55
1.83
164,221
1.22
0.69
0.76
120,747
0.83
0.74
0.74
109,926
49,871
47,493
2.11
1.44
1.59
5,744
4,200
60
5,397,185
1.11
0.70
0.84
35
5,454,961
0.64
0.43
0.51
19
2,635,767
0.72
0.52
0.59
17
2,564,082
0.66
0.40
0.47
39
3,251,327
1.20
0.71
0.85
21
3,182,015
0.66
0.34
0.41
295,331
2.03
1.23
1.39
274,147
0.73
0.40
0.44
55,615
51,693
1.93
1.34
1.48
23
2,017,140
1.14
0.64
0.76
2,131,579
0.28
0.13
0.17
18
1,441,543
1.25
0.77
0.97
15
1,484,897
1.01
0.66
0.78
29
3,364,779
0.86
0.64
0.76
28
3,404,840
0.82
0.60
0.73
16
1,724,239
0.93
0.61
0.68
14
1,655,235
0.85
0.49
0.55
38
2,980,563
1.27
0.77
0.90
13
2,756,345
0.47
0.27
0.31
106,961
94,002
124 11,635,225
1.07
0.68
0.80
76
11,526,898
0.66
0.40
0.47
- 218 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C40 - C41
10 10
10
2 3
10 10
10
2 3
10
1,262,554
0.79
0.68
0.72
1,356,218
0.52
0.48
0.49
754,586
0.40
0.38
0.39
775,361
0.90
1.06
1.04
193,573
1.55
1.56
1.53
190,561
1.05
1.39
1.37
206,243
0.97
0.86
0.89
209,101
0.48
0.63
0.61
525,788
0.95
0.88
0.92
556,511
0.72
0.69
0.70
381,903
0.26
0.29
0.30
390,370
0.51
0.54
0.53
134,036
1.49
1.17
1.32
138,354
0.72
1.38
1.20
15
1,935,668
0.77
0.83
0.81
1,961,699
0.31
0.24
0.27
1,009,274
0.89
0.86
0.87
992,786
0.50
0.51
0.51
264,014
249,001
0.40
0.44
0.41
234,682
2.13
1.80
1.94
225,804
0.89
0.92
0.97
291,177
0.34
0.43
0.41
269,791
0.74
1.00
0.95
793,368
0.76
1.15
0.98
772,752
1.04
0.94
1.02
670,812
1.04
1.01
1.02
636,474
0.79
0.77
0.80
271,053
0.74
0.75
0.75
255,438
1.17
1.56
1.48
374,746
0.80
0.76
0.81
342,907
0.58
0.67
0.70
283,284
259,964
1.54
0.87
0.99
562,141
0.36
0.36
0.38
539,380
0.56
0.46
0.54
636,341
0.63
0.64
0.64
607,195
0.66
0.70
0.70
449,267
1.56
1.37
1.39
424,242
49,769
4.02
3.93
4.11
47,149
174,584
164,221
1.83
1.23
1.29
120,747
109,926
0.91
0.72
0.67
49,871
47,493
2.11
1.28
1.38
5,744
4,200
45
5,397,185
0.83
0.81
0.82
26
5,454,961
0.48
0.47
0.48
23
2,635,767
0.87
0.96
0.92
22
2,564,082
0.86
0.86
0.89
21
3,251,327
0.65
0.62
0.64
21
3,182,015
0.66
0.67
0.68
295,331
274,147
1.46
1.02
1.04
55,615
51,693
1.93
1.18
1.27
13
2,017,140
0.64
0.57
0.60
14
2,131,579
0.66
0.71
0.71
13
1,441,543
0.90
0.85
0.88
10
1,484,897
0.67
0.79
0.77
28
3,364,779
0.83
0.91
0.90
21
3,404,840
0.62
0.58
0.62
16
1,724,239
0.93
0.87
0.88
1,655,235
0.48
0.46
0.48
17
2,980,563
0.57
0.62
0.61
21
2,756,345
0.76
0.71
0.73
106,961
0.93
1.45
1.39
94,002
89 11,635,225
0.76
0.77
0.77
74
11,526,898
0.64
0.63
0.65
- 219 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C47C49
10 10
10
2 3
10 10
10
2 3
37
1,262,554
2.93
1.79
2.04
31
1,356,218
2.29
1.45
1.64
17
754,586
2.25
1.80
1.93
17
775,361
2.19
1.89
1.95
193,573
2.07
1.23
1.49
10
190,561
5.25
3.84
4.12
206,243
1.94
1.36
1.56
209,101
1.43
1.21
1.27
16
525,788
3.04
2.35
2.61
17
556,511
3.05
2.28
2.54
381,903
1.57
1.01
1.13
390,370
1.54
1.05
1.15
134,036
3.73
2.80
3.15
138,354
2.17
1.38
1.75
52
1,935,668
2.69
2.22
2.38
42
1,961,699
2.14
1.63
1.78
27
1,009,274
2.68
2.10
2.34
11
992,786
1.11
0.97
1.07
264,014
1.14
0.82
0.90
249,001
1.20
1.12
1.13
234,682
2.13
1.44
1.55
225,804
1.33
1.24
1.33
291,177
2.75
2.01
2.15
269,791
3.34
1.94
2.17
16
793,368
2.02
1.66
1.81
15
772,752
1.94
1.82
1.86
670,812
1.34
0.95
1.06
10
636,474
1.57
1.38
1.44
271,053
2.21
1.36
1.61
255,438
3.13
1.74
1.98
374,746
2.40
1.73
1.88
342,907
1.46
0.90
0.94
283,284
2.82
2.44
2.49
259,964
2.31
1.40
1.45
15
562,141
2.67
1.80
1.96
10
539,380
1.85
1.32
1.42
14
636,341
2.20
1.37
1.66
10
607,195
1.65
1.43
1.50
449,267
1.78
1.24
1.34
11
424,242
2.59
1.72
1.80
49,769
47,149
4.24
1.84
2.56
174,584
1.15
0.79
0.87
164,221
120,747
4.14
3.23
3.26
109,926
49,871
47,493
5,744
4,200
140
5,397,185
2.59
1.93
2.12
112
5,454,961
2.05
1.51
1.66
56
2,635,767
2.12
1.60
1.77
55
2,564,082
2.15
1.68
1.79
73
3,251,327
2.25
1.62
1.78
65
3,182,015
2.04
1.55
1.65
295,331
2.37
1.76
1.81
274,147
55,615
51,693
54
2,017,140
2.68
1.80
2.00
48
2,131,579
2.25
1.63
1.77
35
1,441,543
2.43
1.77
1.99
39
1,484,897
2.63
1.92
2.11
81
3,364,779
2.41
1.96
2.11
59
3,404,840
1.73
1.40
1.52
37
1,724,239
2.15
1.44
1.65
27
1,655,235
1.63
1.17
1.27
65
2,980,563
2.18
1.65
1.77
58
2,756,345
2.10
1.61
1.69
106,961
2.80
1.80
2.31
94,002
1.06
0.81
0.81
276 11,635,225
2.37
1.75
1.93
232
11,526,898
2.01
1.51
1.63
- 220 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C44
10 10
10
2 3
10 10
10
2 3
186
1,262,554
14.73
8.62
9.72
127
1,356,218
9.36
5.12
5.89
108
754,586
14.31
9.07
10.89
108
775,361
13.93
8.80
10.44
23
193,573
11.88
7.22
8.39
10
190,561
5.25
2.74
3.43
21
206,243
10.18
7.09
8.43
19
209,101
9.09
6.34
7.19
67
525,788
12.74
9.14
11.11
58
556,511
10.42
7.91
9.18
42
381,903
11.00
7.73
8.92
50
390,370
12.81
7.49
9.26
26
134,036
19.40
11.58
14.11
13
138,354
9.40
5.66
6.55
177
1,935,668
9.14
6.88
8.16
197
1,961,699
10.04
7.17
8.57
106
1,009,274
10.50
7.96
9.18
73
992,786
7.35
5.67
6.72
17
264,014
6.44
4.19
4.90
22
249,001
8.84
4.73
5.77
36
234,682
15.34
9.26
10.61
38
225,804
16.83
8.38
10.01
36
291,177
12.36
7.44
8.69
15
269,791
5.56
2.84
3.35
67
793,368
8.45
5.99
7.27
79
772,752
10.22
7.31
8.50
87
670,812
12.97
8.42
9.88
90
636,474
14.14
6.67
8.05
38
271,053
14.02
7.04
8.72
34
255,438
13.31
6.65
7.80
70
374,746
18.68
9.66
12.02
73
342,907
21.29
10.31
11.52
67
283,284
23.65
10.45
13.27
66
259,964
25.39
10.57
12.34
137
562,141
24.37
13.95
16.59
117
539,380
21.69
9.98
11.94
105
636,341
16.50
10.69
12.62
93
607,195
15.32
8.97
10.87
97
449,267
21.59
12.53
14.80
88
424,242
20.74
10.57
12.55
11
49,769
22.10
9.00
11.76
47,149
19.09
6.84
8.69
35
174,584
20.05
10.37
12.75
18
164,221
10.96
5.40
6.67
16
120,747
13.25
9.39
9.99
109,926
4.55
1.76
2.43
49,871
47,493
2.11
1.61
1.61
5,744
4,200
602
5,397,185
11.15
7.50
8.68
501
5,454,961
9.18
5.78
6.80
329
2,635,767
12.48
7.89
9.56
334
2,564,082
13.03
7.69
8.97
593
3,251,327
18.24
10.98
13.15
544
3,182,015
17.10
9.14
10.94
51
295,331
17.27
9.97
11.63
23
274,147
8.39
3.92
4.94
55,615
51,693
1.93
1.48
1.48
294
2,017,140
14.58
8.70
10.01
235
2,131,579
11.02
6.22
7.23
179
1,441,543
12.42
8.46
10.06
150
1,484,897
10.10
6.56
7.77
365
3,364,779
10.85
7.94
9.46
339
3,404,840
9.96
7.15
8.49
255
1,724,239
14.79
9.23
10.83
232
1,655,235
14.02
7.45
8.83
466
2,980,563
15.63
8.87
10.67
435
2,756,345
15.78
7.77
9.24
11
106,961
10.28
7.49
9.56
94,002
8.51
5.31
6.28
1,575 11,635,225
13.54
8.62
10.20
1,403
11,526,898
12.17
7.13
8.44
- 221 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
10 10
10
2 3
10 10
10
2 3
15
1,262,554
1.19
0.71
0.81
1,356,218
0.59
0.31
0.35
754,586
0.93
0.68
0.76
775,361
0.52
0.34
0.41
193,573
0.52
0.26
0.39
190,561
206,243
0.97
0.50
0.69
209,101
0.48
0.37
0.40
525,788
0.38
0.26
0.34
556,511
0.72
0.63
0.63
381,903
0.52
0.40
0.40
390,370
1.79
1.10
1.31
134,036
138,354
0.72
0.23
0.42
14
1,935,668
0.72
0.58
0.66
1,961,699
0.41
0.33
0.38
1,009,274
0.89
0.73
0.80
992,786
0.91
0.64
0.77
264,014
0.38
0.43
0.40
249,001
234,682
0.85
0.29
0.46
225,804
0.44
0.30
0.32
291,177
1.37
0.94
1.10
269,791
0.37
0.30
0.30
793,368
1.01
0.89
0.95
772,752
1.04
0.84
0.90
670,812
0.89
0.59
0.68
636,474
1.10
0.45
0.56
271,053
1.84
1.06
1.22
255,438
1.17
0.63
0.74
374,746
1.33
1.03
1.08
342,907
2.33
1.04
1.23
283,284
1.06
0.62
0.69
259,964
0.38
0.24
0.28
11
562,141
1.96
1.22
1.43
539,380
1.30
0.71
0.81
12
636,341
1.89
1.21
1.44
607,195
0.33
0.18
0.23
10
449,267
2.23
1.50
1.60
424,242
1.41
0.78
0.90
49,769
2.01
0.64
0.96
47,149
174,584
1.72
0.89
1.08
164,221
0.61
0.35
0.38
120,747
1.66
1.26
1.34
109,926
49,871
47,493
5,744
4,200
48
5,397,185
0.89
0.61
0.70
28
5,454,961
0.51
0.34
0.38
26
2,635,767
0.99
0.74
0.82
30
2,564,082
1.17
0.74
0.84
46
3,251,327
1.41
0.93
1.06
28
3,182,015
0.88
0.50
0.59
295,331
1.69
1.04
1.19
274,147
0.36
0.20
0.22
55,615
51,693
22
2,017,140
1.09
0.69
0.79
12
2,131,579
0.56
0.32
0.37
1,441,543
0.49
0.32
0.40
13
1,484,897
0.88
0.60
0.68
32
3,364,779
0.95
0.73
0.83
18
3,404,840
0.53
0.41
0.47
30
1,724,239
1.74
1.25
1.39
15
1,655,235
0.91
0.57
0.65
31
2,980,563
1.04
0.67
0.76
28
2,756,345
1.02
0.52
0.61
106,961
0.93
0.57
0.86
94,002
125 11,635,225
1.07
0.74
0.85
87
11,526,898
0.75
0.47
0.54
- 222 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
10 10
10
2 3
10 10
10
2 3
171
1,262,554
13.54
7.91
8.91
119
1,356,218
8.77
4.81
5.54
101
754,586
13.38
8.40
10.13
104
775,361
13.41
8.45
10.03
22
193,573
11.37
6.96
8.00
10
190,561
5.25
2.74
3.43
19
206,243
9.21
6.58
7.74
18
209,101
8.61
5.97
6.79
65
525,788
12.36
8.87
10.76
54
556,511
9.70
7.28
8.55
40
381,903
10.47
7.33
8.52
43
390,370
11.02
6.40
7.96
26
134,036
19.40
11.58
14.11
12
138,354
8.67
5.42
6.13
163
1,935,668
8.42
6.30
7.50
189
1,961,699
9.63
6.84
8.18
97
1,009,274
9.61
7.23
8.38
64
992,786
6.45
5.03
5.95
16
264,014
6.06
3.76
4.49
22
249,001
8.84
4.73
5.77
34
234,682
14.49
8.98
10.14
37
225,804
16.39
8.08
9.69
32
291,177
10.99
6.51
7.60
14
269,791
5.19
2.54
3.05
59
793,368
7.44
5.10
6.32
71
772,752
9.19
6.47
7.60
81
670,812
12.07
7.83
9.20
83
636,474
13.04
6.22
7.49
33
271,053
12.17
5.98
7.49
31
255,438
12.14
6.02
7.06
65
374,746
17.35
8.63
10.94
65
342,907
18.96
9.27
10.29
64
283,284
22.59
9.84
12.57
65
259,964
25.00
10.33
12.06
126
562,141
22.41
12.74
15.16
110
539,380
20.39
9.26
11.13
93
636,341
14.61
9.48
11.18
91
607,195
14.99
8.79
10.65
87
449,267
19.36
11.03
13.20
82
424,242
19.33
9.79
11.65
10
49,769
20.09
8.36
10.80
47,149
19.09
6.84
8.69
32
174,584
18.33
9.48
11.67
17
164,221
10.35
5.06
6.29
14
120,747
11.59
8.13
8.65
109,926
4.55
1.76
2.43
49,871
47,493
2.11
1.61
1.61
5,744
4,200
554
5,397,185
10.26
6.89
7.98
473
5,454,961
8.67
5.45
6.42
303
2,635,767
11.50
7.15
8.74
304
2,564,082
11.86
6.96
8.13
547
3,251,327
16.82
10.05
12.08
516
3,182,015
16.22
8.63
10.35
46
295,331
15.58
8.93
10.44
22
274,147
8.02
3.72
4.72
55,615
51,693
1.93
1.48
1.48
272
2,017,140
13.48
8.01
9.22
223
2,131,579
10.46
5.90
6.86
172
1,441,543
11.93
8.14
9.66
137
1,484,897
9.23
5.96
7.09
333
3,364,779
9.90
7.22
8.63
321
3,404,840
9.43
6.74
8.03
225
1,724,239
13.05
7.99
9.44
217
1,655,235
13.11
6.88
8.19
435
2,980,563
14.59
8.20
9.91
407
2,756,345
14.77
7.25
8.63
10
106,961
9.35
6.92
8.70
94,002
8.51
5.31
6.28
1,450 11,635,225
12.46
7.88
9.35
1,316
11,526,898
11.42
6.66
7.90
- 223 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C50 C50
10 10
10
2 3
10 10
10
2 3
1,500
1,356,218
110.60
69.70
75.15
1,262,554
0.55
0.31
0.36
728
775,361
93.89
63.88
68.49
754,586
0.27
0.18
0.23
140
190,561
73.47
49.96
53.76
193,573
167
209,101
79.87
59.53
64.83
206,243
513
556,511
92.18
66.72
72.44
525,788
0.57
0.37
0.47
334
390,370
85.56
59.13
63.92
381,903
0.26
0.15
0.18
121
138,354
87.46
62.07
66.88
134,036
0.75
0.57
0.57
1,880
1,961,699
95.84
66.42
71.97
12
1,935,668
0.62
0.45
0.51
748
992,786
75.34
57.54
62.09
1,009,274
0.10
0.07
0.08
157
249,001
63.05
48.58
52.47
264,014
179
225,804
79.27
55.49
59.74
234,682
206
269,791
76.36
55.52
59.94
291,177
563
772,752
72.86
54.27
58.44
793,368
0.25
0.19
0.24
435
636,474
68.35
51.24
54.98
670,812
0.30
0.16
0.22
168
255,438
65.77
47.82
51.27
271,053
0.37
0.19
0.23
194
342,907
56.58
42.09
44.77
374,746
183
259,964
70.39
49.52
53.44
283,284
0.35
0.17
0.21
415
539,380
76.94
53.60
57.52
562,141
0.18
0.14
0.15
478
607,195
78.72
55.09
59.05
636,341
0.31
0.18
0.23
291
424,242
68.59
47.68
51.17
449,267
0.45
0.24
0.29
27
47,149
57.27
43.97
46.41
49,769
137
164,221
83.42
56.87
62.15
174,584
0.57
0.19
0.23
74
109,926
67.32
47.11
51.51
120,747
11
47,493
23.16
15.97
17.24
49,871
4,200
95.24
62.38
65.40
5,744
4,977
5,454,961
91.24
63.25
68.34
20
5,397,185
0.37
0.24
0.28
1,873
2,564,082
73.05
53.58
57.59
2,635,767
0.30
0.18
0.23
2,577
3,182,015
80.99
56.05
60.15
10
3,251,327
0.31
0.18
0.22
211
274,147
76.97
52.93
57.83
295,331
0.34
0.12
0.14
15
51,693
29.02
19.87
21.26
55,615
2,228
2,131,579
104.52
67.71
72.88
2,017,140
0.45
0.26
0.31
1,275
1,484,897
85.86
60.82
65.87
1,441,543
0.35
0.22
0.26
3,079
3,404,840
90.43
64.04
69.27
3,364,779
0.24
0.18
0.20
1,152
1,655,235
69.60
50.40
54.17
1,724,239
0.17
0.11
0.13
1,874
2,756,345
67.99
49.10
52.70
13
2,980,563
0.44
0.23
0.28
32
94,002
34.04
27.62
29.03
106,961
0.93
0.58
0.62
9,655 11,526,898
83.76
58.63
63.16
39
11,635,225
0.34
0.21
0.24
2. * 2
- 224 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C55 C53
10 10
10
2 3
10 10
10
2 3
1,356,218
178
1,356,218
13.12
7.85
8.74
775,361
0.13
0.11
0.11
107
775,361
13.80
9.06
10.22
190,561
29
190,561
15.22
9.28
10.71
209,101
43
209,101
20.56
14.90
16.51
556,511
78
556,511
14.02
10.29
11.24
390,370
63
390,370
16.14
10.99
12.20
138,354
23
138,354
16.62
10.68
12.15
1,961,699
301
1,961,699
15.34
10.56
11.87
992,786
0.30
0.19
0.24
142
992,786
14.30
10.77
11.97
249,001
49
249,001
19.68
14.74
16.09
225,804
37
225,804
16.39
9.99
11.29
269,791
51
269,791
18.90
13.38
14.64
772,752
116
772,752
15.01
10.74
12.09
636,474
0.16
0.06
0.07
80
636,474
12.57
8.59
9.42
255,438
0.39
0.30
0.30
35
255,438
13.70
9.74
10.62
342,907
43
342,907
12.54
9.12
9.68
259,964
37
259,964
14.23
7.74
8.69
539,380
61
539,380
11.31
7.23
8.02
607,195
0.33
0.21
0.23
98
607,195
16.14
11.36
12.29
424,242
75
424,242
17.68
11.00
12.44
47,149
47,149
12.73
8.81
9.59
164,221
17
164,221
10.35
6.17
7.03
109,926
10
109,926
9.10
5.47
6.14
47,493
47,493
2.11
0.88
1.33
4,200
4,200
5,454,961
0.05
0.03
0.04
830
5,454,961
15.22
10.14
11.31
2,564,082
0.08
0.05
0.05
352
2,564,082
13.73
9.70
10.63
3,182,015
0.09
0.07
0.07
470
3,182,015
14.77
9.62
10.71
274,147
27
274,147
9.85
5.87
6.66
51,693
51,693
1.93
0.81
1.21
2,131,579
0.05
0.04
0.04
285
2,131,579
13.37
8.27
9.26
1,484,897
236
1,484,897
15.89
11.03
12.27
3,404,840
0.09
0.06
0.06
504
3,404,840
14.80
10.35
11.70
1,655,235
0.12
0.06
0.07
247
1,655,235
14.92
9.98
11.06
2,756,345
0.07
0.03
0.04
393
2,756,345
14.26
9.65
10.53
94,002
14
94,002
14.89
10.55
11.76
8 11,526,898
0.07
0.04
0.05
1,680
11,526,898
14.57
9.74
10.81
- 225 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
10 10
10
2 3
10 10
10
2 3
268
1,356,218
19.76
12.52
13.57
187
1,356,218
13.79
9.19
9.96
116
775,361
14.96
10.04
10.81
76
775,361
9.80
6.64
7.31
33
190,561
17.32
11.74
12.96
25
190,561
13.12
9.77
10.36
37
209,101
17.69
13.38
14.56
33
209,101
15.78
12.26
12.94
90
556,511
16.17
12.07
12.80
69
556,511
12.40
8.90
9.90
57
390,370
14.60
9.85
10.81
59
390,370
15.11
11.35
12.13
28
138,354
20.24
14.56
15.51
24
138,354
17.35
13.80
14.44
342
1,961,699
17.43
11.83
12.73
224
1,961,699
11.42
8.21
8.85
141
992,786
14.20
10.59
11.31
101
992,786
10.17
7.91
8.62
28
249,001
11.24
8.97
9.51
17
249,001
6.83
5.13
5.56
19
225,804
8.41
5.73
6.25
19
225,804
8.41
5.73
6.33
37
269,791
13.71
10.07
10.72
25
269,791
9.27
6.30
6.91
105
772,752
13.59
10.33
10.99
75
772,752
9.71
7.57
8.11
77
636,474
12.10
9.08
9.70
51
636,474
8.01
6.48
6.95
33
255,438
12.92
8.85
9.54
14
255,438
5.48
3.22
3.64
35
342,907
10.21
7.42
7.91
33
342,907
9.62
7.24
7.68
29
259,964
11.16
7.51
8.14
14
259,964
5.39
4.22
4.46
83
539,380
15.39
10.31
11.04
50
539,380
9.27
6.77
7.26
64
607,195
10.54
7.37
7.88
70
607,195
11.53
8.34
9.00
67
424,242
15.79
11.10
11.99
52
424,242
12.26
8.53
9.29
47,149
8.48
5.23
5.84
47,149
8.48
4.92
5.47
25
164,221
15.22
10.73
11.24
14
164,221
8.53
6.76
7.13
17
109,926
15.46
10.55
11.21
109,926
8.19
5.18
5.74
47,493
4.21
2.61
2.93
47,493
4,200
4,200
905
5,454,961
16.59
11.38
12.27
631
5,454,961
11.57
8.31
8.98
340
2,564,082
13.26
9.79
10.43
242
2,564,082
9.44
7.06
7.64
448
3,182,015
14.08
9.58
10.31
349
3,182,015
10.97
7.89
8.51
42
274,147
15.32
10.64
11.21
23
274,147
8.39
6.12
6.58
51,693
3.87
2.42
2.72
51,693
384
2,131,579
18.01
11.63
12.58
263
2,131,579
12.34
8.27
9.01
245
1,484,897
16.50
11.78
12.72
210
1,484,897
14.14
10.58
11.38
554
3,404,840
16.27
11.41
12.28
395
3,404,840
11.60
8.64
9.36
215
1,655,235
12.99
9.51
10.12
144
1,655,235
8.70
6.24
6.78
331
2,756,345
12.01
8.55
9.17
224
2,756,345
8.13
6.00
6.43
94,002
7.45
6.20
6.55
94,002
8.51
7.58
7.91
1,737 11,526,898
15.07
10.47
11.25
1,245
11,526,898
10.80
7.83
8.46
- 226 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
10 10
10
2 3
10 10
10
2 3
23
1,356,218
1.70
0.95
1.06
737
1,262,554
58.37
30.47
36.42
15
775,361
1.93
1.45
1.63
251
754,586
33.26
22.13
26.33
190,561
69
193,573
35.65
21.80
25.94
209,101
0.96
0.73
0.74
44
206,243
21.33
15.71
18.23
556,511
0.72
0.52
0.63
170
525,788
32.33
25.35
30.37
390,370
1.02
0.70
0.75
133
381,903
34.83
25.88
30.17
138,354
1.45
1.28
1.19
48
134,036
35.81
24.67
28.27
20
1,961,699
1.02
0.64
0.78
792
1,935,668
40.92
32.59
39.26
12
992,786
1.21
0.89
1.07
354
1,009,274
35.07
27.87
32.72
249,001
2.01
1.53
1.72
74
264,014
28.03
18.65
21.60
225,804
2.21
2.48
2.23
87
234,682
37.07
18.95
23.56
269,791
1.11
0.53
0.61
129
291,177
44.30
25.28
29.44
11
772,752
1.42
1.15
1.24
282
793,368
35.54
27.01
32.00
11
636,474
1.73
1.03
1.16
212
670,812
31.60
18.86
22.85
255,438
2.35
1.12
1.33
121
271,053
44.64
24.64
28.95
342,907
1.17
1.09
1.06
117
374,746
31.22
16.24
19.50
259,964
0.38
0.16
0.18
83
283,284
29.30
14.35
17.14
539,380
1.11
0.54
0.64
200
562,141
35.58
20.05
23.75
10
607,195
1.65
1.07
1.19
202
636,341
31.74
19.99
24.15
424,242
1.18
0.60
0.70
172
449,267
38.28
22.05
25.82
47,149
15
49,769
30.14
15.86
18.70
164,221
1.83
1.10
1.24
56
174,584
32.08
16.24
19.71
109,926
35
120,747
28.99
16.59
19.54
47,493
49,871
16.04
10.00
11.59
4,200
5,744
70
5,454,961
1.28
0.86
0.97
2,286
5,397,185
42.36
28.11
33.49
36
2,564,082
1.40
0.97
1.07
902
2,635,767
34.22
22.30
26.62
43
3,182,015
1.35
0.88
0.98
1,104
3,251,327
33.96
20.86
24.68
274,147
1.09
0.66
0.74
91
295,331
30.81
16.42
19.69
51,693
55,615
14.38
9.15
10.60
38
2,131,579
1.78
1.14
1.28
988
2,017,140
48.98
27.62
33.02
12
1,484,897
0.81
0.59
0.63
464
1,441,543
32.19
23.64
27.84
37
3,404,840
1.09
0.79
0.87
1,273
3,364,779
37.83
28.96
34.63
30
1,655,235
1.81
1.04
1.21
654
1,724,239
37.93
22.56
26.91
34
2,756,345
1.23
0.85
0.90
985
2,980,563
33.05
19.11
22.65
94,002
1.06
0.35
0.63
22
106,961
20.57
15.55
19.00
152 11,526,898
1.32
0.88
0.98
4,392
11,635,225
37.75
24.17
28.77
2. * 1
- 227 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C62 C60C63
10 10
10
2 3
10 10
10
2 3
25
1,262,554
1.98
1.89
2.01
15
1,262,554
1.19
0.68
0.76
16
754,586
2.12
2.10
2.16
754,586
1.06
0.76
0.83
193,573
2.07
2.32
2.31
193,573
0.52
0.26
0.39
206,243
1.45
1.42
1.51
206,243
1.45
1.42
1.50
525,788
1.52
1.29
1.45
525,788
0.57
0.51
0.55
381,903
1.57
1.52
1.59
381,903
0.79
0.68
0.68
134,036
0.75
0.77
0.76
134,036
34
1,935,668
1.76
1.70
1.74
1,935,668
0.46
0.30
0.36
16
1,009,274
1.59
1.51
1.55
1,009,274
0.79
0.64
0.68
264,014
1.14
1.34
1.20
264,014
234,682
0.85
0.74
0.73
234,682
1.28
0.97
1.07
291,177
1.37
1.52
1.54
291,177
0.69
0.29
0.39
13
793,368
1.64
1.55
1.58
793,368
0.63
0.52
0.55
10
670,812
1.49
1.49
1.51
670,812
0.75
0.45
0.52
271,053
1.11
1.19
1.16
271,053
0.37
0.32
0.30
374,746
0.53
0.52
0.58
374,746
1.07
0.60
0.66
283,284
0.71
0.80
0.83
283,284
0.71
0.38
0.44
562,141
1.07
1.07
1.11
562,141
0.89
0.43
0.58
11
636,341
1.73
1.49
1.60
636,341
0.94
0.65
0.70
449,267
0.89
0.81
0.86
449,267
0.89
0.49
0.57
49,769
49,769
2.01
0.44
0.80
174,584
2.29
2.14
2.10
174,584
0.57
0.37
0.40
120,747
0.83
0.99
1.02
120,747
0.83
0.29
0.35
49,871
49,871
2.01
1.13
1.22
5,744
5,744
91
5,397,185
1.69
1.66
1.71
41
5,397,185
0.76
0.51
0.58
36
2,635,767
1.37
1.30
1.35
18
2,635,767
0.68
0.51
0.55
46
3,251,327
1.41
1.37
1.43
29
3,251,327
0.89
0.57
0.65
295,331
1.69
1.67
1.65
295,331
0.68
0.33
0.38
55,615
55,615
1.80
1.00
1.08
41
2,017,140
2.03
1.96
2.05
23
2,017,140
1.14
0.70
0.78
22
1,441,543
1.53
1.44
1.53
10
1,441,543
0.69
0.60
0.65
60
3,364,779
1.78
1.72
1.75
11
3,364,779
0.33
0.21
0.25
21
1,724,239
1.22
1.13
1.21
20
1,724,239
1.16
0.79
0.88
33
2,980,563
1.11
1.16
1.16
23
2,980,563
0.77
0.48
0.55
106,961
0.93
0.63
0.63
106,961
3.74
2.82
3.30
178 11,635,225
1.53
1.49
1.54
91
11,635,225
0.78
0.53
0.60
- 228 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C67
10 10
10
2 3
10 10
10
2 3
166
1,262,554
13.15
6.86
8.02
63
1,356,218
4.65
2.38
2.88
89
754,586
11.79
7.80
9.12
36
775,361
4.64
2.86
3.41
17
193,573
8.78
4.82
5.95
13
190,561
6.82
3.84
4.61
15
206,243
7.27
5.53
6.40
209,101
1.43
1.21
1.29
54
525,788
10.27
7.28
8.90
21
556,511
3.77
3.26
3.58
56
381,903
14.66
10.82
12.23
26
390,370
6.66
4.16
4.94
12
134,036
8.95
5.65
6.63
138,354
5.06
3.10
3.51
188
1,935,668
9.71
7.39
8.63
78
1,961,699
3.98
2.86
3.43
96
1,009,274
9.51
7.01
8.34
34
992,786
3.42
2.47
3.09
17
264,014
6.44
3.68
4.61
249,001
1.61
1.13
1.26
38
234,682
16.19
9.47
11.10
16
225,804
7.09
4.07
4.52
38
291,177
13.05
7.32
8.59
13
269,791
4.82
2.72
3.00
96
793,368
12.10
9.39
10.76
34
772,752
4.40
3.03
3.59
74
670,812
11.03
6.76
8.10
32
636,474
5.03
3.09
3.40
35
271,053
12.91
7.57
8.63
16
255,438
6.26
3.15
3.67
57
374,746
15.21
8.73
10.18
17
342,907
4.96
2.03
2.46
53
283,284
18.71
9.94
11.62
16
259,964
6.15
2.62
3.03
118
562,141
20.99
11.58
13.84
39
539,380
7.23
4.18
4.63
85
636,341
13.36
8.78
10.17
31
607,195
5.11
3.05
3.60
78
449,267
17.36
10.33
11.88
24
424,242
5.66
3.00
3.53
49,769
8.04
4.47
5.12
47,149
24
174,584
13.75
7.37
8.66
10
164,221
6.09
3.48
3.93
14
120,747
11.59
5.72
7.07
109,926
2.73
1.72
1.79
49,871
4.01
2.75
2.84
47,493
2.11
1.68
2.02
5,744
4,200
575
5,397,185
10.65
6.92
8.14
224
5,454,961
4.11
2.57
3.06
316
2,635,767
11.99
8.00
9.39
120
2,564,082
4.68
2.87
3.29
495
3,251,327
15.22
9.43
11.00
179
3,182,015
5.63
3.20
3.70
38
295,331
12.87
6.73
8.03
13
274,147
4.74
2.76
3.05
55,615
3.60
2.49
2.57
51,693
1.93
1.53
1.84
255
2,017,140
12.64
7.21
8.42
99
2,131,579
4.64
2.54
3.06
154
1,441,543
10.68
7.52
8.85
70
1,484,897
4.71
3.29
3.78
373
3,364,779
11.09
8.29
9.72
153
3,404,840
4.49
3.18
3.82
228
1,724,239
13.22
7.97
9.43
77
1,655,235
4.65
2.64
3.03
402
2,980,563
13.49
8.03
9.37
137
2,756,345
4.97
2.75
3.14
10
106,961
9.35
7.11
8.48
94,002
1.06
0.44
0.67
1,427 11,635,225
12.26
7.88
9.24
537
11,526,898
4.66
2.80
3.28
2. * 1
- 229 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C64
10 10
10
2 3
10 10
10
2 3
119
1,262,554
9.43
5.92
6.48
52
1,356,218
3.83
2.09
2.44
43
754,586
5.70
4.20
4.57
30
775,361
3.87
2.81
3.11
11
193,573
5.68
3.86
4.19
190,561
1.05
0.73
0.73
17
206,243
8.24
6.79
7.31
209,101
3.83
2.57
3.04
28
525,788
5.33
4.46
4.78
14
556,511
2.52
2.48
2.50
23
381,903
6.02
4.12
4.70
19
390,370
4.87
3.46
3.89
134,036
6.71
4.72
5.32
138,354
5.06
5.39
5.03
121
1,935,668
6.25
5.08
5.44
53
1,961,699
2.70
1.98
2.28
66
1,009,274
6.54
5.08
5.65
29
992,786
2.92
2.24
2.56
264,014
3.41
2.57
2.79
249,001
1.61
0.97
1.20
14
234,682
5.97
4.70
4.86
225,804
3.54
2.41
2.63
291,177
2.75
1.53
1.79
269,791
2.97
2.08
2.13
35
793,368
4.41
3.40
3.77
21
772,752
2.72
2.02
2.23
29
670,812
4.32
3.10
3.48
18
636,474
2.83
1.69
1.90
14
271,053
5.17
3.52
3.66
255,438
3.52
1.87
2.09
19
374,746
5.07
3.03
3.30
342,907
1.46
0.81
0.91
11
283,284
3.88
2.53
2.79
259,964
1.15
0.44
0.52
32
562,141
5.69
3.65
4.15
14
539,380
2.60
1.81
1.89
32
636,341
5.03
3.46
3.85
24
607,195
3.95
2.55
2.79
18
449,267
4.01
2.37
2.77
16
424,242
3.77
2.48
2.69
49,769
4.02
2.56
2.95
47,149
2.12
1.35
1.55
174,584
5.16
3.41
3.84
164,221
1.22
0.94
0.91
120,747
4.14
2.99
3.09
109,926
2.73
1.26
1.54
49,871
6.02
3.61
3.79
47,493
5,744
17.41
11.13
11.13
4,200
365
5,397,185
6.76
5.00
5.44
164
5,454,961
3.01
1.98
2.26
125
2,635,767
4.74
3.50
3.83
67
2,564,082
2.61
1.83
1.99
170
3,251,327
5.23
3.52
3.93
114
3,182,015
3.58
2.48
2.67
14
295,331
4.74
3.22
3.52
274,147
1.82
1.09
1.19
55,615
7.19
4.42
4.58
51,693
162
2,017,140
8.03
5.32
5.81
82
2,131,579
3.85
2.36
2.69
88
1,441,543
6.10
4.71
5.15
50
1,484,897
3.37
2.76
2.92
202
3,364,779
6.00
4.71
5.19
87
3,404,840
2.56
1.88
2.12
76
1,724,239
4.41
3.35
3.59
53
1,655,235
3.20
2.00
2.22
149
2,980,563
5.00
3.25
3.59
74
2,756,345
2.68
1.67
1.83
106,961
94,002
1.06
1.12
1.04
678 11,635,225
5.83
4.20
4.60
350
11,526,898
3.04
2.05
2.27
- 230 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C65
10 10
10
2 3
10 10
10
2 3
44
1,262,554
3.48
2.11
2.37
44
1,356,218
3.24
1.87
2.07
24
754,586
3.18
2.15
2.47
16
775,361
2.06
1.26
1.53
193,573
3.62
2.11
2.36
190,561
3.67
2.43
2.58
206,243
0.97
1.07
1.12
209,101
1.91
1.17
1.47
12
525,788
2.28
2.13
2.30
22
556,511
3.95
2.94
3.50
17
381,903
4.45
2.63
3.52
23
390,370
5.89
3.97
4.67
134,036
4.48
2.94
3.61
12
138,354
8.67
4.66
5.78
45
1,935,668
2.32
1.69
2.02
37
1,961,699
1.89
1.49
1.68
24
1,009,274
2.38
2.32
2.53
18
992,786
1.81
1.37
1.65
264,014
1.89
1.29
1.51
10
249,001
4.02
3.23
3.42
234,682
2.13
1.04
1.35
225,804
3.99
2.35
2.67
291,177
2.40
1.65
1.75
11
269,791
4.08
1.80
2.14
19
793,368
2.39
1.95
2.18
38
772,752
4.92
3.40
3.99
21
670,812
3.13
2.13
2.41
21
636,474
3.30
1.89
2.10
10
271,053
3.69
2.55
2.74
12
255,438
4.70
2.91
3.19
10
374,746
2.67
1.60
1.80
15
342,907
4.37
2.06
2.37
15
283,284
5.30
3.19
3.47
17
259,964
6.54
3.30
3.60
24
562,141
4.27
2.92
3.14
30
539,380
5.56
2.89
3.34
25
636,341
3.93
2.77
3.07
25
607,195
4.12
2.75
3.03
16
449,267
3.56
2.18
2.54
17
424,242
4.01
2.25
2.51
49,769
4.02
3.68
3.68
47,149
174,584
2.86
1.61
1.92
164,221
3.65
1.77
2.18
120,747
2.48
0.91
1.42
109,926
1.82
1.06
1.29
49,871
47,493
5,744
4,200
139
5,397,185
2.58
1.84
2.10
140
5,454,961
2.57
1.74
1.96
72
2,635,767
2.73
2.00
2.22
108
2,564,082
4.21
2.58
2.95
129
3,251,327
3.97
2.59
2.95
140
3,182,015
4.40
2.56
2.95
295,331
2.71
1.33
1.72
274,147
2.92
1.46
1.79
55,615
51,693
68
2,017,140
3.37
2.11
2.39
60
2,131,579
2.81
1.66
1.88
44
1,441,543
3.05
2.18
2.58
68
1,484,897
4.58
3.09
3.65
83
3,364,779
2.47
1.95
2.19
100
3,404,840
2.94
2.21
2.55
54
1,724,239
3.13
2.09
2.34
65
1,655,235
3.93
2.39
2.67
96
2,980,563
3.22
2.06
2.34
102
2,756,345
3.70
2.06
2.34
106,961
1.87
0.94
1.53
94,002
1.06
0.54
0.65
348 11,635,225
2.99
2.07
2.35
396
11,526,898
3.44
2.15
2.46
- 231 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C66
10 10
10
2 3
10 10
10
2 3
19
1,262,554
1.50
0.76
0.89
23
1,356,218
1.70
0.83
0.98
22
754,586
2.92
2.19
2.39
16
775,361
2.06
1.41
1.60
193,573
3.10
2.05
2.42
190,561
2.10
1.36
1.55
206,243
0.48
0.59
0.59
209,101
0.48
0.37
0.40
525,788
1.33
1.03
1.29
556,511
1.62
1.29
1.52
381,903
2.36
1.80
1.99
15
390,370
3.84
2.90
3.09
134,036
1.49
0.81
1.06
138,354
5.78
3.68
4.10
28
1,935,668
1.45
1.19
1.39
26
1,961,699
1.33
1.01
1.12
10
1,009,274
0.99
0.69
0.81
992,786
0.91
0.71
0.83
264,014
249,001
0.80
0.63
0.66
234,682
1.28
0.86
0.91
225,804
3.54
1.86
2.16
291,177
1.03
0.64
0.74
269,791
2.22
1.29
1.38
11
793,368
1.39
1.09
1.20
18
772,752
2.33
1.57
1.88
12
670,812
1.79
1.28
1.40
11
636,474
1.73
0.85
1.01
271,053
1.11
0.66
0.72
255,438
1.17
0.52
0.62
374,746
1.60
1.01
1.11
20
342,907
5.83
2.75
3.14
12
283,284
4.24
2.41
2.69
15
259,964
5.77
2.36
2.72
21
562,141
3.74
2.34
2.61
20
539,380
3.71
1.71
2.05
14
636,341
2.20
1.65
1.75
20
607,195
3.29
1.95
2.32
449,267
1.56
0.85
1.01
13
424,242
3.06
1.72
1.91
49,769
47,149
2.12
1.13
1.25
174,584
1.15
1.03
1.00
164,221
1.83
0.85
1.01
120,747
1.66
1.50
1.44
109,926
49,871
47,493
5,744
4,200
70
5,397,185
1.30
0.89
1.03
79
5,454,961
1.45
0.96
1.09
39
2,635,767
1.48
1.06
1.19
61
2,564,082
2.38
1.38
1.63
87
3,251,327
2.68
1.82
2.02
108
3,182,015
3.39
1.98
2.26
295,331
1.35
1.22
1.18
274,147
1.09
0.50
0.59
55,615
51,693
41
2,017,140
2.03
1.24
1.39
39
2,131,579
1.83
1.03
1.19
25
1,441,543
1.73
1.31
1.53
37
1,484,897
2.49
1.85
2.05
46
3,364,779
1.37
1.03
1.19
59
3,404,840
1.73
1.27
1.50
35
1,724,239
2.03
1.42
1.54
43
1,655,235
2.60
1.40
1.63
52
2,980,563
1.74
1.16
1.29
69
2,756,345
2.50
1.35
1.53
106,961
94,002
1.06
0.73
0.84
200 11,635,225
1.72
1.20
1.35
251
11,526,898
2.18
1.34
1.54
- 232 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C68.0 - C68.1
10 10
10
2 3
10 10
10
2 3
1,262,554
0.08
0.06
0.06
1,356,218
754,586
0.53
0.46
0.45
775,361
0.13
0.07
0.08
193,573
190,561
206,243
209,101
525,788
0.38
0.24
0.33
556,511
0.36
0.20
0.30
381,903
0.26
0.23
0.25
390,370
134,036
138,354
0.72
0.50
0.54
1,935,668
0.05
0.03
0.03
1,961,699
0.05
0.05
0.04
1,009,274
992,786
264,014
249,001
234,682
0.43
0.29
0.31
225,804
291,177
269,791
793,368
0.13
0.11
0.12
772,752
0.13
0.09
0.09
670,812
636,474
0.16
0.06
0.07
271,053
255,438
374,746
342,907
0.29
0.06
0.10
283,284
0.35
0.17
0.21
259,964
562,141
0.18
0.16
0.16
539,380
636,341
0.16
0.12
0.14
607,195
449,267
0.22
0.09
0.14
424,242
49,769
47,149
174,584
0.57
0.37
0.40
164,221
120,747
109,926
49,871
47,493
5,744
4,200
5,397,185
0.06
0.04
0.04
5,454,961
0.02
0.02
0.01
2,635,767
0.11
0.07
0.09
2,564,082
0.20
0.10
0.13
3,251,327
0.28
0.21
0.22
3,182,015
0.06
0.04
0.04
295,331
0.34
0.22
0.24
274,147
55,615
51,693
2,017,140
0.25
0.20
0.20
2,131,579
0.05
0.02
0.03
1,441,543
0.21
0.14
0.17
1,484,897
0.20
0.12
0.15
3,364,779
0.03
0.02
0.02
3,404,840
0.06
0.04
0.04
1,724,239
0.17
0.12
0.13
1,655,235
2,980,563
0.13
0.08
0.09
2,756,345
0.07
0.02
0.03
106,961
94,002
16 11,635,225
0.14
0.10
0.11
11,526,898
0.07
0.04
0.05
- 233 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C68.8
10 10
10
2 3
10 10
10
2 3
1,262,554
1,356,218
754,586
0.13
0.07
0.09
775,361
193,573
190,561
0.52
0.22
0.34
206,243
209,101
525,788
556,511
381,903
390,370
134,036
138,354
1,935,668
0.05
0.03
0.03
1,961,699
1,009,274
992,786
264,014
249,001
234,682
0.43
0.42
0.39
225,804
291,177
269,791
793,368
772,752
0.13
0.10
0.11
670,812
0.15
0.14
0.13
636,474
271,053
255,438
0.39
0.26
0.28
374,746
342,907
0.29
0.07
0.11
283,284
259,964
562,141
539,380
636,341
607,195
0.16
0.06
0.11
449,267
424,242
0.24
0.18
0.18
49,769
47,149
174,584
164,221
0.61
0.25
0.31
120,747
109,926
49,871
47,493
5,744
4,200
5,397,185
0.04
0.03
0.03
5,454,961
0.02
0.01
0.01
2,635,767
0.04
0.04
0.03
2,564,082
0.12
0.07
0.08
3,251,327
0.03
0.02
0.02
3,182,015
0.06
0.04
0.04
295,331
274,147
0.36
0.15
0.18
55,615
51,693
2,017,140
0.05
0.03
0.03
2,131,579
1,441,543
1,484,897
0.07
0.03
0.05
3,364,779
0.06
0.05
0.05
3,404,840
0.06
0.04
0.05
1,724,239
1,655,235
0.06
0.02
0.03
2,980,563
0.03
0.03
0.03
2,756,345
0.11
0.05
0.06
106,961
94,002
4 11,635,225
0.03
0.03
0.03
11,526,898
0.06
0.03
0.04
- 234 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C68.9
10 10
10
2 3
10 10
10
2 3
15
1,262,554
1.19
0.69
0.78
18
1,356,218
1.33
0.74
0.86
11
754,586
1.46
1.15
1.23
10
775,361
1.29
0.87
0.99
193,573
190,561
206,243
1.94
1.53
1.72
209,101
525,788
0.19
0.20
0.22
556,511
0.18
0.20
0.20
381,903
0.79
0.62
0.69
390,370
0.51
0.35
0.40
134,036
138,354
0.72
0.44
0.50
13
1,935,668
0.67
0.56
0.62
14
1,961,699
0.71
0.58
0.64
10
1,009,274
0.99
0.58
0.79
992,786
0.50
0.48
0.53
264,014
249,001
1.20
0.80
0.91
234,682
1.70
0.80
1.05
225,804
0.44
0.35
0.35
291,177
0.69
0.40
0.44
269,791
1.85
0.85
1.05
793,368
0.25
0.27
0.26
772,752
1.04
0.57
0.77
670,812
0.45
0.31
0.35
636,474
0.16
0.09
0.10
271,053
0.37
0.21
0.23
255,438
0.39
0.24
0.27
374,746
1.33
0.80
0.92
342,907
0.87
0.48
0.56
283,284
2.47
1.24
1.46
259,964
1.54
0.83
0.90
562,141
1.60
0.88
1.05
539,380
1.67
0.88
1.00
10
636,341
1.57
1.18
1.28
14
607,195
2.31
1.35
1.62
449,267
0.67
0.42
0.48
10
424,242
2.36
1.25
1.46
49,769
2.01
0.64
0.96
47,149
174,584
0.57
0.41
0.45
164,221
120,747
1.66
0.91
1.14
109,926
1.82
0.99
1.14
49,871
47,493
5,744
4,200
48
5,397,185
0.89
0.61
0.71
46
5,454,961
0.84
0.57
0.66
12
2,635,767
0.46
0.34
0.37
14
2,564,082
0.55
0.30
0.37
44
3,251,327
1.35
0.91
1.02
50
3,182,015
1.57
0.91
1.05
295,331
1.02
0.61
0.73
274,147
0.73
0.41
0.47
55,615
51,693
26
2,017,140
1.29
0.86
0.95
28
2,131,579
1.31
0.78
0.89
1,441,543
0.55
0.44
0.49
1,484,897
0.27
0.21
0.22
27
3,364,779
0.80
0.56
0.69
22
3,404,840
0.65
0.49
0.57
22
1,724,239
1.28
0.85
0.95
18
1,655,235
1.09
0.65
0.73
24
2,980,563
0.81
0.52
0.58
38
2,756,345
1.38
0.74
0.86
106,961
94,002
1.06
0.44
0.67
107 11,635,225
0.92
0.63
0.72
112
11,526,898
0.97
0.60
0.70
- 235 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C69
10 10
10
2 3
10 10
10
2 3
10
1,262,554
0.79
0.97
0.87
1,356,218
0.22
0.29
0.25
754,586
1.06
1.67
1.41
775,361
0.13
0.09
0.10
193,573
190,561
206,243
209,101
0.96
1.37
1.13
525,788
0.57
0.84
0.72
556,511
381,903
390,370
134,036
138,354
1,935,668
0.31
0.37
0.36
1,961,699
0.10
0.08
0.08
1,009,274
0.10
0.24
0.18
992,786
0.71
1.26
1.02
264,014
249,001
0.40
0.87
0.64
234,682
225,804
291,177
269,791
0.37
0.12
0.14
793,368
0.13
0.33
0.24
772,752
670,812
0.30
0.19
0.23
636,474
271,053
255,438
0.39
0.32
0.35
374,746
342,907
283,284
0.71
0.62
0.65
259,964
562,141
0.36
0.23
0.25
539,380
0.37
0.37
0.37
636,341
0.47
1.45
1.06
607,195
0.16
0.10
0.11
449,267
424,242
49,769
47,149
174,584
164,221
120,747
0.83
1.69
1.47
109,926
49,871
47,493
2.11
0.57
1.02
5,744
4,200
17
5,397,185
0.31
0.41
0.37
16
5,454,961
0.29
0.48
0.40
2,635,767
0.23
0.32
0.28
2,564,082
0.04
0.03
0.03
15
3,251,327
0.46
0.78
0.65
3,182,015
0.13
0.11
0.11
295,331
0.34
0.70
0.61
274,147
55,615
51,693
1.93
0.52
0.94
18
2,017,140
0.89
1.21
1.05
2,131,579
0.19
0.22
0.20
1,441,543
0.21
0.31
0.27
1,484,897
0.13
0.25
0.20
10
3,364,779
0.30
0.51
0.42
3,404,840
0.15
0.17
0.16
1,724,239
0.12
0.11
0.11
1,655,235
0.42
0.55
0.48
2,980,563
0.17
0.20
0.18
2,756,345
0.15
0.28
0.23
106,961
0.93
1.74
1.52
94,002
39 11,635,225
0.34
0.49
0.42
22
11,526,898
0.19
0.27
0.23
- 236 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C71
10 10
10
2 3
10 10
10
2 3
58
1,262,554
4.59
3.25
3.50
34
1,356,218
2.51
2.04
2.17
27
754,586
3.58
3.15
3.29
17
775,361
2.19
2.12
2.21
193,573
4.13
3.30
3.54
190,561
1.57
1.32
1.43
206,243
4.36
5.28
4.91
209,101
3.35
2.33
2.68
16
525,788
3.04
2.75
2.90
14
556,511
2.52
2.45
2.41
13
381,903
3.40
3.43
3.38
13
390,370
3.33
2.81
2.90
134,036
2.24
3.30
2.89
138,354
2.17
1.69
1.83
72
1,935,668
3.72
3.53
3.54
53
1,961,699
2.70
2.47
2.59
34
1,009,274
3.37
3.32
3.28
25
992,786
2.52
2.30
2.45
11
264,014
4.17
3.76
3.86
249,001
3.61
3.40
3.45
234,682
2.13
1.41
1.58
225,804
2.66
4.43
3.63
291,177
2.06
1.57
1.64
269,791
2.97
2.40
2.39
25
793,368
3.15
3.29
3.26
16
772,752
2.07
2.45
2.29
29
670,812
4.32
4.03
4.12
24
636,474
3.77
2.95
3.11
11
271,053
4.06
2.94
3.15
11
255,438
4.31
2.59
2.84
17
374,746
4.54
4.19
4.30
13
342,907
3.79
3.49
3.34
13
283,284
4.59
5.57
5.16
259,964
1.54
1.30
1.42
19
562,141
3.38
3.40
3.39
16
539,380
2.97
2.60
2.64
20
636,341
3.14
2.63
2.79
17
607,195
2.80
2.80
2.76
449,267
1.78
1.50
1.60
13
424,242
3.06
2.08
2.28
49,769
47,149
10
174,584
5.73
3.99
4.40
164,221
2.44
1.58
1.65
120,747
3.31
3.44
3.45
109,926
2.73
2.18
2.51
49,871
2.01
1.55
1.96
47,493
5,744
17.41
25.79
24.36
4,200
23.81
21.74
23.91
203
5,397,185
3.76
3.33
3.39
145
5,454,961
2.66
2.37
2.46
98
2,635,767
3.72
3.46
3.53
78
2,564,082
3.04
2.76
2.76
103
3,251,327
3.17
3.03
3.04
83
3,182,015
2.61
2.27
2.33
14
295,331
4.74
3.76
4.01
274,147
2.55
1.82
1.99
55,615
3.60
3.89
4.12
51,693
1.93
1.56
1.72
85
2,017,140
4.21
3.21
3.42
51
2,131,579
2.39
2.05
2.15
49
1,441,543
3.40
3.44
3.42
40
1,484,897
2.69
2.28
2.36
115
3,364,779
3.42
3.25
3.30
102
3,404,840
3.00
2.79
2.88
63
1,724,239
3.65
3.47
3.50
42
1,655,235
2.54
2.16
2.21
103
2,980,563
3.46
3.24
3.26
72
2,756,345
2.61
2.35
2.36
106,961
2.80
2.97
3.14
94,002
5.32
3.51
3.98
420 11,635,225
3.61
3.29
3.35
314
11,526,898
2.72
2.41
2.47
- 237 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C70C72
10 10
10
2 3
10 10
10
2 3
1,262,554
1,356,218
0.15
0.08
0.10
754,586
0.13
0.09
0.11
775,361
193,573
0.52
0.23
0.27
190,561
206,243
209,101
525,788
556,511
0.36
0.24
0.27
381,903
0.52
0.48
0.50
390,370
0.51
0.41
0.41
134,036
138,354
1,935,668
0.41
0.34
0.36
1,961,699
0.05
0.03
0.04
1,009,274
0.20
0.16
0.18
992,786
0.40
0.27
0.31
264,014
0.76
0.72
0.71
249,001
234,682
225,804
0.44
0.12
0.21
291,177
269,791
1.11
0.87
1.01
793,368
0.25
0.19
0.22
772,752
0.39
0.62
0.51
670,812
0.15
0.19
0.18
636,474
0.16
0.09
0.10
271,053
0.37
0.32
0.30
255,438
374,746
0.27
0.27
0.27
342,907
0.87
0.76
0.72
283,284
0.35
0.09
0.16
259,964
562,141
0.18
0.40
0.35
539,380
0.56
0.57
0.56
636,341
0.31
0.27
0.28
607,195
0.16
0.37
0.32
449,267
424,242
0.94
0.61
0.69
49,769
47,149
174,584
164,221
120,747
109,926
49,871
47,493
5,744
4,200
13
5,397,185
0.24
0.18
0.19
11
5,454,961
0.20
0.12
0.14
2,635,767
0.19
0.18
0.18
2,564,082
0.35
0.38
0.35
3,251,327
0.22
0.20
0.21
10
3,182,015
0.31
0.29
0.30
295,331
274,147
55,615
51,693
2,017,140
0.05
0.04
0.05
2,131,579
0.09
0.05
0.07
1,441,543
0.21
0.17
0.18
1,484,897
0.27
0.20
0.21
11
3,364,779
0.33
0.27
0.28
3,404,840
0.26
0.21
0.22
1,724,239
0.35
0.30
0.31
1,655,235
0.30
0.24
0.26
2,980,563
0.13
0.13
0.13
2,756,345
0.25
0.32
0.29
106,961
94,002
2.13
1.08
1.42
25 11,635,225
0.21
0.18
0.19
30
11,526,898
0.26
0.22
0.23
- 238 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C73
10 10
10
2 3
10 10
10
2 3
88
1,262,554
6.97
4.89
5.39
287
1,356,218
21.16
15.20
16.34
40
754,586
5.30
3.85
4.26
102
775,361
13.16
9.02
9.78
17
193,573
8.78
6.19
6.94
16
190,561
8.40
5.86
6.42
12
206,243
5.82
4.59
5.18
31
209,101
14.83
10.90
12.20
24
525,788
4.56
3.48
3.85
75
556,511
13.48
10.18
11.12
20
381,903
5.24
3.80
4.14
84
390,370
21.52
15.65
16.98
134,036
5.22
4.02
4.47
19
138,354
13.73
11.19
11.82
109
1,935,668
5.63
4.29
4.67
377
1,961,699
19.22
14.15
15.30
43
1,009,274
4.26
3.56
3.88
138
992,786
13.90
10.97
11.85
16
264,014
6.06
4.58
5.15
26
249,001
10.44
8.32
9.07
234,682
2.98
2.26
2.41
45
225,804
19.93
14.98
16.16
291,177
2.06
1.33
1.57
29
269,791
10.75
8.15
8.76
30
793,368
3.78
2.87
3.16
88
772,752
11.39
8.71
9.52
28
670,812
4.17
3.15
3.43
79
636,474
12.41
9.77
10.55
271,053
2.58
2.09
2.27
34
255,438
13.31
10.06
11.24
11
374,746
2.94
2.18
2.52
62
342,907
18.08
14.95
15.79
13
283,284
4.59
2.87
3.26
39
259,964
15.00
11.65
12.25
31
562,141
5.51
3.94
4.24
100
539,380
18.54
13.78
15.05
31
636,341
4.87
3.52
3.76
103
607,195
16.96
12.65
13.57
20
449,267
4.45
3.38
3.74
58
424,242
13.67
11.20
11.73
49,769
2.01
1.45
1.45
47,149
12.73
9.91
10.71
174,584
1.72
1.26
1.32
22
164,221
13.40
9.68
10.67
120,747
2.48
2.24
2.35
15
109,926
13.65
10.36
11.23
49,871
6.02
3.73
4.16
47,493
6.32
4.10
4.95
5,744
4,200
298
5,397,185
5.52
4.16
4.57
949
5,454,961
17.40
12.97
14.00
100
2,635,767
3.79
2.87
3.17
338
2,564,082
13.18
10.14
10.98
163
3,251,327
5.01
3.63
3.96
511
3,182,015
16.06
11.94
12.83
295,331
2.03
1.67
1.75
37
274,147
13.50
9.93
10.86
55,615
5.39
3.35
3.74
51,693
5.80
3.76
4.55
128
2,017,140
6.35
4.50
4.96
389
2,131,579
18.25
12.90
13.90
80
1,441,543
5.55
4.16
4.62
225
1,484,897
15.15
11.28
12.29
164
3,364,779
4.87
3.76
4.11
598
3,404,840
17.56
13.02
14.18
79
1,724,239
4.58
3.53
3.87
221
1,655,235
13.35
10.45
11.20
112
2,980,563
3.76
2.77
3.02
389
2,756,345
14.11
11.02
11.82
106,961
4.67
3.31
4.08
11
94,002
11.70
10.21
10.58
571 11,635,225
4.91
3.66
4.02
1,838
11,526,898
15.95
11.96
12.91
- 239 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C74 - C75
10 10
10
2 3
10 10
10
2 3
1,262,554
0.32
0.37
0.33
1,356,218
0.15
0.41
0.32
754,586
0.13
0.11
0.10
775,361
0.13
0.42
0.31
193,573
190,561
0.52
0.23
0.27
206,243
209,101
525,788
556,511
0.18
0.12
0.14
381,903
0.26
0.19
0.19
390,370
0.26
0.18
0.18
134,036
0.75
0.57
0.57
138,354
1,935,668
0.26
0.37
0.32
1,961,699
1,009,274
0.20
0.31
0.26
992,786
0.20
0.33
0.27
264,014
0.38
0.78
0.58
249,001
0.40
0.49
0.51
234,682
225,804
0.89
0.56
0.59
291,177
0.34
0.23
0.25
269,791
0.37
0.30
0.30
793,368
0.13
0.09
0.09
772,752
0.52
0.82
0.72
670,812
0.45
0.64
0.54
636,474
0.16
0.14
0.15
271,053
255,438
0.39
1.28
0.94
374,746
342,907
283,284
0.71
0.50
0.60
259,964
0.77
0.56
0.66
562,141
0.36
0.50
0.46
539,380
0.56
0.38
0.39
636,341
607,195
0.16
0.06
0.11
449,267
0.22
0.14
0.15
424,242
0.47
0.99
0.77
49,769
47,149
174,584
164,221
120,747
109,926
49,871
47,493
5,744
4,200
13
5,397,185
0.24
0.34
0.29
5,454,961
0.16
0.23
0.20
2,635,767
0.15
0.19
0.17
2,564,082
0.27
0.43
0.37
3,251,327
0.25
0.21
0.22
10
3,182,015
0.31
0.37
0.33
295,331
274,147
55,615
51,693
2,017,140
0.25
0.28
0.25
2,131,579
0.14
0.41
0.31
1,441,543
0.14
0.10
0.10
1,484,897
0.20
0.13
0.15
10
3,364,779
0.30
0.43
0.37
3,404,840
0.12
0.23
0.19
1,724,239
0.23
0.29
0.26
1,655,235
0.18
0.17
0.17
2,980,563
0.13
0.14
0.14
13
2,756,345
0.47
0.52
0.48
106,961
94,002
25 11,635,225
0.21
0.27
0.24
26
11,526,898
0.23
0.31
0.27
- 240 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C76
10 10
10
2 3
10 10
10
2 3
1,262,554
0.08
0.02
0.03
1,356,218
0.07
0.04
0.05
754,586
0.53
0.33
0.38
775,361
193,573
190,561
0.52
0.17
0.30
206,243
0.48
0.59
0.59
209,101
525,788
556,511
381,903
0.26
0.75
0.55
390,370
134,036
138,354
1,935,668
1,961,699
1,009,274
0.10
0.13
0.13
992,786
264,014
249,001
234,682
225,804
291,177
269,791
793,368
772,752
0.26
0.21
0.21
670,812
636,474
271,053
255,438
374,746
342,907
0.29
0.25
0.25
283,284
0.35
0.18
0.20
259,964
562,141
539,380
636,341
607,195
0.16
0.14
0.14
449,267
424,242
49,769
47,149
174,584
164,221
120,747
109,926
49,871
47,493
5,744
4,200
5,397,185
0.06
0.04
0.05
5,454,961
0.04
0.02
0.02
2,635,767
2,564,082
0.12
0.09
0.09
3,251,327
0.18
0.19
0.18
3,182,015
0.03
0.03
0.03
295,331
274,147
55,615
51,693
2,017,140
0.25
0.13
0.16
2,131,579
0.05
0.03
0.03
1,441,543
0.14
0.26
0.21
1,484,897
0.07
0.03
0.05
3,364,779
0.03
0.03
0.03
3,404,840
0.03
0.03
0.03
1,724,239
0.06
0.04
0.04
1,655,235
0.12
0.10
0.10
2,980,563
2,756,345
0.04
0.02
0.03
106,961
94,002
9 11,635,225
0.08
0.07
0.07
11,526,898
0.05
0.04
0.04
- 241 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
C80
10 10
10
2 3
10 10
10
2 3
56
1,262,554
4.44
2.58
2.96
64
1,356,218
4.72
2.49
2.93
30
754,586
3.98
2.76
3.06
25
775,361
3.22
2.09
2.39
193,573
3.10
2.51
2.67
190,561
4.20
1.77
2.59
13
206,243
6.30
4.41
5.00
209,101
2.87
1.81
2.24
26
525,788
4.94
3.94
4.63
12
556,511
2.16
1.45
1.82
22
381,903
5.76
3.85
4.62
14
390,370
3.59
2.22
2.66
134,036
5.22
3.29
3.93
138,354
6.51
3.66
4.45
89
1,935,668
4.60
3.55
4.05
67
1,961,699
3.42
2.47
2.94
32
1,009,274
3.17
2.55
2.94
29
992,786
2.92
2.53
2.77
264,014
3.03
2.52
2.59
249,001
3.21
1.51
2.02
12
234,682
5.11
2.97
3.43
225,804
3.54
1.51
1.79
18
291,177
6.18
2.89
3.73
269,791
3.34
1.19
1.63
28
793,368
3.53
2.54
3.07
29
772,752
3.75
2.72
3.15
36
670,812
5.37
3.69
4.19
10
636,474
1.57
0.87
0.97
271,053
3.32
2.25
2.53
255,438
1.17
0.78
0.80
21
374,746
5.60
3.03
3.59
11
342,907
3.21
1.42
1.62
16
283,284
5.65
3.35
3.66
259,964
2.69
1.41
1.47
29
562,141
5.16
3.07
3.54
26
539,380
4.82
2.46
2.86
32
636,341
5.03
3.59
3.98
11
607,195
1.81
0.92
1.23
29
449,267
6.45
3.83
4.60
23
424,242
5.42
2.60
3.22
49,769
6.03
3.95
4.22
47,149
4.24
3.14
3.34
174,584
5.16
2.87
3.31
164,221
2.44
1.21
1.49
120,747
4.97
3.05
3.36
109,926
2.73
1.38
1.54
49,871
2.01
1.19
1.31
47,493
6.32
2.62
3.69
5,744
4,200
234
5,397,185
4.34
2.95
3.38
199
5,454,961
3.65
2.24
2.67
120
2,635,767
4.55
3.07
3.57
65
2,564,082
2.54
1.58
1.82
168
3,251,327
5.17
3.32
3.79
117
3,182,015
3.68
2.02
2.39
15
295,331
5.08
2.91
3.29
274,147
2.55
1.29
1.52
55,615
1.80
1.11
1.22
51,693
5.80
2.41
3.40
86
2,017,140
4.26
2.63
2.99
89
2,131,579
4.18
2.37
2.77
74
1,441,543
5.13
3.69
4.29
49
1,484,897
3.30
1.99
2.51
145
3,364,779
4.31
3.20
3.65
122
3,404,840
3.58
2.66
3.10
75
1,724,239
4.35
2.69
3.13
56
1,655,235
3.38
1.86
2.19
152
2,980,563
5.10
3.16
3.64
71
2,756,345
2.58
1.33
1.57
106,961
2.80
1.93
2.22
94,002
2.13
0.80
1.30
538 11,635,225
4.62
3.06
3.52
391
11,526,898
3.39
2.00
2.36
- 242 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
231
1,262,554
18.30
11.15
12.49
190
1,356,218
14.01
8.59
9.64
103
754,586
13.65
10.30
11.32
82
775,361
10.58
7.20
8.05
19
193,573
9.82
6.69
7.51
18
190,561
9.45
8.54
8.53
43
206,243
20.85
14.75
16.83
16
209,101
7.65
5.68
6.27
60
525,788
11.41
9.66
10.62
60
556,511
10.78
9.41
10.21
58
381,903
15.19
12.23
13.19
41
390,370
10.50
7.37
8.19
26
134,036
19.40
14.76
15.99
14
138,354
10.12
6.76
7.68
294
1,935,668
15.19
12.55
13.79
240
1,961,699
12.23
9.19
10.28
137
1,009,274
13.57
11.08
12.45
99
992,786
9.97
7.78
8.79
38
264,014
14.39
11.15
12.28
27
249,001
10.84
8.85
9.26
33
234,682
14.06
10.31
11.30
25
225,804
11.07
7.03
7.86
42
291,177
14.42
8.68
9.90
34
269,791
12.60
8.46
9.01
110
793,368
13.86
11.27
12.55
68
772,752
8.80
7.06
7.60
92
670,812
13.71
10.00
11.06
63
636,474
9.90
5.93
6.80
28
271,053
10.33
7.33
7.81
33
255,438
12.92
8.06
8.81
34
374,746
9.07
6.66
7.08
37
342,907
10.79
6.22
6.85
35
283,284
12.36
8.15
8.75
28
259,964
10.77
7.13
7.68
93
562,141
16.54
10.70
11.95
58
539,380
10.75
7.13
7.89
74
636,341
11.63
8.46
9.38
56
607,195
9.22
6.16
6.82
46
449,267
10.24
7.26
7.77
35
424,242
8.25
5.56
5.95
10
49,769
20.09
11.80
13.60
47,149
4.24
2.21
2.54
34
174,584
19.47
14.05
15.17
13
164,221
7.92
4.86
5.49
13
120,747
10.77
8.00
9.00
109,926
8.19
4.53
5.17
49,871
12.03
5.95
8.17
47,493
16.84
11.65
12.21
5,744
4,200
837
5,397,185
15.51
11.36
12.64
649
5,454,961
11.90
8.43
9.35
324
2,635,767
12.29
9.44
10.35
261
2,564,082
10.18
7.19
7.90
445
3,251,327
13.69
9.80
10.75
316
3,182,015
9.93
6.67
7.36
47
295,331
15.91
11.56
12.64
22
274,147
8.02
4.69
5.32
55,615
10.79
5.45
7.51
51,693
15.48
10.73
11.25
334
2,017,140
16.56
10.89
12.14
272
2,131,579
12.76
8.12
9.12
206
1,441,543
14.29
11.41
12.53
149
1,484,897
10.03
7.86
8.53
489
3,364,779
14.53
11.69
13.01
350
3,404,840
10.28
7.84
8.69
212
1,724,239
12.30
9.01
9.84
179
1,655,235
10.81
6.93
7.78
406
2,980,563
13.62
9.55
10.50
295
2,756,345
10.70
7.12
7.80
10
106,961
9.35
8.80
8.93
11
94,002
11.70
11.65
11.35
1,659 11,635,225
14.26
10.48
11.58
1,256
11,526,898
10.90
7.57
8.37
- 243 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
12
1,262,554
0.95
0.78
0.79
1,356,218
0.52
0.53
0.55
11
754,586
1.46
1.50
1.48
775,361
0.77
0.60
0.70
193,573
0.52
0.29
0.33
190,561
1.05
0.97
1.04
206,243
0.97
0.93
0.99
209,101
0.96
0.66
0.74
525,788
0.57
0.62
0.59
556,511
0.36
0.38
0.38
381,903
390,370
1.02
0.88
0.95
134,036
138,354
0.72
0.63
0.63
20
1,935,668
1.03
0.93
0.97
13
1,961,699
0.66
0.60
0.63
1,009,274
0.69
0.67
0.67
992,786
0.60
0.51
0.56
264,014
1.14
1.11
1.17
249,001
0.40
0.42
0.41
234,682
0.43
0.87
0.75
225,804
1.33
1.31
1.36
291,177
0.34
0.43
0.41
269,791
0.37
0.35
0.35
793,368
1.13
1.18
1.18
772,752
0.52
0.43
0.46
670,812
1.19
1.11
1.14
636,474
0.31
0.38
0.37
271,053
255,438
0.78
0.75
0.84
374,746
0.27
0.18
0.19
342,907
0.58
0.49
0.50
283,284
0.71
0.71
0.73
259,964
0.77
0.92
0.88
562,141
0.89
0.77
0.79
539,380
0.56
0.51
0.54
10
636,341
1.57
1.37
1.44
607,195
0.33
0.32
0.31
449,267
1.11
0.89
1.00
424,242
0.24
0.15
0.16
49,769
47,149
174,584
1.15
1.15
1.11
164,221
1.22
0.90
1.06
120,747
109,926
49,871
47,493
2.11
1.88
1.88
5,744
4,200
47
5,397,185
0.87
0.81
0.83
35
5,454,961
0.64
0.58
0.61
21
2,635,767
0.80
0.80
0.80
12
2,564,082
0.47
0.44
0.46
33
3,251,327
1.01
0.94
0.97
19
3,182,015
0.60
0.52
0.55
295,331
0.68
0.68
0.66
274,147
0.73
0.54
0.63
55,615
51,693
1.93
1.78
1.78
23
2,017,140
1.14
1.06
1.07
13
2,131,579
0.61
0.55
0.60
1,441,543
0.42
0.40
0.40
11
1,484,897
0.74
0.65
0.69
30
3,364,779
0.89
0.84
0.86
15
3,404,840
0.44
0.40
0.42
12
1,724,239
0.70
0.63
0.65
1,655,235
0.42
0.34
0.37
32
2,980,563
1.07
1.03
1.06
23
2,756,345
0.83
0.79
0.81
106,961
94,002
103 11,635,225
0.89
0.84
0.85
69
11,526,898
0.60
0.54
0.57
- 244 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
170
1,262,554
13.46
8.12
9.11
150
1,356,218
11.06
6.75
7.54
73
754,586
9.67
6.79
7.66
66
775,361
8.51
5.79
6.39
14
193,573
7.23
5.11
5.71
13
190,561
6.82
4.87
5.27
30
206,243
14.55
10.62
12.09
209,101
4.30
3.19
3.56
40
525,788
7.61
6.28
7.01
45
556,511
8.09
6.97
7.57
43
381,903
11.26
9.00
9.75
31
390,370
7.94
5.48
6.12
24
134,036
17.91
13.77
14.89
11
138,354
7.95
5.24
6.05
203
1,935,668
10.49
8.13
9.21
164
1,961,699
8.36
6.30
7.00
106
1,009,274
10.50
8.89
9.90
67
992,786
6.75
5.11
5.83
25
264,014
9.47
7.47
8.09
20
249,001
8.03
5.93
6.52
22
234,682
9.37
6.67
7.38
13
225,804
5.76
3.83
4.21
27
291,177
9.27
5.78
6.50
24
269,791
8.90
6.26
6.62
79
793,368
9.96
8.06
8.98
52
772,752
6.73
5.28
5.74
64
670,812
9.54
6.95
7.66
43
636,474
6.76
4.14
4.74
23
271,053
8.49
6.18
6.52
21
255,438
8.22
4.69
5.26
27
374,746
7.20
5.36
5.71
27
342,907
7.87
4.71
5.18
21
283,284
7.41
4.81
5.19
22
259,964
8.46
4.63
5.33
62
562,141
11.03
6.83
7.82
45
539,380
8.34
5.57
6.15
52
636,341
8.17
5.87
6.54
38
607,195
6.26
4.30
4.71
34
449,267
7.57
5.17
5.57
23
424,242
5.42
3.40
3.76
49,769
16.07
10.16
11.49
47,149
2.12
1.80
1.80
20
174,584
11.46
7.99
8.73
164,221
3.65
2.51
2.63
120,747
6.63
4.77
5.51
109,926
5.46
3.00
3.39
49,871
8.02
4.20
5.25
47,493
12.63
8.88
9.01
5,744
4,200
597
5,397,185
11.06
7.93
8.90
460
5,454,961
8.43
5.90
6.55
233
2,635,767
8.84
6.77
7.43
188
2,564,082
7.33
5.11
5.64
317
3,251,327
9.75
6.77
7.52
237
3,182,015
7.45
4.92
5.46
28
295,331
9.48
6.65
7.39
12
274,147
4.38
2.71
2.94
55,615
7.19
3.84
4.83
51,693
11.61
8.14
8.26
243
2,017,140
12.05
7.67
8.63
216
2,131,579
10.13
6.44
7.17
151
1,441,543
10.47
8.34
9.20
109
1,484,897
7.34
5.57
6.13
348
3,364,779
10.34
8.09
9.12
251
3,404,840
7.37
5.56
6.19
161
1,724,239
9.34
6.82
7.46
135
1,655,235
8.16
5.32
5.94
268
2,980,563
8.99
6.10
6.77
186
2,756,345
6.75
4.45
4.91
106,961
5.61
5.58
5.59
94,002
6.38
6.07
5.97
1,179 11,635,225
10.13
7.30
8.13
903
11,526,898
7.83
5.39
5.97
- 245 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE
10 10
10
2 3
10 10
10
2 3
37
1,262,554
2.93
1.45
1.76
28
1,356,218
2.06
1.12
1.31
15
754,586
1.99
1.37
1.60
775,361
1.16
0.72
0.87
193,573
2.07
1.29
1.46
190,561
1.05
0.78
0.81
206,243
4.36
2.06
2.82
209,101
1.91
1.34
1.52
13
525,788
2.47
2.09
2.29
556,511
1.62
1.34
1.50
13
381,903
3.40
2.82
3.03
390,370
1.28
0.86
0.94
134,036
0.75
0.47
0.54
138,354
1.45
0.88
0.99
52
1,935,668
2.69
2.27
2.46
47
1,961,699
2.40
1.74
1.99
19
1,009,274
1.88
1.27
1.54
19
992,786
1.91
1.54
1.77
264,014
2.27
1.68
1.87
249,001
1.61
1.38
1.41
234,682
1.70
1.00
1.16
225,804
2.66
1.42
1.62
10
291,177
3.43
1.76
2.12
269,791
2.59
1.47
1.62
17
793,368
2.14
1.62
1.90
772,752
1.04
0.61
0.77
13
670,812
1.94
1.21
1.43
13
636,474
2.04
1.06
1.24
271,053
0.74
0.41
0.49
255,438
3.52
2.49
2.56
374,746
1.07
0.74
0.79
342,907
1.75
0.71
0.83
10
283,284
3.53
2.17
2.32
259,964
1.15
0.75
0.74
24
562,141
4.27
2.86
3.08
539,380
1.67
1.00
1.11
636,341
1.41
0.93
1.06
12
607,195
1.98
1.23
1.37
449,267
1.56
1.19
1.20
10
424,242
2.36
1.50
1.57
49,769
2.01
1.20
1.32
47,149
174,584
5.16
3.52
3.99
164,221
2.44
1.21
1.46
120,747
1.66
1.09
1.27
109,926
1.82
0.92
1.12
49,871
4.01
1.75
2.91
47,493
2.11
0.88
1.33
5,744
4,200
141
5,397,185
2.61
1.76
2.02
117
5,454,961
2.14
1.43
1.63
49
2,635,767
1.86
1.28
1.47
45
2,564,082
1.76
1.10
1.25
80
3,251,327
2.46
1.72
1.88
50
3,182,015
1.57
0.97
1.07
11
295,331
3.72
2.52
2.88
274,147
2.19
1.07
1.30
55,615
3.60
1.61
2.68
51,693
1.93
0.81
1.21
52
2,017,140
2.58
1.43
1.71
37
2,131,579
1.74
0.98
1.15
40
1,441,543
2.77
2.05
2.33
22
1,484,897
1.48
1.06
1.18
84
3,364,779
2.50
2.04
2.26
62
3,404,840
1.82
1.34
1.49
29
1,724,239
1.68
1.07
1.23
29
1,655,235
1.75
1.00
1.15
76
2,980,563
2.55
1.63
1.83
65
2,756,345
2.36
1.34
1.51
106,961
1.87
2.03
2.01
94,002
4.26
3.72
3.77
283 11,635,225
2.43
1.66
1.88
219
11,526,898
1.90
1.21
1.36
- 246 -
99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
2. 10 2 1976
3. 10 3 2000
4.
5.
6.
7.
8.
9. 125
10. 50 125
11. 15 50
12.
13.
14.
- 247 -
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
ICD-O-3
C00-C80
C00-C14
3
C00-C14
C44.0
LIPexcludes skin of lip C44.0
C01-C02
C09-C10
C07-C08
C11
C15-C26, C48
C15
C16
C17
942
HYPOPHARYNX
C14
72
236
1,571
NASOPHARYNX
34,255
2,238
ESOPHAGUS
3,854
STOMACH
325
SMALL INTESTINE
1. 96
2. MV%Percentage of morphologically verified cases.
3. ICD-O-3
2,269
635
OROPHARYNX
C12-C13
228
164
FLOOR OF MOUTH
C05-C06
6,560
445
GUM
C04
8,367
1,805
TONGUE
C03
CASE
NUMBER
90,649
ALL SITES
C00
C00-C06C09-C10C12-C14
- 248 -
Morphological confirmation
Clinical confirmation
/
Histology
Unknown
Method
Cytology
MV%
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
ICD-O-3
Unknown
79,719
2,245
90.42
1,783
91
6,116
695
79,719 C00-C80
8,260
15
98.90
12
32
48
8,260 C00-C14
6,482
98.90
10
25
37
6,482 C00-C143
227
99.56
1,789
99.11
444
99.78
444 C03
164
100.00
164 C04
2,251
99.21
10
2,251 C05-C06
620
97.95
620 C09-C10
918
97.88
11
918 C12-C13
69
95.83
225
98.31
1,553
98.98
26,802
517
79.75
1,670
68
4,918
280
2,202
98.39
17
13
2,202 C15
3,777
98.18
11
37
20
3,777 C16
318
97.85
318 C17
- 249 -
227 C00
1,789 C01-C02
69 C14
225 C07-C08
1,553 C11
26,802 C15-C26, C48
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED
ICD-O-3
C18-C21
C18
C22
C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
4
C42
C40-C41
14,040
5,405
11,023
924
1,643
PANCREAS
157
51
11,761
172
635
LARYNX
10,615
62
PLEURA
276
1,823
LEUKEMIA
1. 96
2. MV%Percentage of morphologically verified cases.
4. ICD-O-3
CASE
NUMBER
8,635
COLON
C19-C21
M-CODE p.497
- 250 -
163
Morphological confirmation
Clinical confirmation
/
Histology
MV%2
Unknown
Method
Cytology
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
ICD-O-3
Unknown
13,673
17
97.51
23
27
198
102
8,338
15
96.73
18
19
160
85
- C18
5,335
98.74
38
17
- C19-C21
4,943
324
47.78
1,583
4,077
88
- C22
732
18
81.17
11
145
15
- C23-C24
977
142
68.11
50
13
422
39
- C25
138
89.81
14
- C48
42
94.12
- C26
9,646
1,348
93.48
30
602
134
- C30-C39
168
97.67
- C30-C31
624
98.43
- C32
8,541
1,343
93.11
29
584
117
55
95.16
- C38.4
258
93.48
12
- C37-C38.3, C38.8
1,794
98.85
17
155
95.09
- 251 -
- C18-C21
- C33-C34
- C424
- C40-C41
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED
ICD-O-3
C47, C49
C44
5
C44
C44
C50
C50
C51-C58
C55
C53
C54
C56, C57.0-C57.4
C61
C62
C60,C63
C64-C68
508
212
2,766
9,655
FEMALE BREAST
39
MALE BREAST
4,822
UTERUS, NOS
1,680
CERVIX UTERI
1,737
CORPUS UTERI
1,245
152
4,661
4,392
PROSTATE GLAND
178
TESTIS
91
4,441
URINARY TRACT
1. 96
2. MV%Percentage of morphologically verified cases.
5. ICD-O-3
CASE
NUMBER
2,978
SKIN
C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63
- 252 -
Morphological confirmation
Clinical confirmation
/
Histology
MV%2
Unknown
Method
Cytology
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
ICD-O-3
Unknown
496
97.83
2,956
99.33
15
- C44
207
98.11
- C445
2,749
99.42
12
- C44
9,593
15
99.51
29
17
- C50
39
100.00
- C50
4,680
55
98.20
41
37
75.00
- C55
1,649
21
99.40
- C53
1,730
99.65
- C54
1,146
33
94.70
30
27
149
98.03
4,568
98.05
45
26
20
- C60-C63
4,302
98.00
45
24
19
- C61
177
99.44
- C62
89
97.80
- C60,C63
4,162
88
95.70
152
32
- C64-C68
- 253 -
- C47, C49
- C51-C58
- C56, C57.0-C57.4
- C51-C52, C57.7-C57.9
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED
ICD-O-3
C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80
CASE
NUMBER
1,964
BLADDER
1,028
KIDNEY
744
RENAL PELVIS
451
URETER
24
11
219
61
789
734
BRAIN
55
2,409
THYROID GLAND
51
15
929
MALIGNANT LYMPHOMAM-CODE
1. 96
2. MV%Percentage of morphologically verified cases.
- 254 -
2,915
Morphological confirmation
Clinical confirmation
/
Histology
MV%2
Unknown
Method
Cytology
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
ICD-O-3
Unknown
1,911
19
98.27
14
18
- C67
908
89.11
99
10
- C64
688
31
96.64
23
- C65
427
13
97.56
- C66
24
100.00
- C68.0-C68.1
10
90.91
- C68.8
194
17
96.35
- C68.9
47
77.05
12
- C69
675
85.68
82
29
- C70-C72
631
86.10
76
24
- C71
44
80.00
- C70, C72
2,336
54
99.21
13
- C73
43
84.31
- C74-C75
10
73.33
- C76
612
109
77.61
169
32
- C80
2,843
29
98.52
18
14
11
- 255 -
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS OF LEUKEMIA AND LYMPHOMA, 2010
CASE NUMBER
1,823
734
235
225
135
35
230
MYELOPROLIFERATIVE NEOPLASMS
200
MYELODYSPLASTIC SYNDROMES
13
OTHER LEUKEMIA
12
LEUKEMIA, NOS
1. 96
2. MV%Percentage of morphologically verified cases.
- 256 -
Morphological confirmation
Clinical confirmation
/
Histology
MV%2
Unknown
Method
Cytology
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
Unknown
1,794
98.85
17
731
99.86
235
100.00
222
99.11
134
99.26
33
97.14
223
97.83
190
96.00
100.00
12
92.31
10
83.33
- 257 -
99
METHODS OF ESTABLISHING CANCER DIAGNOSIS OF LEUKEMIA AND LYMPHOMA, 2010
CONTINUED
CASE NUMBER
2,915
MALIGNANT LYMPHOMA
172
HODGKIN LYMPHOMA
2,082
NON-HODGKIN LYMPHOMA
1,750
T/NK
332
502
26
Other LPD
133
- 258 -
Morphological confirmation
Clinical confirmation
/
Histology
MV%2
Unknown
Method
Cytology
Laboratory
Test/Marker
Study
Surgical
Exploration/
Endoscopy
Imaging
Techniques
Clinical
diagnosis
Unknown
2,843
29
98.52
18
14
11
172
100.00
2,071
99.81
1,741
99.83
330
99.70
473
95.22
17
26
100.00
101
17
88.72
- 259 -
99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010
ICD-O-3
C00-C80
C00-C14
3
C00-C14
C44.0
LIPexcludes skin of lip C44.0
C01-C02
C09-C10
C07-C08
C11
C15-C26, C48
C15
C16
C17
942
HYPOPHARYNX
C14
2,269
635
OROPHARYNX
C12-C13
228
164
FLOOR OF MOUTH
C05-C06
6,560
445
GUM
C04
8,367
1,805
TONGUE
C03
CASE NUMBER
90,649
ALL SITES
C00
72
236
1,571
NASOPHARYNX
34,255
2,238
ESOPHAGUS
3,854
STOMACH
325
SMALL INTESTINE
2.
3. ICD-O-3
C00-C06C09-C10C12-C14
- 260 -
Surgery
49,897
Radiotherapy Chemotherapy
Hormone/
Steroid
therapy
889
(0.98)
475
ICD-O-3
No therapy
record
4,559
(54.49)
4,892 (58.47)
4,537 (54.22)
(0.01)
706
(8.44)
468
(5.59) C00-C14
4,358
(66.43)
3,354 (51.13)
3,176 (48.41)
(0.02)
575
(8.77)
367
(5.59) C00-C143
194
(85.09)
57 (25.00)
50 (21.93)
(3.07)
17
(7.46) C00
1,413
(78.28)
758 (41.99)
707 (39.17)
(0.06)
112
(6.20)
87
(4.82) C01-C02
352
(79.10)
252 (56.63)
226 (50.79)
39
(8.76)
18
(4.04) C03
130
(79.27)
77 (46.95)
63 (38.41)
15
(9.15)
11
(6.71) C04
1,761
(77.61)
945 (41.65)
889 (39.18)
170
(7.49)
138
(6.08) C05-C06
225
(35.43)
483 (76.06)
476 (74.96)
85 (13.39)
29
(4.57) C09-C10
256
(27.18)
737 (78.24)
714 (75.80)
137 (14.54)
60
(6.37) C12-C13
27
(37.50)
45 (62.50)
51 (70.83)
10 (13.89)
192
(81.36)
131 (55.51)
63 (26.69)
10
(4.24)
17
(7.20) C07-C08
(0.57)
1,407 (89.56)
1,298 (82.62)
121
(7.70)
84
(5.35) C11
17,892
(52.23)
168
(0.49)
6,224 (18.17)
693
(30.97)
1,540 (68.81)
1,497 (66.89)
(0.04)
668 (29.85)
208
2,351
(61.00)
359
(9.31)
1,620 (42.03)
(0.03)
784 (20.34)
222
(68.31)
16
(4.92)
106 (32.62)
59 (18.15)
42 (12.92) C17
- 261 -
(9.72) C14
(9.29) C15
99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010 CONTINUED
ICD-O-3
C18-C21
C18
C22
C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
5
C42
C40-C41
CASE NUMBER
14,040
8,635
COLON
C19-C21
5,405
11,023
924
1,643
PANCREAS
157
51
11,761
172
635
LARYNX
10,615
62
PLEURA
276
1,823
LEUKEMIA
163
2.
4. 43
5. ICD-O-3
M-CODE p.497
- 262 -
Surgery
Radiotherapy Chemotherapy
11,083
(78.94)
1,773 (12.63)
6,768
(78.38)
4,315
(79.83)
2,606
(23.64)
878
475
Hormone/
Steroid
therapy
ICD-O-3
No therapy
record
7,368 (52.48)
1,479 (10.53)
(2.63)
4,295 (49.74)
935 (10.83)
1,546 (28.60)
3,073 (56.85)
544 (10.06)
409
(7.97)
1,151 (10.44)
165
(1.50)
2,192 (19.89)
(51.41)
119 (12.88)
226 (24.46)
285 (30.84)
328
(19.96)
251 (15.28)
712 (43.34)
730 (44.43)
110
(70.06)
39 (24.84)
46 (29.30)
(0.64)
16 (10.19)
18 (11.46) C48
24
(47.06)
(5.88)
27 (52.94)
11 (21.57)
6 (11.76) C26
2,630
(22.36)
3,486 (29.64)
6,928 (58.91)
17
(0.14)
3,685 (31.33)
109
(63.37)
95 (55.23)
69 (40.12)
(1.16)
14
(8.14)
20 (11.63) C30-C31
308
(48.50)
377 (59.37)
213 (33.54)
32
(5.04)
65 (10.24) C32
2,054
(19.35)
2,887 (27.20)
6,489 (61.13)
15
(0.14)
3,578 (33.71)
15
(24.19)
(9.68)
37 (59.68)
18 (29.03)
14 (22.58) C38.4
144
(52.17)
121 (43.84)
120 (43.48)
43 (15.58)
(0.05)
248 (13.60)
(0.44)
97
(5.32)
267 (14.65)
116
(71.17)
227
50
(2.74)
1,294 (70.98)
32 (19.63)
96 (58.90)
- 263 -
16
(9.82)
1,298
(9.25) C18-C21
(7.57) C19-C21
4
46
(2.52) C425
20 (12.27) C40-C41
99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010CONTINUED
ICD-O-3
C47, C49
C44
6
C44
C44
C50
C50
C51-C58
C55
C53
C54
C56, C57.0-C57.4
C61
C62
C60,C63
C64-C68
CASE NUMBER
508
2,978
SKIN
212
2,766
9,655
FEMALE BREAST
39
MALE BREAST
4,822
UTERUS, NOS
1,680
CERVIX UTERI
1,737
CORPUS UTERI
C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63
1,245
152
4,661
4,392
PROSTATE GLAND
178
TESTIS
91
4,441
URINARY TRACT
2.
6. ICD-O-3
- 264 -
Surgery
Radiotherapy Chemotherapy
Hormone/
Steroid
therapy
ICD-O-3
No therapy
record
386
(75.98)
190 (37.40)
91 (17.91)
(0.20)
34
(6.69)
2,664
(89.46)
202
75
(2.52)
16
(0.54)
55
(1.85)
172
(81.13)
25 (11.79)
12
(5.66)
12
(5.66)
2,492
(90.09)
50
(0.14)
43
(1.55)
186
(6.72) C44
8,808
(91.23)
4,344 (44.99)
6,521 (67.54)
6,066 (62.83)
22
(0.23)
298
(3.09)
255
(2.64) C50
33
(84.62)
9 (23.08)
18 (46.15)
28 (71.79)
(5.13)
(7.69) C50
3,648
(75.65)
1,516 (31.44)
2,081 (43.16)
21
(0.44)
226
(4.69)
272
(50.00)
1 (12.50)
2 (25.00)
1 (12.50)
1 (12.50)
878
(52.26)
940 (55.95)
720 (42.86)
(0.18)
(0.18)
108
(6.43)
120
(7.14) C53
1,580
(90.96)
500 (28.79)
395 (22.74)
160
(9.21)
12
(0.69)
39
(2.25)
68
(3.91) C54
1,103
(88.59)
24
(1.93)
925 (74.30)
17
(1.37)
(0.40)
64
(5.14)
52
83
(54.61)
51 (33.55)
39 (25.66)
13
(8.55)
2,113
(45.33)
1,324 (28.41)
119
(2.55)
2,700 (57.93)
(0.02)
272
(5.84)
380
(8.15)
348
(7.47) C60-C63
1,873
(42.65)
1,272 (28.96)
46
(1.05)
2,698 (61.43)
269
(6.12)
374
(8.52)
339
(7.72) C61
160
(89.89)
43 (24.16)
80
(87.91)
3,587
(80.77)
370
(6.78)
31 (14.62)
171
(6.18)
(1.81)
181
(3.75)
2 (25.00)
209
(7.02) C44
23 (10.85) C446
(5.64) C51-C58
2 (25.00) C55
61 (34.27)
(1.12)
(1.69)
(1.69)
(2.25) C62
(9.89)
12 (13.19)
(1.10)
(3.30)
(5.49) C60,C63
(8.33)
1,501 (33.80)
(0.05)
434
(9.77)
349
(7.86)
438
(9.86) C64-C68
- 265 -
99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010 CONTINUED
ICD-O-3
C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80
CASE NUMBER
1,964
BLADDER
1,028
KIDNEY
744
RENAL PELVIS
451
URETER
24
11
219
61
789
734
BRAIN
55
2,409
THYROID GLAND
51
15
929
2,915
MALIGNANT LYMPHOMA
2.
- 266 -
Surgery
Radiotherapy Chemotherapy
ICD-O-3
Hormone/
Steroid
therapy
1,738
(88.49)
188
(9.57)
955 (48.63)
(0.05)
394 (20.06)
739
(71.89)
46
(4.47)
136 (13.23)
(0.10)
16
571
(76.75)
69
(9.27)
202 (27.15)
336
(74.50)
43
(9.53)
111 (24.61)
22
(91.67)
5 (20.83)
(8.33)
10
(90.91)
171
(78.08)
19
44
No therapy
record
120
(6.11)
109
(1.56)
92
(8.95)
(0.27)
70
(9.41)
84 (11.29) C65
(0.89)
43
(9.53)
62 (13.75) C66
(4.17)
(4.17) C68.0-C68.1
3 (27.27)
(9.09)
(9.09)
(9.09) C68.8
(8.68)
92 (42.01)
17
(7.76)
(72.13)
12 (19.67)
17 (27.87)
575
(72.88)
482 (61.09)
364 (46.13)
(0.13)
(0.13)
58
(7.35)
78
(9.89) C70-C72
535
(72.89)
461 (62.81)
359 (48.91)
(0.14)
(0.14)
55
(7.49)
69
(9.40) C71
40
(72.73)
21 (38.18)
(9.09)
(5.45)
2,241
(93.03)
1,365 (56.66)
26
(1.08)
1,688 (70.07)
46
(1.91)
89
33
(64.71)
8 (15.69)
(7.84)
10 (19.61) C74-C75
(33.33)
104
457
22 (10.05)
(5.55) C67
31 (14.16) C68.9
(4.92) C69
(3.69) C73
17 (33.33)
(3.92)
4 (26.67)
4 (26.67)
7 (46.67) C76
(11.19)
155 (16.68)
279 (30.03)
(0.32)
(0.11)
316 (34.02)
(15.68)
488 (16.74)
2,147 (73.65)
1,666 (57.15)
220
(7.55)
81
(2.78)
360 (12.35)
292 (10.02)
- 267 -
99
METHODS OF CANCER TREATMENT OF LEUKEMIA AND LYMPHOMA, 2010
CASE NUMBER
1,823
734
235
225
135
35
230
MYELOPROLIFERATIVE NEOPLASMS
200
MYELODYSPLASTIC SYNDROMES
13
OTHER LEUKEMIA
12
LEUKEMIA, NOS
1. 96 ICD-O-3 M-CODE p.497
2.
- 268 -
Surgery
Radiotherapy
Chemotherapy
Steroid
therapy
Immunotherapy
Hematologic
transplant/
Endocrine
procedure
Palliative care
No therapy
record
(0.05)
50
(2.74)
1,294
(70.98)
248
(13.60)
(0.44)
97
(5.32)
267
(14.65)
46
(2.52)
(0.14)
15
(2.04)
578
(78.75)
46
(6.27)
(0.68)
59
(8.04)
151
(20.57)
11
(1.50)
26
(11.06)
219
(93.19)
156
(66.38)
29
(12.34)
18
(7.66)
(0.85)
(2.22)
206
(91.56)
(0.44)
(1.78)
15
(6.67)
(1.33)
79
(58.52)
32
(23.70)
(3.70)
(4.44)
17
(48.57)
(8.57)
12
(34.29)
(8.57)
(0.43)
145
(63.04)
(1.30)
12
(5.22)
(0.87)
(0.50)
35
(17.50)
(1.00)
(2.00)
48
(24.00)
16
(8.00)
(25.00)
4 (100.00)
(25.00)
(25.00)
(7.69)
(69.23)
(38.46)
(15.38)
(30.77)
(16.67)
(16.67)
(25.00)
- 269 -
99
METHODS OF CANCER TREATMENT OF LEUKEMIA AND LYMPHOMA, 2010
CONTINUED
CASE NUMBER
2,915
MALIGNANT LYMPHOMA
172
HODGKIN LYMPHOMA
2,082
NON-HODGKIN LYMPHOMA
1,750
T/NK
332
502
26
Other LPD
133
- 270 -
Surgery
Radiotherapy
Chemotherapy
Steroid
therapy
Immunotherapy
Hematologic
transplant/
Endocrine
procedure
Palliative care
No therapy
record
457
(15.68)
488
(16.74)
2,147
(73.65)
1,666
(57.15)
220
(7.55)
81
(2.78)
360
(12.35)
292
(10.02)
26
(15.12)
65
(37.79)
151
(87.79)
30
(17.44)
(1.74)
10
(5.81)
(5.23)
384
(18.44)
301
(14.46)
1,570
(75.41)
1,287
(61.82)
10
(0.48)
33
(1.59)
192
(9.22)
225
(10.81)
338
(19.31)
254
(14.51)
1,322
(75.54)
1,091
(62.34)
(0.17)
25
(1.43)
161
(9.20)
181
(10.34)
46
(13.86)
47
(14.16)
248
(74.70)
196
(59.04)
(2.11)
(2.41)
31
(9.34)
44
(13.25)
20
(3.98)
105
(20.92)
351
(69.92)
297
(59.16)
206
(41.04)
44
(8.76)
138
(27.49)
12
(2.39)
15
(57.69)
(7.69)
19
(73.08)
11
(42.31)
(11.54)
(3.85)
12
(9.02)
15
(11.28)
56
(42.11)
41
(30.83)
(0.75)
(0.75)
20
(15.04)
45
(33.83)
- 271 -
10 99
RANKING OF CANCER INCIDENCE RATE BY PRIMARY ANATOMIC SITES IN VARIOUS
AGE GROUPS, 2010
0-9
10-19
20-29
(M-980-999)4
(M-980-999)4
(M-980-999)4
(C73)
(C62)
(C73)
41
3.70
26.28%
48
4.73
40.34%
53
3.27
22.18%
26
1.74
14.21%
77
4.34
14.53%
191
11.24
27.56%
(C70-C72)
(C70-C72)
(C70-C72)
(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4
(M-980-999)4
(C50)
34
3.07
21.79%
25
2.47
21.01%
33
2.04
13.81%
22
1.48
12.02%
56
3.16
10.57%
105
6.18
15.15%
(M-959-976)4
(C74-C75)
(M-959-976)4
(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4
(M-959-976)4
(C56, C57.0-C57.4)
16
1.44
10.26%
8
0.79
6.72%
27
1.67
11.30%
22
1.48
12.02%
44
2.48
8.30%
65
3.83
9.38%
(C69)
(C69)
(C40-C41)
(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4
(C18-C21)
(M-959-976)4
(M-980-999)4
14
1.26
8.97%
7
0.69
5.88%
25
1.54
10.46%
22
1.48
12.02%
42
2.37
7.92%
39
2.30
5.63%
(C22)
(M-959-976)4
(C62)(M-965966)4
(C40-C41)
(C22)
(M-959-976)4
(M-980-999)4
10
0.90
6.41%
6
0.59
5.04%
18
1.11
7.53%
20
1.34
10.93%
41
2.31
7.74%
39
2.30
5.63%
1. 96
2. ICD-O-3
3. 10
- 272 -
30-39
40-49
50-59
60-69
70+
(C00-C14) 5
(C50)
(C00-C14) 5
(C50)
(C00-C14) 5
(C50)
(C18-C21)
(C50)
(C33-C34)
(C18-C21)
475
24.98
23.61%
832
43.35
34.88%
1,686
89.46
27.98%
2,949
156.64
44.65%
2,104
126.95
18.90%
3,142
185.31
32.86%
2,188
256.72
19.96%
1,591
174.48
20.64%
3,672
438.73
18.60%
2,473
270.54
19.88%
(C22)
(C73)
(C22)
(C73)
(C22)
(C18-C21)
(C22)
(C18-C21)
(C18-C21)
(C33-C34)
268
14.09
13.32%
315
16.41
13.21%
1,044
55.40
17.32%
517
27.46
7.83%
2,037
122.90
18.30%
1,296
76.44
13.55%
1,906
223.63
17.39%
1,406
154.19
18.24%
3,234
386.40
16.38%
1,758
192.32
14.14%
(C18-C21)
(C18-C21)
(C18-C21)
(C18-C21)
(C18-C21)
(C33-C34)
(C33-C34)
(C33-C34)
(C61)
(C22)
217
11.41
10.79%
181
9.43
7.59%
635
33.69
10.54%
510
27.09
7.72%
1,825
110.11
16.39%
821
48.42
8.59%
1,480
173.65
13.50%
888
97.39
11.52%
3,025
361.43
15.32%
1,725
188.71
13.87%
(C11)
(C53)
(C15)
(C54)
(C33-C34)
(C54)
(C00-C14) 5
(C22)
(C22)
(C50)
184
9.68
9.15%
153
7.97
6.42%
508
26.96
8.43%
409
21.72
6.19%
1,056
63.71
9.49%
719
42.41
7.52%
1,070
125.54
9.76%
870
95.41
11.29%
2,442
291.77
12.37%
1,036
113.34
8.33%
(C73)
(C56, C57.0C57.4)
(C33-C34)
(C33-C34)
(C15)
(C22)
(C61)
(C54)
(C16)
(C44)
123
6.47
6.11%
145
7.56
6.08%
392
20.80
6.51%
374
19.87
5.66%
746
45.01
6.70%
489
28.78
5.10%
1,043
122.38
9.52%
307
33.67
3.98%
1,304
155.80
6.61%
857
93.75
6.89%
4. ICD-O-3
5. ICD-O-3
M-CODE p.497
C00-C06C09-C10C12-C14
- 273 -
10 99
RANKING OF CANCER INCIDENCE RATE BY PRIMARY ANATOMIC SITES IN VARIOUS
AGE GROUPS, 2010CONTINUED
0-9
10-19
20-29
(C64.9)
(C22)
(C62)(M-965966)4
(C47, C49)
(C73)
(M-965-966)4
9
0.81
5.77%
5
0.49
4.20%
18
1.11
7.53%
16
1.07
8.74%
39
2.20
7.36%
30
1.77
4.33%
(C74-C75)
(C40-C41)(C47,
C49)(C64.9)
(C47, C49)
(M-959-976)4
(C11)
(C18-C21)
7
0.63
4.49%
3
0.30
2.52%
13
0.80
5.44%
9
0.60
4.92%
32
1.80
6.04%
27
1.59
3.90%
(C62)
(C40-C41)(C47,
C49)(C64.9)
(C11)
(M-965-966)4
(C70-C72)
(C54)
5
0.45
3.21%
3
0.30
2.52%
10
0.62
4.18%
7
0.47
3.83%
29
1.63
5.47%
26
1.53
3.75%
(C40-C41)(C47,
C49)(M-965-966)4
(C40-C41)(C47,
C49)(C64.9)
(C37-C38.3, C38.8)
(C48)
(C44)
(C44)
(C44)
4
0.36
2.56%
3
0.30
2.52%
6
0.37
2.51%
6
0.40
3.28%
26
1.47
4.91%
25
1.47
3.61%
(C40-C41)(C47,
C49)(M-965-966)4
(C48)(C51C52)(C56-C57)
(C37-C38.3, C38.8)
(C48)
(C18-C21)
(M-965-966)4
(C70-C72)
10
4
0.36
2.56%
2
0.20
1.68%
6
0.37
2.51%
4
0.27
2.19%
23
1.30
4.34%
18
1.06
2.60%
1. 96
2. ICD-O-3
3. 10
- 274 -
30-39
40-49
50-59
60-69
70+
(M-980-999)4
(C54)
(C11)
(C53)
(C16)
(C73)
(C16)
(C53)
(C44)
(C16)
90
4.73
4.47%
120
6.25
5.03%
332
17.62
5.51%
360
19.12
5.45%
448
27.03
4.02%
470
27.72
4.92%
446
52.33
4.07%
292
32.02
3.79%
916
109.44
4.64%
708
77.45
5.69%
(C33-C34)
(M-980-999)4
(C16)
(C56, C57.0C57.4)
(C11)
(C53)
(C15)
(C16)
(C67)
(C65-C66,
C68)
86
4.52
4.27%
76
3.96
3.19%
164
8.70
2.72%
306
16.25
4.63%
372
22.45
3.34%
464
27.37
4.85%
404
47.40
3.69%
269
29.50
3.49%
804
96.06
4.07%
436
47.70
3.51%
(M-959-976)4
(C33-C34)
(C73)
(C16)
(C61)
(C56, C57.0C57.4)
(C44)
(C65-C66,
C68)
(C00-C14) 5
(C53)
77
4.05
3.83%
69
3.60
2.89%
125
6.63
2.07%
149
7.91
2.26%
301
18.16
2.70%
365
21.53
3.82%
275
32.27
2.51%
212
23.25
2.75%
669
79.93
3.39%
395
43.21
3.18%
(C44)
(M-959-976)4
(M-959-976)4
(C22)
(C67)
(C16)
(C67)
(C44)
(M-959-976)4
(C25)
63
3.31
3.13%
64
3.33
2.68%
119
6.31
1.97%
122
6.48
1.85%
225
13.58
2.02%
249
14.69
2.60%
274
32.15
2.50%
202
22.15
2.62%
456
54.48
2.31%
391
42.78
3.14%
(C15)
(C11)
(M-980-999)4
(M-959-976)4
(M-959-976)4
(C44)
(M-959-976)4
(C73)
(C25)
(M-959-976)4
62
3.26
3.08%
56
2.92
2.35%
111
5.89
1.84%
114
6.06
1.73%
215
12.97
1.93%
180
10.62
1.88%
225
26.40
2.05%
198
21.71
2.57%
434
51.85
2.20%
302
33.04
2.43%
4. ICD-O-3
5. ICD-O-3
M-CODE p.497
C00-C06C09-C10C12-C14
- 275 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
ICD-O-3
80323
80703
80723
80743
80763
80523
80713
80733
80753
80833
MORPHOLOGY
GENDER
CASE
NUMBER
80513
VERRUCOUS CARCINOMA
80203
CARCINOMA, UNDIFFERENTIATED
81403
82003
83103
84803
85503
81473
82603
84303
85253
85603
80303
80413
80823
85743
80333
80453
82463
89823
80103 80463
CARCINOMA, NOS
87203 87453
MALIGNANT MELANOMA
88013
88153
88513
91403
88003
88113
88503
88903
95403
SPECIFIED SARCOMA
SARCOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
5,633
451
Male
Female
204
11
Male
Female
10
3
Male
Female
37
43
1
2
Male
Female
32
3
Male
Female
40
7
Male
Female
5
8
Male
Female
11
1
1
-
Male
Female
4
-
Male
Female
52
5
Male
Female
6,028
532
2
2
1. 96
- 276 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
2
16
6
112
8
334
16
669
19
925 1,064
53
61
907
54
578
54
415
40
273
49
178
33
110
34
51
22
5
-
14
-
23
-
29
1
40
1
40
1
19
-
18
1
8
3
4
3
1
-
3
1
3
-
2
-
1
2
1
-
2
-
1
1
1
2
4
1
2
1
1
5
2
4
4
3
3
8
5
5
5
3
4
4
2
3
2
-
1
-
1
-
4
-
5
1
5
-
7
1
4
-
2
-
3
-
1
-
1
-
5
-
3
-
4
2
6
-
5
-
4
1
5
2
5
1
2
1
1
-
1
1
1
2
1
-
1
1
1
1
1
-
3
-
2
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
5
-
8
-
4
1
11
-
6
-
4
2
2
-
4
2
5
-
1
-
2
4
20
7
121
10
354
18
707
24
979 1,127
60
70
977
66
619
59
451
48
291
58
196
43
124
36
58
26
- 277 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
C44.0
LIPExcludes Skin of Lip C44.0
ICD-O-3
80703 80713
80723 80743
80763
80513
MORPHOLOGY
GENDER
CASE
NUMBER
VERRUCOUS CARCINOMA
81403 84303
85503
80103
CARCINOMA, NOS
88003
80703 80713
C00
SARCOMA, NOS
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
189
13
Male
Female
14
3
Male
Female
4
1
Male
Female
2
1
Male
Female
1
-
Male
Female
210
18
1. 96
- 278 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
4
-
5
-
19
-
20
1
33
-
33
1
22
3
27
1
18
2
5
2
3
2
1
-
1
-
2
-
4
-
3
-
2
1
1
1
1
-
1
-
1
1
1
-
1
-
1
-
1
-
19
21
36
38
27
30
20
- 279 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
TONGUE
ICD-O-3
80323
80703
80723
80763
80523
80713
80743
80833
C01 - C02
80333
80453
80413
89823
80103
CARCINOMA, NOS
87453
MALIGNANT MELANOMA
91403
SPECIFIED SARCOMA
88003
SARCOMA, NOS
80003
Male
Female
1,506
208
Male
Female
48
2
Male
Female
1
1
Male
Female
1
4
Male
Female
4
2
Male
Female
9
2
Male
Female
Male
Female
2
-
Male
Female
1
-
Male
Female
11
2
Male
Female
1,583
222
GENDER
CARCINOMA, UNDIFFERENTIATED
84303
15
|
19
MORPHOLOGY
82003
85603
10
|
14
VERRUCOUS CARCINOMA
80203
5
|
9
80513
CASE
NUMBER
0
|
4
OTHER MALIGNANCY
TOTAL
1. 96
- 280 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
2
9
5
52
3
120
14
205
11
240
27
275
33
236
25
139
26
90
22
70
12
42
11
18
10
9
7
3
-
3
-
7
-
7
1
11
1
7
-
3
-
5
-
2
-
1
1
1
-
1
-
2
1
1
-
3
-
1
-
1
-
1
-
1
1
1
-
1
-
1
-
1
-
1
-
1
-
3
-
4
-
1
-
2
-
57
124
215
252
287
251
144
97
73
43
21
14
13
30
36
27
27
23
13
12
10
- 281 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
GUM
80703
80723
80753
Male
Female
11
2
Male
Female
1
-
Male
Female
3
1
Male
Female
5
-
Male
Female
2
3
Male
Female
2
-
Male
Female
1
1
Male
Female
384
61
Male
Female
82603
85603
80333
89823
MALIGNANT MELANOMA
SPECIFIED SARCOMA
80003
CASE
NUMBER
81403
85503
88903
359
54
GENDER
CARCINOMA, UNDIFFERENTIATED
88013
15
|
19
MORPHOLOGY
87203
10
|
14
VERRUCOUS CARCINOMA
80203
5
|
9
80513
0
|
4
ICD-O-3
80323
80713
80743
80763
C03
OTHER MALIGNANCY
TOTAL
1. 96
- 282 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
5
-
15
-
39
3
40
4
76
4
60
8
36
8
35
3
16
10
17
2
12
6
7
5
1
-
2
-
2
-
4
-
1
2
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
1
15
41
43
79
65
38
35
19
19
14
11
- 283 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
FLOOR OF MOUTH
ICD-O-3
80323
80703
80723
80523
80713
80763
Male
Female
147
8
Male
Female
1
-
Male
Female
Male
Female
2
4
Male
Female
1
-
Male
Female
151
13
GENDER
95403
15
|
19
MORPHOLOGY
84303
10
|
14
CARCINOMA, UNDIFFERENTIATED
82003
5
|
9
VERRUCOUS CARCINOMA
80203
CASE
NUMBER
0
|
4
80513
C04
SPECIFIED SARCOMA
TOTAL
1. 96
- 284 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
9
1
14
-
29
1
32
3
32
-
17
-
3
1
7
1
1
1
3
-
1
-
1
2
1
-
1
-
10
14
29
32
33
17
- 285 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80323
80703
80723
80743
80763
80523
80713
80733
80753
80833
MORPHOLOGY
GENDER
CASE
NUMBER
80513
VERRUCOUS CARCINOMA
81473
83103
84803
85503
80333 80823
82463
80103
81403
82003
84303
85253
5
|
9
10
|
14
15
|
19
1,930
100
Male
Female
129
4
Male
Female
22
33
1
2
Male
Female
9
0
11
2
3
4
4
1
1
-
Male
Female
MALIGNANT MELANOMA
0
|
4
Male
Female
Male
Female
CARCINOMA, NOS
87203
C05 - C06
88013 88113
88153 88513
91403
SPECIFIED SARCOMA
Male
Female
88003
Male
Female
1
0
Male
Female
16
0
Male
Female
2,125
144
2
2
SARCOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 286 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
6
-
43
3
129
1
244
2
340
8
357
9
285
9
200
10
142
10
74
20
50
9
44
12
16
7
2
-
9
-
15
-
19
-
25
-
25
1
12
-
11
-
5
2
3
1
1
-
2
-
1
2
3
1
1
1
1
3
1
3
3
3
2
6
3
4
3
2
1
2
1
2
1
-
3
-
2
-
1
-
1
-
1
-
1
-
1
-
1
-
3
-
2
-
1
-
1
1
1
-
1
1
1
-
1
2
1
-
1
-
1
-
1
-
1
-
4
-
4
-
2
-
2
-
2
-
2
-
45
141
264
370
392
318
218
160
83
56
46
20
11
14
16
14
12
24
13
13
- 287 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
OROPHARYNX
ICD-O-3
80323
80703
80723
80743
80833
80523
80713
80733
80753
80513
CARCINOMA, NOS
88903
SPECIFIED SARCOMA
88003
SARCOMA, NOS
80003
Male
Female
552
46
Male
Female
1
-
Male
Female
6
1
Male
Female
2
-
Male
Female
7
-
Male
Female
6
2
Male
Female
1
-
Male
Female
1
-
Male
Female
10
-
Male
Female
586
49
GENDER
80103
15
|
19
MORPHOLOGY
10
|
14
80303 80333
80453 80823
82463
5
|
9
CARCINOMA, UNDIFFERENTIATED
81403 85603
CASE
NUMBER
0
|
4
VERRUCOUS CARCINOMA
80203
C09 - C10
OTHER MALIGNANCY
TOTAL
1. 96
- 288 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
3
1
31
-
62
3
109
9
106
9
91
5
57
5
39
3
25
2
17
6
9
2
3
1
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
-
2
-
1
-
2
-
1
-
1
-
2
1
1
-
1
-
1
-
1
1
1
-
1
-
1
-
1
-
1
-
2
-
2
-
1
-
1
-
1
-
33
65
111
112
96
63
43
26
20
11
10
- 289 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
HYPOPHARYNX
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
886
19
Male
Female
2
-
Male
Female
3
-
Male
Female
6
-
Male
Female
10
-
Male
Female
1
-
Male
Female
13
2
Male
Female
921
21
ICD-O-3
80323
80703
80723
80763
80523
80713
80743
80833
80203
CARCINOMA, UNDIFFERENTIATED
81403 81473
84303
80333 80453
80823 82463
85743
80103 80463
CARCINOMA, NOS
88503
SPECIFIED SARCOMA
80003
C12 - C13
OTHER MALIGNANCY
TOTAL
1. 96
- 290 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
5
1
24
-
84
-
139
2
164
3
159
5
100
2
73
-
60
2
41
1
21
2
16
1
1
-
1
-
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
2
-
3
-
3
-
2
-
2
-
1
-
5
1
24
-
87
-
144
2
168
3
165
5
104
2
76
2
60
2
45
1
25
2
18
1
- 291 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
C14
5
|
9
10
|
14
15
|
19
ICD-O-3
80523 80703
80713 80723
80743 80763
80833
80333 80823
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
Male
Female
64
3
Male
Female
1
1
Male
Female
2
-
Male
Female
1
-
Male
Female
68
4
80103
CARCINOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 292 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
2
-
8
1
21
-
11
1
7
-
6
-
3
-
5
1
1
-
2
-
1
-
1
-
2
-
9
1
21
-
11
1
8
-
6
-
3
-
7
1
- 293 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
84303
81403 82553
84403 84803
82003
ADENOCARCINOMA
80203
Male
Female
21
19
2
1
Male
Female
12
1
Male
Female
21
4
Male
Female
23
32
Male
Female
11
21
Male
Female
8
8
Male
Female
12
4
Male
Female
2
-
Male
Female
17
13
Male
Female
2
1
Male
Female
2
2
Male
Female
131
105
2
2
GENDER
CARCINOMA, NOS
89403 89413
15
|
19
MORPHOLOGY
80103
10
|
14
85503
5
|
9
MUCOEPIDERMOID CARCINOMA
CASE
NUMBER
0
|
4
80703 80713
80753
C07 - C08
CARCINOMA, UNDIFFERENTIATED
80413 80823
82903 85003
85623 89823
88303 88513
89803
80003
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
1. 96
- 294 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
2
2
2
3
2
1
1
2
2
1
1
-
1
1
3
1
2
-
2
2
1
-
2
-
1
-
2
-
2
-
1
-
1
1
2
-
2
1
4
-
4
2
2
-
1
-
1
-
5
-
2
-
1
-
1
2
3
6
3
3
6
1
4
2
1
6
1
2
1
3
1
1
1
2
2
-
1
1
1
-
1
4
1
3
2
5
1
1
1
-
1
-
2
1
1
-
2
2
1
1
1
1
1
-
1
2
2
1
3
-
1
-
2
-
2
1
1
-
1
-
1
-
1
-
1
3
4
1
3
2
2
-
3
1
1
-
1
3
1
1
1
-
1
-
1
-
1
-
1
4
4
2
4
6
11
15
14
12
14
10
20
7
19
8
8
11
10
4
4
10
11
5
8
6
1
3
- 295 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
NASOPHARYNX
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
19
11
Male
KERATINIZING SQUAMOUS CELL CARCINOMA Female
34
8
Male
Female
788
223
3
2
Male
Female
289
117
7
-
Male
Female
4
1
Male
Female
17
2
Male
Female
30
12
Male
Female
1
-
Male
Female
12
3
Male
Female
1,194
377
10
2
MORPHOLOGY
GENDER
ICD-O-3
80703
C11
80713
80723 80843
80203 80413
80823
81403 82603
84303 85503
80303
80503
80733
82463
89823
80463
80523
81203
85743
80103
CARCINOMA, UNDIFFERENTIATED
CARCINOMA, NOS
88063
SPECIFIED SARCOMA
80003 87203
OTHER MALIGNANCY
TOTAL
1. 96
- 296 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
4
3
1
1
5
1
4
-
1
2
1
-
2
1
4
-
1
-
8
-
3
2
6
1
6
1
4
1
1
-
1
1
7
3
19
7
61
15
73
18
101
29
120
30
128
30
102
35
64
13
42
11
27
9
24
13
9
5
8
2
1
1
4
4
19
10
15
6
44
11
37
20
57
25
48
14
20
11
14
3
13
7
10
2
1
-
2
-
1
-
1
-
2
-
1
-
4
1
4
-
2
1
2
-
1
-
2
1
2
2
5
-
4
1
2
-
4
1
4
2
1
1
3
3
2
-
1
-
1
-
1
1
1
1
3
-
1
-
2
-
1
-
1
1
2
-
8
4
24
12
87
27
97
29
161
41
171
56
205
58
167
51
96
31
63
15
47
21
38
17
10
9
10
3
- 297 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ESOPHAGUS
C15
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
1,913
119
76
16
5
-
Male
Female
31
5
Male
Female
26
3
Male
Female
4
-
Male
Female
2
-
Male
Female
1
1
Male
Female
33
3
Male
Female
2,091
147
MORPHOLOGY
GENDER
ICD-O-3
80523 80703
80713 80723
80743 80763
81403 81453
82603 84803
84903
ADENOCARCINOMA
Male
Female
84303 85603
Male
Female
ADENOSQUAMOUS CARCINOMA
80203
80333
80453
80833
80323
80413
80463
82463
80103
CARCINOMA, NOS
88023 88903
89363
88003
SPECIFIED SARCOMA
SARCOMA, NOS
87203
MALIGNANT MELANOMA
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 298 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
1
-
7
1
52
1
181
6
299
4
362
12
333
12
223
12
152
19
107
7
86
18
67
16
42
11
1
-
1
-
2
-
3
-
7
1
8
-
8
1
4
1
6
1
9
4
6
2
10
4
11
2
1
-
2
-
1
-
1
-
3
-
1
-
8
-
8
1
4
-
3
-
2
-
1
-
1
3
2
-
5
-
4
-
2
-
3
-
3
-
2
-
3
2
2
-
1
-
1
-
2
-
1
-
1
-
1
-
4
-
2
1
5
-
4
-
4
1
4
-
3
-
5
-
2
1
1
-
2
-
8
1
54
1
192
7
316
5
385
13
361
14
239
13
165
22
126
11
98
21
86
22
58
17
- 299 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
STOMACH
ICD-O-3
81403
81423
81453
82113
82603
84803
81413
81443
82103
82553
82633
84903
85603 85703
80103
LEIOMYOSARCOMA
89363
Male
Female
2,140
1,226
Male
Female
5
2
Male
Female
32
3
Male
Female
47
16
Male
Female
31
17
Male
Female
2
2
Male
Female
127
151
1
-
Male
Female
2
1
Male
Female
29
21
Male
Female
2,415
1,439
1
-
GENDER
CARCINOMA, NOS
88903
15
|
19
MORPHOLOGY
ADENOSQUAMOUS CARCINOMA
80333
80453
82143
82443
85103
85763
10
|
14
80203
80413
80463
82403
82463
85743
5
|
9
ADENOCARCINOMA
CASE
NUMBER
0
|
4
80133 80703
80713 80723
80823
C16
88023 91203
91403
80003 87203
OTHER MALIGNANCY
TOTAL
1. 96
- 300 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
4
7
8
14
35
33
53
48
86
80
172
97
219
104
196
109
193
122
254
148
331
156
352
164
237
142
1
-
1
-
1
-
1
-
1
1
2
-
7
-
5
-
3
-
4
1
2
1
3
1
4
-
2
-
1
-
4
3
4
1
2
2
2
2
6
1
6
1
12
1
8
3
2
1
1
1
3
-
1
2
2
2
2
-
4
-
1
-
5
5
5
3
7
4
1
-
1
-
1
-
3
6
1
-
4
4
9
10
15
11
15
29
13
16
15
14
15
24
15
22
15
10
5
5
1
-
1
-
2
1
2
-
3
3
3
1
4
1
5
2
6
3
4
8
5
7
11
21
36
33
60
54
104
95
202
112
246
137
219
130
227
139
283
176
372
188
391
184
258
160
- 301 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
SMALL INTESTINE
ICD-O-3
81403 82613
84803 84903
85603
82403
80103
Male
Female
77
44
Male
Female
5
6
Male
Female
7
6
Male
Female
8
1
Male
Female
Male
Female
83
71
Male
Female
3
2
Male
Female
1
1
Male
Female
6
3
Male
Female
190
135
GENDER
88013 88063
88583 91203
88003
SARCOMA, NOS
80003 80043
15
|
19
MORPHOLOGY
LEIOMYOSARCOMA
89363
10
|
14
CARCINOMA, NOS
88903
5
|
9
CARCINOID TUMOR
CASE
NUMBER
0
|
4
ADENOCARCINOMA
80203 80333
80413 80703
82463 85003
C17
OTHER MALIGNANCY
TOTAL
1. 96
- 302 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
3
-
1
-
4
-
6
2
5
4
10
5
11
8
11
8
11
5
9
5
5
5
1
-
1
2
1
-
1
-
1
1
1
-
2
-
2
1
2
-
1
-
2
-
1
-
2
-
1
1
1
-
1
-
1
1
3
1
2
1
3
5
10
5
13
4
12
5
10
8
6
14
9
12
4
4
6
5
3
6
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
1
3
1
-
2
3
3
2
6
1
5
6
17
7
21
10
19
11
23
15
21
24
24
21
20
10
19
11
9
14
- 303 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
C18 - C21
ICD-O-3
81403
82113
82213
82603
82623
84703
84813
82103
82203
82553
82613
82633
84803
84903
MORPHOLOGY
GENDER
CASE
NUMBER
ADENOCARCINOMA
82403 82433
82453 82493
80123
80143
80333
80513
80713
80833
81233
82443
85103
85743
80133
80203
80413
80703
80723
81203
81243
82463
85603
CARCINOID TUMOR
80103 80213
80463
88523 89363
CARCINOMA, NOS
SPECIFIED SARCOMA
88003
SARCOMA, NOS
87203
MALIGNANT MELANOMA
80003
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
7,732
5,571
2
-
Male
Female
78
59
Male
Female
56
64
Male
Female
73
42
Male
Female
20
17
Male
Female
2
0
Male
Female
1
6
Male
Female
181
138
Male
Female
8,143
5,897
2
4
1. 96
- 304 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
65
|
69
70
|
74
75
|
79
80
|
84
85+
7
2
30
19
70
68
125
99
209
157
381
325
936
689
899
666
762
514
458
432
3
-
8
2
7
5
4
5
16
8
6
12
7
5
9
5
8
5
5
1
3
-
1
3
1
1
1
-
1
-
2
1
1
3
4
3
9
9
7
7
6
6
3
5
3
8
7
9
7
9
5
4
2
-
2
-
6
-
7
2
7
2
10
2
8
5
5
6
1
6
9
4
16
15
2
-
3
2
2
2
3
2
3
1
4
2
2
2
1
1
1
-
1
-
1
-
1
-
1
2
1
4
3
4
4
3
11
3
12
10
20
8
18
6
19
12
23
15
37
21
31
50
10
3
32
24
82
72
135
109
221
169
414
341
969
717
933
699
818
554
514
503
- 305 -
60
|
64
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
COLON
ICD-O-3
81403
82113
82213
82613
82633
84803
84903
82103
82203
82553
82623
84703
84813
80133
80203
80413
81233
82463
85603
80103
Male
Female
4,634
3,583
2
-
Male
Female
12
12
Male
Female
21
14
Male
Female
51
31
Male
Female
8
3
Male
Female
1
-
Male
Female
144
121
Male
Female
4,871
3,764
2
3
GENDER
CARCINOID TUMOR
SARCOMA, NOS
80003
15
|
19
MORPHOLOGY
SPECIFIED SARCOMA
88003
10
|
14
CARCINOMA, NOS
88523 89363
5
|
9
ADENOCARCINOMA
CASE
NUMBER
0
|
4
82403 82433
82453
80143
80333
80703
82443
85103
85743
C18
OTHER MALIGNANCY
TOTAL
1. 96
- 306 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
4
1
21
13
48
51
73
65
126
103
204
201
423
345
600
430
599
400
640
472
546
442
542
440
504
329
302
291
1
-
2
-
1
2
1
-
2
-
1
-
2
1
1
-
1
2
1
-
1
-
3
1
6
-
2
-
3
1
2
5
3
2
1
-
5
-
6
1
6
-
5
1
6
4
3
5
8
4
11
11
2
-
1
-
1
-
2
-
1
1
1
-
1
-
1
2
1
4
3
4
4
2
9
2
10
9
15
8
12
6
17
10
16
14
29
19
27
41
4
1
21
16
52
53
74
70
129
108
218
203
443
351
624
439
625
409
662
483
569
461
561
464
546
357
341
346
- 307 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81403
82113
82213
82603
82623
84803
84903
82103
82203
82553
82613
82633
84813
80123
80333
80513
80713
80833
81233
82443
85103
85743
80203
80413
80703
80723
81203
81243
82463
85603
89363
CARCINOMA, NOS
SARCOMA, NOS
87203
MALIGNANT MELANOMA
80003
Male
Female
3,098
1,988
Male
Female
66
47
Male
Female
35
50
Male
Female
22
11
Male
Female
12
14
Male
Female
1
-
Male
Female
1
6
Male
Female
37
17
Male
Female
3,272
2,133
GENDER
SPECIFIED SARCOMA
88003
15
|
19
MORPHOLOGY
10
|
14
CARCINOID TUMOR
80103 80213
80463
5
|
9
ADENOCARCINOMA
CASE
NUMBER
0
|
4
82403 82453
82493
C19 - C21
OTHER MALIGNANCY
TOTAL
1. 96
- 308 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
3
1
9
6
22
17
52
34
83
54
177
124
295
205
436
259
407
235
453
254
390
247
357
226
258
185
156
141
3
-
7
2
7
4
4
5
14
8
5
10
6
5
7
5
7
5
3
-
2
-
1
-
1
-
2
1
1
2
3
3
6
8
1
7
4
6
3
6
5
4
4
7
5
2
1
-
2
-
1
-
1
1
1
2
5
1
2
1
2
1
1
1
1
-
5
4
2
-
1
2
1
2
2
2
1
1
4
2
1
1
1
-
1
-
1
-
2
1
2
1
5
-
6
-
2
2
7
1
8
2
4
9
6
2
11
8
30
19
61
39
92
61
196
138
310
228
448
278
429
248
472
266
400
256
372
235
272
197
173
157
- 309 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
C22
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
7,121
2,821
1
-
1
-
Male
Female
471
381
Male
Female
53
14
Male
Female
24
19
Male
Female
12
5
8
5
1
-
1
-
Male
Female
16
7
Male
Female
13
1
Male
Female
13
6
Male
Female
5
3
1
-
Male
Female
1
2
Male
Female
22
13
Male
Female
7,751
3,272
8
5
2
-
2
2
1
-
MORPHOLOGY
GENDER
81703 81713
81723 81733
81743 81753
81603 81623
84813
81803
HEPATOCELLULAR CARCINOMA
CHOLANGIOCARCINOMA
81403 81613
81903 84803
89703
ADENOCARCINOMA
HEPATOBLASTOMA
80323
80413
80713
84533
85743
80333
80463
82463
85603
89803
80103 80203
CARCINOMA, NOS
91203
ANGIOSARCOMA
88013 88033
88903 89333
89913 91333
88003
SARCOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 310 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
8
3
31
6
80
16
178
30
354
33
617
66
811 1,084
143
274
894
320
866
429
847
534
684
464
440
314
225
187
1
-
2
-
4
3
17
8
39
13
36
23
62
36
52
42
61
62
52
58
66
65
47
44
32
25
3
-
4
1
2
-
12
3
8
1
9
1
5
1
3
2
4
3
3
2
1
-
1
-
3
-
3
1
3
1
5
4
2
5
1
3
4
3
1
-
1
-
1
-
3
-
3
1
3
-
1
3
4
1
2
2
1
-
1
1
6
-
1
-
1
-
3
-
1
-
2
-
1
-
3
-
2
3
3
3
1
-
1
-
1
1
1
-
1
-
1
-
2
-
3
1
3
2
1
-
2
4
4
1
5
1
2
4
9
3
32
8
83
16
185
33
376
43
668
79
865 1,172
172
316
970
370
936
500
914
605
769
541
500
361
259
218
- 311 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81403
81623
82603
82633
84903
81603
82103
82613
84803
85743
80203
80413
80503
81443
82403
84533
85763
80103
15
|
19
Male
Female
397
372
Male
Female
11
6
Male
Female
25
18
Male
Female
16
13
Male
Female
Male
Female
37
28
Male
Female
486
438
MORPHOLOGY
GENDER
ADENOCARCINOMA
SPECIFIED SARCOMA
80003 80013
10
|
14
CARCINOMA, NOS
89803
5
|
9
ADENOSQUAMOUS CARCINOMA
80133
80303
80453
80703
81563
82463
85003
CASE
NUMBER
0
|
4
85603
C23 - C24
OTHER MALIGNANCY
TOTAL
1. 96
- 312 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
2
5
3
4
8
25
5
16
25
56
34
39
34
45
47
52
69
62
73
58
40
34
32
1
-
2
1
2
1
1
1
3
1
2
1
1
-
2
-
4
3
4
1
4
-
2
2
5
6
1
1
2
-
2
-
2
-
1
-
1
1
2
1
1
-
3
1
3
3
1
4
1
1
3
-
2
2
1
1
4
4
9
9
7
5
10
6
1
2
7
3
8
8
32
10
23
27
60
40
47
38
51
51
65
81
75
87
70
48
47
43
- 313 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
PANCREAS
ICD-O-3
81403
82113
84403
84533
84803
85003
81443
82603
84413
84703
84903
85033
80213
80413
80703
81543
82463
85603
80103 80203
ADENOCARCINOMA
SARCOMA, NOS
80003
Male
Female
566
418
Male
Female
3
4
Male
Female
1
5
Male
Female
47
36
Male
Female
90
53
Male
Female
2
2
Male
Female
2
1
Male
Female
226
187
Male
Female
937
706
GENDER
SPECIFIED SARCOMA
88003 88053
15
|
19
MORPHOLOGY
CARCINOMA, NOS
88013 89363
10
|
14
80133
80333
80463
81413
82403
84523
85743
5
|
9
81503 81513
CASE
NUMBER
0
|
4
85503
C25
TOTAL
1. 96
- 314 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
3
5
7
16
13
38
19
63
37
71
42
75
56
69
44
80
70
68
66
50
42
30
19
1
-
1
2
1
-
1
-
1
3
1
2
1
2
5
3
2
2
4
2
9
4
7
6
6
3
1
2
6
3
2
1
2
-
2
-
5
-
1
-
6
3
3
5
10
4
13
2
8
6
10
7
14
9
11
6
7
11
2
-
1
-
1
-
4
2
8
2
17
1
14
5
11
6
25
20
26
25
29
42
47
38
45
46
1
3
4
5
11
10
26
18
54
27
87
46
104
58
108
70
108
74
118
106
118
121
111
88
87
76
- 315 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
88503 88513
88523 88543
88553 88583
88903
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
29
20
Male
Female
4
15
Male
Female
5
2
Male
Female
2
4
1
-
Male
Female
18
3
2
-
2
-
4
1
Male
Female
7
12
Male
Female
5
10
Male
Female
2
6
Male
Female
8
5
Male
Female
80
77
1
1
2
1
2
1
4
2
MORPHOLOGY
GENDER
LIPOSARCOMA
LEIOMYOSARCOMA
88113 88303
C48
MALIGNANT FIBROHISTIOCYTOMA
80413 86803
93643 95003
95403
90643 90803
90853
PERIPHERAL PRIMITIVE
NEUROECTODERMAL TUMOR
90503 90513
MALIGNANT MESOTHELIOMA
88013
88603
89013
89303
92603
88023
89003
89103
89803
93703
88003
SPECIFIED SARCOMA
SARCOMA, NOS
80003 80333
OTHER MALIGNANCY
TOTAL
1. 96
- 316 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
2
4
4
4
2
4
3
5
1
5
4
2
3
1
1
2
-
1
-
1
-
1
2
2
1
2
-
1
-
1
-
1
-
1
-
3
1
3
-
2
-
1
-
1
-
2
2
1
1
1
-
1
2
1
2
1
1
1
1
2
3
1
2
1
1
1
1
1
-
1
-
1
1
1
-
1
1
1
-
2
2
1
-
11
12
12
- 317 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
C26
ICD-O-3
81403 81443
82603 84603
84803
80333 85003
MORPHOLOGY
GENDER
CASE
NUMBER
ADENOCARCINOMA
80103
CARCINOMA, NOS
89363
SPECIFIED SARCOMA
80003
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
1
17
Male
Female
1
1
Male
Female
3
2
Male
Female
12
12
Male
Female
2
-
Male
Female
19
32
1. 96
- 318 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
1
-
1
-
1
-
1
-
1
-
1
2
1
1
3
3
2
-
1
3
1
-
1
1
1
-
1
-
1
-
2
1
1
3
2
2
4
8
2
5
2
5
2
1
1
3
3
-
- 319 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80523 80703
80713 80723
80833
81403 81473
82003 82603
80413
MORPHOLOGY
GENDER
CASE
NUMBER
ADENOCARCINOMA
84303 85623
80323
80823
82463
85743
90813
80333
81213
85603
89803
80103 80203
CARCINOMA, NOS
87203
MALIGNANT MELANOMA
88013
88113
88903
89203
91503
88103
88303
89003
91203
95003
80003 93713
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
C30 - C31
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
69
20
Male
Female
8
7
Male
Female
3
1
Male
Female
3
3
Male
Female
11
8
Male
Female
13
6
Male
Female
3
3
Male
Female
7
4
Male
Female
2
1
Male
Female
119
53
1. 96
- 320 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
3
1
3
2
7
2
8
1
14
1
6
3
7
-
9
2
7
2
4
-
1
2
1
2
1
-
3
-
2
1
1
-
1
-
2
-
1
-
1
-
1
-
1
-
2
1
3
-
2
2
2
1
1
1
1
-
1
-
1
-
1
-
4
1
1
-
3
1
1
-
1
1
1
-
1
-
2
-
1
-
1
1
1
-
1
-
1
-
1
-
1
-
1
2
3
2
6
1
7
5
11
7
16
6
17
6
12
3
12
7
16
4
7
3
8
1
3
4
- 321 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
LARYNX
ICD-O-3
80513 80523
80703 80713
80723 80763
80413
MORPHOLOGY
GENDER
CASE
NUMBER
80323 80333
80833 82003
84303 85743
80103 82463
CARCINOMA, NOS
88013
SPECIFIED SARCOMA
80003 87203
C32
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
580
28
Male
Female
3
-
Male
Female
5
2
Male
Female
6
1
Male
Female
Male
Female
8
1
Male
Female
602
33
1. 96
- 322 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
3
-
5
1
20
1
49
1
76
3
97
4
75
3
70
4
57
5
58
-
37
4
32
2
1
-
1
-
1
-
2
1
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
-
2
-
1
-
2
-
1
-
4
-
7
1
20
2
50
2
79
4
100
4
77
3
72
4
59
5
61
1
38
4
34
3
- 323 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
1,660
234
Male
Female
2,954
2,933
1
-
Male
Female
49
41
43
21
784
91
64
20
Male
Female
45
46
Male
Female
15
26
Male
Female
472
211
Male
Female
182
81
MORPHOLOGY
GENDER
ICD-O-3
80523
80713
80733
80823
80843
80703
80723
80743
80833
81403
82113
82513
82603
84803
84903
81413
82503
82553
83103
84813
ADENOCARCINOMA
85603
C33 - C34
ADENOSQUAMOUS CARCINOMA
80123 80143
80203 80213
80313
Male
Female
80413 80443
80453
Male
Female
80133 82403
82463 82493
80223 82003
84303 85503
82523 82533
82543
80323
80463
81233
85743
88063
80333
80503
83333
85763
80103 82303
Male
Female
NEUROENDOCRINE CARCINOMA
BRONCHIOLO-ALVEOLAR CARCINOMA
CARCINOMA, NOS
- 324 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
5
2
4
2
15
7
56
11
58
15
146
26
168
30
191
36
262
30
342
37
279
21
134
17
2
-
5
4
21
17
41
37
83
112
148
196
260
274
316
381
313
349
366
348
383
396
411
357
393
278
211
184
2
2
2
2
1
6
6
5
7
5
3
6
7
7
13
4
5
2
3
1
1
-
3
1
2
1
3
5
4
3
5
1
6
1
6
3
6
-
5
4
2
2
5
1
11
3
19
4
50
4
72
6
90
9
114
7
131
19
142
16
105
14
45
7
1
-
1
1
4
-
3
1
9
4
6
2
8
5
8
3
9
2
8
1
4
1
3
-
1
3
1
-
2
3
2
4
5
9
4
4
11
3
6
6
8
6
4
1
1
2
1
-
1
1
2
1
2
3
1
6
2
5
3
3
2
3
1
1
1
1
1
-
7
5
16
9
17
17
50
22
46
15
62
24
68
27
89
35
74
27
41
29
1
-
2
1
6
4
12
4
13
6
7
4
16
10
25
7
41
12
29
16
30
14
- 325 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
MORPHOLOGY
GENDER
CASE
NUMBER
88153 88933
89803 91203
88003
SPECIFIED SARCOMA
SARCOMA, NOS
80003 80013
91333
C33 - C34CONTINUED
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
6
2
Male
Female
8
3
Male
Female
415
209
Male
Female
6,697
3,918
1
1
1. 96
- 326 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
1
1
1
-
1
-
1
-
1
-
1
2
1
-
1
-
3
-
1
-
1
-
2
-
2
3
6
2
6
6
15
11
17
6
30
13
54
18
92
28
95
39
96
82
4
1
6
5
31
25
55
44
130
140
262
234
421
344
635
477
669
433
811
455
954 1,156
516
499
995
405
567
338
- 327 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
PLEURA
ICD-O-3
C38.4
MORPHOLOGY
GENDER
CASE
NUMBER
90503 90513
90523 90533
80003 91203
91333
MALIGNANT MESOTHELIOMA
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
38
16
Male
Female
5
3
Male
Female
43
19
1. 96
- 328 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
1
-
1
-
4
-
4
1
5
2
3
2
5
4
9
2
3
1
2
2
1
-
2
-
2
-
1
1
1
-
1
-
5
-
4
1
7
2
3
4
5
4
9
3
5
1
2
2
- 329 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80703
85803
85823
85843
85863
80723
85813
85833
85853
MORPHOLOGY
GENDER
CASE
NUMBER
80123
80333
80823
82403
82493
85603
85893
80103
5
|
9
10
|
14
15
|
19
Male
Female
95
84
Male
Female
21
1
1
-
1
-
3
-
Male
Female
22
9
Male
Female
7
3
Male
Female
4
4
1
1
Male
Female
9
1
1
-
Male
Female
2
1
Male
Female
8
5
1
-
Male
Female
168
108
1
1
1
-
2
-
4
2
TERATOMA
CARCINOMA, NOS
80133 94903
95003 95403
88013 88513
88553 91203
93643
88003
NEUROGENIC MALIGNANCIES
SPECIFIED SARCOMA
SARCOMA, NOS
80003 90513
0
|
4
CARCINOMA
90613 90643
90703 90713
90853 91003
80203
80413
81403
82463
82603
85743
90813
C37 - C38.3C38.8
OTHER MALIGNANCY
TOTAL
1. 96
- 330 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
3
4
3
3
1
1
15
9
6
9
15
10
13
14
10
9
7
8
7
10
7
4
6
2
1
-
4
-
1
-
8
1
1
-
1
-
1
-
1
-
1
-
2
-
1
2
2
-
3
-
3
1
5
-
1
1
2
-
1
-
2
-
1
-
1
-
1
-
2
-
1
1
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
-
1
1
3
-
1
2
2
-
6
-
5
4
14
4
2
5
17
11
9
12
20
12
15
17
16
10
12
9
14
11
13
5
11
4
6
1
- 331 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
MORPHOLOGY
GENDER
CASE
NUMBER
91803 91813
91823 91863
91923
92203 92313
92403 92433
92503
OSTEOSARCOMA
CHONDROSARCOMA
Ewing
92603
EWING SARCOMA
93703
CHORDOMA
92703
MALIGNANT AMELOBLASTOMA
88013
88303
88903
90403
91333
88103
88503
89103
91203
95403
88003 88053
SARCOMA, NOS
80003 80203
C40 - C41
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
37
38
1
-
1
2
7
9
10
7
Male
Female
19
12
1
1
Male
Female
1
2
1
-
Male
Female
12
7
1
-
3
1
2
-
Male
Female
5
1
Male
Female
Male
Female
8
6
1
-
Male
Female
3
4
1
-
Male
Female
4
3
Male
Female
89
74
3
-
1
3
12
11
13
9
1. 96
- 332 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
5
3
1
1
2
-
1
2
2
2
1
2
3
2
1
2
1
1
1
-
1
-
3
-
1
4
1
2
3
1
3
-
1
1
2
-
1
-
2
1
2
1
1
1
1
-
1
-
1
-
1
-
2
-
1
-
1
-
1
1
1
-
2
1
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
7
4
4
6
7
2
3
9
5
5
6
3
5
3
6
4
6
4
2
2
3
2
5
2
1
1
- 333 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
88103 88113
88303 88323
MORPHOLOGY
GENDER
CASE
NUMBER
C47C49
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
50
38
1
1
Male
Female
84
46
1
2
2
-
Male
Female
17
18
Male
Female
9
12
4
4
Male
Female
20
19
2
-
FIBROSARCOMA
88503 88513
88523 88543
88553 88583
88903 88963
LIPOSARCOMA
LEIOMYOSARCOMA
89003 89013
89023 89103
89203 95813
91203 91333
91403 91503
90403 90413
90423 90433
SYNOVIAL SARCOMA
Male
Female
11
15
1
-
1
3
94903 95403
( Schwann )
Male
Female
12
8
Male
Female
9
4
1
1
1
1
Male
Female
37
49
1
-
RHABDOMYOSARCOMA
ANGIOSARCOMA
93643 95003
95613
80043
88023
88043
88953
90443
92313
92433
88013
88033
88153
89823
91803
92403
92523
- 334 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
-
3
4
3
-
7
5
8
5
4
4
3
4
5
6
6
-
6
3
2
3
1
1
1
2
4
5
3
2
3
6
14
9
8
2
14
-
8
4
3
2
3
7
8
4
8
-
3
-
1
-
1
-
2
-
1
-
1
2
5
5
2
3
1
2
1
4
1
1
1
-
1
-
1
-
1
-
2
-
2
1
2
1
2
3
4
4
3
1
3
3
2
1
2
1
1
1
1
1
2
-
1
-
2
-
2
-
1
-
2
-
1
-
2
2
2
1
2
1
1
-
1
-
2
-
1
1
1
-
1
-
2
-
1
-
1
1
1
4
1
7
7
2
2
7
7
4
3
4
5
4
4
5
1
7
1
1
- 335 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
MORPHOLOGY
88003
SARCOMA, NOS
85623
SPECIFIED CARCINOMA
80003 90643
OTHER MALIGNANCY
TOTAL
C47C49CONTINUED
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
22
18
1
-
1
-
Male
Female
1
-
Male
Female
4
5
Male
Female
276
232
4
2
1
7
12
9
1. 96
- 336 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
3
1
3
1
1
3
2
3
2
-
3
1
3
3
3
3
1
-
1
-
1
1
2
-
10
3
6
8
11
14
10
11
15
19
35
21
25
21
34
21
21
18
12
13
22
28
26
16
20
10
12
10
- 337 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
SKIN
ICD-O-3
80903 80913
80923 80943
80973 80983
82003
80513
80713
80743
80823
80703
80723
80763
80933
81023
81403
83903
84013
84063
84093
84133
85003
89403
81103
83103
84003
84023
84073
84103
84803
85423
87203
87303
87423
87443
87713
87213
87403
87433
87453
87723
80303
80413
80753
81473
82463
82553
84903
85743
80323
80523
80833
82113
82473
84303
85603
80103
C44
MORPHOLOGY
GENDER
CASE
NUMBER
MALIGNANT MELANOMA
CARCINOMA, NOS
- 338 -
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
674
740
Male
Female
504
391
Male
Female
77
51
1
-
Male
Female
125
87
1
-
1
-
Male
Female
23
25
Male
Female
10
3
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
2
2
4
6
11
8
17
13
21
32
38
45
45
62
61
64
82
71
107
126
110
123
107
106
68
81
8
3
5
3
8
2
17
6
17
10
28
16
27
19
31
18
55
39
102
67
106
72
100
135
1
-
3
1
4
5
2
2
5
4
6
-
9
6
6
5
5
9
14
3
14
8
7
7
1
-
2
3
2
2
6
2
5
5
4
5
9
9
11
13
14
2
15
7
10
14
21
11
11
8
12
6
1
-
1
2
2
-
1
1
2
-
2
2
3
1
4
5
4
8
3
3
1
-
2
-
1
-
2
1
1
-
1
1
2
-
- 339 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
SKIN
ICD-O-3
80803
88113
88323
88503
88903
89353
91403
88043
88303
88333
88553
89013
91203
91703
88003
C44CONTINUED
MORPHOLOGY
GENDER
CASE
NUMBER
SPECIFIED SARCOMA
SARCOMA, NOS
80003 81033
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
154
104
1
2
2
3
Male
Female
1
-
Male
Female
7
2
Male
Female
1,575
1,403
1
1
2
3
3
3
1. 96
- 340 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
7
3
12
15
14
5
9
6
15
11
10
10
8
9
11
11
8
4
15
3
15
7
7
3
17
7
3
4
1
-
1
-
1
-
1
-
2
1
2
1
10
4
16
21
29
16
34
21
51
38
55
57
81
77
102
103
122
95
153
107
196
197
261
212
262
211
197
237
- 341 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
FEMALE BREAST
ICD-O-3
80223
81403
84013
85013
85043
85223
85413
85733
80713
82113
85003
85033
85213
85233
85433
85753
84803 84813
C50
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
8,625
Female
242
Female
47
Female
364
Female
54
Female
16
Female
179
Female
64
MORPHOLOGY
GENDER
MUCINOUS ADENOCARCINOMA
85103 85123
85133
85203
MEDULLARY CARCINOMA
90203
Paget
85403
80113
80323
80413
80703
82013
82463
82603
83143
84903
85073
85303
85603
85723
80103
80213
80333
80503
82003
82303
82553
83103
83153
85023
85243
85503
85703
85743
CARCINOMA, NOS
- 342 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
80
257
804
610
423
241
131
99
24
43
39
26
28
12
16
17
13
14
46
77
63
64
38
30
11
11
12
10
16
26
24
26
18
25
18
10
- 343 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
FEMALE BREAST
ICD-O-3
88023
88303
89353
89823
91803
80003
88153
88523
89803
91203
95403
C50CONTINUED
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
18
Female
46
Female
9,655
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
1. 96
- 344 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
14
91
281
890
701
479
282
159
116
- 345 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
MALE BREAST
ICD-O-3
81403 85003
85233 85413
80503 84013
85033
80103
C50
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
32
Male
Male
Male
Male
39
CARCINOMA, NOS
88513
SPECIFIED SARCOMA
TOTAL
1. 96
- 346 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
- 347 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
UTERUS, NOS
ICD-O-3
83233
C55
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
Female
Female
Female
Female
Female
ADENOCARCINOMA
88113 88963
89803
80103
CARCINOMA, NOS
85603
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 348 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
- 349 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
CERVIX UTERI
ICD-O-3
80513
80703
80723
80763
80523
80713
80743
80823
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
1,254
Female
50
Female
275
Female
Female
41
Female
40
Female
12
Female
1,680
MORPHOLOGY
GENDER
85603
C53
ADENOSQUAMOUS CARCINOMA
81403
82603
82633
83803
84413
84823
81443
82623
83233
83843
84803
85703
ADENOCARCINOMA
83103
80133
80203
80413
80463
80983
85743
80153
80333
80453
80833
82463
80103
CARCINOMA, NOS
80003
80043
OTHER MALIGNANCY
TOTAL
1. 96
- 350 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
10
39
59
94
156
163
167
118
120
95
89
83
58
16
22
42
32
54
41
20
15
13
11
13
61
92
149
211
236
228
148
144
116
103
110
66
- 351 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
CORPUS UTERI
ICD-O-3
80503 81403
82603 82623
83803 83823
85603 85703
C54
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
1,313
Female
34
Female
Female
163
Female
Female
58
Female
47
Female
95
Female
Female
Female
Female
1,737
MORPHOLOGY
GENDER
ADENOCARCINOMA
ADENOSQUAMOUS CARCINOMA
91003 91053
CHORIOCARCINOMA
80203
80333
80703
80723
82553
83203
84413
84803
80303
80413
80713
82463
83103
83233
84603
84903
80103
CARCINOMA, NOS
88903 88913
88963
89303 89313
LEIOMYOSARCOMA
89333 89503
89513 89803
Muller
88013 89633
88003 88053
SARCOMA, NOS
80003 89813
OTHER MALIGNANCY
TOTAL
1. 96
- 352 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
17
48
48
107
198
294
261
142
91
55
34
11
14
33
40
18
23
10
23
15
11
10
14
22
20
23
55
65
140
269
381
338
180
127
73
50
21
12
- 353 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
C56C57.0 - C57.4
MORPHOLOGY
GENDER
CASE
NUMBER
84703 84713
84723 84803
84823 90153
84413 84423
84603 84613
83803 83813
0
|
4
5
|
9
10
|
14
15
|
19
Female
159
Female
377
Female
159
Female
169
Female
51
Female
37
Female
Female
209
Female
27
Female
15
MUCINOUS ADENOCARCINOMA
SEROUS ADENOCARCINOMA
ENDOMETRIOID ADENOCARCINOMA
83103 83133
90603 90713
90803 90843
90853
85903 86203
86313
91003
SEX-CORD-STROMAL TUMOR
CHORIOCARCINOMA
80133
80213
80703
81403
82463
82603
84303
84903
86223
90003
80203
80523
81203
82403
82553
83233
84403
85603
89503
90143
80103
CARCINOMA, NOS
88103 89303
89313 89333
89353 89803
91203
SPECIFIED SARCOMA
- 354 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
11
10
14
13
19
19
20
17
10
10
20
29
54
56
80
49
28
25
20
14
16
36
38
19
18
22
39
29
27
17
16
14
15
29
30
29
17
18
21
10
15
- 355 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
88003 88053
C56C57.0 - C57.4CONTINUED
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
Female
38
Female
1,245
11
11
SARCOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 356 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
31
34
50
95
116
190
183
182
106
78
68
44
30
14
- 357 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80513
80703
80723
80763
80523
80713
80743
80833
81403 82003
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Female
86
Female
Female
Female
14
Female
Female
Female
12
Female
Female
Female
Female
152
ADENOCARCINOMA
91003 91053
CHORIOCARCINOMA
85423
Paget
PAGET DISEASE OF EXTERNAL GENITALIA
80413 80903
81203 82463
83843 84133
80103
CARCINOMA, NOS
87203 87213
87433
88043 88323
88903 89103
89363 90403
88003
MALIGNANT MELANOMA
SARCOMA, NOS
80003 90713
91043
OTHER MALIGNANCY
TOTAL
1. 96
- 358 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
10
12
15
10
14
13
18
19
10
11
20
15
14
- 359 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
PROSTATE GLAND
ICD-O-3
81403 81433
82553 83103
84903 85003
80123
80453
80903
85503
80413
80703
84803
85743
80103
C61
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
4,268
Male
27
Male
19
Male
Male
76
Male
4,392
MORPHOLOGY
GENDER
ADENOCARCINOMA
CARCINOMA, NOS
89103 89353
SPECIFIED SARCOMA
80003
OTHER MALIGNANCY
TOTAL
1. 96
- 360 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
18
76
214
390
641
860
891
789
386
18
35
19
79
222
396
647
874
911
813
427
- 361 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
TESTIS
ICD-O-3
90613 90633
90643
90713
C62
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
91
Male
Male
Male
54
Male
14
Male
Male
Male
Male
Male
178
17
SEMINOMA
90703
EMBRYONAL CARCINOMA
90853 91013
90803 90813
MALIGNANT TERATOMA
91003
CHORIOCARCINOMA
82403 90653
SPECIFIED CARCINOMA
88583 89103
89123
80003
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
1. 96
- 362 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
11
21
20
17
19
12
37
40
29
20
- 363 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80513 80703
80713 80763
80903
C60C63
MORPHOLOGY
GENDER
CASE
NUMBER
0
|
4
5
|
9
10
|
14
15
|
19
Male
48
Male
Male
22
Male
Male
Male
Male
Male
91
85423
Paget
PAGET DISEASE
81403
ADENOCARCINOMA
80943
88323 88513
88543 88583
88903 91203
80003 90503
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
1. 96
- 364 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
10
10
10
14
12
- 365 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
BLADDER
ICD-O-3
80503 81203
81223 81303
81313
81403 82603
83103 84803
80703 80713
80133
80413
81443
83233
84903
80103
Male
Female
1,328
495
1
-
Male
Female
36
14
Male
Female
9
10
Male
Female
20
10
Male
Female
11
-
Male
Female
4
1
1
-
Male
Female
19
7
Male
Female
1,427
537
1
-
1
-
GENDER
CARCINOMA, NOS
15
|
19
MORPHOLOGY
80003 80033
95403
10
|
14
ADENOCARCINOMA
5
|
9
88903 88963
89203 89803
89903
CASE
NUMBER
0
|
4
80123
80333
80453
82403
84703
C67
SPECIFIED SARCOMA
OTHER MALIGNANCY
TOTAL
1. 96
- 366 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
2
-
8
1
11
5
25
5
60
16
81
39
134
47
111
47
148
62
190
75
228
85
189
70
139
43
1
-
2
1
6
1
2
2
5
1
3
1
5
2
3
3
5
-
2
-
2
1
3
-
4
2
2
2
1
-
1
-
1
-
2
-
2
1
1
4
6
2
4
2
2
-
1
-
1
-
1
-
1
-
1
-
5
-
1
-
1
-
1
-
1
-
1
-
1
-
4
1
2
-
5
2
6
1
2
-
2
-
8
2
14
6
32
6
64
18
87
41
138
50
118
49
156
66
200
85
247
89
207
76
150
49
- 367 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
KIDNEY
ICD-O-3
83103 83123
83163 83173
83183 88013
89803
89603
MORPHOLOGY
GENDER
CASE
NUMBER
80333 80413
81233 83193
83203 89593
80103
CARCINOMA, NOS
88583 88603
91203
88053
SPECIFIED SARCOMA
SARCOMA, NOS
80003
C64
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
624
314
2
-
1
1
Male
Female
7
3
5
3
1
-
Male
Female
10
10
1
-
Male
Female
13
10
Male
Female
6
1
Male
Female
1
-
Male
Female
17
12
Male
Female
678
350
8
3
1
-
1
1
1. 96
- 368 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
-
3
4
13
6
27
11
21
26
56
21
73
30
101
38
69
39
59
30
64
36
48
31
51
27
34
14
1
-
1
-
3
-
1
-
1
1
1
1
2
1
1
-
2
-
2
-
1
3
2
1
4
3
1
2
1
-
2
-
3
-
1
-
1
-
4
2
3
-
4
1
1
4
4
4
2
-
3
5
13
7
27
11
24
26
60
21
78
30
102
40
79
42
61
36
71
38
57
36
52
33
39
21
- 369 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
RENAL PELVIS
ICD-O-3
81203 81223
81303 81313
80703 80713
MORPHOLOGY
GENDER
CASE
NUMBER
81403 82553
82603 83103
80413 80523
ADENOCARCINOMA
80103 82303
CARCINOMA, NOS
89003
SPECIFIED SARCOMA
80003
C65
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
271
349
Male
Female
14
6
Male
Female
59
31
Male
Female
2
-
Male
Female
2
2
Male
Female
Male
Female
Male
Female
348
396
1. 96
- 370 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
4
-
7
-
8
9
20
14
33
31
28
47
45
54
34
53
50
59
27
44
15
37
1
-
1
-
1
2
2
1
4
3
3
-
2
-
1
1
2
-
2
3
4
2
7
1
6
1
6
2
7
7
7
3
5
2
9
3
1
2
2
2
1
-
1
-
1
-
1
-
1
1
2
1
6
3
12
2
15
10
27
16
41
36
39
55
53
58
43
60
62
64
30
49
17
39
- 371 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
URETER
ICD-O-3
81203 81223
81303
80703 80713
MORPHOLOGY
GENDER
CASE
NUMBER
81403
ADENOCARCINOMA
80823 82463
80103
CARCINOMA, NOS
88903
SPECIFIED SARCOMA
80003
C66
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
188
241
Male
Female
1
1
Male
Female
Male
Female
2
-
Male
Female
4
5
Male
Female
1
-
Male
Female
4
2
Male
Female
200
251
1. 96
- 372 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
5
-
9
4
17
3
16
20
22
31
35
34
22
52
32
40
16
27
13
28
1
1
1
-
1
-
1
-
1
-
2
1
1
-
1
-
3
1
1
1
5
-
9
4
17
3
17
20
24
33
36
35
25
53
34
42
16
29
16
30
- 373 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81203 81303
MORPHOLOGY
GENDER
CASE
NUMBER
80703 80723
81403
ADENOCARCINOMA
85603
87203
C68.0 - C68.1
MALIGNANT MELANOMA
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
14
3
Male
Female
Male
Female
1
1
Male
Female
1
-
Male
Female
Male
Female
16
8
1. 96
- 374 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
-
1
-
1
1
2
-
4
-
2
-
2
1
1
-
1
-
2
2
1
1
2
1
2
-
5
-
2
-
2
1
- 375 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81203 81303
C68.8
MORPHOLOGY
GENDER
CASE
NUMBER
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
4
7
Male
Female
4
7
1. 96
- 376 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
-
2
-
2
-
2
-
- 377 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81203 81223
81303
83103
MORPHOLOGY
GENDER
CASE
NUMBER
ADENOCARCINOMA
80413 80823
80103
CARCINOMA, NOS
87203
MALIGNANT MELANOMA
80003
C68.9
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
98
108
Male
Female
Male
Female
2
-
Male
Female
4
2
Male
Female
Male
Female
3
-
Male
Female
107
112
1. 96
- 378 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
3
-
6
2
5
5
6
13
10
11
16
17
19
20
19
20
11
14
3
5
1
-
1
-
1
-
1
1
1
-
1
-
1
-
1
-
1
-
3
-
6
2
5
5
6
13
12
12
17
17
20
21
21
20
13
15
4
6
- 379 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
95103 95113
MORPHOLOGY
GENDER
CASE
NUMBER
RETINOBLASTOMA
87203 87703
MALIGNANT MELANOMA
80703 80723
81403 82003
80823
80103
CARCINOMA, NOS
88043 88153
92313
88003
SPECIFIED SARCOMA
SARCOMA, NOS
80003
C69
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
13
7
12
7
1
-
Male
Female
10
9
1
-
1
-
1
-
Male
Female
5
2
Male
Female
5
2
Male
Female
1
-
Male
Female
2
-
Male
Female
1
2
Male
Female
1
-
Male
Female
1
-
Male
Female
39
22
13
7
1
-
1
-
1
-
1. 96
- 380 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
1
1
1
-
1
1
2
-
1
1
4
-
1
1
1
-
1
-
2
-
1
-
1
-
1
-
1
-
1
1
1
-
1
-
2
1
1
-
1
4
1
1
3
1
1
1
1
-
1
1
5
1
3
-
2
2
2
1
- 381 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
BRAIN
ICD-O-3
94003 94013
C71
MORPHOLOGY
GENDER
CASE
NUMBER
MALIGNANT ASTROCYTOMA
94403 94413
GLIOBLASTOMA MULTIFORME
93813 93843
94113 94203
94213 94243
94503 94513
94603
93803 93823
OLIGODENDROGLIOMA
GLIOMA,NOS
94703 94713
94733 94743
95223
MEDULLOBLASTOMA
ESTHESIONEUROBLASTOMA
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
74
54
1
3
3
-
1
1
Male
Female
174
125
1
-
2
2
2
-
Male
Female
12
8
1
2
3
-
Male
Female
23
24
1
-
Male
Female
42
33
3
-
2
3
2
2
1
2
Male
Female
15
7
4
1
6
2
2
1
Male
Female
10
9
1
1
93913 93923
93943
EPENDYMOMA
Male
Female
11
8
2
2
2
2
90643 90803
Male
23
Female
Male
Female
8
11
Male
Female
90813 90853
91003 95083
88013
92203
93703
94423
95403
88003
91503
93623
93713
95063
SPECIFIED SARCOMA
SARCOMA, NOS
- 382 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
4
5
5
3
4
3
4
8
4
11
2
8
2
7
6
4
1
8
8
3
4
3
2
1
-
3
1
3
2
5
3
4
5
9
9
18
12
21
13
22
16
19
13
24
8
21
16
13
15
9
7
1
2
1
-
2
1
2
3
2
-
1
-
1
1
1
-
2
1
2
4
4
2
4
4
1
-
2
4
2
3
2
1
1
2
3
1
2
-
4
2
2
4
7
5
1
2
3
2
2
6
3
1
3
1
1
1
2
-
1
-
1
1
1
-
1
-
1
-
2
1
1
2
1
-
2
2
1
-
1
-
1
-
1
-
1
1
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
1
1
3
1
2
1
1
2
-
1
-
1
-
- 383 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
BRAIN
C71CONTINUED
ICD-O-3
CASE
GENDER NUMBER
MORPHOLOGY
95383
MALIGNANT MENINGIOMA
80003 87203
95013 95053
95373
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
2
4
Male
Female
26
21
1
-
2
-
Male
Female
420
314
16
12
17
11
18
12
12
9
1. 96
- 384 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
1
1
2
1
1
-
1
-
1
1
2
1
3
2
3
4
2
1
1
6
3
1
4
2
11
10
16
7
19
15
18
24
30
23
37
22
36
21
37
37
32
22
41
24
31
25
20
25
18
9
11
6
- 385 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
C70C72
ICD-O-3
CASE
GENDER NUMBER
MORPHOLOGY
93643 94733
94003 94013
94203
93913
ASTROCYTOMA
EPENDYMOMA
95303
MALIGNANT MENINGIOMA
93703
CHORDOMA
90713
91503 91613
95393 95403
88003
SPECIFIED SARCOMA
SARCOMA, NOS
80003
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
Male
Female
3
3
1
-
Male
Female
4
7
Male
Female
10
11
1
-
Male
Female
Male
Female
1
-
1
-
Male
Female
5
5
1
-
Male
Female
1
-
Male
Female
1
1
Male
Female
25
30
1
1
3
-
1. 96
- 386 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
1
-
1
-
1
-
1
-
1
-
1
-
1
2
1
-
1
1
1
-
1
3
1
1
1
1
1
2
1
-
1
-
1
-
1
-
1
-
1
-
2
1
1
2
2
2
2
3
2
1
2
5
1
1
2
4
2
2
1
2
2
1
2
2
- 387 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
THYROID GLAND
ICD-O-3
82903 83303
83353
83453 83473
85103
80703
PAPILLARY CARCINOMA
FOLLICULAR ADENOCARCINOMA
MEDULLARY CARCINOMA
81403
ADENOCARCINOMA, NOS
80203 80213
CARCINOMA, UNDIFFERENTIATED
80313 80413
82623 83373
80103
CARCINOMA, NOS
91203
SPECIFIED SARCOMA
80003
CASE
GENDER NUMBER
MORPHOLOGY
82603 83403
83413 83433
83443 83503
C73
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
479
1,654
5
10
Male
Female
47
107
Male
Female
11
22
Male
Female
4
3
Male
Female
Male
Female
10
16
Male
Female
5
5
Male
Female
10
14
1
-
Male
Female
1
-
Male
Female
4
15
Male
Female
571
1,838
1
-
12
5
14
1. 96
- 388 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
8
62
26
112
52
121
60
169
55
225
60
259
67
245
61
186
32
97
17
75
16
44
9
28
6
9
5
3
2
10
5
8
3
15
4
11
6
8
6
13
5
9
3
6
7
3
3
3
1
3
2
3
1
-
1
-
1
4
2
4
3
2
2
2
1
-
1
-
1
-
1
1
1
-
1
1
1
1
2
3
2
3
3
2
1
3
1
-
1
-
1
-
2
-
1
-
1
-
2
2
1
2
1
-
1
2
2
1
1
-
1
2
2
1
1
1
11
72
28
119
59
129
64
186
59
240
66
277
77
268
71
202
43
109
27
89
26
57
14
35
14
17
6
12
- 389 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
94903 95003
MORPHOLOGY
GENDER
CASE
NUMBER
NEUROBLASTOMA
83703
86803 87003
MALIGNANT PHEOCHROMOCYTOMA
81403
ADENOCARCINOMA, NOS
80703 82463
80103
CARCINOMA, NOS
80003 93823
95083
C74 - C75
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
6
9
4
6
2
2
Male
Female
4
8
Male
Female
4
2
Male
Female
1
1
Male
Female
2
-
Male
Female
6
1
Male
Female
2
5
1
-
Male
Female
25
26
5
6
2
2
1. 96
- 390 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
1
1
-
1
2
1
-
1
1
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
2
-
1
-
1
-
2
1
2
1
2
3
4
1
4
1
2
2
1
1
1
1
- 391 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
81403
MORPHOLOGY
GENDER
CASE
NUMBER
ADENOCARCINOMA, NOS
84803
80103 80203
CARCINOMA, NOS
84303
CHONDROSARCOMA
88103 89363
SPECIFIED SARCOMA
80003 90803
C76
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
1
1
Male
Female
Male
Female
2
-
Male
Female
1
-
Male
Female
1
4
Male
Female
4
-
1
-
Male
Female
9
6
1
-
1. 96
- 392 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
-
1
1
1
1
2
1
2
-
2
1
- 393 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
80703 80713
80723 80743
80203
ADENOCARCINOMA
CARCINOMA, UNDIFFERENTIATED
80413
91003
CHORIOCARCINOMA
80033
80333
80503
82403
82603
84303
84903
85743
91013
80323
80463
80823
82463
83103
84613
85603
85753
80103
CARCINOMA, NOS
93643
88013
88043
88303
89363
91203
95403
88023
88103
88903
89803
91403
CASE
GENDER NUMBER
MORPHOLOGY
81403 84413
84703 84803
84813
C80
SPECIFIED SARCOMA
- 394 -
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
150
152
Male
Female
93
14
Male
Female
5
1
Male
Female
8
5
Male
Female
2
2
1
-
Male
Female
34
53
1
-
Male
Female
118
56
1
-
Male
Female
Male
Female
10
7
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
1
2
1
2
2
1
5
3
7
7
11
8
16
12
12
15
17
8
20
24
22
27
19
25
17
18
1
-
3
-
10
2
10
-
16
1
18
2
11
1
8
1
7
2
6
3
2
1
1
1
1
-
1
-
2
-
1
-
1
-
1
-
3
-
1
1
2
-
1
-
1
1
2
2
3
7
4
7
2
5
1
7
4
9
5
5
3
2
4
5
4
1
4
-
1
-
1
-
2
-
2
4
8
2
8
5
10
4
9
9
15
7
12
7
15
3
20
11
10
4
1
-
1
2
1
-
1
-
1
-
2
-
2
1
1
-
- 395 -
99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)
ICD-O-3
MORPHOLOGY
GENDER
CASE
NUMBER
88003
SARCOMA, NOS
87203
MALIGNANT MELANOMA
80003
80043
90503
90713
80013
88063
90643
90853
C80CONTINUED
OTHER MALIGNANCY
TOTAL
0
|
4
5
|
9
10
|
14
15
|
19
Male
Female
3
1
Male
Female
1
3
Male
Female
114
96
Male
Female
538
391
1
1
2
-
1. 96
- 396 -
20
|
24
25
|
29
30
|
34
35
|
39
40
|
44
45
|
49
50
|
54
55
|
59
60
|
64
65
|
69
70
|
74
75
|
79
80
|
84
85+
2
-
1
-
1
-
1
1
3
1
1
-
1
1
1
-
5
4
5
2
6
1
10
8
10
12
24
9
15
29
32
27
5
1
7
4
6
3
9
4
19
13
31
19
46
25
57
25
41
35
56
34
59
52
71
50
64
74
64
51
- 397 -
99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010
ICD-O-3
C00-C80
C00-C14
2
C00-C14
C44.0
C16
C17
942
HYPOPHARYNX
C14
2,269
635
OROPHARYNX
C12-C13
C15
164
FLOOR OF MOUTH
C09-C10
C15-C26, C48
445
GUM
C05-C06
C11
1,805
TONGUE
C04
6,560
228
C03
C07-C08
8,367
C01-C02
CASE NUMBER
90,649
ALL SITES
C00
72
236
1,571
NASOPHARYNX
34,255
2,238
ESOPHAGUS
3,854
STOMACH
325
SMALL INTESTINE
2. ICD-O-3
C00-C06C09-C10C12-C14
- 398 -
Null
NK
ICD-O-3
Well
Moderately
Poorly
differentiated differentiated differentiated
Anaplastic
Not
determined
T-cell
B-cell
Null cell
NK cell
Not
determined
6,979
27,931
14,859
4,282
31,859
309
2,175
41
2,207
C00-C80
1,542
3,148
841
1,064
1,771
C00-C14
1,491
3,067
660
45
1,296
C00-C14
102
80
10
32
C00
447
935
152
263
C01-C02
134
209
34
66
C03
30
97
13
22
C04
722
1,004
149
385
C05-C06
21
275
132
14
193
C09-C10
29
431
160
315
C12-C13
36
10
20
C14
51
18
17
143
C07-C08
44
30
163
1,002
332
C11
1,866
14,171
4,811
362
13,045
C15-C26, C48
52
994
469
12
711
C15
162
955
1,802
56
879
C16
16
74
38
22
175
C17
- 399 -
99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED
ICD-O-3
C18-C21
C18
C22
C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
3
C42
C40-C41
CASE NUMBER
14,040
8,635
COLON
C19-C21
5,405
11,023
924
1,643
PANCREAS
157
51
11,761
172
635
LARYNX
10,615
62
PLEURA
276
1,823
LEUKEMIA
163
3. ICD-O-3
- 400 -
Null
NK
ICD-O-3
Well
Moderately
Poorly
Anaplastic
differentiated differentiated differentiated
Not
determined
T-cell
B-cell
Null cell
NK cell
Not
determined
1,025
9,275
1,177
136
2,427
C18-C21
650
5,698
786
90
1,411
C18
375
3,577
391
46
1,016
C19-C21
456
2,326
1,050
93
7,098
C22
73
293
131
418
C23-C24
59
244
121
15
1,204
C25
22
14
18
95
C48
38
C26
682
2,159
1,743
137
7,040
C30-C39
10
28
28
18
88
C30-C31
42
301
62
227
C32
614
1,821
1,624
107
6,449
C33-C34
59
C38.4
15
28
216
C37-C38.3, C38.8
39
279
1,501
17
19
117
- 401 -
C42
C40-C41
99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED
ICD-O-3
C47, C49
C44
4
C44
C44
C50
C50
C51-C58
C55
C53
C54
C56, C57.0-C57.4
C61
C62
C60,C63
C64-C68
CASE NUMBER
508
2,978
SKIN
212
2,766
9,655
FEMALE BREAST
39
MALE BREAST
4,822
UTERUS, NOS
1,680
CERVIX UTERI
1,737
CORPUS UTERI
C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63
1,245
152
4,661
4,392
PROSTATE GLAND
178
TESTIS
91
4,441
URINARY TRACT
4. ICD-O-3
- 402 -
Well
Moderately
Poorly
Anaplastic
differentiated differentiated differentiated
Not
determined
Null
NK
T-cell
B-cell
Null cell
NK cell
Not
determined
ICD-O-3
63
68
32
70
275
C47, C49
354
336
87
25
2,176
C44
203
C44
354
331
83
25
1,973
C44
1,384
4,367
2,874
1,028
C50
21
10
C50
546
1,525
894
361
1,496
C51-C58
C55
111
620
310
13
626
C53
331
634
327
169
276
C54
92
239
246
176
492
C56, C57.0-C57.4
12
32
11
95
C51-C52, C57.7-C57.9
170
1,068
3,007
21
395
C60-C63
156
1,036
3,000
17
183
C61
172
C62
13
30
40
C60,C63
139
932
456
1,973
941
C64-C68
- 403 -
99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED
ICD-O-3
C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80
CASE NUMBER
1,964
BLADDER
1,028
KIDNEY
744
RENAL PELVIS
451
URETER
24
11
219
61
789
734
BRAIN
55
2,409
THYROID GLAND
51
15
929
2,915
MALIGNANT LYMPHOMA
1. 96 ICD-O-3 M-CODE P.497
- 404 -
Well
Moderately
Poorly
differentiated differentiated differentiated
Null
NK
Anaplastic
Not
determined
T-cell
B-cell
Null cell
NK cell
Not
determined
ICD-O-3
50
383
144
1,094
293
C67
68
349
188
63
360
C64
19
94
77
404
150
C65
73
28
267
82
C66
C68.0-C68.1
C68.8
26
17
127
49
C68.9
48
C69
36
41
188
517
C70-C72
34
41
181
471
C71
46
C70, C72
212
71
46
34
2,046
C73
44
C74-C75
12
C76
19
897
C80
270
1,896
40
706
- 405 -
99
IMMUNOPHENOTYPE DESIGNATION OF LYMPHOMAS AND LEUKEMIAS, 2010
CASE NUMBER
1,823
734
235
225
135
35
230
MYELOPROLIFERATIVE NEOPLASMS
200
MYELODYSPLASTIC SYNDROMES
13
OTHER LEUKEMIA
12
LEUKEMIA, NOS
1. 96 ICD-O-3 M-CODE P.497
- 406 -
Well
Moderately
Poorly
differentiated differentiated differentiated
Null
NK
Anaplastic
Not
determined
T-cell
B-cell
Null cell
NK cell
Not
determined
39
279
1,501
723
21
178
35
222
91
42
33
229
199
10
- 407 -
99
IMMUNOPHENOTYPE DESIGNATION OF LYMPHOMAS AND LEUKEMIAS, 2010
CONTINUED
CASE NUMBER
2,915
MALIGNANT LYMPHOMA
172
HODGKIN LYMPHOMA
2,082
NON-HODGKIN LYMPHOMA
1,750
T/NK
332
502
26
Other LPD
133
- 408 -
Well
Moderately
Poorly
differentiated differentiated differentiated
Null
NK
Anaplastic
Not
determined
T-cell
B-cell
Null cell
NK cell
Not
determined
270
1,896
40
706
169
265
1,595
40
179
1,593
151
260
39
28
223
278
24
75
56
- 409 -
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010
C44.0
Total
0101
98
99
0102
98
99
0103
98
99
0104
98
99
0105
98
99
0106
98
99
0107
98
99
0108
98
99
0109
98
99
0111
98
99
0113
98
99
0114
98
99
0110
98
99
7,469
7,595
126
6,574
6,554
-20
2,375
2,366
-9
267
266
-1
936
965
29
247
291
44
77
56
-21
360
388
28
3,558
3,707
149
1,163
1,253
90
9,120
9,184
64
1,530
1,484
-46
17
13
-4
C00 C01-C02
35
23
-12
8
9
1
3
2
-1
1
-1
6
7
1
1
2
1
52
36
-16
1
3
2
-
186
177
-9
83
86
3
40
36
-4
2
-2
3
5
2
1
9
8
1
-1
2
-2
57
56
-1
19
18
-1
295
246
-49
22
24
2
-
C03
43
61
18
33
31
-2
17
14
-3
1
1
1
1
19
37
18
7
8
1
95
104
9
7
9
2
-
217
200
-17
107
96
-11
53
38
-15
2
4
2
6
1
-5
1
10
9
1
-1
74
83
9
15
24
9
351
321
-30
21
25
4
-
101 5 21 99 100 6 3 98
- 410 -
78
83
5
57
46
-11
21
13
-8
4
5
1
2
-2
1
1
1
-1
23
18
-5
5
9
4
99
75
-24
5
6
1
-
67
68
1
48
63
15
22
14
-8
2
4
2
31
35
4
4
8
4
128
110
-18
10
10
-
C14 C07-C08
2
3
1
1
1
1
1
2
2
-
42
32
-10
13
21
8
7
4
-3
2
2
2
-2
10
11
1
6
3
-3
43
30
-13
4
2
-2
-
967
867
-100
650
595
-55
227
237
10
16
32
16
125
108
-17
18
18
11
7
-4
9
13
4
328
302
-26
83
107
24
1,035
999
-36
115
133
18
-
59
57
-2
61
71
10
31
15
-16
3
2
-1
13
8
-5
1
3
2
2
1
-1
17
22
5
8
1
-7
100
115
15
7
17
10
-
172
171
-1
149
130
-19
50
40
-10
4
2
-2
26
20
-6
4
6
2
2
2
3
3
49
55
6
27
19
-8
139
134
-5
31
32
1
2
-2
20
19
-1
16
19
3
3
4
1
1
1
2
5
3
2
2
17
20
3
3
2
-1
-
- 411 -
C26 C30-C31
2
4
2
3
5
2
1
-1
1
1
1
-1
1
2
1
1
1
1
1
-
36
27
-9
26
18
-8
3
5
2
1
2
1
10
14
4
2
5
3
22
24
2
6
6
-
C32
C33-C34
43
48
5
60
66
6
18
14
-4
2
-2
2
2
1
-1
1
-1
26
29
3
5
14
9
65
82
17
3
9
6
-
874
898
24
1,011
1,006
-5
307
236
-71
33
40
7
75
83
8
29
30
1
1
6
5
10
15
5
370
354
-16
119
110
-9
919
846
-73
147
97
-50
1
3
2
C48
235
246
11
332
387
55
105
117
12
13
24
11
60
66
6
20
23
3
4
6
2
15
18
3
223
217
-6
76
90
14
467
473
6
114
68
-46
1
1
C25
417
458
41
563
501
-62
189
151
-38
35
32
-3
92
111
19
34
34
9
4
-5
15
28
13
279
339
60
96
123
27
699
796
97
148
127
-21
2
3
1
C23-C24
33
18
-15
17
16
-1
11
10
-1
1
1
4
1
-3
3
3
1
1
17
13
-4
7
5
-2
31
24
-7
7
1
-6
-
C22
318
297
-21
366
352
-14
99
107
8
21
15
-6
72
64
-8
21
21
7
2
-5
15
9
-6
161
178
17
57
45
-12
366
338
-28
74
64
-10
1
1
-
166
168
2
128
136
8
47
48
1
7
7
15
21
6
8
11
3
3
2
-1
68
78
10
14
15
1
209
213
4
17
9
-8
1
-1
202
190
-12
87
95
8
37
33
-4
7
1
-6
7
9
2
2
6
4
2
1
-1
8
4
-4
55
53
-2
22
26
4
194
197
3
20
15
-5
-
C18 C19-C21
C17
C16
C15
C11
0101
0102
0103
0104
0105
0106
0107
0108
0109
0110
0111
0113
0114
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0105
98
99
0106
98
99
0107
98
99
0108
98
99
0109
98
99
0110
98
99
0111
98
99
0113
98
99
0114
98
99
C50
C50
C55
C53
C54
185
204
19
122
90
-32
43
50
7
11
5
-6
17
22
5
14
13
-1
8
5
-3
105
121
16
30
27
-3
258
262
4
50
48
-2
2
-2
835
940
105
555
550
-5
373
417
44
39
38
-1
194
212
18
24
24
2
2
158
168
10
444
527
83
175
224
49
893
978
85
290
279
-11
1
2
1
1
1
2
3
1
2
-2
1
1
6
1
-5
2
1
-1
-
2
-2
1
1
1
1
1
1
-
282
284
2
164
196
32
72
83
11
32
24
-8
28
36
8
32
31
-1
11
5
-6
35
34
-1
433
390
-43
106
68
-38
416
429
13
90
94
4
3
-3
120
136
16
121
115
-6
40
56
16
4
6
2
9
12
3
2
2
1
6
5
7
14
7
91
130
39
45
58
13
207
222
15
27
34
7
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 412 -
0104
48
55
7
36
63
27
11
11
1
1
6
3
-3
1
2
1
2
1
-1
12
15
3
6
2
-4
60
46
-14
5
9
4
-
C44
98
99
24
21
-3
37
47
10
5
3
-2
1
2
1
8
3
-5
3
2
-1
16
22
6
2
2
-
0103
273
305
32
156
159
3
43
42
-1
1
-1
14
15
1
1
2
1
2
2
80
59
-21
14
10
-4
288
261
-27
12
24
12
1
-1
98
99
75
87
12
37
45
8
22
21
-1
2
1
-1
1
-1
1
-1
1
1
13
24
11
2
5
3
80
75
-5
6
6
-
0102
3
6
3
1
8
7
4
-4
1
-1
2
1
-1
1
1
2
6
4
1
1
-
98
99
C42
0101
C37-C38.3,
C38.8
41
36
-5
43
38
-5
7
7
1
1
17
6
-11
1
1
34
23
-11
2
3
1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
85
22
89
23
4
1
85
16
92
10
7
-6
24
6
39
5
15
-1
3
2
-1
10
1
11
3
1
2
1
2
1
1
-1
6
9
2
3
2
76
19
77
17
1
-2
25
2
30
3
5
1
129
18
154
29
25
11
17
4
23
5
6
1
-
13
25
12
7
9
2
4
4
31
35
4
1
1
-
68
76
8
94
122
28
19
33
14
4
4
1
-1
3
-3
12
14
2
10
10
93
99
6
21
12
-9
-
205
248
43
243
248
5
89
101
12
2
3
1
16
6
-10
1
3
2
16
11
-5
4
7
3
84
60
-24
10
16
6
193
206
13
72
90
18
-
- 413 -
5
6
1
8
5
-3
2
2
2
1
-1
9
12
3
1
1
-
14
6
-8
8
5
-3
1
1
1
1
4
2
-2
3
4
1
-
C76
C77
C80
1
1
1
-1
1
-1
1
-1
1
-1
-
157
149
-8
109
104
-5
26
48
22
3
3
12
17
5
1
6
5
30
46
16
18
21
3
168
188
20
21
28
7
1
1
76
67
-9
76
89
13
14
24
10
2
2
10
7
-3
9
7
-2
1
1
2
2
50
55
5
12
12
83
65
-18
11
14
3
-
95
79
-16
98
100
2
34
37
3
3
1
-2
6
13
7
4
4
1
-1
11
16
5
34
32
-2
14
20
6
140
134
-6
24
24
-
89
84
-5
97
118
21
31
24
-7
1
4
3
3
8
5
1
1
1
-1
2
4
2
38
27
-11
20
10
-10
96
119
23
21
18
-3
-
C73 C74-C75
162
114
-48
157
150
-7
76
69
-7
7
8
1
26
19
-7
10
7
-3
23
12
-11
65
66
1
33
27
-6
163
163
28
30
2
1
2
1
C69
C65-C66,
C68
C64
C67
6
8
2
9
9
2
3
1
1
1
1
1
1
-1
4
2
-2
3
1
-2
12
11
-1
1
1
-
21
19
-2
18
17
-1
8
10
2
1
-1
2
2
1
-1
4
3
-1
4
7
3
24
19
-5
6
5
-1
1
-1
337
392
55
445
397
-48
129
139
10
13
6
-7
60
55
-5
4
12
8
8
2
-6
12
16
4
96
114
18
54
61
7
342
411
69
53
68
15
1
-1
C61
0101
0102
0103
0104
0105
0106
0107
0108
0109
0110
0111
0113
0114
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0115
98
99
0119
98
99
0122
98
99
0124
98
99
0125
98
99
0126
98
99
0127
98
99
0128
98
99
0130
98
99
0140
98
99
0141
98
99
0142
98
99
0143
98
99
124
149
25
35
35
81
73
-8
27
27
58
70
12
1
-1
198
195
-3
151
166
15
74
67
-7
271
243
-28
4,145
5,105
960
1,638
1,864
226
983
1,073
90
C00 C01-C02
1
-1
4
6
2
1
8
7
1
1
1
1
1
1
2
2
3
1
-2
3
4
1
85
95
10
40
39
-1
18
10
-8
C03
1
1
1
1
4
1
-3
1
-1
1
-1
17
20
3
10
12
2
1
-1
1
1
2
4
2
1
1
2
2
1
1
2
2
84
85
1
39
43
4
22
16
-6
101 5 21 99 100 6 3 98
- 414 -
1
1
1
-1
1
-1
1
1
1
2
1
43
34
-9
13
27
14
5
6
1
1
-1
1
1
1
-1
27
38
11
11
15
4
6
3
-3
C14 C07-C08
1
-1
-
1
-1
28
20
-8
7
8
1
5
2
-3
C48
2
-2
1
1
2
-2
2
2
1
4
3
2
2
4
4
60
96
36
26
31
5
29
22
-7
1
-1
1
1
3
9
6
2
-2
-
- 415 -
C26 C30-C31
1
2
1
3
-3
1
1
1
2
1
1
-1
1
1
6
12
6
2
6
4
2
1
-1
C32
C33-C34
1
1
1
-1
1
1
2
2
1
-1
27
22
-5
10
22
12
11
9
-2
1
1
2
-2
4
5
1
1
-1
2
8
6
13
21
8
6
8
2
33
33
473
480
7
214
176
-38
100
125
25
C25
1
1
1
-1
2
-2
3
3
12
33
21
14
23
9
10
15
5
C23-C24
4
4
7
-7
4
1
-3
6
6
1
1
10
8
-2
4
2
-2
20
23
3
252
396
144
199
209
10
64
70
6
4
3
-1
3
3
2
2
1
2
1
3
2
-1
1
-1
2
2
6
7
1
11
6
-5
10
15
5
193
197
4
88
106
18
49
51
2
C22
8
13
5
6
-6
10
7
-3
2
2
7
5
-2
2
3
1
19
23
4
16
14
-2
25
22
-3
223
306
83
143
184
41
98
125
27
C18 C19-C21
1
1
8
10
2
7
6
-1
4
3
-1
C17
4
3
-1
5
5
7
2
-5
3
2
-1
2
3
1
13
7
-6
5
-5
16
13
-3
172
211
39
85
96
11
50
73
23
C16
1
1
1
1
1
1
1
-1
2
5
3
3
1
-2
5
3
-2
110
136
26
36
49
13
17
24
7
C15
2
-2
1
2
1
4
4
3
3
108
157
49
24
31
7
15
20
5
C11
0115
0119
0122
0124
0125
0126
0127
0128
0130
0140
0141
0142
0143
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0125
98
99
0126
98
99
0127
98
99
0128
98
99
0130
98
99
0140
98
99
0141
98
99
0142
98
99
0143
98
99
C50
C55
C53
C54
1
16
1
23
7
1
2
1
2
15
13
-2
1
3
1
6
3
2
6
2
4
-2
118
118
10
9
13
9
3
7
4
1
18
-6
14
8
20
1
14
-7
-6
43 1,096
50 1,346
7
250
37
171
22
244
-15
73
14
226
18
203
4
-23
6
3
-3
1
1
1
-1
1
-1
36
46
10
2
1
-1
3
9
6
5
5
8
11
3
55
51
-4
15
14
-1
5
1
-4
11
19
8
141
148
7
56
63
7
43
32
-11
1
8
7
1
5
4
1
1
2
1
-1
11
11
5
5
1
1
5
1
-4
54
88
34
31
28
-3
11
10
-1
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 416 -
0124
1
1
1
1
1
2
1
2
2
45
38
-7
11
9
-2
2
5
3
C50
98
99
1
1
5
10
5
5
3
-2
2
-2
0122
6
3
-3
2
5
3
32
47
15
24
26
2
10
13
3
98
99
3
1
-2
1
1
7
17
10
11
7
-4
4
11
7
C44
0119
2
3
1
1
-1
2
2
98
99
C42
0115
C37-C38.3,
C38.8
17
18
1
9
11
2
4
3
-1
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
4
6
1
2
1
4
4
1
1
1
1
6
1
2
-6
1
1
1
5
1
1
1
-4
49
10
57
7
8
-3
30
2
23
1
-7
-1
8
3
1
-5
1
5
5
3
1
-2
2
-2
- 417 -
1
1
1
-1
1
-1
1
3
2
11
26
15
9
10
1
2
6
4
1
-1
2
2
1
-1
1
-1
C73
C74-C75
C76
C77
C80
4
5
1
1
1
1
-1
1
1
1
1
1
-1
4
2
-2
160
179
19
62
66
4
28
51
23
2
4
2
2
-2
-
1
1
1
-1
1
1
1
1
2
3
1
3
3
89
113
24
12
23
11
10
14
4
1
-1
2
1
-1
1
-1
3
-3
1
-1
3
4
1
30
50
20
11
22
11
10
15
5
3
8
5
1
-1
1
1
1
4
3
1
2
1
10
5
-5
39
53
14
22
29
7
7
13
6
1
1
1
2
1
1
1
1
1
2
1
-1
5
5
40
51
11
12
21
9
8
11
3
18
12
-6
6
4
-2
7
4
-3
3
2
-1
2
2
9
7
-2
4
1
-3
27
15
-12
86
95
9
41
50
9
30
28
-2
C69
C65-C66,
C68
C64
C67
2
1
-1
3
1
-2
2
-2
1
1
2
1
-1
1
2
1
1
-1
12
12
4
2
-2
1
2
1
14
8
-6
5
12
7
3
7
4
6
5
-1
9
14
5
23
18
-5
3
4
1
40
33
-7
224
309
85
89
104
15
49
52
3
C61
0115
0119
0122
0124
0125
0126
0127
0128
0130
0140
0141
0142
0143
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0145
98
99
0146
98
99
0147
98
99
0148
98
99
0150
98
99
0201
98
99
0202
98
99
0203
98
99
0204
98
99
0207
98
99
0301
98
99
0302
98
99
0303
98
99
940
996
56
19
19
26
27
1
168
163
-5
10
8
-2
301
303
2
6
3
-3
39
24
-15
30
43
13
1,332
1,259
-73
279
245
-34
784
750
-34
12
12
-
C00 C01-C02
1
1
4
1
-3
2
2
2
2
-
4
8
4
1
1
1
2
1
2
3
1
38
35
-3
7
4
-3
7
6
-1
1
-1
C03
3
5
2
19
13
-6
3
3
2
1
-1
-
20
20
1
-1
3
6
3
56
33
-23
6
12
6
10
4
-6
-
6
3
-3
2
2
1
1
1
-1
1
1
21
11
-10
5
3
-2
2
4
2
-
101 5 21 99 100 6 3 98
- 418 -
2
5
3
2
1
-1
1
2
1
28
20
-8
1
8
7
1
1
-
C14
C07-C08
1
1
3
1
-2
-
1
-1
1
-1
2
-2
1
-1
5
4
-1
2
1
-1
-
C48
23
20
-3
5
5
1
1
6
10
4
1
1
26
21
-5
4
1
-3
14
16
2
-
2
2
2
2
1
-1
1
1
-
- 419 -
C26 C30-C31
2
2
1
1
-
2
-2
1
-1
1
1
3
-3
1
1
-
C32
C33-C34
5
7
2
2
2
1
3
2
18
16
-2
1
1
4
1
-3
-
102
86
-16
18
18
2
-2
31
17
-14
1
1
26
19
-7
3
1
-2
2
2
192
199
7
16
19
3
68
76
8
2
1
-1
C25
9
12
3
1
-1
3
1
-2
3
1
-2
4
11
7
2
2
6
10
4
-
C23-C24
69
78
9
2
-2
14
12
-2
20
18
-2
6
4
-2
3
1
-2
161
150
-11
19
12
-7
73
56
-17
1
1
56
45
-11
1
7
6
8
10
2
20
24
4
5
-5
10
9
-1
45
53
8
17
14
-3
62
59
-3
2
2
-
C22
79
120
41
3
-3
25
34
9
1
1
29
33
4
5
2
-3
4
8
4
93
115
22
32
34
2
82
94
12
4
4
C18 C19-C21
3
3
2
2
3
2
-1
1
6
5
1
2
1
2
3
1
-
C17
58
64
6
1
-1
31
14
-17
20
25
5
4
1
-3
3
2
-1
78
66
-12
22
9
-13
52
36
-16
2
2
-
C16
11
18
7
1
1
5
6
1
1
1
10
14
4
1
2
1
3
3
39
48
9
9
9
8
8
1
1
-
C15
20
23
3
1
1
2
3
1
1
-1
27
22
-5
7
5
-2
9
11
2
-
C11
0145
0146
0147
0148
0150
0201
0202
0203
0204
0207
0301
0302
0303
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0150
98
99
0201
98
99
0202
98
99
0203
98
99
0204
98
99
0207
98
99
0301
98
99
0302
98
99
0303
98
99
C50
C50
C55
C53
C54
35
31
-4
5
12
7
11
16
5
1
1
1
5
4
17
15
-2
15
6
-9
10
29
19
3
-3
106
121
15
3
6
3
2
-2
29
21
-8
2
1
-1
3
1
-2
2
2
110
95
-15
39
37
-2
208
187
-21
1
-1
3
3
3
1
-2
1
2
1
-
52
47
-5
9
11
2
4
5
1
1
1
30
24
-6
3
2
-1
4
2
-2
1
2
1
84
66
-18
6
11
5
42
28
-14
-
20
14
-6
2
2
1
-1
4
4
1
1
18
31
13
1
-1
15
13
-2
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 420 -
0148
8
7
-1
1
2
1
2
3
1
1
1
8
5
-3
7
4
-3
7
4
-3
-
C44
98
99
1
1
2
1
-1
2
-2
-
0147
17
17
1
1
15
16
1
1
1
1
1
-
98
99
4
2
-2
2
2
1
1
5
6
1
3
3
-
0146
1
1
1
-1
-
98
99
C42
0145
C37-C38.3,
C38.8
3
4
1
1
-1
3
2
-1
2
-2
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
16
3
10
2
-6
-1
1
1
2
2
1
2
1
-2
1
-1
1
-1
8
1
12
4
4
3
1
-1
6
8
2
-
1
1
1
-1
1
1
1
1
-
C76
C77
C80
1
1
-
8
14
6
3
3
3
1
-2
1
-1
14
13
-1
3
1
-2
11
6
-5
-
15
16
1
1
1
1
-1
2
3
1
6
6
6
5
-1
16
4
-12
9
12
3
-
17
23
6
1
2
1
5
7
2
1
-1
5
1
-4
41
33
-8
6
3
-3
8
8
-
1
-1
1
-1
1
1
-
- 421 -
8
17
9
3
4
1
1
1
5
9
4
1
1
-
C73 C74-C75
11
9
-2
3
1
-2
1
-1
4
2
-2
1
-1
25
14
-11
1
-1
3
1
-2
1
1
C69
23
30
7
1
2
1
1
2
1
1
2
1
19
15
-4
1
3
2
1
1
29
23
-6
7
7
22
16
-6
-
C65-C66,
C68
11
11
1
1
7
9
2
1
1
28
25
-3
5
4
-1
1
6
5
-
C64
1
1
1
1
1
1
1
-1
1
-1
-
C67
5
4
-1
1
-1
2
1
-1
1
1
-
102
88
-14
1
-1
6
3
-3
2
1
-1
29
31
2
1
3
2
3
5
2
46
48
2
19
21
2
26
32
6
-
C61
0145
0146
0147
0148
0150
0201
0202
0203
0204
0207
0301
0302
0303
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0304
98
99
0305
98
99
0306
98
99
0307
98
99
0308
98
99
98
99
0312
98
99
0314
98
99
0315
98
99
0316
98
99
0317
98
99
0318
98
99
0319
98
99
0311
160
160
1,938
1,951
13
156
148
-8
111
27
-84
3
13
10
8
6
-2
12
5
-7
3
5
2
519
497
-22
1
1
27
39
12
20
22
2
1,671
1,698
27
C00 C01-C02
4
10
6
2
-2
3
3
-
2
-2
53
43
-10
2
1
-1
1
-1
7
9
2
28
44
16
C03
18
21
3
2
2
6
11
5
8
8
86
55
-31
1
1
2
1
-1
1
1
14
6
-8
1
1
39
59
20
21
17
-4
1
1
1
-1
3
5
2
9
11
2
101 5 21 99 100 6 3 98
- 422 -
18
22
4
1
1
1
-1
4
4
20
17
-3
C14
C07-C08
1
2
1
1
-1
1
-1
-
6
6
2
3
1
5
4
-1
C48
30
21
-9
143
144
1
25
30
5
33
7
-26
1
1
1
1
36
55
19
5
6
1
6
3
-3
170
193
23
15
11
-4
222
170
-52
6
1
-5
5
2
-3
1
-1
3
-3
55
55
3
1
-2
5
-5
224
202
-22
1
1
18
11
-7
1
1
1
1
11
5
-6
21
12
-9
1
2
1
34
35
1
3
1
-2
2
-2
1
1
4
3
-1
1
1
50
39
-11
1
4
3
1
1
2
4
2
17
10
-7
103
118
15
16
20
4
17
4
-13
1
-1
2
-2
32
36
4
2
2
1
4
3
111
113
2
- 423 -
C26 C30-C31
1
-1
-
3
5
2
1
-1
4
4
6
7
1
C32
C33-C34
1
-1
20
11
-9
6
3
-3
11
7
-4
15
15
195
205
10
16
9
-7
13
2
-11
1
4
3
3
1
-2
74
58
-16
4
1
-3
2
4
2
232
211
-21
C25
C23-C24
C22
1
2
1
13
8
-5
1
1
2
2
6
6
-
C18 C19-C21
10
17
7
84
85
1
14
7
-7
5
2
-3
1
1
1
1
40
41
1
2
6
4
3
2
-1
78
83
5
5
7
2
47
65
18
2
2
2
-2
1
1
18
15
-3
1
1
1
2
1
2
2
35
27
-8
1
1
45
35
-10
2
10
8
1
-1
1
-1
12
9
-3
31
42
11
C17
C16
C15
C11
0304
0305
0306
0307
0308
0311
0312
0314
0315
0316
0317
0318
0319
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0308
98
99
0311
98
99
0312
98
99
0314
98
99
0315
98
99
0316
98
99
0317
98
99
0318
98
99
0319
98
99
C47, C49
C44
C50
C50
C55
C53
C54
6
4
-2
3
2
-1
1
1
15
12
-3
1
-1
4
1
-3
11
8
-3
6
3
-3
65
72
7
16
5
-11
3
1
-2
3
3
1
1
20
22
2
2
9
7
1
1
47
33
-14
13
10
-3
178
201
23
18
24
6
8
1
-7
1
1
1
-1
1
-1
38
41
3
2
2
1
1
163
175
12
1
-1
3
1
-2
1
1
1
-1
1
2
1
1
-1
-
16
19
3
83
89
6
10
9
-1
5
5
3
4
1
22
20
-2
3
-3
1
1
54
38
-16
2
1
-1
28
42
14
6
5
-1
5
3
-2
1
1
18
37
19
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 424 -
0307
C40-C41
98
99
0306
20
30
10
1
-1
16
20
4
98
99
14
12
-2
1
2
1
6
8
2
0305
1
-1
1
-1
1
1
98
99
C42
0304
C37-C38.3,
C38.8
1
-1
4
6
2
1
1
7
2
-5
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
2
1
2
12
4
22
2
10
-2
1
1
-1
-1
5
2
1
-4
-2
18
1
18
2
1
1
1
1
1
C76
C77
C80
1
-1
3
1
-2
27
33
6
1
1
11
3
-8
1
-1
11
20
9
3
1
-2
31
36
5
1
1
10
5
-5
2
-2
1
1
15
10
-5
1
1
128
110
-18
1
-1
2
-2
1
1
5
8
3
49
51
2
1
2
1
3
1
-2
- 425 -
1
1
12
9
-3
4
2
-2
13
13
-
C73 C74-C75
1
1
1
1
1
-1
1
2
1
3
3
11
17
6
2
-2
3
3
16
11
-5
C69
7
6
-1
51
40
-11
4
8
4
4
-4
1
2
1
1
-1
1
-1
19
18
-1
2
2
2
2
34
45
11
C65-C66,
C68
1
6
5
33
20
-13
1
1
5
6
1
29
23
-6
C64
1
-1
1
1
1
1
1
-1
4
-4
C67
3
2
-1
1
1
5
1
-4
5
8
3
64
109
45
4
7
3
5
5
2
-2
38
43
5
1
5
4
1
1
55
77
22
C61
0304
0305
0306
0307
0308
0311
0312
0314
0315
0316
0317
0318
0319
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0320
98
99
0321
98
99
0401
98
99
0402
98
99
0403
98
99
0404
98
99
0406
98
99
0407
98
99
0501
98
99
0502
98
99
0503
98
99
0504
98
99
0505
98
99
577
684
107
713
1,249
536
617
791
174
677
723
46
452
545
93
62
42
-20
17
28
11
71
62
-9
1,118
1,286
168
1
-1
31
77
46
61
76
15
41
32
-9
C00 C01-C02
1
1
3
3
1
1
1
2
1
1
1
-
8
18
10
14
24
10
9
7
-2
11
10
-1
2
4
2
1
-1
16
12
-4
1
-1
1
1
C03
1
4
3
2
15
13
8
8
3
3
1
-1
6
9
3
-
13
17
4
15
31
16
10
13
3
16
7
-9
3
5
2
1
-1
1
-1
15
19
4
1
-1
2
1
-1
-
3
7
4
3
13
10
3
7
4
5
12
7
6
2
-4
5
11
6
2
2
1
-1
-
101 5 21 99 100 6 3 98
- 426 -
6
10
4
5
13
8
3
3
13
11
-2
5
3
-2
13
11
-2
-
C14
C07-C08
1
1
-
1
4
3
2
3
1
3
3
4
1
-3
1
-1
1
1
3
2
-1
-
C48
12
21
9
17
20
3
14
12
-2
7
11
4
7
8
1
1
1
26
21
-5
2
2
1
1
2
2
1
1
2
2
2
-2
-
- 427 -
C26 C30-C31
1
1
1
1
-
2
2
3
3
1
2
1
3
2
-1
1
1
1
1
2
4
2
1
1
-
C32
C33-C34
5
4
-1
5
6
1
1
2
1
3
5
2
3
4
1
1
1
1
-1
1
5
4
3
3
1
1
72
64
-8
103
166
63
101
152
51
86
92
6
75
100
25
16
8
-8
14
12
-2
127
161
34
1
21
20
2
6
4
4
1
-3
C25
6
16
10
14
11
-3
3
8
5
5
9
4
10
14
4
2
-2
1
1
7
14
7
2
2
-
C23-C24
85
83
-2
82
124
42
63
58
-5
96
84
-12
61
68
7
7
5
-2
4
4
92
140
48
2
5
3
2
5
3
2
3
1
40
52
12
45
87
42
19
46
27
26
30
4
30
28
-2
5
4
-1
4
7
3
5
6
1
80
69
-11
7
10
3
-
C22
68
51
-17
69
109
40
47
59
12
58
55
-3
51
49
-2
6
4
-2
7
7
6
8
2
98
148
50
2
3
1
11
14
3
5
4
-1
C18 C19-C21
2
2
4
6
2
1
2
1
2
3
1
2
3
1
1
1
4
4
-
C17
35
32
-3
34
65
31
48
53
5
45
46
1
29
45
16
7
4
-3
1
1
7
3
-4
71
61
-10
7
6
-1
1
14
13
2
3
1
C16
14
19
5
15
45
30
14
21
7
22
25
3
18
21
3
2
-2
1
-1
1
-1
28
37
9
3
3
5
1
-4
4
4
-
C15
1
16
15
21
33
12
13
22
9
13
16
3
10
13
3
1
1
27
35
8
2
2
1
2
1
C11
0320
0321
0401
0402
0403
0404
0406
0407
0501
0502
0503
0504
0505
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0403
98
99
0404
98
99
0406
98
99
0407
98
99
0501
98
99
0502
98
99
0503
98
99
0504
98
99
0505
98
99
98
C50
C50
C55
C53
C54
17
19
2
17
28
11
17
13
-4
31
32
1
5
27
22
3
-3
2
2
1
-1
22
23
1
3
5
2
6
3
-3
3
3
-
50
90
40
71
138
67
61
101
40
87
85
-2
24
35
11
1
-1
196
175
-21
4
1
-3
7
1
-6
2
-2
1
1
1
1
36
37
1
31
41
10
20
16
-4
24
29
5
33
25
-8
2
1
-1
6
10
4
3
3
75
68
-7
1
7
6
8
9
1
5
6
1
8
16
8
5
15
10
5
9
4
5
3
-2
4
5
1
3
-3
15
15
1
2
1
1
1
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 428 -
0402
6
6
4
4
7
4
-3
1
1
2
4
2
1
-1
6
8
2
1
1
-
C44
98
99
1
1
1
2
1
3
4
1
2
2
1
1
3
1
-2
-
0401
3
3
4
17
13
40
47
7
5
11
6
1
1
3
1
-2
8
4
-4
1
-1
98
99
5
3
-2
7
13
6
7
5
-2
3
2
-1
1
1
1
1
9
10
1
1
1
-
0321
1
-1
1
-1
1
1
1
1
2
2
-
98
99
C42
0320
C37-C38.3,
C38.8
1
1
1
6
5
1
3
2
3
3
1
1
1
1
4
5
1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
8
3
4
-4
-3
9
8
1
-1
1
3
1
2
-2
2
6
2
4
2
-2
8
4
-4
7
6
16
5
9
-1
1
2
-1
-2
-
2
2
1
1
1
2
1
-
- 429 -
4
6
2
6
17
11
1
3
2
2
2
2
3
1
1
1
2
13
11
1
1
-
2
1
-1
1
1
1
1
1
-1
1
1
1
1
-
7
5
-2
11
15
4
14
8
-6
9
18
9
10
9
-1
1
-1
23
33
10
2
1
-1
1
-1
1
1
1
-1
-
C76
C77
C80
1
1
-
6
6
18
16
-2
6
12
6
12
9
-3
4
4
13
14
1
-
6
9
3
9
14
5
12
15
3
6
6
8
6
-2
2
1
-1
20
15
-5
2
2
-
5
5
10
16
6
2
5
3
14
13
-1
1
6
5
4
1
-3
7
7
1
1
1
-1
8
4
-4
5
8
3
8
4
-4
5
8
3
3
4
1
1
1
1
3
2
5
8
3
1
1
1
1
2
-2
C73 C74-C75
10
10
15
34
19
21
20
-1
19
27
8
11
22
11
1
1
3
4
1
24
24
1
-1
4
2
-2
3
4
1
1
-1
C69
C65-C66,
C68
C64
C67
1
1
1
1
1
1
1
-1
-
2
1
-1
4
2
-2
1
-1
2
2
3
3
-
20
33
13
29
66
37
37
36
-1
30
34
4
17
15
-2
9
11
2
12
7
-5
42
69
27
3
4
1
4
4
2
-2
C61
0320
0321
0401
0402
0403
0404
0406
0407
0501
0502
0503
0504
0505
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0507
98
99
0509
98
99
98
99
0511
0512
98
99
0513
98
99
0515
98
99
0516
98
99
0602
98
99
0603
98
99
0604
98
99
0605
98
99
0606
98
99
0607 ()
98
99
237
248
11
35
42
7
65
43
-22
1
1
1
1
687
898
211
299
310
11
19
33
14
309
340
31
724
825
101
259
235
-24
454
558
104
9
7
-2
C00 C01-C02
2
1
-1
2
1
-1
-
1
1
1
1
14
21
7
9
9
7
6
-1
20
16
-4
1
4
3
5
2
-3
1
-1
C03
4
4
2
5
3
1
1
2
3
1
2
2
-
4
1
-3
1
1
3
3
12
14
2
5
9
4
5
13
8
13
16
3
2
1
-1
7
12
5
-
1
-1
1
-1
11
6
-5
3
5
2
2
-2
2
8
6
4
4
-
101 5 21 99 100 6 3 98
- 430 -
1
1
9
9
2
3
1
9
8
-1
1
1
1
1
-
C14
C07-C08
1
-1
1
-1
-
1
1
2
8
6
1
-1
2
2
2
2
1
-1
-
C48
27
37
10
2
7
5
7
5
-2
64
93
29
36
51
15
5
2
-3
33
48
15
89
104
15
27
24
-3
42
56
14
1
1
26
24
-2
4
13
9
12
7
-5
1
1
75
114
39
35
21
-14
3
3
35
32
-3
79
69
-10
28
33
5
37
49
12
2
2
-
5
-5
1
-1
1
5
4
1
1
4
6
2
9
3
-6
5
3
-2
3
3
-
5
2
-3
3
-3
2
-2
11
20
9
3
4
1
1
-1
7
5
-2
8
12
4
10
5
-5
9
11
2
-
1
1
1
1
1
1
1
1
-
17
20
3
1
-1
9
3
-6
33
52
19
19
14
-5
1
3
2
10
18
8
43
54
11
19
18
-1
25
47
22
1
-1
- 431 -
C26 C30-C31
1
1
3
-3
1
-1
-
1
1
4
2
-2
1
2
1
1
-1
3
3
-
C32
C33-C34
1
-1
1
-1
4
5
1
1
1
6
5
-1
1
-1
2
3
1
-
21
27
6
7
9
2
3
8
5
1
-1
65
81
16
14
16
2
46
43
-3
95
133
38
34
30
-4
54
50
-4
1
3
2
C25
C23-C24
C22
1
1
1
-1
1
-1
3
3
2
-2
1
1
4
4
1
1
1
2
1
-
C18 C19-C21
16
20
4
3
1
-2
2
1
-1
28
40
12
18
18
1
1
29
27
-2
40
34
-6
15
18
3
31
38
7
2
-2
3
6
3
1
-1
1
1
12
18
6
10
-10
2
2
9
11
2
23
26
3
13
14
1
18
22
4
1
1
-
7
7
1
-1
17
25
8
6
9
3
4
4
20
21
1
1
3
2
6
4
-2
-
C17
C16
C15
C11
0507
0509
0511
0512
0513
0515
0516
0602
0603
0604
0605
0606
0607
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0513
98
99
0515
98
99
0516
98
99
0602
98
99
0603
98
99
0604
98
99
0605
98
99
0606
98
99
0607
98
99
C50
C50
C55
C53
C54
7
8
1
1
1
10
2
-8
1
1
23
22
-1
15
14
-1
1
1
8
5
-3
20
27
7
16
4
-12
9
5
-4
-
21
21
2
1
-1
2
4
2
102
110
8
46
58
12
57
46
-11
97
107
10
20
20
69
103
34
-
1
-1
1
-1
-
1
1
-
24
18
-6
3
2
-1
4
3
-1
77
83
6
24
34
10
2
7
5
6
16
10
26
30
4
17
14
-3
47
47
-
4
6
2
1
-1
15
20
5
9
11
2
7
4
-3
4
11
7
13
16
3
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 432 -
0512
4
-4
1
-1
2
-2
3
-3
2
2
3
3
4
7
3
1
4
3
1
2
1
-
C44
98
99
3
3
1
1
1
-1
1
-1
-
0511
1
-1
1
-1
14
25
11
1
1
1
3
2
4
4
5
-5
-
98
99
1
1
2
8
6
2
2
1
1
3
3
1
4
3
2
-2
-
0509
1
1
1
1
-
98
99
C42
0507
C37-C38.3,
C38.8
1
1
1
1
3
3
2
2
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
3
-3
12
2
11
3
-1
1
1
1
1
-1
2
1
2
1
5
2
6
2
1
3
2
3
1
-1
7
2
10
3
-2
-
- 433 -
5
5
1
1
2
4
2
2
1
-1
1
1
-
1
-1
1
1
1
1
1
-1
-
8
6
-2
1
-1
11
12
1
10
7
-3
3
8
5
9
12
3
4
-4
5
9
4
-
1
1
-
C76
C77
C80
1
1
-
4
2
-2
2
-2
7
9
2
1
2
1
5
6
1
10
8
-2
1
1
2
5
3
-
7
4
-3
1
1
1
1
6
4
-2
3
3
1
-1
12
5
-7
9
6
-3
8
7
-1
9
6
-3
-
6
2
-4
8
9
1
4
1
-3
3
1
-2
4
4
1
1
5
3
-2
-
1
2
1
1
1
2
5
3
4
2
-2
6
4
-2
2
3
1
7
5
-2
-
C73 C74-C75
6
10
4
1
1
3
3
15
19
4
5
1
-4
1
2
1
5
6
1
12
22
10
8
3
-5
9
14
5
-
C69
C65-C66,
C68
C64
C67
1
-1
1
1
1
1
2
-2
1
1
-
1
-1
2
1
-1
1
1
2
2
1
-1
-
11
15
4
3
1
-2
1
1
10
19
9
13
8
-5
4
12
8
8
11
3
36
47
11
7
3
-4
17
21
4
1
-1
C61
0507
0509
0511
0512
0513
0515
0516
0602
0603
0604
0605
0606
0607
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0608
98
99
0609
98
99
0610
98
99
0612
98
99
0613
98
99
0614
98
99
0615
98
99
0616
98
99
0618
98
99
0619
98
99
0701
98
99
0702
98
99
0703
98
99
88
49
-39
10
11
1
102
84
-18
82
131
49
7
9
2
535
530
-5
142
96
-46
2
-2
150
135
-15
34
25
-9
39
41
2
222
194
-28
1
1
C00 C01-C02
-
3
1
-2
5
12
7
3
-3
3
4
1
-
C03
1
2
1
-
1
3
2
1
1
13
8
-5
2
3
1
1
-1
1
1
2
-2
6
4
-2
-
2
2
1
-1
1
1
4
8
4
1
1
1
1
-
101 5 21 99 100 6 3 98
- 434 -
2
2
5
9
4
2
2
1
-1
2
-2
-
C14
C07-C08
1
-1
-
1
1
1
1
1
1
-
4
1
-3
1
1
10
7
-3
2
12
10
63
43
-20
7
6
-1
18
16
-2
6
2
-4
5
6
1
47
19
-28
-
1
1
1
1
4
4
2
1
-1
1
1
1
-1
4
2
-2
-
1
-1
1
1
5
5
10
8
-2
3
1
-2
6
2
-4
1
1
2
2
6
4
-2
-
2
2
-
- 435 -
C26 C30-C31
1
-1
-
1
1
2
2
1
2
1
-
C32
C33-C34
1
-1
1
1
4
3
-1
1
-1
1
-1
-
18
10
-8
1
2
1
7
2
-5
10
32
22
75
71
-4
10
9
-1
18
13
-5
4
2
-2
1
2
1
25
26
1
1
1
C48
9
2
-7
5
3
-2
4
2
-2
2
2
32
38
6
17
6
-11
11
15
4
3
2
-1
5
11
6
27
31
4
-
C25
5
4
-1
8
12
4
15
13
-2
3
2
-1
45
59
14
24
24
1
-1
24
16
-8
4
6
2
9
10
1
13
23
10
-
C23-C24
1
-1
2
2
2
-2
1
1
1
-1
2
-2
-
C22
2
2
2
-2
13
8
-5
6
8
2
1
1
28
38
10
6
14
8
16
12
-4
4
3
-1
5
3
-2
8
12
4
-
3
4
1
1
-1
4
3
-1
1
1
13
10
-3
3
3
3
6
3
1
-1
2
2
11
8
-3
-
1
-1
1
1
1
1
14
11
-3
1
-1
2
3
1
3
3
2
-2
1
2
1
-
C18 C19-C21
C17
C16
C15
C11
0608
0609
0610
0612
0613
0614
0615
0616
0618
0619
0701
0702
0703
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0613
98
99
0614
98
99
0615
98
99
0616
98
99
0618
98
99
0619
98
99
0701
98
99
0702
98
99
0703
98
99
C50
C50
C55
C53
C54
1
-1
1
1
6
7
1
1
2
1
1
4
3
13
12
-1
10
4
-6
6
10
4
3
3
12
4
-8
-
13
-13
1
2
1
10
8
-2
2
1
-1
44
47
3
19
12
-7
1
-1
13
10
-3
16
13
-3
-
1
-1
1
1
-
1
-1
-
5
1
-4
11
6
-5
6
4
-2
3
-3
43
24
-19
10
7
-3
2
1
-1
1
1
11
10
-1
-
3
-3
1
1
7
4
-3
1
1
1
1
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 436 -
0612
1
1
3
-3
1
-1
3
2
-1
2
-2
2
-2
-
C44
98
99
1
1
1
-1
-
0610
6
2
-4
1
1
2
1
-1
-
98
99
1
-1
3
3
5
2
-3
2
-2
-
0609
1
1
-
98
99
C42
0608
C37-C38.3,
C38.8
1
2
1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
2
2
-2
-2
4
1
9
1
5
1
-1
2
-2
-
- 437 -
2
1
-1
1
1
1
1
2
10
8
1
-1
1
1
-
1
1
1
1
-
1
-1
1
1
1
1
15
14
-1
1
-1
1
1
1
-1
1
-1
-
1
1
-
C76
C77
C80
1
1
1
-1
-
2
-2
3
-3
9
11
2
4
-4
1
2
1
4
-4
-
1
1
2
1
-1
4
4
10
7
-3
2
1
-1
4
6
2
2
8
6
-
2
1
-1
1
1
1
2
1
12
3
-9
1
-1
3
3
2
2
-
1
-1
1
-1
1
3
2
4
9
5
3
-3
2
1
-1
-
C73 C74-C75
2
5
3
1
2
1
5
6
1
8
8
17
20
3
1
2
1
7
7
2
1
-1
4
2
-2
4
11
7
-
C69
C65-C66,
C68
C64
C67
1
-1
-
1
1
1
-1
-
9
6
-3
1
1
7
9
2
17
27
10
17
15
-2
9
-9
5
4
-1
4
2
-2
6
6
-
C61
0608
0609
0610
0612
0613
0614
0615
0616
0618
0619
0701
0702
0703
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0704
98
99
0705
98
99
0709
98
99
0710
98
99
0712
98
99
0801
98
99
0802
98
99
0803
98
99
0804
98
99
0805
98
99
0806
98
99
0808
98
99
0810
98
99
50
65
15
210
244
34
382
363
-19
24
26
2
4
9
5
311
433
122
1,483
1,550
67
5
-5
232
193
-39
358
422
64
1
-1
4,566
4,786
220
4,541
4,528
-13
C00 C01-C02
1
1
1
1
10
16
6
30
22
-8
12
17
5
2
2
4
4
6
4
-2
5
-5
58
62
4
1
-1
4
3
-1
144
121
-23
133
125
-8
C03
2
2
1
1
24
22
-2
1
-1
48
38
-10
35
28
-7
3
2
-1
5
8
3
1
-1
9
9
87
86
-1
1
1
6
2
-4
177
164
-13
131
148
17
1
-1
2
-2
1
1
9
14
5
2
2
3
3
41
43
2
53
47
-6
101 5 21 99 100 6 3 98
- 438 -
1
1
3
-3
1
1
20
21
1
1
1
4
4
52
53
1
73
72
-1
C14
C07-C08
1
1
1
1
1
4
3
2
2
1
-1
3
-3
3
1
-2
2
-2
4
2
-2
1
1
1
1
17
11
-6
9
10
1
C48
3
5
2
21
34
13
41
33
-8
3
5
2
1
-1
22
61
39
122
122
1
-1
16
27
11
32
31
-1
326
370
44
282
333
51
16
11
-5
34
38
4
40
43
3
3
5
2
1
2
1
19
20
1
161
140
-21
25
20
-5
71
86
15
482
498
16
624
601
-23
1
-1
2
2
2
4
2
3
1
-2
14
22
8
2
-2
5
7
2
38
38
38
31
-7
2
3
1
8
9
1
12
7
-5
1
1
3
7
4
22
22
4
4
9
10
1
73
77
4
67
74
7
1
-1
2
2
2
2
4
1
-3
1
-1
1
2
1
11
9
-2
2
10
8
2
1
-1
7
14
7
24
21
-3
6
2
-4
1
1
23
21
-2
65
78
13
1
-1
24
16
-8
40
44
4
235
272
37
182
192
10
- 439 -
C26 C30-C31
1
-1
2
-2
2
3
1
2
3
1
1
1
4
1
-3
1
1
12
14
2
23
13
-10
C32
C33-C34
1
-1
2
3
1
11
16
5
1
-1
1
1
36
36
38
30
-8
8
9
1
30
32
2
40
46
6
1
6
5
1
-1
29
41
12
176
163
-13
30
31
1
29
60
31
534
508
-26
516
473
-43
C25
C23-C24
C22
1
-1
11
11
1
1
3
4
1
17
19
2
24
20
-4
C18 C19-C21
1
4
3
12
14
2
16
13
-3
1
2
1
10
17
7
37
43
6
2
-2
18
8
-10
22
22
204
237
33
161
165
4
2
3
1
8
8
11
12
1
2
-2
5
8
3
42
45
3
2
3
1
6
15
9
126
164
38
136
136
-
4
4
2
3
1
5
6
1
38
29
-9
1
2
1
6
3
-3
103
101
-2
85
94
9
C17
C16
C15
C11
0704
0705
0709
0710
0712
0801
0802
0803
0804
0805
0806
0808
0810
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0712
98
99
0801
98
99
0802
98
99
0803
98
99
0804
98
99
0805
98
99
0806
98
99
0808
98
99
0810
98
99
C50
C50
C55
C53
C54
3
2
-1
5
7
2
15
7
-8
1
-1
1
1
16
16
59
58
-1
3
4
1
11
12
1
94
105
11
99
99
-
2
5
3
8
16
8
40
50
10
1
1
84
125
41
154
159
5
27
19
-8
46
49
3
435
500
65
463
505
42
1
-1
2
-2
1
1
2
5
3
1
2
1
1
1
6
11
5
5
11
6
37
22
-15
9
9
75
102
27
11
9
-2
9
6
-3
176
161
-15
229
228
-1
2
2
2
1
-1
14
8
-6
4
8
4
33
38
5
8
4
-4
4
8
4
65
78
13
75
80
5
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 440 -
0710
2
2
2
-2
8
12
4
1
1
2
1
-1
24
26
2
33
20
-13
C44
98
99
1
1
7
4
-3
1
-1
1
1
15
14
-1
14
19
5
0709
1
1
2
1
-1
1
1
15
17
2
1
2
1
112
119
7
171
130
-41
98
99
1
1
1
1
2
1
-1
1
1
1
1
6
6
1
1
28
34
6
36
25
-11
0705
1
1
3
6
3
1
-1
98
99
C42
0704
C37-C38.3,
C38.8
2
-2
1
1
2
1
-1
1
-1
1
1
22
27
5
22
15
-7
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
2
1
3
1
-1
1
4
4
3
-4
1
1
1
3
2
32
5
33
5
1
3
-3
4
1
8
4
-1
48
5
50
9
2
4
47
16
56
8
9
-8
2
1
-1
4
9
5
3
2
-1
- 441 -
8
6
-2
2
-2
2
4
2
11
15
4
2
3
1
1
2
1
51
53
2
41
39
-2
1
-1
3
3
3
2
-1
4
2
-2
1
-1
2
3
1
2
3
1
23
25
2
4
1
-3
4
5
1
74
70
-4
115
104
-11
1
1
1
-1
1
-1
1
1
5
5
1
6
5
C76
C77
C80
1
-1
1
2
1
2
4
2
6
5
-1
1
-1
2
3
1
9
7
-2
5
1
-4
3
2
-1
85
78
-7
92
78
-14
1
1
3
4
1
7
7
6
2
-4
11
15
4
3
3
12
9
-3
57
55
-2
52
49
-3
2
1
-1
4
5
1
1
-1
3
7
4
25
24
-1
5
3
-2
4
2
-2
86
95
9
81
88
7
2
4
2
1
1
1
-1
3
-3
10
12
2
1
3
2
1
-1
47
53
6
42
40
-2
C73 C74-C75
1
-1
12
7
-5
12
10
-2
4
4
13
22
9
34
45
11
1
-1
5
7
2
8
10
2
92
119
27
97
110
13
C69
C65-C66,
C68
C64
C67
1
1
1
-1
2
1
-1
7
4
-3
3
4
1
2
2
2
-2
5
4
-1
1
1
8
6
-2
9
10
1
3
3
14
8
-6
22
35
13
1
1
1
1
22
31
9
32
41
9
22
11
-11
8
8
1
-1
295
288
-7
160
165
5
C61
0704
0705
0709
0710
0712
0801
0802
0803
0804
0805
0806
0808
0810
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0811
98
99
0812
98
99
0813
98
99
0814
98
99
0815
98
99
0816
98
99
0817
98
99
0901
98
99
0903
98
99
0906
98
99
0909
98
99
0910
98
99
0912
98
99
62
28
-34
8
10
2
512
578
66
691
755
64
336
367
31
17
-17
2
5
3
866
918
52
1,008
1,086
78
505
542
37
62
48
-14
90
96
6
7
3
-4
C00 C01-C02
1
-1
1
1
2
-2
2
-2
1
1
1
2
1
-
2
-2
8
10
2
14
10
-4
12
10
-2
14
24
10
25
15
-10
9
3
-6
1
1
-
C03
2
1
-1
2
2
3
4
1
3
4
1
1
-1
-
3
1
-2
1
1
11
7
-4
6
7
1
10
11
1
20
23
3
29
16
-13
6
10
4
1
1
-
1
-1
3
5
2
2
6
4
4
3
-1
14
9
-5
9
12
3
4
3
-1
-
101 5 21 99 100 6 3 98
- 442 -
2
2
8
6
-2
13
3
-10
5
6
1
13
13
12
6
-6
7
4
-3
-
C14
C07-C08
2
2
-
1
2
1
3
1
-2
2
1
-1
2
1
-1
4
2
-2
2
2
-
C48
1
1
10
15
5
14
24
10
2
14
12
3
-3
5
8
3
19
15
-4
8
6
-2
8
7
-1
4
4
-
1
-1
1
1
1
1
1
1
2
2
1
1
1
1
-
- 443 -
C26 C30-C31
2
2
1
1
1
-1
-
1
1
1
2
1
1
1
3
2
-1
4
2
-2
1
-1
-
C32
C33-C34
3
2
-1
5
3
-2
1
-1
5
9
4
11
6
-5
1
6
5
3
3
-
14
6
-8
2
1
-1
49
40
-9
80
87
7
21
35
14
4
-4
1
1
90
96
6
103
103
46
54
8
8
13
5
-
C25
3
7
4
10
7
-3
5
1
-4
5
4
-1
16
8
-8
6
7
1
3
2
-1
2
1
-1
-
C23-C24
7
4
-3
3
3
76
76
167
167
23
24
1
3
-3
1
1
106
120
14
121
148
27
48
55
7
14
13
-1
1
1
C22
1
1
29
66
37
63
77
14
18
22
4
76
76
83
109
26
30
42
12
8
5
-3
-
3
1
-2
1
1
58
74
16
41
44
3
40
41
1
4
-4
1
-1
89
94
5
63
97
34
48
45
-3
11
12
1
1
1
C18 C19-C21
1
-1
1
1
1
1
4
4
4
2
-2
1
-1
3
1
-2
3
2
-1
2
2
1
1
-
C17
1
4
3
1
1
17
29
12
25
40
15
19
25
6
1
-1
50
47
-3
48
49
1
26
25
-1
1
-1
7
9
2
3
-3
C16
3
2
-1
16
17
1
12
14
2
5
16
11
31
29
-2
28
40
12
17
14
-3
3
3
-
C15
2
-2
1
-1
11
4
-7
14
20
6
6
8
2
21
14
-7
15
11
-4
6
6
2
-2
1
1
-
C11
0811
0812
0813
0814
0815
0816
0817
0901
0903
0906
0909
0910
0912
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
0815
98
99
0816
98
99
0817
98
99
0901
98
99
0903
98
99
0906
98
99
0909
98
99
0910
98
99
0912
98
99
C50
C50
C55
C53
C54
3
1
-2
15
21
6
13
12
-1
9
8
-1
32
26
-6
16
18
2
22
19
-3
11
11
2
2
1
-1
4
1
-3
1
1
49
59
10
70
64
-6
49
38
-11
2
2
59
89
30
69
101
32
73
65
-8
4
5
1
-
1
1
1
-1
1
1
-
2
-2
1
-1
-
2
1
-1
19
11
-8
26
33
7
32
24
-8
64
69
5
96
87
-9
55
49
-6
4
6
2
-
1
1
9
10
1
13
15
2
4
7
3
11
13
2
9
14
5
5
5
1
-1
2
-2
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 444 -
0814
1
3
2
1
6
5
1
7
6
3
3
4
2
-2
1
3
2
1
4
3
1
1
-
C44
98
99
1
-1
2
2
1
-1
2
-2
2
-2
-
0813
1
1
3
13
10
10
3
-7
10
8
-2
2
6
4
14
13
-1
-
98
99
1
-1
2
2
4
7
3
1
-1
4
3
-1
1
1
3
9
6
-
0812
2
2
-
98
99
C42
0811
C37-C38.3,
C38.8
1
1
3
2
-1
2
2
4
5
1
1
-1
1
-1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
3
1
5
2
2
1
8
1
7
-1
-1
3
7
4
5
7
1
2
1
7
4
8
4
1
1
8
2
7
2
1
1
1
-1
-
- 445 -
2
2
2
6
4
1
5
4
1
-1
4
1
-3
17
8
-9
2
5
3
2
1
-1
1
1
-
1
1
1
-1
1
-1
-
2
-2
9
13
4
2
4
2
3
4
1
22
22
26
16
-10
5
9
4
3
1
-2
2
-2
-
1
-1
1
-1
-
C76
C77
C80
1
1
-
4
4
10
12
2
6
4
-2
7
14
7
11
11
5
1
-4
1
-1
-
1
-1
10
7
-3
9
15
6
6
5
-1
8
11
3
11
14
3
7
7
12
8
-4
2
-2
-
1
-1
4
15
11
10
11
1
1
7
6
10
7
-3
19
22
3
8
9
1
9
4
-5
3
3
-
9
2
-7
7
4
-3
1
2
1
1
-1
7
7
8
10
2
1
1
3
2
-1
1
-1
C73 C74-C75
3
-3
1
1
30
22
-8
16
14
-2
8
5
-3
25
17
-8
45
33
-12
12
15
3
2
5
3
2
1
-1
C69
C65-C66,
C68
C64
C67
1
-1
1
-1
4
4
1
1
1
1
1
1
-
1
-1
3
1
-2
1
-1
1
1
1
3
2
2
-2
1
1
-
4
1
-3
2
-2
37
32
-5
16
11
-5
11
13
2
1
1
40
37
-3
57
65
8
19
33
14
11
9
-2
-
C61
0811
0812
0813
0814
0815
0816
0817
0901
0903
0906
0909
0910
0912
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
0913
98
99
0914
98
99
0915
98
99
0916
98
99
1001
98
99
1002
98
99
1006
98
99
1007
98
99
1008
98
99
1013
98
99
1014
98
99
1018
98
99
1020
98
99
22
38
16
17
32
15
11
13
2
599
633
34
353
381
28
3,560
3,701
141
917
865
-52
136
167
31
38
21
-17
24
24
33
20
-13
370
358
-12
17
11
-6
C00 C01-C02
2
-2
2
2
22
24
2
8
2
-6
1
2
1
-
2
-2
1
1
1
7
6
9
13
4
126
105
-21
18
10
-8
4
6
2
1
-1
5
4
-1
-
C03
2
4
2
2
1
-1
50
49
-1
4
5
1
2
1
-1
-
4
13
9
13
20
7
151
176
25
41
19
-22
14
10
-4
1
-1
7
9
2
1
1
2
2
6
4
-2
30
42
12
9
8
-1
1
1
4
3
-1
1
1
101 5 21 99 100 6 3 98
- 446 -
1
1
1
1
4
8
4
4
13
9
56
50
-6
7
15
8
1
2
1
1
1
1
1
4
4
-
C14
C07-C08
1
1
2
-2
1
-1
1
1
-
2
-2
10
12
2
5
1
-4
-
C48
4
3
-1
1
5
4
1
2
1
55
60
5
27
37
10
266
315
49
71
73
2
9
17
8
8
5
-3
2
1
-1
62
60
-2
1
-1
1
1
4
5
1
1
3
2
67
70
3
52
45
-7
385
450
65
135
131
-4
11
11
4
2
-2
1
1
32
27
-5
3
4
1
4
6
2
2
2
43
43
12
9
-3
2
2
1
1
16
16
7
3
-4
46
51
5
11
11
3
-3
2
-2
5
4
-1
1
-1
3
1
-2
3
1
-2
1
-1
1
5
4
2
1
-1
58
70
12
16
18
2
161
140
-21
41
47
6
5
18
13
2
2
3
3
14
24
10
1
1
- 447 -
C26 C30-C31
2
-2
3
3
1
1
-
1
-1
10
4
-6
7
1
-6
2
-2
-
C32
C33-C34
4
4
1
7
6
37
23
-14
3
6
3
3
1
-2
1
1
3
4
1
2
6
4
1
2
1
79
88
9
53
59
6
400
382
-18
92
92
13
21
8
3
2
-1
1
5
4
35
21
-14
1
-1
C25
C23-C24
C22
1
1
5
4
-1
1
1
14
15
1
7
5
-2
-
C18 C19-C21
3
3
4
4
32
40
8
11
19
8
136
139
3
46
33
-13
5
6
1
4
2
-2
1
1
18
19
1
2
-2
2
7
5
3
1
-2
1
1
22
22
15
14
-1
105
91
-14
25
24
-1
6
5
-1
2
2
1
-1
15
12
-3
1
1
1
-1
4
8
4
7
6
-1
64
72
8
13
9
-4
2
4
2
10
16
6
1
-1
C17
C16
C15
C11
0913
0914
0915
0916
1001
1002
1006
1007
1008
1013
1014
1018
1020
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1001
98
99
1002
98
99
1006
98
99
1007
98
99
1008
98
99
1013
98
99
1014
98
99
1018
98
99
1020
98
99
C50
C50
C55
C53
C54
1
1
2
2
1
-1
13
9
-4
13
20
7
126
131
5
37
19
-18
4
9
5
5
1
-4
2
1
-1
13
10
-3
-
1
4
3
1
1
1
1
79
70
-9
20
19
-1
424
508
84
62
91
29
14
20
6
1
-1
4
3
-1
4
8
4
60
64
4
1
-1
3
1
-2
1
1
-
1
1
-
1
1
12
10
-2
23
16
-7
212
175
-37
65
50
-15
15
16
1
4
1
-3
10
7
-3
22
10
-12
14
13
-1
1
-1
6
6
1
2
1
45
57
12
20
13
-7
2
2
1
1
4
1
-3
3
-3
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 448 -
0916
1
1
1
-1
3
2
-1
1
1
22
22
2
3
1
1
1
1
-1
2
1
-1
-
C44
98
99
3
4
1
2
2
1
-1
1
1
-
0915
7
3
-4
1
-1
91
73
-18
5
10
5
2
-2
3
2
-1
-
98
99
10
6
-4
1
1
17
18
1
5
6
1
3
-3
1
-1
0914
1
2
1
1
-1
-
98
99
C42
0913
C37-C38.3,
C38.8
3
4
1
1
1
6
5
-1
2
2
1
-1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
4
3
4
1
-3
35
10
37
11
2
1
6
4
10
2
4
-2
1
1
-1
-1
1
-1
1
3
2
2
2
1
-1
-
C76
C77
C80
1
1
1
1
7
12
5
3
-3
41
45
4
8
9
1
2
2
3
4
1
3
1
-2
1
-1
1
1
9
5
-4
10
3
-7
25
33
8
13
15
2
2
2
2
4
2
-
1
-1
1
-1
-
1
1
1
1
1
-1
17
17
3
3
90
90
33
25
-8
3
1
-2
1
1
10
10
-
1
-1
3
3
-
C73 C74-C75
- 449 -
1
-1
6
7
1
3
-3
16
18
2
2
4
2
1
1
1
-1
-
5
6
1
-
7
5
-2
2
3
1
21
26
5
9
8
-1
1
3
2
-
C69
1
2
1
1
1
1
1
13
16
3
11
20
9
64
64
33
27
-6
6
5
-1
3
3
12
14
2
-
C65-C66,
C68
1
1
2
-2
15
9
-6
4
3
-1
49
44
-5
12
18
6
1
1
8
6
-2
-
C64
1
1
1
-1
3
3
2
1
-1
1
-1
-
C67
2
-2
2
7
5
1
2
1
-
1
1
1
3
2
3
-3
28
25
-3
21
19
-2
116
124
8
34
43
9
9
5
-4
15
10
-5
-
C61
0913
0914
0915
0916
1001
1002
1006
1007
1008
1013
1014
1018
1020
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1021
98
99
1022
98
99
1102
98
99
1103
98
99
1104
98
99
1105
98
99
1106
98
99
1107
98
99
1108
98
99
1201
98
99
1202
98
99
1203
98
99
1206
98
99
454
369
-85
151
155
4
122
163
41
113
113
71
58
-13
1
3
2
90
70
-20
101
119
18
127
140
13
53
50
-3
885
854
-31
77
130
53
17
22
5
C00 C01-C02
3
-3
1
1
1
1
5
6
1
1
1
-
12
-12
4
3
-1
2
2
3
2
-1
2
4
2
6
-6
4
4
23
32
9
1
2
1
-
C03
1
-1
2
2
2
2
2
2
10
14
4
-
14
4
-10
4
3
-1
1
1
2
2
3
1
-2
4
4
3
3
9
2
-7
42
56
14
2
1
-1
-
2
3
1
1
1
1
-1
1
1
1
1
1
1
4
1
-3
8
8
1
-1
-
101 5 21 99 100 6 3 98
- 450 -
2
4
2
1
-1
1
1
2
-2
1
1
1
1
3
2
-1
11
12
1
2
2
-
C14
C07-C08
1
1
-
1
1
2
2
1
1
-
42
33
-9
11
5
-6
5
12
7
9
11
2
4
4
4
2
-2
1
3
2
17
16
-1
2
10
8
158
164
6
5
15
10
1
4
3
3
4
1
1
1
2
2
1
-1
1
-1
2
1
-1
1
1
9
2
-7
5
5
-
9
7
-2
1
-1
2
5
3
2
3
1
3
-3
1
1
3
3
1
-1
17
13
-4
3
3
1
1
-
1
1
1
1
1
1
-
- 451 -
C26 C30-C31
-
1
-1
1
-1
1
-1
1
1
1
-1
5
3
-2
-
C32
C33-C34
2
-2
2
3
1
2
1
-1
4
1
-3
1
1
1
1
11
10
-1
1
-1
-
55
64
9
23
17
-6
8
16
8
9
6
-3
8
14
6
4
2
-2
5
7
2
6
8
2
13
11
-2
102
101
-1
9
14
5
3
3
-
C48
19
30
11
14
8
-6
10
19
9
5
9
4
8
1
-7
4
4
9
5
-4
5
6
1
4
1
-3
44
30
-14
5
10
5
1
1
-
C25
31
49
18
12
20
8
11
20
9
8
12
4
9
4
-5
9
12
3
8
12
4
13
17
4
2
3
1
60
49
-11
14
18
4
1
4
3
C23-C24
5
2
-3
1
-1
2
2
6
1
-5
2
-2
-
C22
23
16
-7
13
10
-3
7
3
-4
6
9
3
2
5
3
2
2
2
5
3
8
8
2
4
2
25
18
-7
7
8
1
1
-1
16
17
1
4
3
-1
6
5
-1
4
7
3
2
1
-1
2
2
2
8
6
12
6
-6
2
2
23
19
-4
2
5
3
1
1
12
6
-6
3
3
3
-3
3
1
-2
4
1
-3
4
2
-2
6
1
-5
19
17
-2
1
1
-
C18 C19-C21
C17
C16
C15
C11
1021
1022
1102
1103
1104
1105
1106
1107
1108
1201
1202
1203
1206
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1104
98
99
1105
98
99
1106
98
99
1107
98
99
1108
98
99
1201
98
99
1202
98
99
1203
98
99
1206
98
99
C50
C50
C55
C53
C54
24
10
-14
4
9
5
4
11
7
6
7
1
3
3
6
4
-2
13
11
-2
2
5
3
4
-4
25
21
-4
9
9
3
1
-2
38
30
-8
10
16
6
13
19
6
12
5
-7
7
1
-6
1
1
22
11
-11
4
11
7
11
19
8
11
8
-3
87
111
24
4
10
6
1
-1
1
-1
1
1
1
1
-
65
24
-41
13
15
2
13
9
-4
19
16
-3
8
2
-6
10
7
-3
5
11
6
3
1
-2
1
1
48
40
-8
3
3
3
3
6
10
4
3
6
3
1
1
1
1
1
-1
2
2
9
6
-3
2
-2
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 452 -
1103
5
4
-1
1
-1
1
1
1
-1
1
1
1
1
3
5
2
1
1
-
C44
98
99
3
2
-1
1
1
1
-1
1
1
-
1102
5
2
-3
1
1
1
1
1
-1
1
1
4
5
1
1
-1
98
99
1
1
1
-1
1
-1
1
-1
4
1
-3
-
1022
1
2
1
1
1
-
98
99
C42
1021
C37-C38.3,
C38.8
1
-1
2
-2
6
5
-1
1
1
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
6
3
4
4
-2
1
1
1
1
1
1
1
1
3
1
-3
1
1
1
-1
1
1
1
1
7
10
3
1
-1
-
- 453 -
1
3
2
1
1
1
1
1
1
3
3
-
1
1
1
1
-
10
8
-2
7
5
-2
2
-2
1
-1
3
2
-1
8
9
1
24
11
-13
3
3
1
-1
4
2
-2
-
C76
C77
C80
1
-1
-
5
5
1
1
1
3
2
1
1
1
-1
1
1
1
1
2
2
10
11
1
2
2
-
1
-1
2
1
-1
3
-3
4
1
-3
1
1
1
-1
14
6
-8
-
6
1
-5
1
1
3
1
-2
1
1
5
6
1
1
1
1
1
11
14
3
1
-1
-
2
3
1
1
-1
1
1
1
1
2
2
1
1
8
5
-3
-
C73 C74-C75
9
8
-1
5
7
2
7
4
-3
8
8
1
4
3
2
2
5
4
-1
12
13
1
3
8
5
5
2
-3
19
21
2
6
4
-2
3
3
C69
C65-C66,
C68
C64
C67
1
1
1
-1
-
1
-1
1
-1
1
1
1
-1
-
9
9
6
10
4
19
26
7
9
6
-3
3
10
7
1
-1
6
2
-4
12
10
-2
5
8
3
8
2
-6
22
17
-5
5
10
5
3
-3
C61
1021
1022
1102
1103
1104
1105
1106
1107
1108
1201
1202
1203
1206
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1207
98
99
1210
98
99
1214
98
99
1215
98
99
1216
98
99
1301
98
99
1302
98
99
1303
98
99
1304
98
99
1305
98
99
1308
98
99
1401
98
99
1402
98
99
1,926
2,120
194
2
8
6
1,482
1,443
-39
1,599
1,619
20
26
126
100
138
152
14
1,084
1,077
-7
1
-1
173
170
-3
141
183
42
167
193
26
302
378
76
2,647
2,731
84
C00 C01-C02
19
22
3
9
9
8
8
1
1
5
2
-3
2
2
4
3
-1
12
11
-1
64
53
-11
33
46
13
30
33
3
2
5
3
25
30
5
1
1
2
-2
7
5
-2
3
7
4
48
65
17
C03
25
27
2
11
18
7
9
9
5
7
2
1
-1
2
-2
2
2
2
2
23
13
-10
82
95
13
1
1
72
46
-26
37
47
10
2
-2
40
34
-6
7
3
-4
4
2
-2
5
13
8
5
6
1
89
73
-16
16
22
6
10
16
6
6
12
6
8
15
7
1
3
2
3
3
2
2
5
5
15
13
-2
101 5 21 99 100 6 3 98
- 454 -
31
25
-6
19
24
5
29
25
-4
2
1
-1
11
24
13
4
2
-2
3
1
-2
2
5
3
16
20
4
C14
C07-C08
2
-2
1
1
1
-1
1
-1
8
4
-4
2
3
1
2
2
1
1
5
1
-4
3
3
4
7
3
C48
104
155
51
1
1
112
110
-2
123
186
63
1
20
19
16
16
73
73
14
15
1
9
11
2
16
16
52
54
2
194
227
33
318
303
-15
268
238
-30
289
300
11
18
35
17
28
20
-8
210
179
-31
1
-1
21
28
7
10
18
8
39
23
-16
21
16
-5
383
378
-5
27
24
-3
1
1
11
16
5
12
15
3
1
-1
2
2
18
11
-7
1
1
1
1
2
2
27
36
9
35
28
-7
36
29
-7
20
22
2
2
2
2
2
21
23
2
1
2
1
2
-2
1
2
1
4
7
3
49
34
-15
1
1
3
3
2
1
-1
1
1
1
-1
3
3
1
-1
2
5
3
94
105
11
86
97
11
141
134
-7
1
6
5
8
13
5
47
68
21
7
15
8
3
5
2
1
17
16
29
28
-1
165
179
14
- 455 -
C26 C30-C31
1
1
1
1
1
-1
1
1
-
5
6
1
6
2
-4
6
3
-3
3
3
1
-1
1
1
10
1
-9
C32
C33-C34
10
7
-3
9
11
2
12
8
-4
8
5
-3
1
1
1
-1
13
8
-5
202
193
-9
2
2
192
189
-3
208
184
-24
3
8
5
7
15
8
179
161
-18
31
18
-13
12
13
1
8
18
10
34
53
19
297
292
-5
C25
C23-C24
C22
5
10
5
5
6
1
7
8
1
1
-1
3
3
1
1
1
1
1
1
3
3
14
8
-6
C18 C19-C21
76
67
-9
57
46
-11
60
68
8
9
9
3
9
6
42
42
8
6
-2
2
2
5
12
7
17
23
6
112
101
-11
48
52
4
3
3
32
24
-8
61
45
-16
4
4
3
4
1
33
37
4
7
4
-3
4
4
7
4
-3
1
3
2
48
51
3
26
29
3
26
21
-5
17
13
-4
5
5
13
25
12
1
1
1
-1
4
6
2
2
3
1
38
33
-5
C17
C16
C15
C11
1207
1210
1214
1215
1216
1301
1302
1303
1304
1305
1308
1401
1402
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1216
98
99
1301
98
99
1302
98
99
1303
98
99
1304
98
99
1305
98
99
1308
98
99
1401
98
99
1402
98
99
C50
C50
C55
C53
C54
72
87
15
50
60
10
55
53
-2
1
5
4
14
14
38
39
1
11
15
4
4
11
7
4
10
6
11
17
6
103
109
6
152
206
54
108
117
9
83
110
27
1
18
17
10
9
-1
53
59
6
5
8
3
9
19
10
10
27
17
27
34
7
223
253
30
2
1
-1
1
1
1
-1
1
-1
1
-1
1
1
-
127
149
22
39
47
8
86
57
-29
5
5
24
15
-9
40
35
-5
8
8
7
4
-3
16
8
-8
15
10
-5
113
121
8
28
35
7
14
17
3
15
16
1
1
1
3
2
-1
6
19
13
1
1
1
4
3
5
3
-2
29
46
17
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 456 -
1215
7
10
3
8
7
-1
3
6
3
1
1
1
-1
4
8
4
1
-1
1
1
3
2
-1
17
12
-5
C44
98
99
1
2
1
1
1
1
1
3
3
1
1
1
-1
8
2
-6
1214
28
49
21
36
23
-13
24
21
-3
8
3
-5
1
-1
1
1
1
7
6
33
38
5
98
99
9
7
-2
9
6
-3
9
6
-3
1
1
13
6
-7
1
-1
1
-1
1
-1
9
15
6
1210
1
-1
1
3
2
2
2
1
-1
5
-5
98
99
C42
1207
C37-C38.3,
C38.8
8
4
-4
2
3
1
3
1
-2
7
4
-3
1
1
18
7
-11
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
16
3
19
4
3
1
11
1
9
3
-2
2
13
10
-3
1
1
1
3
2
7
1
11
4
-1
1
1
1
-1
1
-1
5
2
1
-3
1
34
2
29
2
-5
-
1
2
1
2
-2
3
3
- 457 -
9
16
7
2
10
8
13
8
-5
1
2
1
6
14
8
1
1
3
3
2
3
1
24
32
8
1
-1
5
1
-4
2
1
-1
4
-4
56
45
-11
47
36
-11
22
19
-3
1
1
2
3
1
12
7
-5
1
-1
59
69
10
1
2
1
12
11
-1
67
67
-
2
-2
1
1
2
-2
1
2
1
3
3
-
C76
C77
C80
2
2
-
21
25
4
22
23
1
12
19
7
4
4
13
10
-3
3
-3
2
-2
1
-1
1
6
5
27
21
-6
20
24
4
19
13
-6
13
12
-1
3
3
1
1
9
14
5
2
-2
1
1
1
-1
3
5
2
30
42
12
35
44
9
22
17
-5
39
45
6
1
1
1
-1
19
22
3
4
6
2
1
1
1
4
3
3
5
2
79
84
5
8
15
7
8
5
-3
6
11
5
1
1
11
6
-5
2
2
2
-2
2
4
2
31
33
2
C73 C74-C75
56
54
-2
35
44
9
52
47
-5
1
1
4
3
-1
32
24
-8
15
8
-7
3
7
4
10
5
-5
15
23
8
99
95
-4
C69
C65-C66,
C68
C64
C67
1
-1
1
1
1
1
2
2
2
3
1
1
1
2
2
3
3
-
2
2
2
1
-1
1
1
2
6
4
60
84
24
41
41
60
40
-20
2
1
-1
39
38
-1
13
17
4
5
7
2
10
4
-6
18
19
1
118
141
23
C61
1207
1210
1214
1215
1216
1301
1302
1303
1304
1305
1308
1401
1402
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1404
98
99
1408
98
99
1409
98
99
1410
98
99
1501
98
99
1502
98
99
1503
98
99
1508
98
99
1509
98
99
1510
98
99
1601
98
99
1603
98
99
1604
98
99
294
332
38
3,485
3,645
160
746
788
42
611
611
27
24
-3
128
103
-25
113
117
4
264
293
29
33
31
-2
1,834
2,060
226
171
112
-59
2,839
2,850
11
345
420
75
C00 C01-C02
8
12
4
1
-1
1
1
6
11
5
30
16
-14
1
1
1
1
77
79
2
7
10
3
1
5
4
1
1
1
-1
2
2
1
-1
33
44
11
109
121
12
4
1
-3
C03
21
29
8
2
2
1
1
1
-1
18
10
-8
42
32
-10
-
1
3
2
88
86
-2
4
7
3
5
8
3
1
1
1
-1
3
4
1
1
1
47
52
5
161
192
31
10
4
-6
2
-2
29
29
1
2
1
2
3
1
2
1
-1
2
2
23
21
-2
23
26
3
1
1
-
101 5 21 99 100 6 3 98
- 458 -
1
1
40
36
-4
2
-2
1
8
7
1
-1
2
2
18
15
-3
32
39
7
3
3
C14
C07-C08
1
-1
1
-1
1
-1
-
2
1
-1
13
14
1
2
2
2
2
3
3
3
3
8
5
-3
-
C48
35
24
-11
205
204
-1
111
111
67
59
-8
3
3
8
5
-3
12
15
3
25
24
-1
6
11
5
122
156
34
19
12
-7
156
200
44
34
60
26
14
14
418
446
28
164
137
-27
73
76
3
3
3
8
13
5
17
16
-1
39
42
3
4
1
-3
287
347
60
8
6
-2
371
351
-20
47
41
-6
3
3
31
36
5
16
11
-5
6
6
3
2
-1
1
-1
4
3
-1
19
14
-5
24
19
-5
7
6
-1
2
2
76
82
6
22
11
-11
15
10
-5
4
4
1
-1
4
10
6
34
34
1
1
53
39
-14
3
9
6
3
8
5
1
-1
1
-1
1
6
5
2
1
-1
1
2
1
22
35
13
155
176
21
69
78
9
75
81
6
3
3
3
6
3
9
7
-2
17
29
12
5
5
90
93
3
12
19
7
109
131
22
35
46
11
- 459 -
C26 C30-C31
2
1
-1
1
1
1
2
1
1
2
1
1
1
-
1
1
6
13
7
1
1
2
1
-1
1
-1
1
-1
6
2
-4
15
5
-10
1
1
-
C32
C33-C34
1
-1
32
20
-12
2
2
1
1
15
14
-1
28
20
-8
1
1
-
29
34
5
405
415
10
80
97
17
82
31
-51
3
3
34
27
-7
11
13
2
39
24
-15
4
3
-1
225
212
-13
13
15
2
240
235
-5
45
47
2
C25
C23-C24
C22
9
14
5
4
7
3
2
1
-1
2
-2
4
13
9
9
14
5
1
3
2
C18 C19-C21
6
6
106
105
-1
51
47
-4
28
27
-1
3
1
-2
15
11
-4
9
9
24
19
-5
1
2
1
56
68
12
8
4
-4
92
80
-12
22
17
-5
12
6
-6
61
55
-6
31
30
-1
7
13
6
1
1
1
3
2
1
1
1
6
5
1
-1
45
44
-1
3
5
2
69
77
8
7
13
6
1
3
2
77
83
6
9
13
4
10
9
-1
1
1
2
5
3
1
-1
28
36
8
1
1
78
67
-11
5
10
5
C17
C16
C15
C11
1404
1408
1409
1410
1501
1502
1503
1508
1509
1510
1601
1603
1604
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1501
98
99
1502
98
99
1503
98
99
1508
98
99
1509
98
99
1510
98
99
1601
98
99
1603
98
99
1604
98
99
C50
C50
C55
C53
C54
9
7
-2
98
94
-4
22
22
19
25
6
1
1
3
1
-2
25
31
6
28
23
-5
1
1
82
132
50
6
6
120
126
6
12
12
-
34
64
30
466
451
-15
48
77
29
80
96
16
1
3
2
9
2
-7
5
3
-2
17
24
7
1
1
130
149
19
56
20
-36
345
364
19
34
31
-3
2
2
1
1
1
1
-
54
45
-9
185
173
-12
21
15
-6
29
41
12
1
-1
1
1
5
1
-4
14
14
3
4
1
94
78
-16
21
11
-10
80
89
9
18
14
-4
17
17
59
66
7
4
4
18
15
-3
2
4
2
2
2
19
33
14
1
1
33
26
-7
2
3
1
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 460 -
1410
2
-2
22
20
-2
2
1
-1
1
1
2
2
1
2
1
2
3
1
9
8
-1
14
22
8
2
1
-1
C44
98
99
8
5
-3
1
-1
1
1
5
2
-3
8
8
1
-1
1409
100
92
-8
4
4
16
2
-14
2
2
2
1
-1
40
46
6
76
76
3
1
-2
98
99
1
1
15
25
10
10
10
1
4
3
1
1
11
19
8
19
15
-4
3
1
-2
1408
2
2
1
1
1
-1
1
1
3
1
-2
2
3
1
1
1
98
99
C42
1404
C37-C38.3,
C38.8
23
17
-6
6
5
-1
1
2
1
1
1
10
13
3
10
5
-5
1
-1
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
7
2
6
3
-1
1
29
9
55
7
26
-2
4
4
11
2
14
1
3
-1
2
1
2
1
15
6
14
5
-1
-1
1
-1
32
9
23
2
-9
-7
3
2
-1
-
2
9
7
1
1
2
4
2
6
8
2
-
- 461 -
1
1
25
35
10
1
1
1
6
5
2
2
6
17
11
21
20
-1
1
1
-
5
6
1
1
1
1
1
2
1
-1
3
1
-2
-
2
1
-1
133
173
40
18
19
1
6
9
3
2
-2
1
-1
1
-1
3
7
4
106
98
-8
1
-1
102
98
-4
5
6
1
2
3
1
3
2
-1
1
4
3
-
C76
C77
C80
1
1
1
1
1
1
5
2
-3
46
63
17
4
10
6
3
1
-2
1
1
2
2
3
2
-1
25
20
-5
24
33
9
3
3
-
1
3
2
32
42
10
3
1
-2
5
6
1
1
-1
2
1
-1
1
1
3
2
-1
18
21
3
1
-1
34
30
-4
3
8
5
10
8
-2
89
83
-6
8
10
2
7
6
-1
4
1
-3
1
1
4
2
-2
42
47
5
3
-3
55
48
-7
4
9
5
6
6
30
29
-1
3
3
4
3
-1
1
1
3
5
2
13
12
-1
1
-1
22
14
-8
1
3
2
C73 C74-C75
13
21
8
120
117
-3
27
27
13
22
9
3
1
-2
9
7
-2
9
10
1
9
13
4
57
63
6
7
5
-2
72
62
-10
8
23
15
C69
C65-C66,
C68
C64
C67
2
5
3
1
-1
1
1
1
1
1
2
1
2
7
5
-
2
2
5
6
1
3
-3
1
-1
2
2
1
-1
2
5
3
1
1
-
10
11
1
107
119
12
4
8
4
13
11
-2
1
3
2
17
8
-9
3
4
1
6
6
3
-3
48
69
21
9
6
-3
83
79
-4
15
32
17
C61
1404
1408
1409
1410
1501
1502
1503
1508
1509
1510
1601
1603
1604
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1605
98
99
1609
98
99
1610
98
99
98
99
1613
98
99
1615
98
99
1616
98
99
1618
98
99
1619
98
99
1621
98
99
1622
98
99
1624
98
99
1627
98
99
1611
C00 C01-C02
C03
C14
C07-C08
1,242
1,392
150
216
211
-5
240
249
9
7
-7
414
430
16
2,629
2,775
146
16
6
4
8
4
1
1
6
6
-
26
35
9
3
3
1
2
1
1
3
2
54
49
-5
1
13
13
7
19
12
-
2
1
-1
1
1
1
1
3
7
4
-
48
34
-14
2
2
4
1
-3
1
3
2
61
60
-1
-
5
4
-1
1
1
2
1
-1
2
2
22
15
-7
-
9
8
-1
2
2
1
1
27
22
-5
-
7
7
-
2
3
1
1
-1
12
4
-8
-
-10
3
2
-1
290
317
27
16
7
-9
18
15
-3
584
674
90
26
359
333
9
3
-6
-
1
3
3
15
14
-1
4
4
1
-1
7
4
-3
1
1
1
4
3
1
1
10
3
-7
1
1
31
26
-5
1
1
1
1
6
6
2
2
3
3
2
6
4
3
3
1
1
-
1
1
-
101 5 21 99 100 6 3 98
- 462 -
C48
28
20
-8
3
10
7
3
5
2
1
-1
2
3
1
59
52
-7
1
2
1
4
5
1
3
3
2
3
1
1
2
1
6
5
-1
1
1
1
1
-
- 463 -
C26 C30-C31
2
2
1
-1
1
-1
-
1
-1
1
1
1
-1
5
6
1
2
-2
1
-1
-
C32
C33-C34
2
6
4
2
1
-1
2
2
4
4
38
28
-10
5
1
-4
4
4
5
5
112
136
24
22
20
-2
38
41
3
2
-2
41
39
-2
357
353
-4
4
-4
15
19
4
4
2
-2
39
45
6
22
22
C25
13
20
7
3
2
-1
3
2
-1
2
2
34
26
-8
2
1
-1
6
6
-
C23-C24
227
179
-48
25
26
1
29
32
3
32
27
-5
327
335
8
2
1
-1
2
-2
23
36
13
3
-3
80
87
7
2
40
38
65
93
28
15
16
1
15
16
1
14
22
8
123
128
5
1
-1
14
16
2
1
-1
27
41
14
1
14
13
C22
111
141
30
23
23
28
25
-3
36
57
21
182
214
32
2
1
-1
17
19
2
1
1
51
77
26
34
34
C18 C19-C21
6
10
4
1
-1
1
1
1
3
2
14
14
1
1
2
3
1
2
2
C17
53
63
10
17
5
-12
13
15
2
21
14
-7
125
115
-10
1
1
15
8
-7
24
13
-11
10
10
C16
35
37
2
6
4
-2
3
5
2
6
7
1
74
79
5
1
-1
1
10
9
1
-1
17
18
1
5
5
C15
11
19
8
2
6
4
6
7
1
4
3
-1
50
59
9
6
4
-2
1
-1
15
16
1
1
7
6
C11
1605
1609
1610
1611
1613
1615
1616
1618
1619
1621
1622
1624
1627
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1613
98
99
1615
98
99
1616
98
99
1618
98
99
1619
98
99
1621
98
99
1622
98
99
1624
98
99
1627
98
99
C50
C50
C55
C53
C54
39
49
10
3
2
-1
10
9
-1
13
12
-1
82
82
1
-1
1
1
9
7
-2
3
1
-2
31
30
-1
11
11
152
184
32
18
34
16
30
19
-11
2
-2
154
162
8
319
364
45
106
119
13
2
1
-1
88
107
19
17
62
45
1
1
1
-1
2
1
-1
1
1
2
2
-
75
110
35
25
13
-12
3
6
3
46
30
-16
95
110
15
1
1
12
17
5
14
12
-2
38
40
2
19
19
32
38
6
5
3
-2
2
1
-1
8
5
-3
46
52
6
2
3
1
2
-2
4
5
1
7
7
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 464 -
1611
7
7
1
1
1
2
1
2
2
9
17
8
1
-1
2
3
1
-
C44
98
99
1
-1
2
5
3
-
1610
1
3
2
1
1
5
3
-2
29
30
1
2
2
8
8
98
99
2
1
-1
2
1
-1
14
14
1
3
2
1
1
1
1
1609
2
1
-1
1
6
5
1
1
-
98
99
C42
1605
C37-C38.3,
C38.8
2
7
5
1
-1
1
1
2
2
8
14
6
3
-3
1
1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
29
11
24
8
-5
-3
8
1
2
-6
-1
3
3
2
1
1
-1
-1
29
8
35
6
6
-2
3
1
3
-1
2
2
3
4
1
10
1
10
1
2
2
2
1
-1
1
1
1
1
- 465 -
2
4
2
1
1
3
3
21
24
3
1
5
4
1
2
1
2
2
5
2
-3
1
-1
1
-1
-
7
7
1
2
1
5
2
-3
2
-2
2
2
41
38
-3
5
1
-4
10
10
15
15
1
-1
1
-1
-
C76
C77
C80
1
1
-
7
8
1
2
2
2
2
2
2
43
61
18
1
1
4
11
7
-
13
16
3
1
3
2
3
1
-2
3
2
-1
21
24
3
13
12
-1
3
3
13
15
2
3
1
-2
7
6
-1
3
2
-1
59
56
-3
1
1
4
1
-3
6
10
4
1
7
6
8
8
2
4
2
3
3
1
1
32
34
2
2
2
5
5
9
9
C73 C74-C75
42
29
-13
16
11
-5
9
4
-5
15
9
-6
61
77
16
1
-1
5
9
4
1
1
22
27
5
2
17
15
C69
C65-C66,
C68
C64
C67
1
-1
1
-1
4
3
-1
2
-2
1
1
2
1
-1
2
-2
1
1
3
4
1
1
1
2
2
20
37
17
1
6
5
12
24
12
1
7
6
105
109
4
5
-5
13
15
2
16
24
8
2
28
26
C61
1605
1609
1610
1611
1613
1615
1616
1618
1619
1621
1622
1624
1627
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1701
98
99
1702
98
99
1703
98
99
1704
98
99
1705
98
99
1707
98
99
1708
98
99
1709
98
99
1714
98
99
1801
98
99
1802
98
99
1901
98
99
1903
98
99
25
50
25
55
66
11
20
31
11
4,622
4,652
30
135
114
-21
76
69
-7
41
37
-4
5
8
3
2,296
2,452
156
27
58
31
145
173
28
170
437
267
222
239
17
C00 C01-C02
18
22
4
7
18
11
2
-2
1
2
1
1
2
1
118
104
-14
2
1
-1
2
-2
63
71
8
1
1
2
1
-1
5
18
13
2
4
2
C03
1
1
33
34
1
18
30
12
5
5
-
3
2
-1
154
115
-39
3
3
1
1
1
-1
1
-1
92
78
-14
2
2
1
1
5
17
12
2
3
1
3
-3
65
38
-27
1
-1
1
-1
32
31
-1
1
1
2
16
14
-
101 5 21 99 100 6 3 98
- 466 -
55
58
3
1
1
34
52
18
1
2
1
1
14
13
2
-2
C14
C07-C08
3
2
-1
1
-1
2
1
-1
1
-1
4
8
4
11
11
1
2
1
-
C48
2
3
1
7
14
7
2
7
5
298
388
90
25
25
5
10
5
7
6
-1
2
1
-1
143
176
33
2
9
7
19
20
1
10
36
26
31
30
-1
2
2
3
4
1
1
1
803
852
49
20
14
-6
17
13
-4
1
2
1
2
2
380
401
21
4
7
3
37
44
7
13
32
19
22
22
-
37
35
-2
2
2
3
-3
24
21
-3
1
2
1
1
3
2
2
-2
1
1
1
1
80
73
-7
2
1
-1
1
2
1
1
1
36
54
18
1
-1
6
3
-3
1
3
2
5
1
-4
12
7
-5
1
-1
7
5
-2
1
-1
1
-1
-
1
3
2
3
6
3
2
1
-1
242
306
64
9
12
3
3
9
6
1
-1
153
141
-12
3
1
-2
11
14
3
8
24
16
9
16
7
- 467 -
C26 C30-C31
1
3
2
1
1
-
18
11
-7
2
5
3
2
3
1
-
C32
C33-C34
45
47
2
1
-1
1
-1
15
23
8
1
1
3
7
4
1
1
-
3
3
7
7
394
415
21
16
7
-9
4
7
3
2
2
226
227
1
1
3
2
21
17
-4
28
52
24
9
13
4
C25
C23-C24
C22
1
1
1
1
16
19
3
1
-1
6
7
1
1
-1
1
1
-
C18 C19-C21
4
4
6
6
1
3
2
159
145
-14
7
7
6
3
-3
2
4
2
90
77
-13
2
2
10
12
2
8
6
-2
13
13
-
2
4
2
2
3
1
2
2
131
86
-45
5
6
1
7
8
1
4
4
86
92
6
1
2
1
3
9
6
7
14
7
6
3
-3
1
-1
2
1
-1
1
-1
114
88
-26
1
4
3
33
45
12
1
1
1
4
3
2
13
11
2
3
1
C17
C16
C15
C11
1701
1702
1703
1704
1705
1707
1708
1709
1714
1801
1802
1901
1903
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1705
98
99
1707
98
99
1708
98
99
1709
98
99
1714
98
99
1801
98
99
1802
98
99
1901
98
99
1903
98
99
C50
C50
C55
C53
C54
2
3
1
5
11
6
4
4
140
139
-1
5
3
-2
4
3
-1
8
3
-5
1
1
48
61
13
4
10
6
5
6
1
8
23
15
31
35
4
6
10
4
1
1
1
1
314
349
35
5
10
5
1
-1
15
11
-4
106
138
32
6
17
11
5
3
-2
21
62
41
32
30
-2
2
2
2
1
-1
1
-1
-
2
1
-1
-
5
5
5
3
-2
7
5
-2
270
218
-52
6
1
-5
6
2
-4
94
91
-3
1
-1
3
9
6
12
18
6
19
26
7
2
1
-1
76
89
13
18
19
1
1
4
3
4
11
7
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 468 -
1704
23
19
-4
1
-1
15
8
-7
1
1
1
1
C44
98
99
8
8
4
4
1
1
-
1703
118
108
-10
1
1
1
1
26
26
3
-3
-
98
99
16
33
17
10
11
1
-
1702
6
3
-3
1
-1
1
2
1
1
1
-
98
99
C42
1701
C37-C38.3,
C38.8
27
17
-10
1
-1
1
1
16
13
-3
1
1
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
59
9
74
16
15
7
1
1
14
1
14
7
6
1
1
2
1
-1
3
1
-2
-
7
7
-
- 469 -
30
29
-1
1
1
19
24
5
1
3
2
-
4
3
-1
1
-1
5
2
-3
1
1
-
123
109
-14
2
2
1
-1
106
89
-17
1
-1
2
2
2
2
3
5
2
2
1
-1
1
1
1
-1
-
C76
C77
C80
1
1
1
1
-
1
-1
69
68
-1
1
-1
1
-1
23
21
-2
2
2
1
3
2
3
1
-2
1
-1
1
-1
1
-1
45
40
-5
3
3
1
-1
38
22
-16
1
1
1
1
8
9
1
4
2
-2
101
92
-9
2
1
-1
1
1
2
2
1
1
64
86
22
1
2
1
2
2
5
4
-1
38
53
15
2
-2
18
30
12
2
1
-1
1
1
1
1
-
C73 C74-C75
4
9
5
1
1
128
118
-10
6
4
-2
5
2
-3
2
2
76
84
8
1
1
2
3
1
6
21
15
8
8
-
C69
C65-C66,
C68
C64
C67
2
7
5
3
1
-2
1
1
8
13
5
2
4
2
1
1
-
1
2
1
5
3
-2
3
5
2
188
173
-15
6
4
-2
8
6
-2
2
2
114
115
1
1
1
4
3
-1
11
22
11
1
2
1
C61
1701
1702
1703
1704
1705
1707
1708
1709
1714
1801
1802
1901
1903
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
1904
98
99
1905
98
99
1908
98
99
1909
98
99
1910
98
99
1913
98
99
1914
98
99
1915
98
99
1918
98
99
2001
98
99
2002
98
99
2003
98
99
2004
98
99
719
740
21
7
3
-4
52
51
-1
10
19
9
65
96
31
478
523
45
327
313
-14
11
7
-4
22
-22
68
51
-17
96
80
-16
343
472
129
17
5
-12
C00 C01-C02
2
-2
1
4
3
2
2
3
7
4
-
7
6
-1
3
3
3
-3
12
10
-2
3
1
-2
1
1
1
-1
13
12
-1
-
C03
2
2
5
5
1
1
2
5
3
-
13
8
-5
2
3
1
2
2
17
21
4
4
4
2
2
1
-1
4
4
3
2
-1
17
38
21
-
2
3
1
1
-1
1
1
3
4
1
1
1
3
-3
12
5
-7
-
101 5 21 99 100 6 3 98
- 470 -
1
3
2
1
1
1
1
6
6
1
1
1
-1
1
3
2
15
14
-1
-
C14
C07-C08
1
-1
1
1
1
1
-
2
2
1
-1
1
2
1
2
2
1
-1
2
1
-1
-
75
57
-18
4
4
2
2
1
12
11
95
72
-23
40
47
7
1
1
4
-4
12
16
4
10
4
-6
47
54
7
4
-4
12
7
-5
5
3
-2
1
1
6
4
-2
7
2
-5
1
-1
1
1
6
4
-2
-
18
24
6
3
5
2
5
5
8
8
7
6
-1
1
-1
4
5
1
3
8
5
-
2
2
1
-1
1
1
-
- 471 -
C26 C30-C31
1
1
1
1
-
1
1
1
-1
1
1
1
1
-
C32
C33-C34
2
1
-1
1
1
1
4
3
3
9
6
2
2
1
-1
1
-1
1
2
1
3
7
4
-
97
82
-15
4
-4
7
9
2
6
7
1
15
12
-3
73
65
-8
31
20
-11
5
-5
10
7
-3
5
5
51
68
17
2
-2
C48
42
51
9
1
1
2
3
1
4
4
20
19
-1
29
21
-8
4
-4
4
4
12
6
-6
9
25
16
1
1
C25
54
72
18
5
8
3
1
3
2
4
6
2
31
52
21
35
37
2
1
-1
3
3
9
7
-2
28
32
4
-
C23-C24
7
1
-6
1
-1
3
2
-1
5
2
-3
1
-1
4
4
1
3
2
-
C22
33
40
7
1
-1
2
2
1
2
1
9
6
-3
15
28
13
19
18
-1
1
-1
6
3
-3
8
4
-4
25
26
1
-
16
15
-1
2
1
-1
3
4
1
1
2
1
2
2
24
27
3
9
16
7
1
-1
4
3
-1
6
6
18
16
-2
4
-4
8
10
2
2
-2
2
1
-1
13
17
4
6
7
1
2
2
4
21
17
-
C18 C19-C21
C17
C16
C15
C11
1904
1905
1908
1909
1910
1913
1914
1915
1918
2001
2002
2003
2004
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
1910
98
99
1913
98
99
1914
98
99
1915
98
99
1918
98
99
2001
98
99
2002
98
99
2003
98
99
2004
98
99
C50
C50
C55
C53
C54
29
32
3
1
-1
5
2
-3
18
16
-2
31
18
-13
1
-1
1
-1
3
1
-2
5
7
2
2
2
-
69
107
38
2
1
-1
2
2
7
7
24
32
8
18
18
2
-2
10
9
-1
20
31
11
1
1
1
-1
-
72
49
-23
1
-1
1
3
2
14
28
14
37
38
1
10
2
-8
5
3
-2
5
2
-3
14
24
10
-
9
5
-4
1
1
3
7
4
8
2
-6
2
-2
6
9
3
-
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 472 -
1909
3
7
4
2
-2
1
3
2
4
2
-2
1
1
2
-2
-
C44
98
99
1
1
1
1
1
1
1
-1
-
1908
15
14
-1
1
-1
1
-1
6
6
1
1
4
2
-2
1
-1
98
99
3
3
1
-1
1
1
-
1905
2
-2
1
2
1
-
98
99
C42
1904
C37-C38.3,
C38.8
1
-1
2
2
1
-1
2
2
-
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
5
2
8
1
3
-1
1
-1
1
1
1
6
5
1
1
1
1
2
-2
2
1
1
1
-1
4
3
-1
-
1
-1
1
-1
-
C76
C77
C80
13
12
-1
2
-2
3
3
2
-2
1
1
2
3
1
-
7
16
9
1
1
2
-2
4
8
4
5
4
-1
1
-1
1
-1
1
1
5
4
-1
-
15
13
-2
1
-1
3
5
2
2
3
1
3
3
-
1
-1
-
- 473 -
2
4
2
2
2
2
4
2
2
2
-
C73 C74-C75
1
-1
1
1
-
2
4
2
1
1
2
5
3
1
-1
1
3
2
-
C69
30
23
-7
3
1
-2
8
9
1
25
17
-8
9
15
6
6
3
-3
2
3
1
7
12
5
1
-1
C65-C66,
C68
8
10
2
1
1
9
8
-1
2
8
6
1
1
1
4
3
-
C64
1
1
1
1
-
C67
1
-1
1
-1
-
36
45
9
1
1
1
-1
2
9
7
19
14
-5
9
10
1
1
-1
7
4
-3
9
7
-2
3
13
10
3
1
-2
C61
1904
1905
1908
1909
1910
1913
1914
1915
1918
2001
2002
2003
2004
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
C44.0
Total
2101
98
99
2102
98
99
2103
98
99
2104
98
99
2105
98
99
2106
98
99
2201
98
99
98
99
59
56
-3
11
15
4
470
527
57
19
31
12
1,336
1,395
59
12
3
-9
30
28
-2
121,965
128,444
6,479
C00 C01-C02
C03
4
4
16
15
-1
402
417
15
3
5
2
1
1
14
20
6
782
893
111
1
1
6
6
221
267
46
10
8
-2
1
1
53
41
-12
2,660
2,616
-44
3
-3
12
15
3
1
1
70
66
-4
3,424
3,366
-58
1
-1
3
2
-1
23
23
1,031
1,034
3
101 5 21 99 100 6 3 98
- 474 -
1
1
4
6
2
1
1
32
41
9
1,233
1,330
97
C14
C07-C08
1
1
37
40
3
9
5
-4
374
327
-47
3
6
3
3
-3
1
2
-1
-2
12
64
20
51
8
-13
2
2
2
1
-1
68
162
77
150
9
-12
1
1
7
1
4
1
-3
6,570 14,695
7,348 14,746
778
51
7
7
8
11
3
1
-1
1
1
1,136
1,154
18
1
-1
1
1
8
12
4
1
1
30
32
2
1
-1
2,230
2,242
12
6
1
-5
166
204
38
- 475 -
C26 C30-C31
1
1
45
55
10
5
3
-2
333
289
-44
C32
C33-C34
16
16
847
865
18
15
11
-4
2
2
47
43
-4
4
4
149
137
-12
3
-3
4
6
2
13,862
13,843
-19
C48
C25
C23-C24
C22
3
4
2
6
-1
2
2
2
39
3
54
3
15
1
3
2
6
80
13
85
7
5
1
3
2
460 9,571
472 11,112
12 1,541
4
6
2
5
5
34
42
8
1
5
4
66
62
-4
5
2
-3
3
1
-2
5,653
5,671
18
4
3
-1
22
21
-1
2
2
47
49
2
2
4
2
3,067
3,319
252
C18 C19-C21
1
1
8
4
-4
1
1
20
34
14
3
-3
2,258
2,438
180
C17
C16
C15
C11
2101
2102
2103
2104
2105
2106
2201
98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )
98
99
2105
98
99
2106
98
99
2201
98
99
98
99
1
-1
1
1
65
51
-14
C53
2
1
1
-2
3
-3
52
8
1
35
15
1
-17
7
1
-1
55
10
48
18
-7
8
2
3
1
14 6,510 1,891
12 6,204 2,255
-2 -306
364
101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497
- 476 -
C54
2104
2
5
2
3
4
2
1
-1
2
1
2
1
1
18
51
1
23
82
5
31
2
1
1
-1
1
6
31
78
2
41
122
-4
10
44
1
-1
1
1
2
-1
1
676 3,632 13,744
684 3,788 15,615
8
156 1,871
C55
98
99
C50
2103
1
1
1
-1
3
2
-1
246
242
-4
C50
98
99
3
1
8
2
5
1
1
1
14
42
7
46
-7
4
1
-1
645 2,212
726 2,213
81
1
C44
2102
1
1
1
1
61
83
22
98
99
C42
2101
C37-C38.3,
C38.8
1
2
1
3
6
3
1
1
446
397
-49
C38.4
C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
6
2
4
1
-2
-1
8
1
13
2
5
1
1,315
285
1,470
271
155
-14
1
2
1
102
149
47
2
3
1
9
17
8
809
1,037
228
- 477 -
1
-1
1
-1
105
75
-30
1
-1
4
1
-3
30
33
3
1
-1
3,158
3,195
37
1
-1
78
63
-15
C76
C77
C80
10
16
6
5
3
-2
27
12
-15
1
-1
1,618
1,760
142
1
1
4
4
15
15
1
1
1,367
1,379
12
3
6
3
1
-1
24
18
-6
1,897
1,976
79
1
1
2
2
15
12
-3
1
-1
1,093
1,182
89
C73 C74-C75
1
4
3
7
13
6
1
-1
34
28
-6
3,293
3,339
46
C69
C65-C66,
C68
C64
C67
1
-1
2
2
117
119
2
1
3
2
2
2
1
-1
234
222
-12
3
3
1
1
24
18
-6
4
5
1
39
57
18
1
-1
1
1
5,284
5,872
588
C61
2101
2102
2103
2104
2105
2106
2201
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
C00-C80
ALL SITES
Male
9,881 10,234 10,919 11,322 13,615 13,041 15,630 14,133 17,196 18,811 19,609
Female
7,922
Total
C00-C14
Male
C00-C14
1,604
1,761
1,648
2,003
2,291
2,370
443
430
447
408
473
440
485
451
534
588
585
Total
1,692
1,792
1,795
1,721
1,955
2,044
2,246
2,099
2,537
2,879
2,955
Male
453
541
574
582
718
760
879
865
1,087
1,309
1,397
Female
99
79
113
81
119
118
139
124
160
176
173
552
620
687
663
837
878
1,018
989
1,247
1,485
1,570
17
20
26
21
23
26
35
29
34
54
48
10
Total
24
23
31
26
32
32
45
35
41
62
53
Male
123
145
162
147
213
175
217
223
303
362
374
33
20
38
27
34
44
42
51
52
69
71
Total
156
165
200
174
247
219
259
274
355
431
445
Male
25
22
24
18
31
41
36
43
59
73
64
Female
13
12
13
11
10
Total
38
25
31
25
34
48
48
56
67
84
74
Male
13
12
14
15
23
20
22
26
30
31
Female
Total
10
17
15
14
17
24
25
26
28
37
35
Male
157
196
208
229
242
309
354
337
403
481
530
26
35
43
29
41
43
46
33
56
55
57
Total
183
231
251
258
283
352
400
370
459
536
587
Male
40
54
45
50
62
50
54
67
74
96
100
Female
10
12
15
11
18
15
16
Total
50
66
54
56
77
58
65
75
92
111
116
Male
82
86
90
98
118
131
148
132
177
201
237
10
Total
88
88
95
103
126
138
157
138
187
208
243
Male
14
15
12
11
12
13
Female
Total
10
21
19
15
18
16
17
Male
40
40
31
28
44
47
35
45
68
66
46
Female
26
30
25
32
33
25
38
34
48
45
50
Total
66
70
56
60
77
72
73
79
116
111
96
Female
C44.0
OROPHARYNX
C12-C13
HYPOPHARYNX
C14
Female
C07-C08
Female
Female
C09-C10
Male
Female
FLOOR OF MOUTH
C05-C06
17,803 18,201 19,398 19,540 23,408 22,691 26,985 24,494 30,197 33,210 34,502
1,482
GUM
C04
1,313
TONGUE
C03
9,793
1,348
C01-C02
8,218
1,362
Total
C00
8,479
1,249
7,967
C00-C06C09-C10C12-C14
- 478 -
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
20,395 21,450 24,617 26,691 29,712 32,275 33,777 34,599 36,705 36,590 40,885 41,062 43,334 45,378 46,287 49,966 50,892
ICD-O-3
C00-C80
15,284 16,083 18,520 20,500 22,265 24,108 25,144 25,625 26,456 26,767 30,075 30,683 32,272 33,926 35,486 38,854 39,757
35,679 37,533 43,137 47,191 51,977 56,383 58,921 60,224 63,161 63,357 70,960 71,745 75,606 79,304 81,773 88,820 90,649
2,552 2,675 3,034 3,340
587
587
638
652
3,688 4,099
699
752
812
738
756
861
894
973
4,387 4,851
2,554 2,965
165
182
238
243
251
295
2,805 3,260
298
322
333
353
395
415
450
480
441
555
72
88
88
101
115
142
148
125
123
146
158
143
164
170
191
210
11
20
14
16
13
14
19
12
14
28
16
24
21
23
24
27
18
70
92
102
104
114
129
161
160
139
151
162
182
164
187
194
218
228
435
484
523
587
707
806
825
902
59
65
99
94
84
123
123
133
136
494
549
622
681
791
929
79
92
106
141
156
166
209
220
217
240
269
282
342
340
409
350
384
15
12
23
20
17
29
23
31
27
33
25
25
35
48
41
45
61
94
104
129
161
173
195
232
251
244
273
294
307
377
388
450
395
445
41
30
37
59
55
84
78
82
78
80
96
105
113
126
145
124
151
11
14
10
12
10
14
17
10
15
13
52
34
40
73
61
93
88
87
90
83
106
119
130
132
155
139
164
600
656
793
893
50
53
72
79
650
709
865
972
127
108
133
171
189
221
237
280
283
330
396
379
473
494
539
623
586
20
16
11
25
26
25
26
27
33
46
37
40
45
51
48
49
135
128
149
182
214
247
262
306
310
363
442
416
513
539
590
671
635
232
221
294
301
367
375
393
408
510
511
599
561
708
782
762
861
921
15
12
12
19
15
14
30
23
19
19
16
24
21
241
228
302
308
382
387
405
427
525
525
629
584
727
801
778
885
942
13
21
30
23
31
26
35
34
53
51
64
43
47
28
46
45
68
15
22
33
25
35
29
39
42
60
55
65
45
50
30
48
50
72
68
55
65
75
80
102
86
97
100
102
94
105
116
116
112
154
131
47
46
50
45
49
66
70
96
74
58
91
80
95
76
102
123
105
115
101
115
120
129
168
156
193
174
160
185
185
211
192
214
277
236
948 1,172
87
79
1,035 1,251
174
165
88
95
106
93
125
- 479 -
C00-C142
532
59
132
C00-C14
202
176
239
C00
C01-C02
222
135
121
152
C03
C04
C05-C06
144
C12-C13
C14
C07-C08
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
Male
756
781
743
703
720
797
847
738
848
916
927
Female
318
321
309
295
321
297
308
293
326
367
362
Total
1,074
1,102
1,052
998
1,041
1,094
1,155
1,031
1,174
1,283
1,289
C11
NASOPHARYNX
C15-C26,
Male
4,594
4,723
5,031
5,356
6,451
6,111
7,383
6,498
7,973
8,561
8,859
C48
Female
1,749
1,909
1,960
2,074
2,624
2,513
2,975
2,749
3,646
4,005
4,128
Total
6,343
6,632
6,991
7,430
9,075
8,624 10,358
Male
447
430
408
460
465
459
525
466
560
598
610
55
50
43
42
51
43
55
56
62
83
63
Total
502
480
451
502
516
502
580
522
622
681
673
Male
1,444
1,375
1,513
1,446
1,757
1,546
1,761
1,546
1,789
1,915
1,851
541
565
582
580
701
610
734
648
865
870
829
Total
1,985
1,940
2,095
2,026
2,458
2,156
2,495
2,194
2,654
2,785
2,680
Male
23
36
31
45
56
44
71
57
63
69
81
Female
22
28
21
25
39
41
49
29
47
40
52
Total
45
64
52
70
95
85
120
86
110
109
133
Male
946
1,053
1,097
1,224
1,502
1,372
1,739
1,528
1,966
2,253
2,403
Female
706
766
832
875
1,076
1,089
1,196
1,159
1,507
1,670
1,817
Total
1,652
1,819
1,929
2,099
2,578
2,461
2,935
2,687
3,473
3,923
4,220
Male
478
551
571
630
779
740
912
812
1,012
1,157
1,235
Female
382
391
461
494
571
604
652
609
788
918
1,001
Total
860
942
1,032
1,124
1,350
1,344
1,564
1,421
1,800
2,075
2,236
Male
468
502
526
594
723
632
827
716
954
1,096
1,168
Female
324
375
371
381
505
485
544
550
719
752
816
RECTUM, RECTOSIGMOID
JUNCTION AND ANUS
Total
792
877
897
975
1,228
1,117
1,371
1,266
1,673
1,848
1,984
Male
1,462
1,548
1,697
1,880
2,282
2,315
2,814
2,506
3,097
3,172
3,287
Female
249
314
289
362
509
462
622
607
814
961
943
Total
1,711
1,862
1,986
2,242
2,791
2,777
3,436
3,113
3,911
4,133
4,230
Male
65
74
81
90
112
117
151
129
157
145
230
50
74
74
75
81
87
110
90
140
149
192
Total
115
148
155
165
193
204
261
219
297
294
422
Male
166
170
178
181
225
219
269
222
280
346
343
90
86
91
90
124
136
153
125
164
179
179
Total
256
256
269
271
349
355
422
347
444
525
522
Male
26
27
20
22
34
31
38
34
46
46
36
RETROPERITONEUM AND
PERITONEUM
Female
20
17
19
18
30
34
42
20
31
37
36
Total
46
44
39
40
64
65
80
54
77
83
72
C15
ESOPHAGUS
C16
STOMACH
C17
SMALL INTESTINE
C18-C21
C18
COLON
C19-C21
C22
C23-C24
Female
Female
C25
PANCREAS
C48
Female
- 480 -
1994
1995
1996
1997
898
936
965 1,002
375
359
350
364
1998
1999
2000
2001
391
377
394
2002
2003
2004
2005
2006
2007
345
375
399
368
417
2008
2009
2010
ICD-O-3
347
377
8,963 9,647 11,038 12,052 13,568 14,463 15,120 15,597 16,598 16,227 18,173 18,151 18,983 19,810 20,020 21,360 22,112 C15-C26, C48
4,358 4,556 5,361 6,150
13,321 14,203 16,399 18,202 20,316 21,831 22,886 23,585 25,093 24,768 27,782 27,801 29,144 30,327 30,973 33,192 34,255
659
791
819
870
917
66
64
90
76
92
92
701
723
881
895
826
999 1,167
83
91
635
117
110
104
98
115
141
143
149
147
65
69
89
105
116
127
137
140
162
155
159
170
166
199
199
203
190 C17
51
55
58
74
60
87
91
96
93
127
126
92
101
123
132
130
135
116
124
147
179
176
214
228
236
255
282
285
262
267
322
331
333
325
962 1,140
882
833
193
211
216
236
289
312
326
326
365
357
433
375
395
457
447
499
486 C23-C24
179
185
200
242
244
282
292
304
355
293
339
372
372
374
421
452
438
372
396
416
478
533
594
618
630
720
650
772
747
767
831
868
951
924
313
361
414
459
518
557
636
640
643
690
676
671
841
842
881
981
937 C25
198
184
276
300
330
370
379
390
462
479
502
542
559
582
642
700
706
511
545
690
759
848
45
39
57
66
62
73
59
59
71
55
65
58
74
84
77
78
80 C48
42
37
51
51
64
59
77
67
72
64
71
83
63
58
67
65
77
87
76
108
117
126
132
136
126
143
119
136
141
137
142
144
143
157
- 481 -
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
Male
15
10
18
15
10
15
17
18
Female
16
13
11
14
15
16
16
17
Total
31
19
15
15
31
19
29
25
31
33
35
Male
1,773
1,852
1,984
2,087
2,458
2,343
2,750
2,472
2,994
3,291
3,337
Female
603
575
657
698
859
793
1,016
922
1,159
1,236
1,259
Total
2,376
2,427
2,641
2,785
3,317
3,136
3,766
3,394
4,153
4,527
4,596
Male
73
72
68
44
74
91
72
75
73
99
72
Female
41
24
38
30
46
34
38
36
54
55
51
Total
114
96
106
74
120
125
110
111
127
154
123
Male
194
185
211
234
294
254
250
224
278
317
282
11
11
14
13
23
11
22
10
22
19
15
Total
205
196
225
247
317
265
272
234
300
336
297
Male
1,481
1,558
1,661
1,752
2,039
1,930
2,370
2,100
2,572
2,792
2,887
523
527
583
631
759
722
921
844
1,053
1,099
1,137
Total
2,004
2,085
2,244
2,383
2,798
2,652
3,291
2,944
3,625
3,891
4,024
Male
10
11
19
18
14
12
10
Female
11
14
Total
12
17
19
26
29
19
26
16
Male
19
34
43
47
39
49
39
59
66
69
84
Female
22
10
17
17
23
19
24
27
25
49
50
Total
41
44
60
64
62
68
63
86
91
118
134
Male
Male
303
302
299
293
342
283
343
340
382
366
429
Female
172
203
186
223
249
199
270
220
255
288
289
Total
475
505
485
516
591
482
613
560
637
654
718
Male
43
64
44
56
65
91
106
64
85
90
84
Female
35
33
44
36
53
59
71
47
72
74
70
Total
78
97
88
92
118
150
177
111
157
164
154
Male
73
76
83
75
91
82
107
93
109
98
110
Female
30
39
48
47
48
77
69
59
69
87
107
CONNECTIVE,
SUBCUTANEOUS
AND OTHER SOFT TISSUES
Total
103
115
131
122
139
159
176
152
178
185
217
C26
C30-C39
C30-C31
C32
LARYNX
C33-C34
C38.4
PLEURA
C37-C38.3,
C38.8
C39
Female
Female
Female
OTHER AND ILL-DEFINED SITES
WITHIN RESPIRATORY SYSTEM AND
Total
INTRATHORACIC ORGANS
3
C42
LEUKEMIA
C40-C41
C47, C49
- 482 -
ICD-O-3
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
14
15
13
16
10
14
15
13
13
10
11
19
24
18
19 C26
22
15
11
19
22
25
12
12
18
12
22
34
25
32
36
30
19
25
21
28
36
40
18
25
25
28
23
41
58
43
51
2010
84
84
79
100
74
98
132
99
99
91
109
114
129
106
132
129
39
26
41
40
46
49
61
50
56
51
52
34
56
45
54
78
53
123
110
120
140
120
147
193
149
155
142
161
148
185
151
186
207
172
345
361
368
395
397
431
485
506
513
465
529
530
542
546
548
591
602 C32
18
19
29
29
16
23
23
23
26
27
32
21
36
25
30
32
33
363
380
397
424
413
454
508
529
539
492
561
551
578
571
578
623
635
14
13
15
16
16
21
14
18
21
16
18
34
45
32
30
43 C38.4
11
17
10
15
19
10
18
20
20
21
19
28
22
27
27
21
29
51
55
39
45
62
71
77
108
103
81
114
121
123
103
120
127
131
134
155
125
196
168 C37-C38.3,
46
47
60
52
73
61
70
66
77
85
91
95
95
100
112
134
108 C38.8
117
124
168
155
154
175
191
189
180
205
218
226
229
255
237
330
276
1 C39
446
489
488
507
515
562
620
616
831
862
876
925
915
993
319
342
356
369
392
396
447
431
563
556
599
646
639
656
715
765
831
844
876
907
87
86
93
89
96
87
82
96
88
72
86
115
79
86
91
99
89 C40-C41
46
63
66
62
65
56
76
70
74
49
68
74
77
78
80
87
74
133
149
159
151
161
143
158
166
162
121
154
189
156
164
171
186
163
128
149
155
145
182
189
206
243
241
197
229
228
247
263
258
310
96
85
131
137
140
159
164
140
164
189
192
180
172
160
182
212
232
224
234
286
282
322
348
370
383
405
386
421
408
419
423
440
522
508
- 483 -
791
736
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
Male
283
250
289
255
281
288
365
329
393
462
455
Female
196
165
212
139
203
214
278
266
304
368
377
Total
479
415
501
394
484
502
643
595
697
830
832
Male
35
26
32
28
29
23
34
38
42
54
54
Female
14
14
20
13
27
17
24
25
33
47
42
Total
49
40
52
41
56
40
58
63
75
101
96
Male
248
224
257
227
252
265
331
291
351
408
401
Female
182
151
192
126
176
197
254
241
271
321
335
Total
430
375
449
353
428
462
585
532
622
729
736
1,080
1,071
1,175
1,144
1,314
1,425
1,705
1,617
1,991
2,265
2,399
15
15
18
10
10
14
18
19
Female
2,720
2,674
2,728
2,402
2,614
2,626
2,896
2,547
3,079
3,345
3,369
Female
35
30
30
25
40
53
54
35
43
33
23
Female
2,282
2,262
2,281
1,921
2,072
2,075
2,173
1,924
2,279
2,484
2,471
Female
121
124
163
157
143
162
215
181
262
311
325
Female
202
179
192
246
310
267
378
334
415
407
462
Female
80
79
62
53
49
69
76
73
80
110
88
299
305
344
332
457
453
590
574
709
794
937
C44
SKIN
C44
C44
C50
Female
FEMALE BREAST
C50
Male
MALE BREAST
C51-C58
C55
UTERUS, NOS
C53
CERVIX UTERI
C54
CORPUS UTERI
C56,
C57.0-C57.4
C57.7-C57.9
C51-C52,
C60-C63
Male
- 484 -
ICD-O-3
1994
1995
1996
1997
1998
1999
2000
2001
2002
532
483
646
715
808
904
892
982
1,128
421
451
540
625
742
724
760
867
918
953
2003
2004
2005
2006
2007
2008
2009
2010
4
125 C44
51
38
72
60
77
90
79
85
102
72
99
92
103
111
103
142
39
43
53
64
70
76
79
75
77
71
91
83
81
92
88
123
87
90
81
125
124
147
166
158
160
179
143
190
175
184
203
191
265
212
481
445
574
655
731
814
813
897
1,026
382
408
487
561
672
648
681
792
841
863
24
18
12
23
35
17
738
24
29
25
27
11
11
12
38
31
910
48
49
47
38
18
36
49
39 C50
11
8 C55
327
344
399
495
550
553
627
714
786
814
480
514
546
633
677
732
791
789
815
860
886
C57.0-C57.4
76
110
99
94
123
131
127
118
107
151
129
144
120
158
166
156
152 C51-C52
C57.7-C57.9
- 485 -
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
Male
204
216
271
260
353
363
484
480
597
669
803
Male
51
36
40
38
50
44
55
34
59
66
70
Male
44
53
33
34
54
46
51
60
53
59
64
Male
533
529
650
621
782
710
903
873
1,026
1,160
1,195
Female
233
216
263
242
311
345
421
411
460
540
615
Total
766
745
913
863
1,093
1,055
1,324
1,284
1,486
1,700
1,810
Male
393
382
425
412
503
478
592
570
666
750
753
Female
139
112
159
137
179
170
206
193
237
264
289
Total
532
494
584
549
682
648
798
763
903
1,014
1,042
140
147
225
209
279
232
311
303
360
410
442
94
104
104
105
132
175
215
218
223
276
326
Total
234
251
329
314
411
407
526
521
583
686
768
Male
71
68
120
108
132
133
143
160
184
215
205
Female
39
47
45
55
62
79
93
96
86
112
118
Total
110
115
165
163
194
212
236
256
270
327
323
Male
69
79
105
101
147
99
168
143
176
195
237
Female
55
57
59
50
70
96
122
122
137
164
208
C61
PROSTATE GLAND
C62
TESTIS
C60,C63
C64-C68
URINARY TRACT
C67
BLADDER
C64-C66,
Male
C68
Female
C64
KIDNEY
C65-C66,
C68
C69
Total
124
136
164
151
217
195
290
265
313
359
445
Male
23
18
19
21
21
23
22
22
31
27
24
Female
25
13
15
14
18
17
19
25
27
26
24
Total
48
31
34
35
39
40
41
47
58
53
48
Male
185
172
169
205
226
208
250
258
308
289
324
Female
119
113
119
143
180
175
185
166
208
213
200
Total
304
285
288
348
406
383
435
424
516
502
524
Male
169
158
159
186
204
199
233
238
283
267
289
Female
108
104
105
131
167
151
167
153
189
193
178
Total
277
262
264
317
371
350
400
391
472
460
467
Male
16
14
10
19
22
17
20
25
22
35
Female
11
14
12
13
24
18
13
19
20
22
Total
27
23
24
31
35
33
35
33
44
42
57
C70-C72
C71
BRAIN
C70, C72
- 486 -
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
ICD-O-3
79
82
59
64
81
94
106
102
120
112
121
133
156
144
180
170
55
54
64
61
71
73
77
83
99
105
89
92
92
84
97
91
178 C62
91 C60,C63
992
646
750
952
834
808
309
291
349
434
413
477
492
524
508
533
543
548
597
607
580
590
537
516
514
575
643
679
795
753
885
852
897
933
357
355
401
518
579
641
718
700
702
803
822
873
869
265
265
294
319
330
378
380
414
404
410
438
513
499
539
617
630
678 C64
133
151
165
198
214
205
218
202
212
232
258
266
281
289
289
356
350
398
416
459
517
544
583
598
616
616
642
696
779
780
828
906
986 1,028
251
249
281
324
349
417
373
471
448
487
495
524
573
582
552
678
675 C65-C66
224
204
236
320
365
436
500
498
490
571
564
600
659
633
726
770
774 C68
475
453
517
644
714
853
873
969
26
25
24
24
25
30
39
34
35
20
30
30
29
30
38
24
39 C69
22
30
19
21
21
25
29
32
14
19
16
18
22
24
15
24
22
48
55
43
45
46
55
68
66
49
39
46
48
51
54
53
48
61
341
290
325
352
330
400
392
388
383
359
375
368
395
385
412
439
445 C70-C72
226
199
229
228
276
266
303
297
261
246
291
297
320
291
310
288
344
567
489
554
580
606
666
695
685
644
605
666
665
715
676
722
727
789
313
275
310
325
294
370
362
352
337
327
350
333
357
345
374
394
420 C71
204
174
204
204
250
244
266
271
228
214
257
252
289
250
267
236
314
517
449
514
529
544
614
628
623
565
541
607
585
646
595
641
630
734
28
15
15
27
36
30
30
36
46
32
25
35
38
40
38
45
25 C70, C72
22
25
25
24
26
22
37
26
33
32
34
45
31
41
43
52
30
50
40
40
51
62
52
67
62
79
64
59
80
69
81
81
97
55
- 487 -
866
940
72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED
ICD-O-3
Year
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
63
82
78
77
95
78
89
114
135
196
201
Female
202
226
281
243
314
288
354
343
476
597
667
Total
265
308
359
320
409
366
443
457
611
793
868
Male
15
24
15
22
24
18
13
31
32
24
Female
19
18
11
17
28
25
16
Total
16
22
29
24
41
42
29
30
59
57
40
Male
38
30
30
36
84
49
54
50
51
60
47
Female
29
15
32
29
56
62
72
32
63
47
41
Total
67
45
62
65
140
111
126
82
114
107
88
Male
41
41
90
110
174
147
306
262
288
368
406
Female
46
53
64
87
135
120
198
186
251
256
288
Total
87
94
154
197
309
267
504
448
539
624
694
Male
282
354
361
405
483
368
457
412
513
626
699
Female
177
185
205
228
253
185
241
236
279
386
408
Total
459
539
566
633
736
553
698
648
792
1,012
1,107
C73
Male
THYROID GLAND
C74-C75
C76
C80
MALIGNANT LYMPHOMA
- 488 -
ICD-O-3
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
185
181
202
196
238
224
291
273
367
312
356
377
422
437
427
546
593
630
704
775
902 1,004
778
811
906
31
34
30
43
35
37
51
34
47
29
40
35
27
30
30
35
25 C74-C75
18
22
28
32
28
30
29
27
27
33
26
22
30
32
29
28
26
49
56
58
75
63
67
80
61
74
62
66
57
57
62
59
63
51
40
27
11
9 C76
27
32
67
59
13
13
11
16
10
11
18
12
10
15
467
463
511
525
636
678
710
614
634
628
584
602
599
519
504
471
538 C80
311
314
370
369
431
433
470
442
426
464
396
404
445
392
360
433
391
778
777
881
980 1,006
1,044
911
864
904
929
683
720
863
776
881
959
419
419
498
567
631
570
664
930
765
856
873
- 489 -
937
2010
571 C73
ICD-O-3
1.
2.
4.1 systemicmulticentric
- 490 -
ICD-O-3
Multifocal tumours that is, discrete masses apparently not in continuity with other
primary cancers originating in the same primary site or tissue, for example
bladder are counted as a single cancer.
4. Rule 3 dose not apply in two circumstances:
4.1. Systemic (or multicentric) cancers potentially involving many different organs
are only counted once in any individual. These are Kaposi sarcoma (group
15 in Table 2) and tumours of the haematopoietic system (group 8-14 in
Table 2).
4.2. Neoplasms of different morphology should be regarded as multiple cancers
(even if they are diagnosed simultaneously in the same site).
If the morphological diagnoses fall into one category in Table 2, and arise in
the same primary site, they are considered to be the same morphology for
the purpose of counting multiple primaries. If the morphological diagnoses
fall into two or more of the categories in Table 2, even if they concern the
same site, the morphology is considered to be different, and two or more
cases should be counted.
Single tumours containing several different histologies which fall into one
histological group in Table 2 are registered as a single case, using the
numerically highest ICD-O morphology code.
If, however, one morphology is not specific (group (5), (14) and (17)) and a
specific morphology is available, the case should be reported with the
specific histology and the non-specific diagnosis should be ignored.
- 491 -
ICD-O-3
Label
C01
Base of tongue
C02
C00
Lip
C03
Gum
C04
Floor of mouth
C05
Palate
C06
C09
Tonsil
C10
Oropharynx
C12
Pyriform sinus
C13
Hypopharynx
C14
C19
Rectosigmoid junction
C20
Rectum
C23
Gallbladder
C24
C33
Trachea
C34
C40
C41
C65
Renal pelvis
C66
Ureter
C67
Bladder
C68
C02.9
C06.9
C14.0
C20.9
C24.9
C34.9
- 492 -
C41.9
C68.9
ICD-O-3
Group
Carcinomas
1. Squamous and transitional cell carcinoma
8051-8084, 8120-8131
8090-8110
3. Adenocarcinomas
7. Mesothelioma
9050-9055
9. B-cell neoplasms
9650-9667
9740-9742
9750-9758
9140
8000-8005
- 493 -
()
- 494 -
99
POPULATION DEMOGRAPHY OF TAIWAN IN 2010
115,065 (0.99%)
85+
125,778 (1.09%)
188,509 (1.62%)
80-84
175,596 (1.52%)
234,614 (2.02%)
75-79
262,595 (2.28%)
298,770 (2.57%)
70-74
350,116 (3.04%)
351,553 (3.02%)
65-69
385,297 (3.34%)
500,740 (4.30%)
60-64
526,541 (4.57%)
773,674 (6.65%)
55-59
798,855 (6.93%)
883,709 (7.60%)
50-54
896,683 (7.78%)
952,466 (8.19%)
45-49
952,402 (8.26%)
932,140 (8.01%)
40-44
930,305 (8.07%)
889,468 (7.64%)
35-39
902,236 (7.83%)
1,012,113 (8.70%)
30-34
1,016,997 (8.82%)
953,304 (8.19%)
25-29
933,395 (8.10%)
821,067 (7.06%)
20-24
765,670 (6.64%)
836,734 (7.19%)
15-19
771,420 (6.69%)
782,666 (6.73%)
10-14
719,248 (6.24%)
605,233 (5.20%)
5-9
553,071 (4.80%)
503,400 (4.33%)
0-4
460,693 (4.00%)
11,635,225 (100.00%)
Total
11,526,898 (100.00 %)
1976 2000
1976
2000
04
12,000
8,800
59
10,000
8,700
10 14
9,000
8,600
15 19
9,000
8,500
20 24
8,000
8,200
25 29
8,000
7,900
30 34
6,000
7,600
35 39
6,000
7,200
40 44
6,000
6,600
45 49
6,000
6,000
50 54
5,000
5,400
55 59
4,000
4,600
60 64
4,000
3,700
65 69
3,000
3,000
70 74
2,000
2,200
75 79
1,000
1,500
80 84
500
900
85
500
600
100,000
100,000
- 496 -
WHO 2008
WHO 2008
HEMATOPOIETIC AND LYMPHOID TUMORS
ICD-O-3 codes
98663/98713/98963/98973/98653/98693/
99113
98953
99203
98613
98403/98673/98703/98723/98733/98743/
98913/99103/99313
99303
98983
97273
98113/98123/98133/98143/98153/98163/
98173/98183(C42, except for C422)
98373(C42, except for C422)
98633/98753/98763/99453/99463/99633/
99643
98233(C42, except for C422)
98013/98063/98073/98083/98093
97401/97403/97413/97423/99503/99613/
99623/99653/99663/99673/99753
99803/99823/99833/99853/99863/99893/
99913/99923
98273(C42, except for C422)
-
98663/98713/98963/98973
98953
99203
98613
98403/98673/98703/98723/98733/
98743/98913/99103/99313
99303
97273
98353/98363
98373
98633/98753/98763/99453/99463/
99633/99643
98233
98013
97401/97403/97413/97423/99503/
99603/99613/99623/99753
99803/99823/99833/99843/99853/
99863/99873/99893
98053
98203/98323/98603
98003
96503/96513/96523/96533/96543/96553/
96593/96633
96503/96513/96523/96533/96593/
96613/96623/96633/96643/96653/
96673
96893/96993
96893/96993
96713/97613
95973/96903
96733
96873
96803/96843/96883/97123/97373/97353/
97383
96793
96713/97613
96753/96903/96913/96953/96983
96733
96873/98263
96803/96843
95963/96783/98333/99403/97623;
98113/98123/98133/98143/98153/98163/
98173/98183/98233 (except for C42 but
not C422)
95963/96703/96783/97283/98333/
99403
97193
97193
97003/97013/97093/97183/97263
97003/97013/97093/97183
97173
97163
97083
97023
97053
97143
98273
98343/99483/98313;98373 (except for
C42 but not C422)
97313/97323/97343
97173
97163
97083
97023
97053
97143
98273
97293/98343/99483
97243/97253/99713
97513/97553/97563/97573/97583/97593
97513/97553/97563/97573/97583
95903/95913/97503/97543/97603/
97643
- 497 -
96793
97313/97323/97333/97343
- 498 -
99
15
- 499 -
- 500 -
99 15
................................................................................................................ 501
....................................................................................... 506
99 .................................... 513
..................................................... 517
................................. 517
..................................................... 517
...................................... 518
0~39 1 ....................... 518
40~59 ....................... 519
60 1 .................... 519
..................................................... 521
................................. 521
..................................................... 521
...................................... 522
0~39 1 ....................... 522
40~59 ....................... 523
60 1 .................... 523
..................................................... 525
................................. 525
..................................................... 525
...................................... 526
0~39 1 ....................... 526
40~59 ....................... 527
60 1 .................... 527
............................................. 529
.......................... 529
............................................. 529
-i-
...................................................................................................................... 530
0~49 .................. 531
50~69 1 .............. 531
70 .............. 532
..................................................... 533
................................. 533
...................................... 534
0~49 ......................... 534
50~69 ....................... 535
70 ...................... 535
..................................................... 537
................................. 537
..................................................... 537
................. 538
0~49 ......................... 539
50~69 1 ..................... 539
70 ...................... 540
........................................................ 541
.................................... 541
........................................................ 541
.................... 542
0~49 ............................ 543
50~69 1 ......................... 543
70 ......................... 544
..................................................... 545
................................. 545
..................................................... 545
...................................... 546
- ii -
................................. 549
..................................................... 549
...................................... 550
0~49 1 ....................... 550
50~69 ....................... 551
70 1 .................... 551
.................................... 553
........................................................ 553
(C220) .. 554
(C220)0~49 .................. 556
(C220)50~64 1 2 ............. 556
(C220)65 ........ 558
BCLC(C220) 2 ...................... 558
(C221) .. 560
(C221)0~49 .................. 561
(C221)50~64 1 2 ......... 561
(C221)65 .... 562
..................................................... 565
................................. 565
..................................................... 565
() .................. 566
() 0~49 1 ... 566
- iii -
() 50~69 .. 567
() 70 1 567
() 568
..................................................... 569
................................. 569
..................................................... 569
...................................... 570
0~34 1 ....................... 570
35~49 ....................... 572
50~69 1 ..................... 572
70 ...................... 574
............................................. 577
........... 578
............................................. 578
FIGO ............................ 579
0~29 FIGO ............................. 580
30~49 FIGO ............ 581
50~69 FIGO ............ 582
70 FIGO ........... 583
............................... 584
0~29 1 .......................... 584
30~49 ............ 585
50~69 1 ......... 585
70 ........... 586
............................................. 587
.......................... 587
............................................. 587
............................... 588
- iv -
............................. 591
................................................. 591
................................... 592
0~39 1 .................... 592
40~59 ................... 593
60 1 ................ 593
FIGO ............................... 594
............................................. 595
.......................... 595
............................................. 595
......... 596
0~59 .................. 598
60~74 1 .............. 598
................................................. 603
............................. 603
................................................. 603
............. 604
0~49 ..................... 606
50~69 1 .................. 606
70 .................. 608
.......................................... 611
Ann Arbor ................................... 611
Ann Arbor ................. 612
0~39 Ann Arbor ... 613
-v-
- vi -
71 10
68
50
85 7
Cancer Registry System, CRS
200
20
92 5 21
90
15 Taiwan
Cancer Center Data Base, TCDBAmerican College
of Surgeons Commission on Cancer FORDS Facility
Oncology Registry Data Standards
92
91 1 1
91
15 5
93 10 27
- 93 1
1 91~93
94~95
- 501 -
65
20
(94~95 )
FORDS95
9533
9611
953350
6
97
98
159915
9291
91~99322,75391159217
9330943395339643
974498549976
94~9994959698
9915
- 502 -
94~99
94 95 96 97 98 99
()
()
- 503 -
94 95 96 97 98 99
()
- 504 -
94 95 96 97 98 99
- 505 -
68 1 1
International Classification of Diseases for OncologyICD-O
5 2 3
68
-1976 ICD-O, 1976 79 Field Trial, 1988
ICD-O-FT, 1988 91 ICD-O, Third Edition
ICD-O-3, 2000
478
Case
Class 0
Includes
Class 1
(Staff physician)
Class 2
Class 3
- 506 -
Case
Includes
Class 4
68
Class 5
Class 6
(Staff physician)
Class 7
Class 8
Class 9
(1) 91 1
1 1
2
(2) 039
AJCC TNM
AJCC
4 4
TNM stage
group
1 2 AJCC
- 507 -
TNM 999
No therapy
Cancer recurrencedisease-free
intervalremission
Palliative therapy
palliative care
- 508 -
discharge plan
established
protocolaccepted management guidelines
4
4
subsequent treatment
99
(1)
1 2 P.516
(2) ICD-O-3
- 509 -
ICD-O-3
Oral cavity
C000-C009
Lip
C020-C023C028-C029
C030-C031C039
Gum
C040-C041C048-C049
Floor of mouth
C050
Hard palate
C058-C059
C060-C062C068-C069
C019
Base of tongue
C024
Lingual tonsil
C051
Soft palate
C052
Uvula
C090-C091C098-C099
Tonsil
C100-C104C108-C109
Oropharynx
C142
Waldeyer ring
C148
Oropharynx
pharynx
Hypopharynx
C129
Pyriform sinus
C130-C132C138-C139
Hypopharynx
C140
Pharynx,NOS
C079
Parotid gland
C080
Submandibular gland
C081
Sublingual gland
C089
Nasopharynx
C110-C119
Nasopharynx
Esophagus
C150-C155C158-C159
Esophagus
Stomach
C160-C166C168-C169
Stomach
Colon
C180-C189
Colon
Rectum
C199
Rectosigmoid junction
C209
Rectum
C220
Liver
C221
Lung
C340-C343C348-C349
Breast
C500-C509
Breast
Salivary
Liver
- 510 -
ICD-O-3
Cervix
C530-C531C538-C539
Cervix uteri
Corpus Uteri
C540
Isthmus uteri
C541
Endometrium
C542
Myometrium
C543
Fundus uteri
C549
Corpus uteri
C559
Uterus,NOS
Ovary
C569
Ovary
Prostate
C619
Prostate gland
Bladder
C670-C679
Bladder
Lymphoma
M-code: 9650-9667
Hodgkin lymphoma
99 99
99 93,569 1
69,757
90.72%
- 511 -
99
(%)*
6413
6258
97.58
4985
4110
798
77
4294
61
1765
1718
97.34
1362
1238
124
1274
59
1289
1248
96.82
972
885
84
918
57
289
270
93.43
230
198
32
205
46
2246
2127
94.70
1573
1415
158
1448
58
2986
2782
93.17
2141
1932
200
1974
61
5006
4567
91.23
3576
3229
326
21
3314
66
11076
9715
87.71
8215
7258
884
73
7439
75
7201
6424
89.21
5420
4783
604
33
4906
75
14099
13247
93.96
10421
9396
982
43
9644
67
13226
12107
91.54
9918
9002
870
46
9337
65
14674
14146
96.40
11884
9665
2102
117
10124
72
5934
5273
88.86
4522
4158
358
4240
69
2127
2048
96.29
1733
1531
190
12
1564
65
1409
1334
94.68
1163
1094
66
1107
59
5556
5017
90.30
4265
3538
688
39
3719
62
3157
2694
85.33
2352
2139
210
2191
61
2868
2594
90.45
2157
1969
182
1969
60
101321
93569
92.35
76889
67540
8858
491
69757
76
0.64%
90.72%
*(%)
0-35-69
99 1 1
12
- 512 -
99
1 99 ()
neoadjuvant ?
th
199 (AJCC_7 )
2 99
FIGO ?
AJCC
FIGO 0~IV
FIGO
FIGO 0~IV
299 FIGO
- 513 -
3 99
FIGO ?
AJCC
FIGO 0~IV
FIGO
FIGO 0~IV
399 FIGO
4 99
ANN ARBOR ?
ANN ARBOR
499
- 514 -
- 515 -
- 516 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
2
2
21
94
261
491
0
0
0
2
4
7
7
16
20
0
0
0
4
6
28
101
277
511
602
711
630
384
283
201
103
71
29
33
51
58
43
39
50
31
30
18
635
762
688
427
322
251
134
101
47
3885
409
4294
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
4294
100.00
4294
100.00
0
I
II
III
IV
14
1047
857
526
1565
285
0.33
24.38
19.96
12.25
36.45
6.64
23
1266
747
382
1051
825
0.54
29.48
17.4
8.9
24.48
19.21
4294
22
1286
797
436
1537
216
100.00
0.51
29.95
18.56
10.15
35.79
5.03
- 99 (AJCC_7th) 1
0
4
I
5
II
2
12
798
58
44
22
927
II
180
429
87
67
763
III
88
114
150
111
463
IV
55
111
92
836
1095
10
1126
714
373
1037
3260
Kappa=0.5602
Kappa
- 517 -
III
IV
0
I
47.07
266
6.19
419
9.76
22 100.00
0.00
0.00
84.21
75
5.83
55
4.28
79
9.91
4294 2021
22
1286 1083
140
3.26
61
1.42
254
5.92
0.00
0.00
0.00
35
2.72
0.31
0.54
73
9.16
10
1.25
10
980 22.82
19
0.44
112
2.61
22
0.51
0.00
0.00
0.00
0.00
10
0.78
0.00
12
0.93
0.39
1.25
14
1.76
0.13
14
1.76
0.50
17
3.90
0.00
11
2.52
0.69
II
797
526
66.00
66
8.28
III
436
122
27.98
26
5.96
109 25.00
134 30.73
1.61
1.61
IV
1537
130
8.46
85
5.53
159 10.34
735 47.82
115
7.48
37
2.41
210 13.66
15
0.98
46
2.99
0.33
M0
1498
130
8.68
84
5.61
159 10.61
729 48.66
101
6.74
35
2.34
199 13.28
11
0.73
45
3.00
0.33
M1
39
0.00
2.56
0.00
6 15.38
14 35.90
5.13
11 28.21
4 10.26
2.56
0.00
216
138
63.89
14
6.48
17
7.87
0.00
29 13.43
2.31
1.39
1.85
1.39
1.39
0~39 1
226
54.33
12
2.88
36
8.65
3 100.00
0.00
0.00
89.78
3.65
2.92
59
70.24
1.19
48
12
25.00
IV
125
13
10.40
M0
125
13
M1
19
416
137
123
II
84
III
111 26.68
0.72
0.48
13
3.13
0.00
12
2.88
0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.65
0.00
0.00
0.00
0.00
0.00
0.00
8.33
10 11.90
0.00
1.19
2.38
0.00
4.76
0.00
0.00
9 18.75
24 50.00
2.08
0.00
0.00
0.00
2.08
2.08
4.80
15 12.00
72 57.60
1.60
0.80
11
8.80
0.00
4.00
0.00
10.40
4.80
15 12.00
72 57.60
1.60
0.80
11
8.80
0.00
4.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
16
84.21
0.00
5.26
0.00
0.00
0.00
0.00
0.00
2 10.53
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
6
- 518 -
40~59 1
1175
45.26
178
6.86
244
9.40
13 100.00
0.00
0.00
3.91
24
2596
13
767
641
83.57
49
6.39
30
II
465
302
64.95
44
9.46
III
271
75
27.68
19
IV
954
64
6.71
M0
925
64
M1
29
126
654 25.19
83
3.20
15
0.58
162
6.24
0.35
65
2.50
11
0.42
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.13
0.26
0.52
0.78
0.00
0.91
0.52
52 11.18
48 10.32
0.86
0.22
1.72
0.00
1.08
0.22
7.01
65 23.99
86 31.73
1.48
0.37
12
4.43
0.00
2.95
0.37
56
5.87
89
9.33
494 51.78
71
7.44
0.94
135 14.15
0.73
29
3.04
0.00
6.92
55
5.95
89
9.62
488 52.76
61
6.59
0.76
127 13.73
0.54
29
3.14
0.00
0.00
3.45
0.00
6 20.69
10 34.48
6.90
8 27.59
6.90
0.00
0.00
80
63.49
10
7.94
6.35
0.00
1.59
16 12.70
3.97
1.59
1.59
0.79
60 1
620
48.36
76
5.93
6 100.00
0.00
0.00
1282
382
319
83.51
21
5.50
21
5.50
II
248
165
66.53
21
8.47
20
8.06
III
117
35
29.91
5.98
IV
458
53
11.57
23
M0
448
53
11.83
M1
10
71
42
139 10.84
215 16.77
54
4.21
44
3.43
79
6.16
10
0.78
35
2.73
10
0.78
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.57
0.52
0.79
1.05
0.00
1.31
0.26
15
6.05
2.42
3.23
1.61
0.40
2.02
1.21
35 29.91
24 20.51
1.71
5.13
4.27
0.00
1.71
0.85
5.02
55 12.01
169 36.90
42
9.17
27
5.90
64 13.97
1.75
12
2.62
1.09
23
5.13
55 12.28
169 37.72
38
8.48
27
6.03
61 13.62
1.34
11
2.46
1.12
0.00
0.00
0.00
0.00
4 40.00
0.00
3 30.00
20.00
1 10.00
0.00
59.15
5.63
8 11.27
1.41
0.00
1.41
11 15.49
0.00
2.82
2.82
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 519 -
- 520 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
1
0
0
1
0
2
7
59
120
0
1
1
0
0
2
3
2
6
1
1
1
1
0
4
10
61
126
199
226
199
121
85
54
41
25
9
21
21
14
13
14
7
12
4
4
220
247
213
134
99
61
53
29
13
1149
125
1274
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
1274
100.00
1274
100.00
0
I
II
III
IV
3
172
187
173
645
94
0.24
13.5
14.68
13.58
50.63
7.38
7
120
79
61
163
844
0.55
9.42
6.2
4.79
12.79
66.25
%
1274
7
164
161
170
630
142
100.00
0.55
12.87
12.64
13.34
49.45
11.15
- 99 (AJCC_7th) 1
0
2
I
0
II
0
III
0
IV
0
80
96
II
17
50
11
86
III
11
25
13
50
IV
18
125
157
103
78
58
149
391
Kappa=0.6125
Kappa
- 521 -
1274
198 15.54
63
4.95
65
5.10
257 20.17
121
9.50
38
2.98
1 14.29
0.00
8.54
14
8.54
13
1.02
32
2.51
0.55
0.00
0.00
0.00
0.00
5.49
0.00
4.27
0.00
480 37.68
5 71.43
0.00
0.00
1 14.29
164
93 56.71
11
6.71
10
6.10
II
161
34 21.12
3.11
14
8.70
23 14.29
26 16.15
5.59
47 29.19
0.00
1.24
0.62
III
170
17 10.00
2.35
11
6.47
31 18.24
15
8.82
2.35
83 48.82
1.18
1.18
0.59
IV
630
14
2.22
16
2.54
20
3.17
156 24.76
49
7.78
10
1.59
335 53.17
1.43
17
2.70
0.63
M0
591
14
2.37
16
2.71
19
3.21
151 25.55
35
5.92
10
1.69
320 54.15
1.35
15
2.54
0.51
M1
39
0.00
0.00
2.56
5 12.82
14 35.90
0.00
15 38.46
2.56
5.13
2.56
142
27 19.01
10
7.04
40 28.17
16 11.27
0.70
1.41
2.82
0.70
35 24.65
3.66
14
4.23
0~39 1
79
8 10.13
2.53
7.59
0.00
0.00
0.00
3 37.50
0.00
2 25.00
II
14
2 14.29
0.00
III
1 16.67
0.00
IV
44
2.27
M 0
41
2.44
M 1
0.00
1 14.29
9 11.39
3.80
0.00
0.00
0.00
0.00
1 12.50
0.00
7.14
5 35.71
0.00
2 33.33
2.27
2.27
15 34.09
2.44
2.44
15 36.59
0.00
0.00
1 14.29
3 42.86
20 25.32
0.00
2 28.57
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2 25.00
0.00
0.00
0.00
7.14
5 35.71
0.00
0.00
0.00
0.00
0.00
3 50.00
0.00
0.00
0.00
6.82
4.55
21 47.73
0.00
0.00
0.00
2.44
4.88
20 48.78
0.00
0.00
0.00
2 66.67
0.00
1 33.33
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
31 39.24
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 522 -
40~59 1
806
123 15.26
40
4.96
40
4.96
176 21.84
4 66.67
0.00
0.00
107
64 59.81
8.41
6.54
II
92
21 22.83
5.43
III
104
8.65
2.88
IV
418
1.67
11
M0
393
1.78
M1
25
0.00
79
18 22.78
65
8.06
18
2.23
1 16.67
1 16.67
0.00
2.80
5.61
8.41
7.61
16 17.39
9.78
5.77
22 21.15
5.77
2.63
15
3.59
110 26.32
33
11
2.80
14
3.56
106 26.97
23
0.00
4.00
12 15.19
6.33
319 39.58
0.50
19 2.36
0.25
0.00
0.00
0 0.00
0.00
3.74
0.00
5 4.67
0.00
2.17
30 32.61
0.00
2 2.17
0.00
0.00
55 52.88
0.00
2 1.92
0.96
7.89
1.44
225 53.83
0.96
7 1.67
0.00
5.85
1.53
217 55.22
0.76
6 1.53
0.00
4 16.00
10 40.00
0.00
8 32.00
4.00
1 4.00
0.00
24 30.38
10 12.66
1.27
0.00
3 3.80
1.27
6.33
60 1
389
67 17.22
21
5.40
19
4.88
1 100.0
0.00
0.00
0.00
49
26 53.06
4.08
2.04
6.12
II
55
11 20.00
0.00
7 12.73
III
60
7 11.67
1.67
IV
168
3.57
2.38
M 0
157
3.82
M 1
11
0.00
56
16 28.57
61 15.68
17
4.37
0.00
7 14.29
5 10.20
6 10.91
12 21.82
8.33
7 11.67
9 15.00
2.38
31 18.45
13
2.55
2.55
30 19.11
11
0.00
0.00
14 25.00
3.57
2.31
13
3.34
1.29
0.00
0.00
0.00
0.00
6.12
0.00
4.08
0.00
6 10.91
12 21.82
0.00
0.00
1.82
6.67
25 41.67
3.33
0.00
0.00
7.74
1.19
89 52.98
2.98
10
5.95
2.38
7.01
1.27
83 52.87
3.18
5.73
1.91
9.09
2 18.18
0.00
6 54.55
0.00
9.09
9.09
14 25.00
6 10.71
0.00
3.57
1.79
0.00
0.00
130 33.42
47 12.08
1.79
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 523 -
- 524 -
0
0
0
0
0
0
4
25
82
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
5
25
82
3
3
3
2
0
3
1
2
1
19
144
176
158
98
74
57
43
22
16
899
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
147
179
161
100
74
60
44
24
17
918
%
918
100.00
0
I
II
III
IV
3
46
62
130
645
32
%
918
100.00
0.33
5.01
6.75
14.16
70.26
3.49
1
12
17
32
177
679
%
918
100.00
0.11
1.31
1.85
3.49
19.28
73.97
4
48
56
117
662
31
0.44
5.23
6.1
12.75
72.11
3.38
- 99 (AJCC_7th) 1
0
0
I
0
II
0
III
0
IV
0
II
22
III
15
23
40
IV
12
143
159
11
15
31
172
229
Kappa=0.4626
Kappa
- 525 -
918
50
5.45
10
1.09
34
3.70
1 25.00
0.00
0.00
48
9 18.75
0.00
4.17
II
56
8 14.29
0.00
8.93
III
117
5.13
0.00
IV
662
17
2.57
10
1.51
M0
605
17
2.81
M1
57
0.00
31
9 29.03
197 21.46
37
4.03
478 52.07
18
1.96
0.00
0.00
0.00
1 25.00
0.00
1 25.00
1 25.00
6.25
2.08
8 16.67
25 52.08
0.00
0.00
0.00
8.93
1.79
7.14
28 50.00
1.79
7.14
0.00
4.27
22 18.80
2.56
3.42
69 58.97
2.56
2.56
1.71
22
3.32
161 24.32
49
7.40
20
3.02
348 52.57
11
1.66
18
2.72
0.91
1.49
22
3.64
159 26.28
29
4.79
20
3.31
319 52.73
1.16
17
2.81
0.99
1.75
0.00
20 35.09
0.00
29 50.88
7.02
1.75
0.00
0.00
0.00
6 19.35
3.23
7 22.58
9.68
9.68
0.00
6.45
6.10
3.16
56
3.51
29
0.98
0~39 1
30
3.33
3.33
0.00
30.00
3.33
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
0.00
0.00
0.00
0.00
0.00
III
0.00
0.00
0.00
0.00
0.00
IV
29
3.45
3.45
0.00
31.03
M 0
27
3.70
3.70
0.00
33.33
M 1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.33
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1 100.0
0.00
0.00
0.00
3.45
0.00
16 55.17
0.00
0.00
3.45
0.00
0.00
15 55.56
0.00
0.00
3.70
0.00
1 50.00
0.00
1 50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
17 56.67
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 526 -
40~59 1
569
32
5.62
1.23
16
2.81
1 33.33
0.00
0.00
35
7 20.00
0.00
2.86
II
35
5 14.29
0.00
III
62
6.45
0.00
IV
418
10
2.39
M0
386
10
2.59
M1
32
16
124 21.79
38
6.68
21
3.69
308 54.13
1.05
0.00
0.00
0.00
1 33.33
5.71
2.86
5 14.29
19 54.29
8.57
5 14.29
0.00
2.86
4.84
15 24.19
3.23
1.67
2.15
99 23.68
34
8.13
1.81
2.33
97 25.13
21
0.00
0.00
0.00
5 31.25
0.00
0.00
3 18.75
6.25
2.46
0.53
0.00
1 33.33
0.00
0.00
0.00
0.00
18 51.43
0.00
8.57
0.00
3.23
36 58.06
0.00
0.00
0.00
13
3.11
230 55.02
1.20
1.91
0.72
5.44
13
3.37
215 55.70
0.78
2.07
0.78
13 40.63
0.00
15 46.88
6.25
0.00
0.00
0.00
4 25.00
6.25
2 12.50
0.00
6.25
14
60 1
319
17
5.33
0.63
18
5.64
0.00
0.00
0.00
13
2 15.38
0.00
7.69
II
21
3 14.29
0.00
III
54
3.70
0.00
IV
215
2.79
M 0
192
3.13
M 1
23
15
64 20.06
17
5.33
16
5.02
0.00
0.00
0.00
7.69
0.00
9.52
0.00
3.70
7 12.96
0.93
13
6.05
0.52
13
6.77
0.00
4.35
0.00
4 26.67
0.00
0.00
3 20.00
12
3.76
15
4.70
0.00
0.00
0.00
1 100.0
3 23.08
6 46.15
0.00
0.00
0.00
4.76
3 14.29
10 47.62
4.76
4.76
0.00
1.85
3.70
32 59.26
5.56
5.56
3.70
53 24.65
14
6.51
3.26
102 47.44
2.79
10
4.65
0.93
53 27.60
4.17
3.65
89 46.35
2.08
4.69
1.04
6 26.09
0.00
13 56.52
8.70
4.35
0.00
6.67
3 20.00
2 13.33
6.67
0.00
0.00
6.67
153 47.96
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 527 -
1.57
- 528 -
0
0
0
2
1
3
4
8
13
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
2
4
2
4
13
11
0
0
0
4
5
5
8
21
24
9
7
4
10
3
10
5
4
3
91
11
16
18
8
8
4
10
8
0
114
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
20
23
22
18
11
14
15
12
3
205
%
205
100.00
I
II
III
IV
25
33
18
48
81
%
205
100.00
12.2
16.1
8.78
23.41
39.51
45
51
25
37
47
%
205
100.00
21.95
24.88
12.2
18.05
22.93
43
53
26
56
27
20.98
25.85
12.68
27.32
13.17
- 99 (AJCC_7th) 1
0
20
I
1
II
1
III
0
IV
22
20
18
27
II
17
III
25
29
IV
23
24
16
32
95
23
20
22
20
Kappa=0.6725
Kappa
- 529 -
205
74 36.10
1.95
66 32.20
25
15 60.00
0.00
9 36.00
II
33
15 45.45
0.00
III
18
4 22.22
IV
48
8.33
81
40 19.51
0.98
1.46
3.90
0.49
2.44
0.98
4.00
0.00
0.00
0.00
0.00
0.00
0.00
9 27.27
8 24.24
0.00
0.00
0.00
0.00
3.03
0.00
0.00
9 50.00
4 22.22
0.00
0.00
5.56
0.00
0.00
0.00
6.25
10 20.83
14 29.17
4.17
4.17
7 14.58
2.08
6.25
4.17
36 44.44
1.23
29 35.80
13 16.05
0.00
1.23
0.00
0.00
1.23
0.00
205
74 36.10
1.95
66 32.20
40 19.51
0.98
1.46
3.90
0.49
2.44
0.98
45
25 55.56
0.00
17 37.78
6.67
0.00
0.00
0.00
0.00
0.00
0.00
II
51
21 41.18
0.00
22 43.14
8 15.69
0.00
0.00
0.00
0.00
0.00
0.00
III
25
8 32.00
0.00
10 40.00
7 28.00
0.00
0.00
0.00
0.00
0.00
0.00
IV
37
6 16.22
2.70
12 32.43
18 48.65
0.00
0.00
0.00
0.00
0.00
0.00
47
14 29.79
6.38
5 10.64
8.51
4.26
6.38
8 17.02
2.13
5 10.64
4.26
205
74 36.10
1.95
66 32.20
40 19.51
0.98
1.46
3.90
0.49
2.44
0.98
43
25 58.14
0.00
16 37.21
4.65
0.00
0.00
0.00
0.00
0.00
0.00
II
53
21 39.62
0.00
22 41.51
9 16.98
0.00
0.00
0.00
0.00
1.89
0.00
III
26
8 30.77
0.00
10 38.46
7 26.92
0.00
0.00
3.85
0.00
0.00
0.00
IV
56
6 10.71
5.36
12 21.43
18 32.14
3.57
3.57
7 12.50
1.79
5.36
3.57
27
14 51.85
3.70
6 22.22
4 14.81
0.00
3.70
0.00
3.70
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 530 -
0~49 1
87
29 33.33
0.00
28 32.18
23
14 60.87
0.00
8 34.78
II
29
9 31.03
0.00
III
10
2 20.00
IV
17
0.00
4 50.00
22 25.29
1.15
1.15
3.45
0.00
3.45
0.00
4.35
0.00
0.00
0.00
0.00
0.00
0.00
12 41.38
7 24.14
0.00
0.00
0.00
0.00
3.45
0.00
0.00
3 30.00
5 50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3 17.65
9 52.94
5.88
0.00
3 17.65
0.00
5.88
0.00
0.00
2 25.00
0.00
1 12.50
0.00
1 12.50
0.00
0.00
0.00
50~69 1
74
27 36.49
2.70
23 31.08
18
10 55.56
0.00
7 38.89
II
16
7 43.75
0.00
III
10
4 40.00
IV
21
3 14.29
3 33.33
14 18.92
1.35
0.00
5.41
1.35
1.35
1.35
5.56
0.00
0.00
0.00
0.00
0.00
0.00
7 43.75
2 12.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3 30.00
2 20.00
0.00
0.00
1 10.00
0.00
0.00
0.00
4.76
4 19.05
6 28.57
4.76
0.00
3 14.29
4.76
4.76
4.76
1 11.11
2 22.22
3 33.33
0.00
0.00
0.00
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 531 -
70 1
44
18 40.91
4.55
15
34.09
9.09
0.00
4.55
2.27
0.00
2.27
2.27
1 50.00
0.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
5 62.50
0.00
37.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
III
2 33.33
0.00
66.67
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IV
18
3 16.67
2 11.11
27.78
3 16.67
0.00
2 11.11
5.56
0.00
5.56
5.56
10
7 70.00
20.00
1 10.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 532 -
0
0
0
8
7
19
76
95
150
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
1
3
3
10
25
28
39
0
0
1
11
10
29
101
123
189
54
60
52
28
19
19
15
7
2
365
150
193
151
90
54
41
35
8
6
1083
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
204
253
203
118
73
60
50
15
8
1448
1448
100.00
1448
100.00
0.00
0.00
I
II
III
IV
145
282
471
521
29
10.01
19.48
32.53
35.98
2
15
4
8
15
1406
1.04
0.28
0.55
1.04
97.1
%
1448
0
146
284
476
521
21
100.00
0.00
10.08
19.61
32.87
35.98
1.45
- 99 (AJCC_7th) 1
- 533 -
143
9.88
1116 77.07
0.28
39
2.69
15
1.04
30 20.69
0.00
2.76
0.69
1448
0.62
0.21
20
1.38
45
3.11
54
3.73
145
3.45
0.69
10
6.90
0.00
2.76
90 62.07
II
282
0.00
0.00
0.71
11
3.90
2.13
22
7.80
232 82.27
0.00
1.77
1.42
III
471
0.21
0.00
0.00
13
2.76
13
2.76
18
3.82
409 86.84
0.21
11
2.34
1.06
IV
521
0.00
0.19
0.00
18
3.45
30
5.76
13
2.50
443 85.03
0.58
1.54
0.96
M0
423
0.00
0.00
0.00
13
3.07
13
3.07
1.89
377 89.13
0.47
1.18
1.18
M1
98
0.00
1.02
0.00
5.10
17 17.35
5.10
66 67.35
1.02
3.06
0.00
29
3 10.34
3.45
8 27.59
0.00
0.00
11 37.93
0.00
3 10.34
3.45
6.90
0~49
668
1.05
0.15
0.45
19
2.84
17
2.54
38
5.69
568 85.03
0.00
11
1.65
0.60
55
5.45
0.00
1.82
0.00
5.45
28 50.91
19 34.55
0.00
1.82
0.00
II
134
0.00
0.00
0.00
3.73
0.75
2.24
122 91.04
0.00
1.49
0.75
III
242
0.41
0.00
0.00
2.89
1.65
1.65
218 90.08
0.00
2.07
1.24
IV
225
0.00
0.00
0.00
2.22
4.00
1.33
208 92.44
0.00
0.00
0.00
M0
190
0.00
0.00
0.00
2.11
1.58
1.05
181 95.26
0.00
0.00
0.00
M1
35
0.00
0.00
0.00
2.86
6 17.14
2.86
27 77.14
0.00
0.00
0.00
12
3 25.00
8.33
2 16.67
0.00
0.00
3 25.00
0.00
2 16.67
0.00
8.33
1
2
3 ()
4
5
- 534 -
50~69
647
0.31
0.15
68
2.94
II
126
0.00
III
192
IV
246
M0
16
2.47
22
3.40
25
3.86
63
9.74
486 75.12
0.31
21
3.25
1.39
1.47
8 11.76
0.00
1.47
44 64.71
9 13.24
0.00
4.41
0.00
0.00
1.59
3.97
3.97
11
8.73
99 78.57
0.00
1.59
1.59
0.00
0.00
0.00
3.13
2.08
2.08
171 89.06
0.00
2.60
1.04
0.00
0.00
0.00
10
4.07
14
5.69
1.63
206 83.74
0.81
2.03
2.03
192
0.00
0.00
0.00
3.13
2.60
1.04
170 88.54
0.52
1.56
2.60
M1
54
0.00
0.00
0.00
7.41
9 16.67
3.70
36 66.67
1.85
3.70
0.00
15
0.00
0.00
6 40.00
6.67
0.00
0.00
6 40.00
0.00
6.67
6.67
70
133
0.00
0.75
0.75
3.01
12
9.02
42
31.58
22
0.00
0.00
4.55
0.00
0.00
18
81.82
II
22
0.00
0.00
0.00
4.55
0.00
III
37
0.00
0.00
0.00
0.00
5 13.51
IV
50
0.00
2.00
0.00
6.00
M0
41
0.00
0.00
0.00
M1
0.00
1 11.11
0.00
0.00
0.00
0.00
1.50
5.26
1.50
9.09
0.00
0.00
4.55
36.36
11 50.00
0.00
4.55
4.55
10
27.03
20 54.05
2.70
2.70
0.00
7 14.00
12.00
29 58.00
2.00
6.00
0.00
7.32
5 12.20
9.76
26 63.41
2.44
4.88
0.00
0.00
2 22.22
22.22
3 33.33
0.00
11.11
0.00
0.00
0.00
0.00
2 100.0
0.00
0.00
62 46.62
0.00
1
2
3 ()
4
5
- 535 -
- 536 -
0
0
0
0
1
2
9
49
175
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
1
1
7
0
0
0
0
1
2
10
50
182
5
14
13
11
18
12
18
13
13
126
278
344
325
211
149
110
83
65
47
1848
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
283
358
338
222
167
122
101
78
60
1974
%
1974
100.00
0
I
II
III
IV
13
120
341
929
472
99
%
1974
100.00
0.66
6.08
17.27
47.06
23.91
5.02
9
125
219
177
56
1388
%
1974
100.00
0.46
6.33
11.09
8.97
2.84
70.31
16
147
327
944
474
66
0.81
7.45
16.57
47.82
24.01
3.34
- 99 (AJCC_7th) 1
0
1
I
3
II
0
III
0
IV
0
50
66
II
34
89
36
161
III
28
106
120
261
IV
48
51
116
204
160
55
543
Kappa=0.3916
Kappa
- 537 -
1974
188
9.52
43
2.18
29
1.47
420 21.28
105
5.32
128
6.48
849 43.01
89
4.51
93
4.71
30
1.52
13
4 30.77
0.00
0.00
0.00
0.00
0.00
4 30.77
0.00
3 23.08
2 15.38
120
66 55.00
1.67
1.67
5.83
2.50
5.83
24 20.00
0.83
3.33
3.33
II
341
65 19.06
16
4.69
17
4.99
83 24.34
10
2.93
19
5.57
110 32.26
1.76
14
4.11
0.29
III
929
23
2.48
20
2.15
0.75
277 29.82
22
2.37
59
6.35
453 48.76
40
4.31
23
2.48
0.54
IV
472
1.69
0.21
0.64
33
6.99
68
14.41
37
7.84
252 53.39
33
6.99
30
6.36
1.48
99
22 22.22
4.04
0.00
20 20.20
2.02
6.06
6.06
9.09
19 19.19
11 11.11
43
2.18
29
1.47
420 21.28
105
5.32
128
6.48
849 43.01
89
4.51
93
4.71
30
1.52
1 11.11
0.00
2 22.22
0.00
0.00
0.00
0.00
0.00
0.00
1974
188
9.52
6 66.67
125
91 72.80
0.80
2.40
30 24.00
0.00
0.00
0.00
0.00
0.00
0.00
II
219
59 26.94
15
6.85
16
7.31
129 58.90
0.00
0.00
0.00
0.00
0.00
0.00
III
177
13
7.34
21 11.86
2.82
136 76.84
0.00
0.56
0.56
0.00
0.00
0.00
IV
56
8.93
5.36
5.36
24 42.86
5.36
3.57
14 25.00
1.79
0.00
1.79
1388
14
1.01
0.14
0.14
99
7.13
102
7.35
125
9.01
834 60.09
88
6.34
93
6.70
29
2.09
1974
188
9.52
43
2.18
29
1.47
420 21.28
105
5.32
128
6.48
849 43.01
89
4.51
93
4.71
30
1.52
16
6 37.50
6.25
0.00
0.00
0.00
0.00
4 25.00
0.00
3 18.75
2 12.50
147
93 63.27
0.68
2.04
4.76
2.04
4.76
24 16.33
0.68
2.72
2.72
II
327
59 18.04
15
4.59
16
4.89
77 23.55
10
3.06
19
5.81
110 33.64
1.83
14
4.28
0.31
III
944
14
1.48
22
2.33
0.53
301 31.89
22
2.33
59
6.25
453 47.99
40
4.24
23
2.44
0.53
IV
474
1.90
0.63
0.63
32
6.75
68
14.35
37
7.81
252 53.16
33
6.96
30
6.33
1.48
66
7 10.61
1.52
3.03
4.55
3.03
9.09
9.09
9 13.64
19 28.79
11 16.67
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 538 -
0~49 1
528
1 16.67
40
II
81
III
279
IV
104
18
46
8.71
15
2.84
0.95
1 16.67
0.00
25 62.50
0.00
2.50
15 18.52
7.41
0.36
2.87
0.96
3 16.67
143 27.08
26
4.92
18
3.41
236 44.70
16
3.03
0.00
0.00
0.00
2 33.33
7.50
2.50
0.00
9 22.50
3.70
29 35.80
0.00
1.23
0.00
104 37.28
2.51
14
0.00
0.00
17 16.35
0.00
5.56
2 11.11
4.81
5.56
3.03
1.33
0.00
2 33.33
0.00
0.00
0.00
2.50
21 25.93
0.00
7.41
0.00
5.02
134 48.03
2.51
1.43
0.00
1.92
68 65.38
4.81
1.92
3.85
5.56
2 11.11
4 22.22
16
2 11.11
2 11.11
50~69 1
106
9.77
25
2.30
18
1.66
1085
4 50.00
0.00
0.00
78
51 65.38
1.28
2.56
II
172
34 19.77
3.49
10
III
519
1.54
14
2.70
IV
286
1.75
22
4 18.18
253 23.32
61
5.62
52
4.79
488 44.98
37
3.41
35
3.23
0.00
0.00
0.00
2 25.00
0.00
0.00
2 25.00
5.13
0.00
3.85
11 14.10
1.28
3.85
2.56
5.81
46 26.74
2.33
3.49
63 36.63
0.58
0.58
0.58
0.77
178 34.30
12
2.31
22
4.24
257 49.52
14
2.70
1.54
0.39
1.05
0.70
24
8.39
45 15.73
20
6.99
151 52.80
19
6.64
16
5.59
0.35
4.55
0.00
4.55
4.55
4 18.18
9.09
7 31.82
9.09
0.00
10
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 539 -
0.92
70 1
361
36
9.97
0.83
1.66
24
6.65
18
4.99
1 50.00
0.00
0.00
0.00
0.00
29
17 58.62
0.00
0.00
0.00
6.90
II
74
10 13.51
4.05
4.05
2.70
III
146
3.42
0.00
0.68
19 13.01
IV
84
3.57
0.00
1.19
26
0.00
0.00
3.85
58 16.07
36
9.97
42 11.63
13
3.60
0.00
0.00
1 50.00
0.00
4 13.79
4 13.79
0.00
3.45
3.45
8.11
12 16.22
26 35.14
6.76
9.46
0.00
2.05
23 15.75
62 42.47
19 13.01
11
7.53
2.05
3.57
7.14
15 17.86
33 39.29
9 10.71
12 14.29
2.38
0.00
3.85
4 15.38
3 11.54
10 38.46
7 26.92
0.00
125 34.63
0.00
1(99 )(AJCC_7th) 1
2
3 ()
4
5
- 540 -
0
0
1
0
0
5
10
31
50
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
2
0
7
19
32
50
0
0
1
2
0
12
29
63
100
81
103
125
114
122
162
157
159
118
1251
102
175
229
200
201
240
315
318
186
2063
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
183
278
354
314
323
402
472
477
304
3314
%
3314
100.00
0
I
II
III
IV
19
741
569
483
894
608
%
3314
100.00
0.57
22.36
17.17
14.57
26.98
18.35
27
649
435
745
415
1043
%
3314
100.00
0.81
19.58
13.13
22.48
12.52
31.47
34
734
513
850
993
190
1.03
22.15
15.48
25.65
29.96
5.73
- 99 (AJCC_7th) 1
0
6
I
5
II
0
III
0
IV
0
11
432
121
72
641
II
51
195
220
25
491
III
43
279
51
381
IV
296
310
15
502
359
579
379
1834
Kappa=0.5457
Kappa
- 541 -
11
0.33
213
6.43
0.00
0.00
0.00
468 14.12
26
0.78
83
2.50
216
6.52
0.00
0.00
0.00
0.00
264
7.97
48
1.45
7 36.84
0.00
19
12
63.16
741
501
67.61
128 17.27
0.13
30
4.05
17
2.29
0.00
0.81
12
1.62
36
4.86
10
1.35
II
569
218
38.31
201 35.33
0.00
71 12.48
19
3.34
0.88
1.41
17
2.99
22
3.87
1.41
III
483
150
31.06
167 34.58
0.41
63 13.04
35
7.25
1.66
17
3.52
23
4.76
13
2.69
1.04
IV
894
53
5.93
129 14.43
0.45
22
2.46
379 42.39
11
1.23
48
5.37
104 11.63
11
1.23
608
269
44.24
157 25.82
0.66
27
4.44
2.96
0.33
0.66
31
5.10
82 13.49
14
2.30
11
0.33
213
6.43
468 14.12
26
0.78
83
2.50
216
6.52
264
7.97
48
1.45
27
649
575
88.60
II
435
223
III
745
IV
27 100.00
18
133 14.88
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
60
9.24
0.15
13
2.00
0.00
0.00
0.00
0.00
0.00
0.00
51.26
171 39.31
0.23
40
9.20
0.00
0.00
0.00
0.00
0.00
0.00
271
36.38
338 45.37
0.67
129 17.32
0.00
0.13
0.13
0.00
0.00
0.00
415
68
16.39
194 46.75
0.96
27
6.51
78 18.80
0.00
10
2.41
19
4.58
14
3.37
0.24
1043
39
3.74
1.82
0.00
0.38
390 37.39
25
2.40
72
6.90
197 18.89
250 23.97
47
4.51
11
0.33
213
6.43
468 14.12
26
0.78
83
2.50
216
6.52
264
7.97
48
1.45
7 20.59
0.00
19
34
27
79.41
0.00
0.00
0.00
0.00
0.00
0.00
0.00
734
578
78.75
61
8.31
0.14
13
1.77
17
2.32
0.00
0.82
12
1.63
36
4.90
10
1.36
II
513
223
43.47
169 32.94
0.19
41
7.99
19
3.70
0.97
1.56
17
3.31
22
4.29
1.56
III
850
273
32.12
342 40.24
0.47
130 15.29
35
4.12
0.94
17
2.00
23
2.71
13
1.53
0.59
IV
993
73
7.35
201 20.24
0.40
29
2.92
379 38.17
11
1.11
48
4.83
133 13.39
104 10.47
11
1.11
190
29
15.26
0.53
0.00
1.05
2.11
31 16.32
82 43.16
14
7.37
4.74
18
9.47
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 542 -
0~49 1
390
106
27.18
0.00
75
59
II
50
III
138 35.38
0.26
0.00
0.00
0.00
78.67
11 14.67
0.00
4.00
19
38.00
23 46.00
0.00
109
23
21.10
54 49.54
0.92
IV
146
2.05
48 32.88
0.00
3.42
10
20.00
2 20.00
0.00
0.00
40 10.26
70 17.95
0.00
1.54
11
2.82
16
4.10
0.51
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.67
0.00
7 14.00
2.00
0.00
0.00
0.00
0.00
0.00
25 22.94
2.75
0.00
0.00
0.92
0.92
0.92
66 45.21
0.00
4.11
6.16
5.48
0.68
0.00
0.00
1 10.00
5 50.00
0.00
0.00
50~69 1
1237
461 37.27
0.32
112
9.05
0.00
0.00
0.00
2.33
354 28.62
177 14.31
0.32
35
2.83
31
2.51
47
3.80
12
0.97
0.00
0.00
0.00
0.00
0.00
0.00
1.33
0.00
0.67
1.00
1.67
1.00
16
16 100.0
300
245 81.67
30 10.00
0.33
II
204
87 42.65
79 38.73
0.00
25 12.25
0.98
0.49
0.98
0.98
2.94
0.00
III
314
82 26.11
148 47.13
0.32
65 20.70
10
3.18
0.32
1.59
0.32
0.32
0.00
IV
367
21
94 25.61
0.54
15
4.09
158 43.05
0.54
26
7.08
24
6.54
24
6.54
0.27
36
0.00
0.00
0.00
0.00
2.78
11 30.56
5.72
10 27.78
8.33
8.33
8 22.22
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 543 -
70 1
1655
634
38.31
278 16.80
0.30
56
3.38
216 13.05
22
1.33
42
2.54
174 10.51
194 11.72
34
2.05
5 31.25
0.00
16
11
68.75
0.00
0.00
0.00
0.00
0.00
0.00
0.00
355
272
76.62
19
5.35
0.00
0.56
13
3.66
0.00
1.13
2.54
29
8.17
1.97
II
257
117
45.53
67 26.07
0.39
3.11
16
6.23
1.56
2.33
15
5.84
15
5.84
3.11
III
420
168
40.00
136 32.38
0.48
37
8.81
22
5.24
1.67
12
2.86
21
5.00
11
2.62
0.95
IV
464
49
10.56
52 11.21
0.22
1.94
150 32.33
1.94
16
3.45
100 21.55
69 14.87
1.94
143
17
11.89
0.70
0.00
15 10.49
1.40
2.80
29 20.28
65 45.45
4.20
2.80
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 544 -
0
1
0
1
3
18
42
63
114
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
1
2
15
43
62
84
0
1
0
2
5
33
85
125
198
183
325
402
373
439
395
403
291
269
3287
192
396
545
550
563
504
481
425
254
4152
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
375
721
947
923
1002
899
884
716
523
7439
7439
100.00
7439
100.00
7439
100.00
196
1015
1197
1952
1550
1529
2.63
13.64
16.09
26.24
20.84
20.55
651
1087
1753
1865
1142
941
8.75
14.61
23.56
25.07
15.35
12.65
672
1136
9.03
15.27
1695
1937
1643
236
24.39
26.04
22.09
3.17
0
I
II
III
IV
- 99 (AJCC_7th) 1
0
I
II
III
IV
145
57
6
11
2
221
I
24
518
115
126
4
787
II
2
190
631
637
19
1479
Kappa=0.5220
Kappa
- 545 -
III
2
171
356
1015
25
1569
IV
0
8
20
87
992
1107
173
944
1128
1876
1042
5163
128
1.72
380
5.11
13
0.17
53
0.71
181
2.43
227
3.05
61
0.82
0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV
0
1
0
1
0
0
0
0
1
1
2
0
0.00
0.09
0.00
0.07
0.00
0.00
0.00
0.00
0.08
0.21
0.12
0.00
0
1
0
17
8
9
0
0
22
16
53
2
0.00
0.09
0.00
1.11
4.91
7.50
0.00
0.00
1.68
3.35
3.23
0.85
0 0.00
6 0.53
2 33.33
6 0.39
1 0.61
1 0.83
4 100.0
0 0.00
6 0.46
7 1.47
337 20.51
10 4.24
0
1
0
1
0
1
0
0
1
0
8
1
0.00
0.09
0.00
0.07
0.00
0.83
0.00
0.00
0.08
0.00
0.49
0.42
0
0
0
3
0
0
0
0
5
3
41
1
0.00
0.00
0.00
0.20
0.00
0.00
0.00
0.00
0.38
0.63
2.50
0.42
1
2
0
8
5
3
0
0
7
6
129
20
0.15
0.18
0.00
0.52
3.07
2.50
0.00
0.00
0.53
1.26
7.85
8.47
17 2.53
29 2.55
1 16.67
17 1.11
3 1.84
2 1.67
0 0.00
2 1.36
21 1.60
5 1.05
68 4.14
62 26.27
2
9
0
3
1
1
0
0
3
2
17
23
0.30
0.79
0.00
0.20
0.61
0.83
0.00
0.00
0.23
0.42
1.03
9.75
649
1019
2
766
51
33
0
15
175
60
164
92
96.58
89.70
33.33
50.20
31.29
27.50
0.00
10.20
13.37
12.58
9.98
38.98
3
68
1
704
94
70
0
130
1068
377
824
25
0.45
5.99
16.67
46.13
57.67
58.33
0.00
88.44
81.59
79.04
50.15
10.59
0.08
672
1136
6
1526
163
120
4
147
1309
477
1643
236
0~49 1
824
0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV
67
89
0
134
15
14
1
15
152
77
245
15
227 27.55
67
84
0
44
0
2
0
0
8
4
11
7
100.0
94.38
0.00
32.84
0.00
14.29
0.00
0.00
5.26
5.19
4.49
46.67
507
61.53
0.00
27
0
0.00
4
4.49
0
0.00
87 64.93
11 73.33
11 78.57
0
0.00
15 100.00
138 90.79
68 88.31
170 69.39
3 20.00
0
0
0
0
0
0
0
0
0
0
0
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0 0.00
0 0.00
2 1.49
4 26.67
1 7.14
0 0.00
0 0.00
4 2.63
4 5.19
12 4.90
0 0.00
3.28
38
4.61
0.12
0.97
0.61
1.09
0.24
0 0.00
0 0.00
0 0.00
1 0.75
0 0.00
0 0.00
1 100.0
0 0.00
1 0.66
1 1.30
33 13.47
1 6.67
0
0
0
0
0
0
0
0
0
0
1
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.41
0.00
0
0
0
0
0
0
0
0
0
0
7
1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.86
6.67
0
0
0
0
0
0
0
0
0
0
5
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.04
0.00
0 0.00
1 1.12
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
1 0.66
0 0.00
5 2.04
2 13.33
0
0
0
0
0
0
0
0
0
0
1
1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.41
6.67
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 546 -
50~69 1
158
4.40
0.06
14
0.39
27
0.75
63
1.75
17
0.47
0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV
0
1
0
1
0
0
0
0
0
0
1
0
0.00
0.15
0.00
0.15
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
0
0
0
5
3
3
0
0
13
8
24
2
0.00
0.00
0.00
0.73
4.62
8.11
0.00
0.00
2.22
3.65
3.48
2.08
0 0.00
0 0.00
1 25.00
1 0.15
0 0.00
0 0.00
0 0.00
0 0.00
1 0.17
2 0.91
152 22.06
1 1.04
0
0
0
0
0
0
0
0
0
0
1
1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
1.04
0
0
0
1
0
0
0
0
0
1
12
0
0.00
0.00
0.00
0.15
0.00
0.00
0.00
0.00
0.00
0.46
1.74
0.00
0
1
0
1
0
0
0
0
1
0
23
1
0.00
0.15
0.00
0.15
0.00
0.00
0.00
0.00
0.17
0.00
3.34
1.04
6 1.34
11 1.62
1 25.00
4 0.59
0 0.00
0 0.00
0 0.00
0 0.00
6 1.03
1 0.46
16 2.32
18 18.75
0
4
0
0
0
0
0
0
0
0
5
8
0.00
0.59
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.73
8.33
441
627
1
312
13
6
0
7
29
17
45
55
98.44
92.21
25.00
45.81
20.00
16.22
0.00
7.87
4.96
7.76
6.53
57.29
1
36
1
356
49
28
0
82
535
190
410
10
0.22
5.29
25.00
52.28
75.38
75.68
0.00
92.13
91.45
86.76
59.51
10.42
1.61
58
448
680
4
681
65
37
0
89
585
219
689
96
0.08
70 1
1.42
184
6.09
10
0.33
31
1.03
149
4.93
155
5.13
0
I
II
IA
IB
IIC
III
I IA
I IB
I IC
IV
0
0
0
0
0
0
0
0
1
1
1
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.17
0.55
0.14
0.00
0
1
0
10
1
5
0
0
5
4
17
0
0.00
0.27
0.00
1.41
1.20
7.25
0.00
0.00
0.87
2.21
2.40
0.00
0 0.00
6 1.63
1 50.00
4 0.56
1 1.20
1 1.45
3 100.0
0 0.00
4 0.70
4 2.21
152 21.44
8 6.40
0
1
0
1
0
1
0
0
1
0
6
0
0.00
0.27
0.00
0.14
0.00
1.45
0.00
0.00
0.17
0.00
0.85
0.00
0
0
0
2
0
0
0
0
5
2
22
0
0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
0.87
1.10
3.10
0.00
1 0.64
1 0.27
0 0.00
7 0.98
5 6.02
3 4.35
0 0.00
0 0.00
6 1.05
6 3.31
101 14.25
19 15.20
141
308
1
410
38
25
0
8
138
39
108
30
89.81
83.92
50.00
57.67
45.78
36.23
0.00
18.60
24.13
21.55
15.23
24.00
2
28
0
261
34
31
0
33
395
119
244
12
1.27
7.63
0.00
36.71
40.96
44.93
0.00
76.74
69.06
65.75
34.41
9.60
43
157
367
2
711
83
69
3
43
572
181
709
125
0.10
11 7.01
17 4.63
0 0.00
13 1.83
3 3.61
2 2.90
0 0.00
2 4.65
14 2.45
4 2.21
47 6.63
42 33.60
42
1.39
2 1.27
5 1.36
0 0.00
3 0.42
1 1.20
1 1.45
0 0.00
0 0.00
3 0.52
2 1.10
11 1.55
14 11.20
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 547 -
MAC
722
293 40.58
87
84 96.55
305
C
D
407 56.37
0.00
15
2.08
0.69
0.00
0.14
0.00
0.14
0.00
3.45
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
160 52.46
141 46.23
0.00
0.98
0.33
0.00
0.00
0.00
0.00
0.00
251
39 15.54
203 80.88
0.00
3.59
0.00
0.00
0.00
0.00
0.00
0.00
79
10 12.66
60 75.95
0.00
3.80
5.06
0.00
1.27
0.00
1.27
0.00
MAC AJCC ()
1
2 ()
3
4
- 548 -
0
0
0
0
5
6
27
56
80
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
1
2
8
18
37
56
0
0
0
1
7
14
45
93
136
124
217
250
223
257
236
208
170
122
1929
183
292
415
409
434
374
321
237
138
2977
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
307
509
665
632
691
610
529
407
260
4906
0
I
II
III
IV
%
4906
100.00
%
4906
100.00
102
953
786
1301
920
844
329
947
842
1229
649
910
2.08
19.43
16.02
26.52
18.75
17.2
6.71
19.3
17.16
25.05
13.23
18.55
%
4906
100.00
331
972
887
1520
956
240
6.75
19.81
18.08
30.99
19.49
4.89
- 99 (AJCC_7th) 1
II
III
IV
72
16
88
40
467
133
184
830
II
125
310
219
17
678
III
144
291
644
33
1116
IV
10
13
580
605
123
754
744
1060
636
3317
Kappa=0.5025
Kappa
- 549 -
68
1.39
0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV
2
25
0
10
0
1
3
11
4
5
7
0.60
2.57
0.00
1.31
0.00
2.13
1.51
1.13
1.16
0.52
2.92
331
972
3
763
74
47
199
977
344
956
240
316
738
2
304
17
8
15
96
32
62
111
95.47
75.93
66.67
39.84
22.97
17.02
7.54
9.83
9.30
6.49
46.25
1
61
1
224
29
18
100
419
137
399
7
0.30
6.28
33.33
29.36
39.19
38.30
50.25
42.89
39.83
41.74
2.92
1024 20.87
4
76
0
166
16
10
68
365
139
149
31
1.21
7.82
0.00
21.76
21.62
21.28
34.17
37.36
40.41
15.59
12.92
178
3.63
40
0.82
2 0.60
6 0.62
0 0.00
2 0.26
1 1.35
1 2.13
4 2.01
5 0.51
6 1.74
142 14.85
9 3.75
1
6
0
6
1
2
1
5
2
16
0
0.30
0.62
0.00
0.79
1.35
4.26
0.50
0.51
0.58
1.67
0.00
249
5.08
66
1.35
149
3.04
35
0.71
0 0.00
30 3.09
0 0.00
37 4.85
4 5.41
5 10.64
5 2.51
53 5.42
19 5.52
90 9.41
6 2.50
0
2
0
2
3
1
0
5
3
39
11
0.00
0.21
0.00
0.26
4.05
2.13
0.00
0.51
0.87
4.08
4.58
4 1.21
25 2.57
0 0.00
10 1.31
3 4.05
1 2.13
3 1.51
13 1.33
1 0.29
40 4.18
49 20.42
1
3
0
2
0
0
0
5
1
14
9
0.30
0.31
0.00
0.26
0.00
0.00
0.00
0.51
0.29
1.46
3.75
0~49 1
603
0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV
27
111
1
68
15
7
19
119
57
134
45
182 30.18
27
87
1
20
2
1
2
8
3
3
28
100.0
78.38
100.0
29.4
13.33
14.29
10.53
6.72
5.26
2.24
62.22
167
27.69
0.83
0
6
0
23
8
4
9
39
22
55
1
0.00
5.41
0.00
33.82
53.33
57.14
47.37
32.77
38.60
41.04
2.22
0
2
0
0
0
0
1
1
0
0
1
0.00
1.80
0.00
0.00
0.00
0.00
5.26
0.84
0.00
0.00
2.22
169 28.03
0
10
0
23
5
2
7
62
27
29
4
0.00
9.01
0.00
33.82
33.33
28.57
36.84
52.10
47.37
21.64
8.89
24
3.98
0.33
36
5.97
0.33
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
1 1.75
23 17.16
0 0.00
0
0
0
0
0
0
0
0
0
2
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.00
0 0.00
3 2.70
0 0.00
2 2.94
0 0.00
0 0.00
0 0.00
9 7.56
4 7.02
16 11.94
2 4.44
0
0
0
0
0
0
0
0
0
2
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.00
12
1.99
0.66
0 0.00
3 2.70
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
2 1.49
7 15.56
0
0
0
0
0
0
0
0
0
2
2
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
4.44
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 550 -
50~69 1
2497
884 35.40
761 30.48
27
1.08
572 22.91
64
0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV
208
424
0
123
3
4
4
31
10
17
60
0
32
1
124
11
8
58
222
75
226
4
2
13
0
5
0
0
0
2
1
1
3
0.93
2.39
0.00
1.39
0.00
0.00
0.00
0.40
0.56
0.22
2.83
1
47
0
87
6
2
40
207
83
80
19
0 0.00
1 0.18
0 0.00
2 0.55
0 0.00
0 0.00
2 1.87
2 0.40
1 0.56
54 12.08
2 1.89
214
544
1
361
21
20
107
498
178
447
106
97.20
77.94
0.00
34.07
14.29
20.00
3.74
6.22
5.62
3.80
56.60
0.00
5.88
100.0
34.35
52.38
40.00
54.21
44.58
42.13
50.56
3.77
0.47
8.64
0.00
24.10
28.57
10.00
37.38
41.57
46.63
17.90
17.92
2.56
11
0.44
108
4.33
10
0.40
53
2.12
0.28
0 0.00
14 2.57
0 0.00
16 4.43
0 0.00
3 15.00
2 1.87
23 4.62
7 3.93
40 8.95
3 2.83
0
0
0
0
0
0
0
1
0
9
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.20
0.00
2.01
0.00
3 1.40
12 2.21
0 0.00
2 0.55
1 4.76
1 5.00
0 0.00
6 1.20
0 0.00
16 3.58
12 11.32
0
0
0
0
0
0
0
2
0
2
3
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.40
0.00
0.45
2.83
0 0.00
1 0.18
0 0.00
2 0.55
0 0.00
2 10.00
1 0.93
2 0.40
1 0.56
2 0.45
0 0.00
70 1
1806
635 35.16
468
25.91
36
1.99
0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV
81
227
1
161
12
3
9
57
19
42
23
1
23
0
77
10
6
33
158
40
118
2
1.11
7.26
0.00
23.05
26.32
30.00
45.21
43.89
36.70
31.47
2.25
0
10
0
5
0
1
2
8
3
4
3
0.00
3.15
0.00
1.50
0.00
5.00
2.74
2.22
2.75
1.07
3.37
90
317
1
334
38
20
73
360
109
375
89
90.00
71.61
100.0
48.20
31.58
15.00
12.33
15.83
17.43
11.20
25.84
283 15.67
3
19
0
56
5
6
21
96
29
40
8
3.33
5.99
0.00
16.77
13.16
30.00
28.77
26.67
26.61
10.67
8.99
4.98
27
1.50
105
5.81
2 2.22
5 1.58
0 0.00
0 0.00
1 2.63
1 5.00
2 2.74
3 0.83
4 3.67
65 17.33
7 7.87
1
5
0
4
1
0
0
3
1
12
0
1.11
1.58
0.00
1.20
2.63
0.00
0.00
0.83
0.92
3.20
0.00
90
0 0.00
13 4.10
0 0.00
19 5.69
4 10.53
2 10.00
3 4.11
21 5.83
8 7.34
34 9.07
1 1.12
54
2.99
0 0.00
2 0.63
0 0.00
2 0.60
3 7.89
1 5.00
0 0.00
4 1.11
3 2.75
28 7.47
11 12.36
84
4.65
24
1.33
1 1.11
10 3.15
0 0.00
8 2.40
2 5.26
0 0.00
3 4.11
7 1.94
1 0.92
22 5.87
30 33.71
1
3
0
2
0
0
0
3
1
10
4
1.11
0.95
0.00
0.60
0.00
0.00
0.00
0.83
0.92
2.67
4.49
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 551 -
MAC
484
152 31.40
63
46 73.02
212
173
36
13
2.69
156 32.23
0.41
0.00
0.62
0.00
0.41
0.00
7.94
1.59
11 17.46
0.00
0.00
0.00
0.00
0.00
0.00
85 40.09
49 23.11
12
5.66
64 30.19
0.47
0.00
0.47
0.00
0.00
0.00
20 11.56
85 49.13
0.00
66 38.15
0.00
0.00
0.00
0.00
1.16
0.00
17 47.22
0.00
15 41.67
2.78
0.00
5.56
0.00
0.00
0.00
2.78
156 32.23
MAC AJCC ()
1
2 ()
3
4
- 552 -
8
2
2
1
9
27
72
166
326
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
5
0
2
0
2
6
15
28
36
13
2
4
1
11
33
87
194
362
71
151
285
322
456
529
477
286
164
2835
587
760
1059
878
844
814
658
402
194
6809
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
658
911
1344
1200
1300
1343
1135
688
358
9644
I
II
III
IV
%
9644
100.00
%
9644
100.00
3334
1908
2498
1552
352
1046
765
404
205
7224
34.57
19.78
25.9
16.09
3.65
10.85
7.93
4.19
2.13
74.91
%
9644
100.00
2859
2238
2518
1585
444
29.65
23.21
26.11
16.44
4.6
- 99 (AJCC_7th) 1
0
0
I
0
II
0
III
0
IV
0
910
432
59
14
1415
II
76
266
44
15
401
III
27
44
278
20
369
IV
148
162
1015
746
389
197
2347
Kappa=0.5140
Kappa
- 553 -
(C220) 1 2
8859
2384
26.91
1073
12.11
2270
25.62
251
2.83
992
11.20
804
9.08
236
2.66
3206
1455
45.38
736
22.96
596
18.59
123
3.84
68
2.12
153
4.77
53
1.65
II
1799
404
22.46
272
15.12
759
42.19
109
6.06
68
3.78
132
7.34
28
1.56
III
2449
389
15.88
47
1.92
710
28.99
12
0.49
485
19.80
304
12.41
99
4.04
IV
1153
35
3.04
12
1.04
178
15.44
0.26
331
28.71
172
14.92
48
4.16
252
101
40.08
2.38
27
10.71
1.59
40
15.87
43
17.06
3.17
8859
2384
26.91
1073
12.11
2270
25.62
251
2.83
992
11.20
804
9.08
236
2.66
973
971
99.79
0.21
0.00
0.00
0.00
0.00
0.00
II
714
713
99.86
0.14
0.00
0.00
0.00
0.00
0.00
III
385
385
100.00
0.00
0.00
0.00
0.00
0.00
0.00
IV
102
43
42.16
0.98
11
10.78
1.96
8.82
1.96
0.98
6685
272
4.07
1069
15.99
2259
33.79
249
3.72
983
14.70
802
12.00
235
3.52
8859
2384
26.91
1073
12.11
2270
25.62
251
2.83
992
11.20
804
9.08
236
2.66
2752
1001
36.37
736
26.74
596
21.66
123
4.47
68
2.47
153
5.56
53
1.93
II
2122
727
34.26
272
12.82
759
35.77
109
5.14
68
3.20
132
6.22
28
1.32
III
2460
400
16.26
47
1.91
710
28.86
12
0.49
485
19.72
304
12.36
99
4.02
IV
1167
49
4.20
12
1.03
178
15.25
0.26
331
28.36
172
14.74
48
4.11
358
207
57.82
1.68
27
7.54
1.12
40
11.17
43
12.01
2.23
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()
8
9
- 554 -
10
353
3.98
250
2.82
95
1.07
21
0.24
22
0.25
11
0.12
20
0.23
77
0.87
0.16
13
0.41
0.00
0.06
0.03
0.00
0.00
0.03
10
0.56
10
0.56
0.06
0.22
0.06
0.00
0.00
0.06
179
7.31
125
5.10
45
1.84
11
0.45
0.33
0.33
0.24
21
0.86
147
12.75
98
8.50
44
3.82
0.26
12
1.04
0.26
14
1.21
53
4.60
12
4.76
1.59
1.98
0.40
0.00
0.00
0.00
0.40
353
3.98
250
2.82
95
1.07
21
0.24
22
0.25
11
0.12
20
0.23
77
0.87
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
5.88
1.96
2.94
0.00
0.00
0.00
0.98
21
20.59
347
5.19
248
3.71
92
1.38
21
0.31
22
0.33
11
0.16
19
0.28
56
0.84
353
3.98
250
2.82
95
1.07
21
0.24
22
0.25
11
0.12
20
0.23
77
0.87
0.18
13
0.47
0.00
0.07
0.04
0.00
0.00
0.04
10
0.47
10
0.47
0.05
0.19
0.05
0.00
0.00
0.05
179
7.28
125
5.08
45
1.83
11
0.45
0.33
0.33
0.24
21
0.85
147
12.60
98
8.40
44
3.77
0.26
12
1.03
0.26
14
1.20
53
4.54
12
3.35
1.12
1.40
0.28
0.00
0.00
0.00
0.28
10
- 555 -
(C220)0~49 1 2
1278
437
34.19
100
7.82
268
20.97
28
2.19
135
10.56
93
7.28
31
2.43
302
151
50.00
68
22.52
50
16.56
13
4.30
0.99
2.65
1.99
II
268
131
48.88
27
10.07
70
26.12
13
4.85
3.36
3.36
1.12
III
423
93
21.99
0.71
113
26.71
0.24
64
15.13
48
11.35
15
3.55
IV
218
15
6.88
0.46
32
14.68
0.46
56
25.69
22
10.09
2.75
67
47
70.15
1.49
4.48
0.00
4.48
8.96
1.49
(C220)50~64 1 2
3207
1033
32.21
375
11.69
796
24.82
87
2.71
279
8.70
225
7.02
69
2.15
977
290
29.68
256
26.20
166
16.99
33
3.38
13
1.33
34
3.48
12
1.23
II
808
311
38.49
95
11.76
290
35.89
44
5.45
15
1.86
34
4.21
10
1.24
III
871
166
19.06
14
1.61
253
29.05
0.80
145
16.65
89
10.22
31
3.56
IV
433
18
4.16
2.08
79
18.24
0.23
101
23.33
57
13.16
13
3.00
118
80
67.80
0.85
6.78
1.69
4.24
11
9.32
2.54
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()
8
9
- 556 -
10
87
6.81
41
3.21
25
1.96
0.23
0.31
0.16
0.23
21
1.64
0.66
0.33
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.00
0.37
0.37
0.00
0.00
0.00
0.00
39
9.22
22
5.20
12
2.84
0.47
0.47
0.24
0.24
1.65
39
17.89
17
7.80
11
5.05
0.00
0.92
0.46
0.92
13
5.96
4.48
1.49
1.49
0.00
0.00
0.00
0.00
1.49
146
4.55
95
2.96
41
1.28
0.22
0.28
0.19
0.16
34
1.06
0.10
0.31
0.00
0.00
0.10
0.00
0.00
0.00
0.25
0.74
0.00
0.12
0.00
0.00
0.00
0.00
79
9.07
48
5.51
18
2.07
0.46
0.34
0.57
0.11
0.92
60
13.86
38
8.78
19
4.39
0.46
1.15
0.23
0.92
26
6.00
3.39
0.00
3.39
0.00
0.00
0.00
0.00
0.00
10
- 557 -
10
(C220)65 1 2
4374
914
20.90
598
13.67
1206
27.57
136
3.11
578
13.21
486
11.11
136
3.11
1473
392
26.61
412
27.97
380
25.80
77
5.23
52
3.53
111
7.54
35
2.38
II
1046
285
27.25
150
14.34
399
38.15
52
4.97
44
4.21
89
8.51
15
1.43
III
1166
141
12.09
30
2.57
344
29.50
0.34
276
23.67
167
14.32
53
4.55
IV
516
16
3.10
0.39
67
12.98
0.19
174
33.72
93
18.02
29
5.62
173
80
46.24
2.31
16
9.25
1.16
32
18.50
26
15.03
2.31
BCLC(C220) 2
8469
2281
26.93
1052
12.42
2201
25.99
249
2.94
933
11.02
716
8.45
223
2.63
332
135
40.66
122
36.75
47
14.16
15
4.52
0.30
2.41
1.20
2826
1109
39.24
707
25.02
684
24.20
158
5.59
32
1.13
94
3.33
25
0.88
A1
10
70.00
10.00
20.00
0.00
0.00
0.00
0.00
A2
66.67
16.67
16.67
0.00
0.00
0.00
0.00
A3
0.00
0.00
0.00
0.00
0.00
0.00
0.00
A4
13
23.08
0.00
10
76.92
0.00
0.00
0.00
0.00
1992
679
34.09
112
5.62
779
39.11
48
2.41
109
5.47
131
6.58
50
2.51
2364
322
13.62
78
3.30
588
24.87
26
1.10
429
18.15
267
11.29
82
3.47
926
22
2.38
31
3.35
90
9.72
0.22
362
39.09
216
23.33
62
6.70
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()
8
9
- 558 -
120
2.74
114
2.61
29
0.66
11
0.25
0.21
0.07
12
0.27
22
0.50
0.14
0.61
0.00
0.14
0.00
0.00
0.00
0.07
0.38
0.38
0.00
0.19
0.10
0.00
0.00
0.10
61
5.23
55
4.72
15
1.29
0.43
0.26
0.17
0.34
0.51
48
9.30
43
8.33
14
2.71
0.19
0.97
0.19
1.55
14
2.71
2.89
1.73
0.00
0.58
0.00
0.00
0.00
0.00
10
338
3.99
244
2.88
89
1.05
18
0.21
22
0.26
11
0.13
18
0.21
74
0.87
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
12
0.42
0.00
0.04
0.00
0.00
0.04
0.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
34
1.71
29
1.46
0.30
0.30
0.05
0.15
0.10
0.15
264
11.17
149
6.30
68
2.88
0.17
17
0.72
0.30
10
0.42
53
2.24
38
4.10
54
5.83
15
1.62
0.76
0.43
0.11
0.54
17
1.84
10
- 559 -
10
(C221) 1 2
785
188
23.95
136
17.32
42
5.35
135
17.20
179
22.80
80
10.19
20
2.55
0.64
128
83
64.84
0.78
0.00
24
18.75
10
7.81
4.69
3.13
0.00
II
109
36
33.03
14
12.84
2.75
17
15.60
21
19.27
14
12.84
3.67
0.00
III
49
10.20
13
26.53
6.12
12.24
13
26.53
14.29
4.08
0.00
IV
399
28
7.02
100
25.06
28
7.02
71
17.79
112
28.07
46
11.53
10
2.51
1.00
100
36
36.00
8.00
8.00
17
17.00
23
23.00
7.00
0.00
1.00
785
188
23.95
136
17.32
42
5.35
135
17.20
179
22.80
80
10.19
20
2.55
0.64
73
60
82.19
0.00
0.00
13
17.81
0.00
0.00
0.00
0.00
II
51
43
84.31
0.00
0.00
15.69
0.00
0.00
0.00
0.00
III
19
14
73.68
0.00
0.00
21.05
0.00
5.26
0.00
0.00
IV
103
32
31.07
8.74
1.94
46
44.66
8.74
2.91
0.97
0.97
539
39
7.24
127
23.56
40
7.42
64
11.87
170
31.54
76
14.10
19
3.53
0.74
785
188
23.95
136
17.32
42
5.35
135
17.20
179
22.80
80
10.19
20
2.55
0.64
107
70
65.42
0.93
0.00
16
14.95
10
9.35
5.61
3.74
0.00
II
116
44
37.93
14
12.07
2.59
16
13.79
21
18.10
14
12.07
3.45
0.00
III
58
14
24.14
13
22.41
5.17
10.34
13
22.41
12.07
3.45
0.00
IV
418
34
8.13
100
23.92
28
6.70
84
20.10
112
26.79
46
11.00
10
2.39
0.96
86
26
30.23
9.30
9.30
13
15.12
23
26.74
8.14
0.00
1.16
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 ()
5
6
7
- 560 -
(C221)0~49 1 2
87
29
33.33
24
27.59
3.45
22
25.29
3.45
4.60
2.30
0.00
13
10
76.92
7.69
0.00
15.38
0.00
0.00
0.00
0.00
II
14
57.14
21.43
0.00
14.29
0.00
7.14
0.00
0.00
III
33.33
33.33
0.00
0.00
33.33
0.00
0.00
0.00
IV
50
12.00
19
38.00
4.00
16
32.00
4.00
6.00
4.00
0.00
57.14
0.00
14.29
28.57
0.00
0.00
0.00
0.00
(C221)50~64 1 2
248
61
24.60
59
23.79
12
4.84
66
26.61
29
11.69
17
6.85
1.61
0.00
31
26
83.87
0.00
0.00
12.90
0.00
3.23
0.00
0.00
II
38
16
42.11
15.79
2.63
23.68
5.26
7.89
2.63
0.00
III
23
26.09
30.43
4.35
21.74
8.70
8.70
0.00
0.00
IV
136
5.88
42
30.88
6.62
42
30.88
21
15.44
11
8.09
2.21
0.00
20
25.00
20.00
5.00
30.00
20.00
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 ()
5
6
7
- 561 -
(C221)65 1 2
450
98
21.78
53
11.78
27
6.00
47
10.44
147
32.67
59
13.11
14
3.11
1.11
63
34
53.97
0.00
0.00
10
15.87
10
15.87
7.94
6.35
0.00
II
64
20
31.25
7.81
3.13
7.81
19
29.69
10
15.63
4.69
0.00
III
32
21.88
15.63
6.25
3.13
10
31.25
15.63
6.25
0.00
IV
232
20
8.62
39
16.81
17
7.33
26
11.21
89
38.36
32
13.79
2.16
1.72
59
17
28.81
6.78
10.17
8.47
19
32.20
11.86
0.00
1.69
1 (99 )(AJCC_7th) 1
2
3 1320~2930~353850~5559~6165667590 p.563
4 ()
5
6
7
- 562 -
Codes
00
10
20
30
Lobectomy, NOS
31 Right lobectomy
32 Left lobectomy
33 Lobectomy AND local tumor destruction TAE only
34 Lobectomy AND local tumor destruction PEI /acetic acid only
35 Lobectomy AND local tumor destruction RFA only
38 Lobectomy AND local tumor destructions
50
Extended lobectomy, NOS (extended: resection of a single lobe plus a segment of another lobe)
51 Extended Right lobectomy
52 Extended Left lobectomy
53 Extended lobectomy AND local tumor destruction TAE only
54 Extended lobectomy AND local tumor destruction PEI /acetic acid only
55 Extended lobectomy AND local tumor destruction RFA only
59 Extended lobectomy AND local tumor destructions
60
Hepatectomy, NOS
61 Total hepatectomy and transplant
65
75
90
Surgery, NOS
99
- 563 -
- 564 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
1
3
5
29
53
119
0
1
0
0
1
5
22
44
123
0
1
0
1
4
10
51
97
242
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
247
398
593
611
727
849
974
812
408
5829
222
325
442
415
417
483
437
334
237
3508
469
723
1035
1026
1144
1332
1411
1146
645
9337
9337
100.00
9337
100.00
9337
100.00
5
1255
451
1702
5689
235
0.05
13.44
4.83
18.23
60.93
2.52
4
1139
306
369
1207
6312
0.04
12.2
3.28
3.95
12.93
67.6
4
1298
462
1731
5719
123
0.04
13.9
4.95
18.54
61.25
1.32
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
1
0
0
1
0
2
1
860
80
88
6
1035
0
99
149
40
1
289
1
79
49
221
3
353
0
14
11
17
1159
1201
3
1052
289
367
1169
2880
Kappa=0.7475
Kappa
- 565 -
() 1
9.05
81
0.98
371
4.18 453
5.48
0.00
0.00
0.00
1 25.00
1026 12.42
483
5.85 523
6.33 163
1.97
0.00
0.00
0.00
3 75.00
0.00
0.00
0.00
I 1266
918 72.51
175
13.82
0.63
0.71
36
2.84
39
3.08
11
0.87
0.71
0.55
38
3.00
16
1.26
16
II
441
90 20.41
166
37.64
12
2.72
30
6.80
52 11.79
20
4.54
3.63
1.59
13
2.95
29
6.58
1.36
IIIA
770
49
6.36
172
22.34
13
1.69
90 11.69
173 22.47
43
38
4.94
20
2.60
50
6.49
13
1.69
IIIB
735
0.82
29
3.95
0.68
36
259 35.24
43
56
7.62
22
2.99
62
8.44
15
2.04
IV 4951
59
1.19
197
3.98
43
0.87
201
914 18.46
406
6.48 109
2.20
29 30.21
9.38
0.00
96
4.90
4.00 112
2.26
5.21
2.08
3.13
4.17
2.08
8.20 321
15 15.63
23 23.96
4.17
() 0~49 1
104
13.13
0.88
71
8.96
0.00
0.00
0.00
0.00
792
156
124 79.49
26
16.67
0.64
0.64
II
38
5 13.16
23
60.53
2.63
IIIA
52
3.85
18
34.62
IIIB
80
1.25
7.50
IV
449
1.34
28
17
8 47.06
146 18.43
233 29.42
1.14
60
7.58
0.00
0.00
0.00
0.00
0.00
0.64
7 18.42
0.00
0.00
3.85
13 25.00
5.77
1.25
8 10.00
20 25.00
6.24
0.45
42
9.35
209 46.55
17.65
0.00
0.00
5.88
122 15.40
13
1.64
24
3.03
0.38
0.00
0.00
0.00
0.00
0.00
0.00
1.92
0.00
0.00
0.00
0.00
5.26
0.00
0.00
11 21.15
1.92
0.00
3.85
0.00
3.75
33 41.25
6.25
0.00
3.75
0.00
1.34
14
3.12
116 25.84
12
2.67
11
2.45
0.67
0.00
5.88
5.88
3 17.65
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 566 -
() 50~69 1
25
0.72
221
86
2.49 210
6.07
501 14.48
60
1.73 116
3.35
35
1.01
3 75.00
0.00
0.00
0.00
1 25.00
0.00
0.00
0.00
0.00
0.00
0.00
627
502 80.06
99
15.79
0.48
0.32
0.80
0.64
0.48
0.64
0.00
0.64
0.16
II
202
38 18.81
110
54.46
2.48
17
8.42
12
5.94
1.49
2.48
0.50
0.99
3.96
0.50
IIIA
330
19
5.76
114
34.55
1.52
69 20.91
51 15.45
1.52
49 14.85
10
3.03
0.30
1.82
0.30
IIIB
271
0.37
15
5.54
0.37
19
92 33.95
16
5.90
0.37
15
5.54
0.74
IV 1993
23
1.15
105
5.27
11
0.55
111
67
3.36
49
2.46
468 23.48
54
2.71
76
3.81
29
1.46
10 30.30
15.15
0.00
0.00
6.06
6.06
7 21.21
3.03
33
7.01
9.09
3.03
6.06
() 70 1
4011
412 10.27
196
4.89
49
1.22
79
0.00
0.00
0.00
403 10.05
6.23 183
4.56
0.00
0.00
0.00
0.00
0.00
0.00
9.55 125
3.12
0.00
0.00
483
292 60.46
50
10.35
0.83
1.24
31
6.42
35
7.25
1.45
1.04
1.45
31
6.42
15
3.11
II
201
47 23.38
33
16.42
2.99
2.99
40 19.90
17
8.46
11
5.47
2.99
11
5.47
19
9.45
2.49
IIIA
388
28
7.22
40
10.31
1.55
2.06
119 30.67
38
9.79
49 12.63
27
6.96
19
4.90
42 10.82
12
3.09
IIIB
384
1.04
2.08
0.78
2.34
147 38.28
33
8.59
67 17.45
35
9.11
21
5.47
44 11.46
13
3.39
IV 2509
30
1.20
64
2.55
30
1.20
48
4.98
49
1.95
9.33
77
3.07
11 23.91
2.17
0.00
4.35
4.35
0.00
13 28.26
6.52
46
4.35
330 13.15
0
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 567 -
()
490
1.22
11
2.24
0.61
23
4.69
191
38.98
25
5.10
71
14.49
87
17.76
31
6.33
31
6.33
11
2.24
331
1.21
1.51
0.91
16
4.83
149
45.02
16
4.83
14
4.23
66
19.94
26
7.85
24
7.25
2.42
159
1.26
3.77
0.00
4.40
42
26.42
5.66
57
35.85
21
13.21
3.14
4.40
1.89
1
2 ()
3
4
- 568 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
0
0
1
0
0
0
1
16
82
251
538
1193
0
0
0
1
16
82
251
538
1194
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
0
9
5
1
1
5
6
2
4
34
1947
1837
1535
946
717
492
273
162
100
10090
1947
1846
1540
947
718
497
279
164
104
10124
10124
100.00
10124
100.00
10124
100.00
1350
2976
3569
780
573
876
13.33
29.4
35.25
7.7
5.66
8.65
1481
3168
3037
1296
296
846
14.63
31.29
30
12.8
2.92
8.36
1522
3169
3210
1485
605
133
15.03
31.3
31.71
14.67
5.98
1.31
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
972
155
63
4
0
1194
268
1983
612
43
1
2907
40
614
2033
163
5
2855
8
105
661
437
2
1213
0
2
19
13
257
291
1288
2859
3388
660
265
8460
Kappa=0.5407
Kappa
- 569 -
10124
1582
15.63
1604
15.84
1030
10.17
2084
20.58
857
8.47
1106
10.92
238
2.35
1522
512
33.64
0.59
359
23.59
0.39
449
29.50
0.59
120
7.88
IA
3069
694
22.61
483
15.74
515
16.78
504
16.42
242
7.89
270
8.80
92
3.00
IB
100
10
10.00
27
27.00
8.00
37
37.00
2.00
7.00
0.00
II
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
IIA
2163
218
10.08
582
26.91
86
3.98
525
24.27
80
3.70
364
16.83
14
0.65
IIB
1046
64
6.12
252
24.09
26
2.49
313
29.92
24
2.29
175
16.73
0.48
III
1485
51
3.43
168
11.31
23
1.55
623
41.95
21
1.41
205
13.80
0.27
IV
605
1.16
63
10.41
0.66
67
11.07
1.49
67
11.07
0.00
133
26
19.55
19
14.29
6.77
6.77
30
22.56
6.77
2.26
0~34 1
350
30
8.57
52
14.86
33
9.43
99
28.29
28
8.00
18
5.14
12
3.43
46
10
21.74
0.00
12
26.09
0.00
15
32.61
0.00
15.22
IA
116
17
14.66
13
11.21
15
12.93
34
29.31
7.76
3.45
4.31
IB
0.00
0.00
0.00
25.00
25.00
25.00
0.00
II
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIA
77
2.60
22
28.57
5.19
22
28.57
0.00
9.09
0.00
IIB
43
0.00
10
23.26
2.33
16
37.21
0.00
6.98
0.00
III
43
2.33
6.98
0.00
24
55.81
0.00
6.98
0.00
IV
17
0.00
23.53
0.00
11.76
0.00
0.00
0.00
0.00
0.00
25.00
0.00
75.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
- 570 -
910
8.99
228
2.25
32
0.32
97
0.96
14
0.14
217
2.14
30
0.30
95
0.94
0.39
0.00
0.13
0.00
0.00
44
2.89
0.13
0.26
193
6.29
0.07
0.03
0.00
0.00
58
1.89
0.16
10
0.33
9.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
209
9.66
0.14
0.14
0.05
0.00
49
2.27
0.37
21
0.97
143
13.67
0.76
0.00
0.10
0.00
21
2.01
0.48
0.86
312
21.01
28
1.89
0.27
11
0.74
0.00
13
0.88
0.27
18
1.21
33
5.45
187
30.91
21
3.47
84
13.88
13
2.15
15
2.48
0.83
30
4.96
3.76
0.00
0.75
0.00
0.75
17
12.78
0.75
2.26
59
16.86
1.43
0.00
1.43
0.00
2.57
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.35
0.00
0.00
15
12.93
0.00
0.00
0.00
0.00
3.45
0.00
0.00
25.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
18
23.38
0.00
0.00
0.00
0.00
2.60
0.00
0.00
12
27.91
0.00
0.00
0.00
0.00
2.33
0.00
0.00
12
27.91
0.00
0.00
0.00
0.00
0.00
0.00
0.00
5.88
29.41
0.00
29.41
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3 ()
4
5
- 571 -
35~49 1
3679
450
12.23
599
186
31.05
IA
1180
206
17.46
IB
47
8.51
II
IIA
748
IIB
383
III
635
971
26.39
259
7.04
324
8.81
94
2.56
17.26
408
11.09
0.83
172
28.71
0.33
151
25.21
0.33
56
9.35
208
17.63
193
16.36
264
22.37
75
6.36
94
7.97
28
2.37
13
27.66
4.26
25
53.19
0.00
2.13
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
32
4.28
226
30.21
28
3.74
239
31.95
19
2.54
96
12.83
0.94
1.83
98
25.59
1.57
158
41.25
0.26
52
13.58
0.26
502
1.00
54
10.76
0.20
255
50.80
0.80
63
12.55
0.20
IV
176
0.57
23
13.07
1.14
24
13.64
1.70
13
7.39
0.00
44
20.45
18.18
9.09
9.09
13.64
6.82
2.27
50~69 1
5051
723
14.31
833
16.49
503
9.96
955
761
267
35.09
0.53
166
21.81
IA
1513
335
22.14
247
16.33
276
IB
42
7.14
12
28.57
18.91
426
8.43
674
0.53
237
31.14
18.24
197
13.02
118
11.90
11
26.19
13.34
118
2.34
0.66
53
6.96
7.80
165
10.91
56
3.70
2.38
9.52
0.00
II
0.00
0.00
0.00
0.00
0.00
0.00
IIA
1070
73
6.82
305
28.50
36
3.36
251
23.46
33
3.08
232
21.68
0.37
IIB
509
18
3.54
131
25.74
1.77
131
25.74
13
2.55
108
21.22
0.39
III
767
15
1.96
88
11.47
0.91
321
41.85
0.91
109
14.21
0.26
IV
328
0.91
34
10.37
0.00
37
11.28
1.22
46
14.02
0.00
60
15.00
11
18.33
6.67
5.00
13
21.67
8.33
1.67
1 100.00
1 (99 )(AJCC_7th) 1
2
- 572 -
1.96
0.24
25
0.68
0.08
81
2.20
10
0.27
0.24
0.50
0.00
0.00
0.00
0.00
20
3.34
0.17
0.17
86
7.29
0.00
0.00
0.00
0.00
23
1.95
0.08
0.17
4.26
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
81
10.83
0.00
0.00
0.00
0.00
15
2.01
0.40
0.27
52
13.58
0.26
0.00
0.00
0.00
1.57
0.26
0.00
96
19.12
12
2.39
0.00
0.60
0.00
1.20
0.20
0.20
3.98
59
33.52
5.11
22
12.50
1.70
3.41
1.14
1.14
4.55
0.00
0.00
0.00
0.00
11.36
2.27
2.27
491
9.72
125
2.47
12
0.24
53
1.05
0.12
97
1.92
12
0.24
23
0.46
0.26
0.00
0.00
0.00
0.00
20
2.63
0.13
0.26
89
5.88
0.13
0.07
0.00
0.00
23
1.52
0.20
0.07
14.29
0.00
0.00
0.00
0.00
0.00
0.00
0.00
72
8.94
329
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106
9.91
0.19
0.09
0.00
0.00
19
1.78
0.28
0.47
74
14.54
0.79
0.00
0.20
0.00
11
2.16
0.79
0.59
188
24.51
12
1.56
0.13
0.91
0.00
0.91
0.00
0.39
23
7.01
105
32.01
2.44
45
13.72
1.52
2.74
0.30
2.44
5.00
0.00
1.67
0.00
1.67
13.33
0.00
1.67
3 ()
4
5
- 573 -
70 1
1044
379
36.30
84
8.05
86
8.24
59
5.65
144
13.79
90
8.62
14
1.34
116
49
42.24
0.00
7.76
0.00
46
39.66
1.72
3.45
IA
260
136
52.31
15
5.77
31
11.92
3.46
40
15.38
2.69
1.15
IB
42.86
28.57
14.29
0.00
0.00
14.29
0.00
II
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIA
268
111
41.42
29
10.82
18
6.72
13
4.85
28
10.45
29
10.82
1.12
IIB
111
39
35.14
13
11.71
10
9.01
7.21
10
9.01
12
10.81
1.80
III
173
30
17.34
23
13.29
15
8.67
23
13.29
10
5.78
30
17.34
0.58
IV
84
3.57
2.38
2.38
4.76
2.38
9.52
0.00
25
32.00
0.00
0.00
8.00
32.00
4.00
4.00
1 (99 )(AJCC_7th) 1
2
- 574 -
31
2.97
26
2.49
11
1.05
14
1.34
0.48
30
2.87
0.77
63
6.03
0.86
0.00
1.72
0.00
0.00
1.72
0.00
0.86
0.38
2.69
1.15
0.00
0.00
0.00
0.00
3.08
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.37
0.75
0.37
0.00
13
4.85
0.75
14
5.22
4.50
2.70
0.00
0.00
0.00
2.70
0.00
5.41
16
9.25
2.31
1.73
0.58
0.00
0.00
1.73
14
8.09
2.38
18
21.43
4.76
12
14.29
5.95
0.00
2.38
20
23.81
0.00
0.00
0.00
0.00
0.00
16.00
0.00
4.00
3 ()
4
5
- 575 -
- 576 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
0
0
0
0
0
0
1
48
159
444
469
530
0
0
0
1
48
159
444
469
530
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
0
0
0
0
0
0
0
0
0
0
546
489
426
297
270
214
168
113
66
4240
546
489
426
297
270
214
168
113
66
4240
FIGO
FIGO
4240
100.00
0
I
I A
IA1
IA2
I B
IB1
IB2
I I
IIA
IIB
III
IIIA
IIIB
IVA
IVB
2664
5
21
156
15
40
427
93
5
126
236
6
18
142
53
95
138
62.83
0.12
0.5
3.68
0.35
0.94
10.07
2.19
0.12
2.97
5.57
0.14
0.42
3.35
1.25
2.24
3.25
:- 99 FIGO 2
- 577 -
4240
100.00
4240
100.00
4240
100.00
2371
582
280
231
192
584
55.92
13.73
6.6
5.45
4.53
13.77
2646
519
79
122
60
814
62.41
12.24
1.86
2.88
1.42
19.2
2753
590
290
297
210
100
64.93
13.92
6.84
7
4.95
2.36
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
2177
7
1
0
0
2185
58
379
25
6
0
468
4
35
27
6
1
73
1
51
25
32
0
109
0
7
1
9
40
57
2240
479
79
53
41
2892
Kappa=0.7879
Kappa
- 578 -
FIGO 1
4240
3114
73.44 49
1.16
104
2.45
240
5.66
22
0.52
157
3.70
374
8.82
15
0.35
122
2.88
43
1.01
0 2664
2645
99.29
0.00
0.15
0.00
0.00
0.00
0.00
0.00
15
0.56
0.00
80.00
0.00
0.00
0.00
0.00
0.00
0.00
1 20.00
0.00
0.00
IA
21
18
85.71
0.00
9.52
0.00
0.00
0.00
0.00
0.00
0.00
4.76
IA1
156
147
94.23
0.00
1.92
2.56
0.00
0.64
0.00
0.00
0.00
0.64
IA2
15
11
73.33
0.00
3 20.00
6.67
0.00
0.00
0.00
0.00
0.00
0.00
IB
40
18
45.00
5.00
7.50
7 17.50
0.00
5 12.50
2.50
0.00
2.50
7.50
IB1
427
211
49.41 19
4.45
56 13.11
89 20.84
0.00
35
8.20
12
2.81
0.00
1.17
0.00
IB2
93
9.68 13
13.98
11 11.83
33 35.48
2.15
2.15
20 21.51
0.00
3.23
0.00
II
20.00
0.00
1 20.00
1 20.00
0.00
1 20.00
1 20.00
0.00
0.00
IIA
126
16
12.70
4.76
4.76
35 27.78
1.59
24 19.05
33 26.19
0.00
3.17
0.00
IIB
236
0.42
1.27
2.54
37 15.68
0.42
37 15.68
146 61.86
0.42
1.69
0.00
III
83.33
0.00
0.00
0.00
0.00
0.00
1 16.67
0.00
0.00
0.00
IIIA
18
11.11
0.00
0.00
5.56
0.00
5 27.78
8 44.44
0.00
11.11
0.00
IIIB
142
2.11
1.41
1.41
20 14.08
2.11
20 14.08
85 59.86
0.00
3.52
1.41
IVA
53
9.43
0.00
5.66
7.55
0.00
15 28.30
21 39.62
5.66
3.77
0.00
IVB
95
2.11
3.16
3.16
7.37
14 14.74
10 10.53
45 47.37
6.32
1.05
4.21
138
16
11.59
0.72
0.72
0.72
2.17
0.00
1.45
0.00
1.45
80 57.97
32 23.19
1 99 FIGO 2
2
3 ()
4
5
- 579 -
0~29 FIGO 1
208
189
90.87
1.44
0.00
1.92
0.00
0.00
0.48
0.00
4.33
0.96
184
183
99.46
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.54
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA1
2 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA2
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IB
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IB1
60.00
0.00
0.00
40.00
0.00
0.00
0.00
0.00
0.00
0.00
IB2
0.00
2 100.0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIA
0.00
1 100.0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIB
50.00
0.0
0.00
0.00
0.00
0.00
50.00
0.00
0.00
0.00
III
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIB
0.00
0.00
0.00
100.00
0.00
0.00
0.00
0.00
0.00
0.00
IVA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IVB
0.00
0.00
0.00
100.00
0.00
0.00
0.00
0.00
0.00
0.00
10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
8 80.00
20.00
1 99 FIGO 2
2
3 ()
4
5
- 580 -
30~49 FIGO 1
1989
1701
85.52
23
1.16
24
1.21
94
4.73
0.40
0 1479
1471
99.46
0.00
0.07
0.00
0.40
83
4.17
0.00
0.00
0.05
36
1.81
11
0.55
0.00
0.00
0.47
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA
88.89
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
11.11
IA1
85
84
98.82
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.18
IA2
6 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IB
12
66.67
8.33
8.33
16.67
0.00
0.00
0.00
0.00
0.00
0.00
IB1
159
95
59.75
4.40
15
9.43
34
21.38
0.00
3.14
0.63
0.00
1.26
0.00
IB2
41
12.20
17.07
4.88
18
43.90
2.44
0.00
19.51
0.00
0.00
0.00
II
50.00
0.00
0.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
IIA
25
28.00
12.00
4.00
11
44.00
0.00
0.00
8.00
0.00
4.00
0.00
IIB
52
0.00
3.85
3.85
15
28.85
1.92
0.00
32
61.54
0.00
0.00
0.00
III
5 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIA
25.00
0.00
0.00
25.00
0.00
0.00
50.00
0.00
0.00
0.00
IIIB
32
0.00
3.13
3.13
25.00
3.13
3.13
20
62.50
0.00
0.00
0.00
IVA
11.11
0.00
0.00
22.22
0.00
11.11
55.56
0.00
0.00
0.00
IVB
26
3.85
3.85
3.85
7.69
19.23
3.85
13
50.00
3.85
3.85
0.00
42
16.67
2.38
0.00
0.00
0.00
0.00
0.00
0.00
25
59.52
21.43
1 99 FIGO 2
2
3 ()
4
5
- 581 -
50~69 FIGO 1
1482
982
66.26
20
1.35
54
3.64
125
8.43
0.61
37
2.50
205
13.83
0.13
35
2.36
13
0.88
799
792
99.12
0.00
0.13
0.00
0.00
0.00
0.00
0.00
0.75
0.00
3 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA
10
90.00
0.00
10.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA1
60
53
88.33
0.00
5.00
5.00
0.00
1.67
0.00
0.00
0.00
0.00
IA2
55.56
0.00
33.33
11.11
0.00
0.00
0.00
0.00
0.00
0.00
IB
16
43.75
6.25
12.50
12.50
0.00
6.25
6.25
0.00
0.00
12.50
IB1
206
95
46.12
11
5.34
29
14.08
50
24.27
0.00
13
6.31
2.43
0.00
1.46
0.00
IB2
36
8.33
11.11
19.44
13
36.11
2.78
0.00
22.22
0.00
0.00
0.00
II
0.00
0.00
0.00
0.00
0.00
100.0
0.00
0.00
0.00
0.00
IIA
56
12.50
3.57
3.57
20
35.71
1.79
8.93
19
33.93
0.00
0.00
0.00
IIB
121
0.00
0.00
2.48
19
15.70
0.00
5.79
90
74.38
0.00
1.65
0.00
III
0.00
0.00
0.00
0.00
0.00
0.00
100.0
0.00
0.00
0.00
IIIA
0.00
0.00
0.00
0.00
0.00
0.00
80.00
0.00
20.00
0.00
IIIB
70
1.43
1.43
1.43
10
14.29
1.43
5.71
50
71.43
0.00
2.86
0.00
IVA
12
8.33
0.00
0.00
16.67
0.00
16.67
58.33
0.00
0.00
0.00
IVB
37
0.00
2.70
2.70
10.81
16.22
8.11
20
54.05
2.70
0.00
2.70
40
15.00
0.00
2.50
2.50
0.00
0.00
0.00
2.50
21
52.50
10
25.00
1 99 FIGO 2
2
3 ()
4
5
- 582 -
70 FIGO 1
561
242
43.14
0.53
26
4.63
17
3.03
0.89
112
19.96
202
199
98.51
0.00
0.99
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA
50.00
0.00
1 50.00
0.00
0.00
IA1
88.89
0.00
0.00
11.11
0.00
IA2
0.00
0.00
0.00
0.00
IB
12
25.00
0.00
0.00
3 25.00
IB1
57
18
31.58
1.75
12 21.05
IB2
14
7.14
0.00
II
0.00
IIA
44
4.55
IIB
61
III
IIIA
85 15.15
12
2.14
42
7.49
17
3.03
0.00
0.00
0.50
0.00
0.00
1 100.0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
33.33
0.00
0.00
8.33
8.33
5.26
0.00
17
29.82
6 10.53
0.00
0.00
0.00
2 14.29
2 14.29
0.00
14.29
4 28.57
0.00
3 21.43
0.00
0.00
1 50.00
0.00
0.00
0.00
1 50.00
0.00
0.00
0.00
6.82
9.09
2.27
19
43.18
12 27.27
0.00
6.82
0.00
0.00
1.64
1.64
4.92
0.00
30
49.18
23 37.70
1.64
3.28
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
11.11
0.00
0.00
0.00
0.00
55.56
2 22.22
0.00
1 11.11
0.00
IIIB
39
5.13
0.00
0.00
2.56
2.56
15
38.46
15 38.46
0.00
7.69
5.13
IVA
32
9.38
0.00
9.38
0.00
0.00
12
37.50
9 28.13
9.38
6.25
0.00
IVB
31
3.23
3.23
3.23
0.00
9.68
19.35
12 38.71
4 12.90
0.00
9.68
46
6.52
0.00
0.00
0.00
0.00
4.35
0.00
4.35
4.35
26 56.52
11 23.91
1 99 FIGO 2
2
3 ()
4
5
- 583 -
4240
3114
73.44
49
1.16
104
2.45
240
5.66
22
0.52
157
3.70
374
8.82
0 2753
2641
95.93
0.00
0.15
0.00
0.00
0.07
7.12
22
15
0.35
122
2.88
43
1.01
0.00
0.00
81
2.94
25
0.91
3.73
0.17
1.53
0.34
590
378
64.07
16
2.71
62 10.51
56
9.49
0.34
42
II
290
20
6.90
2.07
16
5.52
59 20.34
0.69
54 18.62
127 43.79
0.00
2.07
0.00
III
297
14
4.71
20
6.73
10
3.37
86 28.96
1.01
28
9.43
130 43.77
0.00
1.68
0.34
IV
210
10
4.76
2.86
2.86
31 14.76
15
7.14
30 14.29
92 43.81
10
4.76
2.38
2.38
100
51
51.00
1.00
6.00
0.00
4.00
8.00
1.00
3.00
16 16.00
10 10.00
0~29 1
208
189
90.87
1.44
0.00
1.92
0.00
0.00
0.48
0.00
4.33
0.96
192
182
94.79
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.17
1.04
62.50
2 25.00
0.00
12.50
0.00
0.00
0.00
0.00
0.00
0.00
II
50.00
1 50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
III
0.00
0.00
0.00
100.00
0.00
0.00
0.00
0.00
0.00
0.00
IV
0.00
0.00
0.00
50.00
0.00
0.00
50.00
0.00
0.00
0.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1 50.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 584 -
30~49 1
1989
1701
85.52
23
1.16
24
1.21
94
4.73
0.40
0 1510
1471
97.42
0.00
0.07
0.00
0.40
83
4.17
0.00
0.00
0.05
36
1.81
11
0.55
0.00
0.00
30
1.99
0.53
246
185
75.20
3.66
16
6.50
24
9.76
0.41
2.03
0.81
0.00
0.81
0.81
II
56
14.29
7.14
5.36
16
28.57
1.79
0.00
24
42.86
0.00
0.00
0.00
III
91
7.69
7.69
3.30
38
41.76
1.10
1.10
34
37.36
0.00
0.00
0.00
IV
49
4.08
4.08
2.04
13
26.53
10.20
4.08
22
44.90
2.04
2.04
0.00
37
28
75.68
2.70
0.00
8.11
0.00
0.00
2.70
0.00
8.11
2.70
50~69 1
1482
982
66.26
20
1.35
54
3.64
125
8.43
0.61
37
2.50
205
13.83
0.13
35
2.36
13
0.88
819
78
9.52
0.00
0.12
0.00
0.00
0.00
0.00
0.00
21
2.56
0.98
255
161
63.14
1.96
34
13.33
27
10.59
0.39
14
5.49
10
3.92
0.00
1.18
0.00
II
143
6.29
0.70
10
6.99
35
24.48
0.70
11
7.69
74
51.75
0.00
1.40
0.00
III
147
2.72
11
7.48
2.04
43
29.25
0.68
4.08
78
53.06
0.00
0.68
0.00
IV
78
1.28
3.85
1.28
16
20.51
7.69
7.69
41
52.56
1.28
2.56
1.28
40
18
45.00
0.00
12.50
10.00
0.00
0.00
5.00
2.50
15.00
10.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 585 -
70 1
561
242
43.14
0.53
26
4.63
17
3.03
0.89
112
19.96
232
199
85.78
0.00
0.86
0.00
0.00
0.86
81
27
33.33
0.00
12 14.81
4.94
0.00
23
II
89
2.25
0.00
3.37
8.99
0.00
III
57
5.26
3.51
7.02
5.26
IV
81
8.64
1.23
4.94
1.23
21
19.05
0.00
4.76
4.76
85 15.15
12
2.14
42
7.49
17
3.03
0.00
0.00
22
9.48
3.02
28.40
10 12.35
1.23
4.94
0.00
43
48.31
29 32.58
0.00
4.49
0.00
1.75
21
36.84
18 31.58
0.00
7.02
1.75
4.94
22
27.16
28 34.57
9.88
2.47
4.94
0.00
4.76
0.00
3 14.29
6 28.57
5 23.81
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 586 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
0
0
0
0
0
0
0
2
20
45
59
123
0
0
0
0
2
20
45
59
123
0
0
0
0
0
0
0
0
0
0
243
333
314
169
119
66
45
18
8
1564
243
333
314
169
119
66
45
18
8
1564
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
1564
100.00
1564
100.00
1564
100.00
5
710
75
92
79
603
0.32
45.4
4.8
5.88
5.05
38.55
5
1059
94
189
81
136
0.32
67.71
6.01
12.08
5.18
8.7
5
1084
100
196
104
75
0.32
69.31
6.39
12.53
6.65
4.8
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
2
0
0
0
0
2
2
605
27
16
4
654
1
22
34
5
0
62
0
38
8
63
4
113
0
8
0
2
49
59
5
673
69
86
57
890
Kappa=0.6356
Kappa
- 587 -
1564 865
55.31
100.0
0.00
I 1084 767
70.76
79
II
100
18
18.00
III
196
19
IV
104
75
182 11.64
274 17.52
162 10.36
11
0.70
10
0.64
0.58
0.38
23
1.47
9 0.58
13
0.83
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
7.29
181 16.70
28
2.58
0.00
0.55
0.00
0.09
0.65
2 0.18
13
1.20
6.00
53 53.00
17 17.00
0.00
2.00
1.00
0.00
2.00
1 1.00
0.00
9.69
58 29.59
26 13.27
87 44.39
1.02
0.00
1.53
0.51
0.00
0 0.00
0.00
17
16.35
31 29.81
29 27.88
6.73
0.96
4.81
2.88
2.88
3 2.88
0.00
39
52.00
8 10.67
2.67
1.33
0.00
1.33
11 14.67
3 4.00
0.00
4.81
9 12.00
1.33
0~39 1
126
69
54.76
0.00
0.00
86
61
70.93
II
14.29
III
13
IV
12
18 14.29
18 14.29
5.56
0.00
0.00
0.00
0.00
1.59
0.79
11
8.73
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
5.81
9 10.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
5 71.43
1 14.29
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
6 46.15
3 23.08
4 30.77
0.00
0.00
0.00
0.00
0.00
0.00
0.00
25.00
3 37.50
0.00
2 25.00
0.00
0.00
0.00
0.00
0.00
1 12.50
0.00
41.67
4 33.33
8.33
0.00
0.00
0.00
0.00
2 16.67
0 0.00
0.00
0.00
11 12.79
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
6
- 588 -
40~59 1
1013 593
58.54
100.0
0.00
716
532
74.30
57
II
68
13
19.12
III
129
IV
51
44
116 11.45
164 16.19
110 10.86
0.49
0.30
0.39
0.10
11
1.09
5 0.49
0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
7.96
100 13.97
18
2.51
0.00
0.28
0.00
0.00
0.56
2 0.28
0.14
5.88
38 55.88
12 17.65
0.00
0.00
0.00
0.00
0.00
1 1.47
0.00
6.20
37 28.68
18 13.95
63 48.84
0.00
0.00
2.33
0.00
0.00
0 0.00
0.00
15.69
15 29.41
16 31.37
7.84
1.96
1.96
1.96
1.96
1 1.96
0.00
27
61.36
2.27
0.00
0.00
0.00
6 13.64
1 2.27
0.00
6.82
5.88
5 11.36
2.27
60 1
425
203
47.76
0.00
0.00
282
174
61.70
17
II
25
16.00
III
54
11
20.37
15 27.78
IV
45
15.56
13 28.89
19
36.84
48 11.29
92 21.65
45 10.59
1.41
1.65
1.18
1.18
10
2.35 3
0.71
0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00 0
0.00
0.00
6.03
72 25.53
10
3.55
0.00
1.42
0.00
0.35
1.06 0
0.00
0.35
8.00
10 40.00
4 16.00
0.00
8.00
4.00
0.00
8.00 0
0.00
0.00
9.26
20 37.04
3.70
0.00
0.00
1.85
0.00 0
0.00
0.00
4.44
11 24.44
6.67
0.00
8.89
4.44
4.44 1
2.22
0.00
5.26
5.26
0.00
5.26
3 15.79 2
10.53
0.00
5.26
3 15.79
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
6
- 589 -
FIGO 1
1564 865
55.31
182
11.64
274 17.52
162
10.36
11
0.70
10
0.64
0.58
0.38
23
1.47
9 0.58
13
0.83
718 434
60.45
75
10.45
133 18.52
70
9.75
0.28
0.14
0.28
0.00
0.14
0 0.00
0.00
0.00
16.67
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
83.33
0.00
IA
119
85
71.43
11
9.24
20 16.81
1.68
0.00
0.00
0.00
0.00
0.84
0 0.00
0.00
IB
64
23
35.94
6.25
27 42.19
10
15.63
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IC
14
35.71
14.29
5 35.71
14.29
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
II
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IIA
0.00
33.33
1 33.33
33.33
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IIB
100.0
1
0
III
11
9.09
27.27
0.00
54.55
0.00
0.00
9.09
0.00
0.00
0 0.00
0.00
IIIA
16.67
33.33
0.00
50.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IIIB
33.33
0.00
0.00
66.67
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IIIC
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IV
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
IVB
0.00
50.00
0.00
50.00
0.00
0.00
0.00
0.00
0.00
0 0.00
0.00
614 310
50.49
80
13.03
87 14.17
64
10.42
1.47
1.47
0.98
0.98
21
3.42
9 1.47
13
2.12
1 FIGO - 99 FIGO 3
2
3 ()
4
5
6
- 590 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
0
0
0
0
2
10
11
31
28
42
87
108
0
2
10
11
31
28
42
87
108
0
0
0
0
0
0
0
0
0
0
169
162
164
90
67
65
40
25
6
1107
169
162
164
90
67
65
40
25
6
1107
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
1107
100.00
1107
100.00
1107
100.00
0
204
43
264
141
455
0.00
18.43
3.88
23.85
12.74
41.1
0
403
81
366
132
125
0.00
36.4
7.32
33.06
11.92
11.29
0
402
82
386
163
74
0.00
36.31
7.41
34.87
14.72
6.68
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
0
0
0
0
0
0
0
173
8
12
1
194
0
5
29
7
1
42
0
13
4
204
3
224
0
0
0
12
103
115
0
191
41
235
108
575
Kappa=0.8327
Kappa
- 591 -
1107
220
19.87
801
72.36
0.00
20
1.81
42
3.79
0.27
13
1.17
0.54
0.18
402
140
34.83
260
64.68
0.00
0.50
0.00
0.00
0.00
0.00
0.00
II
82
10.98
71
86.59
0.00
1.22
0.00
0.00
1.22
0.00
0.00
III
386
21
5.44
339
87.82
0.00
1.81
12
3.11
0.00
1.55
0.26
0.00
IV
163
11
6.75
102
62.58
0.00
5.52
29
17.79
1.84
3.68
1.23
0.61
74
39
52.70
29
39.19
0.00
1.35
1.35
0.00
0.00
4.05
1.35
0~39 1
211
71
33.65
138
65.40
0.00
0.47
0.47
0.00
0.00
0.00
0.00
110
45
40.91
65
59.09
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
10
0.00
10 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
III
51
9.80
44
86.27
0.00
1.96
1.96
0.00
0.00
0.00
0.00
IV
12
8.33
11
91.67
0.00
0.00
0.00
0.00
0.00
0.00
0.00
28
20
71.43
28.57
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 592 -
40~59 1
603
98
16.25
472
78.28
0.00
16
2.65
1.00
0.50
0.50
0.50
0.33
235
69
29.36
164
69.79
0.00
0.85
0.00
0.00
0.00
0.00
0.00
II
47
14.89
40
85.11
0.00
0.00
0.00
0.00
0.00
0.00
0.00
III
211
3.79
196
92.89
0.00
2.37
0.47
0.00
0.47
0.00
0.00
IV
78
3.85
57
73.08
0.00
10.26
5.13
3.85
2.56
0.00
1.28
32
11
34.38
15
46.88
0.00
3.13
3.13
0.00
0.00
9.38
3.13
60 1
293
51
17.41
191
65.19
0.00
1.02
35
11.95
0.00
10
3.41
1.02
0.00
57
26
45.61
31
54.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
25
8.00
21
84.00
0.00
4.00
0.00
0.00
4.00
0.00
0.00
III
124
6.45
99
79.84
0.00
0.81
10
8.06
0.00
4.03
0.81
0.00
IV
73
9.59
34
46.58
0.00
1.37
25
34.25
0.00
5.48
2.74
0.00
14
57.14
42.86
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2
3 ()
4
5
- 593 -
FIGO 1
1107
220
19.87
801
72.36
0.00
20
1.81
42
3.79
0.27
13
1.17
0.54
0.18
478
100
20.92
364
76.15
0.00
1.67
0.63
0.00
0.63
0.00
0.00
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IA
36
16
44.44
20
55.56
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IB
50.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IC
22
0.00
22 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
II
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIA
40.00
60.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIB
0.00
5 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIC
0.00
5 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
III
50.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIA
22.22
77.78
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIB
0.00
6 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
IIIC
45
4.44
91.11
0.00
2.22
2.22
0.00
0.00
0.00
0.00
IV
0.00
8 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
482
96
19.92
0.00
11
2.28
38
7.88
0.62
10
2.07
1.24
0.41
316
65.56
41
1 FIGO - 99 FIGO 3
2
3 ()
4
5
- 594 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
18
67
192
344
551
756
766
681
340
3719
0
0
0
0
0
0
0
0
0
0
18
67
192
344
551
756
766
681
340
3719
3719
100.00
3719
100.00
3719
100.00
0
393
1421
481
1233
191
0.00
10.57
38.21
12.93
33.15
5.14
0
30
304
200
134
3051
0.00
0.81
8.17
5.38
3.6
82.04
0
338
1377
594
1243
167
0.00
9.09
37.03
15.97
33.42
4.49
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
0
0
0
0
0
0
0
15
8
1
0
24
0
50
200
26
1
277
0
15
127
47
5
194
0
0
13
4
110
127
0
80
348
78
116
622
Kappa=0.3989
Kappa
- 595 -
1
2
3
4
5
Hyperthermia
3719
574
15.43
100
2.69
0.11
267
7.18
232
6.24
415
11.16
178
4.79
393
84
21.37
13
3.31
0.25
94
23.92
18
4.58
49
12.47
35
8.91
II
1421
364
25.62
50
3.52
0.14
94
6.62
93
6.54
117
8.23
95
6.69
III
481
74
15.38
33
6.86
0.21
1.25
38
7.90
27
5.61
21
4.37
IV
1233
11
0.89
0.24
0.00
14
1.14
69
5.60
194
15.73
23
1.87
191
41
21.47
0.52
0.00
59
30.89
14
7.33
28
14.66
2.09
3719
574
15.43
100
2.69
0.11
267
7.18
232
6.24
415
11.16
178
4.79
30
26
86.67
0.00
0.00
6.67
0.00
6.67
0.00
II
304
289
95.07
0.00
0.00
2.63
0.66
1.64
0.00
III
200
194
97.00
0.50
0.00
0.00
1.50
0.50
0.00
IV
134
21
15.67
0.00
0.00
2.99
14
10.45
16
11.94
0.75
3051
44
1.44
99
3.24
0.13
253
8.29
213
6.98
391
12.82
177
5.80
3719
574
15.43
100
2.69
0.11
267
7.18
232
6.24
415
11.16
178
4.79
338
34
10.06
13
3.85
0.30
91
26.92
18
5.33
47
13.91
35
10.36
II
1377
315
22.88
50
3.63
0.15
99
7.19
94
6.83
117
8.50
95
6.90
III
594
188
31.65
33
5.56
0.17
1.01
38
6.40
28
4.71
21
3.54
IV
1243
15
1.21
0.24
0.00
14
1.13
69
5.55
195
15.69
23
1.85
167
22
13.17
0.60
0.00
57
34.13
13
7.78
28
16.77
2.40
(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90
- 596 -
10
11
692
18.61
1013
27.24
44
1.18
20
0.54
149
4.01
24
0.65
0.19
20
5.09
38
9.67
0.25
1.02
32
8.14
1.02
0.00
269
18.93
255
17.95
0.14
0.14
66
4.64
12
0.84
0.00
157
32.64
104
21.62
0.21
0.00
14
2.91
0.62
0.42
239
19.38
595
48.26
38
3.08
14
1.14
24
1.95
0.32
0.41
3.66
21
10.99
1.05
0.00
13
6.81
0.52
0.00
692
18.61
1013
27.24
44
1.18
20
0.54
149
4.01
24
0.65
0.19
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.50
0.00
0.00
0.00
0.00
0.00
34
25.37
40
29.85
0.75
0.00
0.00
0.75
1.49
658
21.57
972
31.86
43
1.41
20
0.66
149
4.88
23
0.75
0.16
692
18.61
1013
27.24
44
1.18
20
0.54
149
4.01
24
0.65
0.19
20
5.92
38
11.24
0.30
1.18
32
9.47
1.18
0.00
268
19.46
255
18.52
0.15
0.15
66
4.79
12
0.87
0.00
157
26.43
102
17.17
0.17
0.00
14
2.36
0.51
0.34
241
19.39
598
48.11
38
3.06
14
1.13
24
1.93
0.32
0.40
3.59
20
11.98
1.20
0.00
13
7.78
0.60
0.00
6
7 30/
8 ()
9
10
11
- 597 -
0~59 1
Hyperthermia
281
118
41.99
3.20
0.00
2.85
11
3.91
13
4.63
10
3.56
22
40.91
13.64
0.00
4.55
0.00
0.00
18.18
II
105
67
63.81
2.86
0.00
2.86
0.95
2.86
2.86
III
57
36
63.16
5.26
0.00
1.75
3.51
0.00
1.75
IV
89
4.49
0.00
0.00
0.00
7.87
10
11.24
1.12
25.00
0.00
0.00
37.50
12.50
0.00
12.50
60~74 1
1
2
3
4
5
412
24.95
1651
142
21
II
624
225
III
350
IV
Hyperthermia
118
7.15
124
7.51
82
4.97
61
3.69
0.18
91
5.51
14.79
4.93
0.70
30
21.13
6.34
13
9.15
16
11.27
36.06
26
4.17
0.16
34
5.45
45
7.21
31
4.97
46
7.37
139
39.71
25
7.14
0.29
1.14
24
6.86
2.29
13
3.71
472
10
2.12
0.42
0.00
0.42
33
6.99
65
13.77
1.27
63
17
26.98
1.59
0.00
21
33.33
11.11
11.11
1.59
(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90
- 598 -
10
11
42
14.95
56
19.93
0.36
0.00
3.20
1.07
0.36
0.00
0.00
0.00
0.00
18.18
4.55
0.00
12
11.43
10
9.52
0.00
0.00
1.90
0.95
0.00
15.79
3.51
0.00
0.00
3.51
1.75
0.00
21
23.60
43
48.31
1.12
0.00
1.12
0.00
1.12
0.00
12.50
0.00
0.00
0.00
0.00
0.00
351
21.26
320
19.38
15
0.91
10
11
0.30
56
3.39
10
0.61
0.18
13
9.15
16
11.27
0.00
2.11
12
8.45
0.70
0.00
123
19.71
54
8.65
0.00
0.16
32
5.13
0.96
0.00
94
26.86
35
10.00
0.00
0.00
1.43
0.29
0.29
121
25.64
211
44.70
15
3.18
0.21
0.42
0.42
0.42
0.00
6.35
0.00
0.00
7.94
0.00
0.00
1
7 30/
8 ()
9
10
11
- 599 -
75 1
1
2
3
4
5
Hyperthermia
1787
44
2.46
30
1.68
0.06
168
9.40
103
5.76
278
15.56
86
4.81
174
2.30
1.72
0.00
60
34.48
5.17
34
19.54
15
8.62
II
648
23
3.55
21
3.24
0.15
62
9.57
48
7.41
83
12.81
46
7.10
III
187
13
6.95
2.67
0.00
0.53
12
6.42
20
10.70
3.74
IV
682
0.15
0.15
0.00
12
1.76
29
4.25
120
17.60
16
2.35
96
3.13
0.00
0.00
33
34.38
5.21
21
21.88
2.08
(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90
- 600 -
299
16.73
637
35.65
28
1.57
15
0.84
84
4.70
11
0.62
0.17
4.02
22
12.64
0.57
0.57
16
9.20
1.15
0.00
133
20.52
191
29.48
0.31
0.15
32
4.94
0.77
0.00
54
28.88
65
34.76
0.53
0.00
3.74
0.53
0.53
99
14.52
344
50.44
22
3.23
13
1.91
21
3.08
0.29
0.29
6.25
15
15.63
2.08
0.00
8.33
1.04
0.00
11
10
6
7 30/
8 ()
9
10
11
- 601 -
- 602 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
0
0
1
1
2
2
10
14
43
0
0
0
0
0
0
1
7
8
0
0
1
1
2
2
11
21
51
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
73
97
158
147
181
213
281
196
145
1564
26
40
68
60
87
117
96
72
45
627
99
137
226
207
268
330
377
268
190
2191
2191
100.00
2191
100.00
2191
100.00
537
726
346
131
177
274
24.51
33.14
15.79
5.98
8.08
12.51
260
224
108
61
78
1460
11.87
10.22
4.93
2.78
3.56
66.64
639
734
318
139
197
164
29.16
33.5
14.51
6.34
8.99
7.49
0
I
II
III
IV
:-(99 )(AJCC_7th) 1
II
III
IV
II
III
IV
151
28
12
2
3
196
6
161
18
10
0
195
0
9
64
11
3
87
1
5
21
21
5
53
0
3
11
8
47
69
158
206
126
52
58
600
Kappa=0.6548
Kappa
- 603 -
(TURBT)
(TURBT)
(TURBT)
(TURBT)
2191
455
20.77
121
5.52
908
41.44
59
2.69
42
1.92
0.14
70
3.19
537
118
21.97
1.12
295
54.93
0.00
0.37
0.00
0.00
726
118
16.25
22
3.03
337
46.42
0.83
0.69
0.14
0.69
II
346
86
24.86
40
11.56
92
26.59
24
6.94
17
4.91
0.58
24
6.94
III
131
17
12.98
26
19.85
19
14.50
12
9.16
10
7.63
0.00
17
12.98
IV
177
46
25.99
2.82
53
29.94
11
6.21
2.82
0.00
17
9.60
274
70
25.55
22
8.03
112
40.88
2.19
1.09
0.00
2.55
2194
455
20.77
121
5.52
908
41.44
59
2.69
42
1.92
0.14
70
3.19
260
62
23.85
3.46
144
55.38
0.38
0.77
0.00
0.00
224
37
16.52
27
12.05
110
49.11
2.68
0.45
0.45
0.45
II
108
20
18.52
43
39.81
16
14.81
7.41
0.93
0.00
6.48
III
61
3.28
25
40.98
4.92
19
31.15
3.28
1.64
4.92
IV
78
15
19.23
10
12.82
13
16.67
16
20.51
2.56
1.28
10.26
1460
319
21.85
0.48
622
42.60
0.62
34
2.33
0.00
51
3.49
2191
20.77
121
639
144
22.54
1.41
353
55.24
0.16
0.47
0.00
0.00
734
122
16.62
27
3.68
331
45.10
0.68
0.82
0.14
0.54
II
318
83
26.10
44
13.84
80
25.16
2.20
16
5.03
0.00
27
8.49
III
139
16
11.51
25
17.99
19
13.67
21
15.11
11
7.91
0.72
18
12.95
IV
197
51
25.89
10
5.08
52
26.40
17
8.63
2.03
0.51
19
9.64
164
39
23.78
3.66
73
44.51
4.88
1.22
0.00
1.22
455
5.52
908
41.44
59
2.69
42
1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610
- 604 -
1.92
0.14
70
3.19
16
0.73
20
0.91
404
18.44
37
1.69
11
0.50
28
1.28
10
0.46
0.32
0.00
0.00
96
17.88
0.93
0.00
1.12
0.93
0.74
0.00
0.00
210
28.93
13
1.79
0.14
0.69
0.14
0.28
1.45
0.87
44
12.72
1.73
0.00
0.58
0.29
0.00
4.58
2.29
12
9.16
2.29
2.29
1.53
0.00
0.76
2.26
11
6.21
2.82
10
5.65
2.26
2.82
0.56
0.00
0.36
1.09
37
13.50
0.00
1.09
2.92
0.73
0.00
16
0.73
20
0.91
404
18.44
37
1.69
11
0.50
28
1.28
10
0.46
0.32
0.00
0.00
42
16.15
0.00
0.00
0.00
0.00
0.00
0.00
0.00
41
18.30
0.00
0.00
0.00
0.00
0.00
1.85
0.00
11
10.19
0.00
0.00
0.00
0.00
0.00
9.84
0.00
0.00
0.00
0.00
0.00
0.00
0.00
8.97
2.56
2.56
1.28
0.00
1.28
0.00
0.00
0.07
18
1.23
308
21.10
36
2.47
11
0.75
27
1.85
10
0.68
0.48
16
0.73
20
0.91
404
18.44
37
1.69
11
0.50
28
1.28
10
0.46
0.32
0.00
0.00
109
17.06
0.78
0.00
0.94
0.78
0.63
0.00
0.00
216
29.43
13
1.77
0.14
0.68
0.14
0.27
0.63
0.94
47
14.78
1.89
0.00
0.63
0.31
0.00
4.32
2.16
10
7.19
2.16
2.16
1.44
0.00
0.72
3.55
11
5.58
2.54
10
5.08
2.03
2.54
0.51
0.00
0.61
1.83
17
10.37
0.00
1.83
4.88
1.22
0.00
4 01 16 27 p.610
5
6 ()
7
8
9
- 605 -
0~49 1
(TURBT)
(TURBT)
(TURBT)
(TURBT)
188
37
19.68
18
9.57
76
40.43
10
5.32
0.53
0.00
1.60
59
16
27.12
3.39
35
59.32
0.00
0.00
0.00
0.00
73
12.33
8.22
27
36.99
1.37
1.37
0.00
1.37
II
23
30.43
21.74
17.39
8.70
0.00
0.00
4.35
III
0.00
50.00
12.50
25.00
0.00
0.00
12.50
IV
14
21.43
0.00
21.43
35.71
0.00
0.00
0.00
11
18.18
9.09
54.55
0.00
0.00
0.00
0.00
50~69 1
(TURBT)
(TURBT)
(TURBT)
(TURBT)
838
148
17.66
51
6.09
357
42.60
28
3.34
0.36
0.12
25
2.98
285
59
20.70
1.40
154
54.04
0.35
0.00
0.00
0.00
270
37
13.70
14
5.19
119
44.07
0.74
0.37
0.00
0.37
II
110
22
20.00
17
15.45
33
30.00
0.91
1.82
0.00
10
9.09
III
53
7.55
11
20.75
13.21
14
26.42
0.00
0.00
15.09
IV
67
17
25.37
4.48
19
28.36
7.46
0.00
1.49
8.96
53
16.98
3.77
25
47.17
9.43
0.00
0.00
0.00
1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610
- 606 -
2.66
0.53
31
16.49
1.60
0.00
1.06
0.00
0.53
0.00
0.00
8.47
0.00
0.00
0.00
0.00
1.69
0.00
0.00
23
31.51
4.11
0.00
2.74
0.00
0.00
8.70
0.00
8.70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
21.43
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
9.09
9.09
0.00
0.00
0.00
0.00
0.00
0.84
0.72
178
21.24
17
2.03
0.12
10
1.19
0.48
0.24
0.00
0.00
55
19.30
1.05
0.00
1.40
1.40
0.35
0.00
0.00
91
33.70
1.48
0.00
0.00
0.00
0.37
0.00
0.91
21
19.09
2.73
0.00
0.00
0.00
0.00
7.55
1.89
3.77
3.77
0.00
0.00
0.00
0.00
4.48
5.97
2.99
7.46
0.00
2.99
0.00
0.00
0.00
0.00
13.21
0.00
1.89
7.55
0.00
0.00
4 01 16 27 p.610
5
6 ()
7
8
9
- 607 -
70 1
(TURBT)
(TURBT)
(TURBT)
(TURBT)
1165
270
23.18
52
4.46
475
40.77
21
1.80
38
3.26
0.17
42
3.61
295
69
23.39
1.02
164
55.59
0.00
1.02
0.00
0.00
391
76
19.44
1.79
185
47.31
0.51
1.02
0.26
0.51
II
185
54
29.19
22
11.89
43
23.24
2.16
14
7.57
0.00
16
8.65
III
78
12
15.38
10
12.82
11
14.10
6.41
11
14.10
1.28
11.54
IV
116
31
26.72
6.03
30
25.86
6.03
3.45
0.00
13
11.21
100
28
28.00
3.00
42
42.00
3.00
2.00
0.00
2.00
1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610
- 608 -
0.34
13
1.12
195
16.74
17
1.46
10
0.86
16
1.37
0.52
0.34
0.00
0.00
49
16.61
0.68
0.00
0.68
0.34
0.68
0.00
0.00
102
26.09
1.53
0.26
0.77
0.26
0.26
0.00
1.08
24
12.97
1.62
0.00
1.08
0.54
0.00
2.56
2.56
10.26
1.28
3.85
2.56
0.00
1.28
0.86
6.03
2.59
4.31
3.45
2.59
0.86
0.00
1.00
2.00
9.00
0.00
2.00
4.00
2.00
0.00
4 01 16 27 p.610
5
6 ()
7
8
9
- 609 -
Bladder
C670C679
(Except for M9727, 9733, 9741-9742, 9764-9809, 9832, 9840-9931, 9945-9946, 9950-9967, 9975-9992)
Codes
00 None; no surgery of primary site; autopsy ONLY
10 Local tumor destruction, NOS
11 Photodynamic therapy (PDT)
12 Electrocautery; fulguration (includes use of hot forceps for tumor destruction)
13 Cryosurgery
14 Laser
15 Intravesical therapy
16 Bacillus Calmette-Guerin (BCG) or other immunotherapy
[SEER NoteCode BCG as both surgery and immunotherapy]
30
50
60
For females, includes removal of bladder, uterus, ovaries, entire vaginal wall, and entire urethra.
For males, includes removal of the prostate. When a procedure is described as a pelvic
exenteration for males, but the prostate is not removed, the surgery should be coded as a
cystectomy (code 60-64).
72 Posterior exenteration
For females, also includes removal of vagina, rectum and anus. For males, also includes
prostate, rectum and anus.
73 Total exenteration
Includes all tissue and organs removed for an anterior and posterior
exenteration. [SEER NoteIncludes removal of all pelvic contents and pelvic lymph nodes. The
lymph node dissection should also be coded under Scope of Regional Lymph Node Surgery (
#4.16 or 4.17).]
74 Extended exenteration
Includes pelvic blood vessels and/or bony pelvis
80 Cystectomy, NOS
Specimen sent to pathology from surgical events 20-80.
90 Surgery, NOS
99 Unknown if surgery performed; death
- 610 -
00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44
8
10
22
25
26
37
38
41
43
3
5
4
13
20
47
36
32
45
11
15
26
38
46
84
74
73
88
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85
66
88
118
94
104
111
118
92
76
1117
51
73
85
83
78
89
92
59
37
852
117
161
203
177
182
200
210
151
113
1969
Ann Arbor 1
1
1A
1B
1E
2
2A
2B
2E
3
3A
3B
3E
3S
4
4A
4B
B T/NK
156
100.00
1425
100.00
265
100.00
123
100.00
7
2
0
0
34
7
3
0
14
2
3
0
0
24
1
2
57
4.49
1.28
0.00
0.00
21.79
4.49
1.92
0.00
8.97
1.28
1.92
0.00
0.00
15.38
0.64
1.28
36.54
150
14
2
13
172
21
3
10
166
31
7
3
1
238
22
14
558
10.53
0.98
0.14
0.91
12.07
1.47
0.21
0.70
11.65
2.18
0.49
0.21
0.07
16.70
1.54
0.98
39.16
15
1
2
6
23
4
2
1
33
2
6
2
0
53
3
2
110
5.66
0.38
0.75
2.26
8.68
1.51
0.75
0.38
12.45
0.75
2.26
0.75
0.00
20.00
1.13
0.75
41.51
12
0
0
1
6
2
1
0
8
1
3
1
0
31
1
2
54
9.76
0.00
0.00
0.81
4.88
1.63
0.81
0.00
6.50
0.81
2.44
0.81
0.00
25.20
0.81
1.63
43.90
1 99 4
- 611 -
Ann Arbor 1
1969
90
4.57
26
1.32
25
1.27
197
10.01
219
11.12 49
2.49 1106
56.17
36
1.83
156
7.92
23
1.17
42
2.13
184
21
11.41
1.63
11
5.98
26
14.13
30
16.30 16
8.70
51
27.72
2.17
18
9.78
1.09
1.09
1A
17
5.88
0.00
0.00
41.18
5.88
11.76
29.41
0.00
5.88
0.00
0.00
1B
25.00
0.00
0.00
0.00
25.00
25.00
25.00
0.00
0.00
0.00
0.00
1E
20
5.00
5.00
10.00
15.00
20.00
0.00
30.00
0.00
15.00
0.00
0.00
235
2.55
2.13
0.85
33
14.04
40
17.02
1.70
122
51.91
1.28
16
6.81
0.85
0.85
2A
34
5.88
0.00
0.00
11.76
8.82
2.94
20
58.82
0.00
2.94
2.94
5.88
2B
0.00
11.11
0.00
0.00
11.11
0.00
66.67
0.00
0.00
0.00
11.11
2E
11
0.00
18.18
0.00
36.36
9.09
0.00
27.27
0.00
0.00
9.09
0.00
221
2.26
0.90
0.45
11
4.98
21
9.50
0.90
153
69.23
0.90
18
8.14
0.90
1.81
3A
36
0.00
0.00
0.00
16.67
5.56
0.00
26
72.22
0.00
5.56
0.00
0.00
3B
19
0.00
0.00
0.00
10.53
0.00
0.00
14
73.68
0.00
15.79
0.00
0.00
3E
16.67
0.00
16.67
16.67
0.00
0.00
33.33
16.67
0.00
0.00
0.00
3S
0.00
0.00
0.00
0.00
0.00
0.00
1 100.00
0.00
0.00
0.00
0.00
346
1.45
0.87
0.00
20
5.78
32
9.25
1.45
241
69.65
17
4.91
15
4.34
0.87
1.45
4A
27
0.00
0.00
0.00
7.41
3.70
0.00
19
70.37
0.00
11.11
7.41
0.00
4B
20
5.00
0.00
0.00
5.00
15.00
0.00
15
75.00
0.00
0.00
0.00
0.00
779
46
5.91
1.16
1.03
77
9.88
79
10.14 18
2.31
421
54.04
1.16
76
9.76
10
1.28
26
3.34
1 99 4
2
3 ()
4
5
6
- 612 -
0~39 Ann Arbor 1
367
20
5.45
1.09
1.91
37
10.08
82
22.34
30
16.67
0.00
16.67
10.00
26.67
10.00
1A
0.00
0.00
0.00
20.00
0.00
1B
0.00
0.00
0.00
0.00
0.00
1E
25.00
0.00
0.00
0.00
60
0.00
0.00
0.00
10.00
2A
10
10.00
0.00
0.00
2B
0.00
20.00
0.00
2E
0.00
0.00
29
0.00
3.45
3A
0.00
3B
0.00
3E
3S
50.68
0.00
15
4.09
0.82
1.63
16.67
0.00
3.33
0.00
0.00
0.00
80.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
25.00
0.00
50.00
0.00
0.00
0.00
0.00
23
38.33
0.00
31
51.67
0.00
0.00
0.00
0.00
0.00
20.00
0.00
70.00
0.00
0.00
0.00
0.00
0.00
20.00
0.00
40.00
0.00
0.00
0.00
20.00
0.00
50.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.45
24.14
0.00
20
68.97
0.00
0.00
0.00
0.00
0.00
0.00
42.86
14.29
0.00
42.86
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2 100.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
41
0.00
0.00
0.00
7.32
10
24.39
4.88
23
56.10
0.00
2.44
2.44
2.44
4A
0.00
0.00
0.00
0.00
0.00
0.00
2 100.00
0.00
0.00
0.00
0.00
4B
0.00
0.00
0.00
0.00
0.00
0.00
2 100.00
0.00
0.00
0.00
0.00
168
13
7.74
1.19
1.19
19
11.31
28
16.67
1.19
0.00
13
7.74
1.19
2.38
1.91 186
83
49.40
1 99 4
2
3 ()
4
5
6
- 613 -
40~59 Ann Arbor 1
569
24
4.22
1.58
1.23
67
11.78
67
11.78
13
65
9.23
1.54
3.08
14
21.54
14
21.54
10.77
1A
0.00
0.00
0.00
50.00
16.67
16.67
1B
0.00
0.00
0.00
0.00
0.00
1E
0.00
11.11
22.22
22.22
22.22
54
3.70
1.85
0.00
16.67
2A
0.00
0.00
0.00
28.57
2B
0.00
0.00
0.00
2E
0.00
20.00
0.00
48
2.08
0.00
3A
11
0.00
0.00
3B
0.00
3E
33.33
3S
119
4A
4B
2.28 323
56.77
0.53
43
7.56
1.05
1.23
14
21.54
0.00
7.69
1.54
1.54
0.00
0.00
16.67
0.00
0.00
0.00
1 100.00
0.00
0.00
0.00
0.00
0.00
11.11
0.00
11.11
0.00
0.00
12.96
0.00
29
53.70
1.85
5.56
3.70
0.00
14.29
0.00
42.86
0.00
0.00
0.00
14.29
0.00
0.00
0.00
2 100.00
0.00
0.00
0.00
0.00
40.00
0.00
0.00
40.00
0.00
0.00
0.00
0.00
0.00
4.17
12.50
0.00
32
66.67
0.00
12.50
0.00
2.08
0.00
18.18
9.09
0.00
72.73
0.00
0.00
0.00
0.00
0.00
0.00
25.00
0.00
0.00
75.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
66.67
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.52
1.68
0.00
5.88
11
9.24
0.00
93
78.15
0.00
2.52
0.00
0.00
10
0.00
0.00
0.00
10.00
0.00
0.00
70.00
0.00
0.00
2 20.00
0.00
14.29
0.00
0.00
14.29
14.29
0.00
57.14
0.00
0.00
0.00
0.00
218
10
4.59
1.38
1.38
21
9.63
23
10.55
2.29 122
55.96
0.92
24
11.01
0.46
1.83
1 99 4
2
3 ()
4
5
6
- 614 -
60 Ann Arbor 1
6.78 29
2.81
597
57.79
33
3.19
98
9.49
14
1.36
29
2.81
1033
46
4.45
13
1.26
11
1.06
93
9.00
70
89
10
11.24
2.25
4.49
10.11
8.99
6.74
32
35.96
4.49
12
13.48
1.12
1.12
1A
16.67
0.00
0.00
50.00
0.00
16.67
16.67
0.00
0.00
0.00
0.00
1B
33.33
0.00
0.00
0.00
33.33
33.33
0.00
0.00
0.00
0.00
0.00
1E
0.00
0.00
0.00
14.29
14.29
0.00
42.86
0.00
28.57
0.00
0.00
121
3.31
3.31
1.65
18
14.88
10
8.26
3.31
62
51.24
1.65
13
10.74
0.00
1.65
2A
17
5.88
0.00
0.00
11.76
0.00
5.88
10
58.82
0.00
5.88
5.88
5.88
2B
0.00
0.00
0.00
0.00
0.00
0.00
2 100.00
0.00
0.00
0.00
0.00
2E
0.00
25.00
0.00
25.00
0.00
0.00
25.00
0.00
0.00
1 25.00
0.00
144
2.78
0.69
0.69
5.56
5.56
1.39
101
70.14
1.39
12
8.33
1.39
2.08
3A
18
0.00
0.00
0.00
5.56
0.00
0.00
15
83.33
0.00
11.11
0.00
0.00
3B
13
0.00
0.00
0.00
7.69
0.00
0.00
69.23
0.00
23.08
0.00
0.00
3E
0.00
0.00
33.33
33.33
0.00
0.00
0.00
33.33
0.00
0.00
0.00
3S
0.00
0.00
0.00
0.00
0.00
0.00
1 100.00
0.00
0.00
0.00
0.00
186
1.08
0.54
0.00
10
5.38
11
5.91
1.61
125
67.20
17
9.14
11
5.91
1.08
2.15
4A
15
0.00
0.00
0.00
6.67
6.67
0.00
10
66.67
0.00
20.00
0.00
0.00
4B
11
0.00
0.00
0.00
0.00
18.18
0.00
81.82
0.00
0.00
0.00
0.00
393
23
5.85
1.02
0.76
37
9.41
28
7.12
11
2.80
216
54.96
1.78
39
9.92
1.78
18
4.58
1 99 4
2
3 ()
4
5
6
- 615 -